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Abstract 
The modification of surfaces has been a key aspect in biology and biotechnology, for applications 
including cell expansion, biomaterials development and preparation of substrates for regenerative 
medicine. In this thesis, the layer-by-layer (LbL) technique was employed in the modification of surfaces 
for multiple purposes, namely for films with improved adhesiveness, enhanced cell adhesion, drug 
delivery capsules, and magnetic spatial positioning. The working hypothesis was that LbL could be used 
in the modification of surfaces not only planar but also three-dimensional, using solely polymeric 
materials from a variety of natural origins or obtained by recombinant routes. 
Herein, chitosan (CHI), a well-known polycation with marine origins, was used recurrently as an 
ingredient in various multilayer formulations, driven by intermolecular forces such as electrostatic and 
hydrophobic interactions. First, multilayer coatings of CHI and an adhesive bacterial exopolysaccharide, 
levan, were fabricated. As a control, CHI and alginate films – two marine polysaccharides often 
regarded as good natural adhesives – were assembled in parallel. The adhesive strength of 50 
CHI/levan bilayers was determined to be about 3 times higher than the control. The adhesion of L929 
cells was also higher in levan-based films. 
Next, CHI was used along polyanionic elastin-like recombinamers (ELRs), a recombinant class of 
elastin-like polymers, exhibiting the cell adhesion motif arginine-glycine-aspartic acid (RGD). Although 
electrostatic interactions were relied upon to construct LbL coatings, they were not the sole mechanism 
of buildup between CHI and ELRs. The film construction of CHI and one of nine ELRs differing in amino 
acid content, length and biofunctionality was followed in situ at pH 4.0 and 5.5 using a quartz-crystal 
microbalance. Their thicknesses were estimated using the Voigt-based model for viscoelastic films, 
revealing that thicker films were obtained in the presence of hydrophobic interactions between ELRs 
and partially neutralized chitosan, i.e., when the pH was adjusted to 5.5, near its pKa. ELR/alginate 
coatings were also monitored, completing a total of 36 combinations studied. The results agreed with 
the ones from the CHI-based films: thicker films were obtained for partially neutralized alginate, at a pH 
value of 4.0. 
Bidimensional coatings of CHI and CHI/ELR-RGD were demonstrated to be stimuli-responsive by means 
of wettability measurements: they exhibited a moderate hydrophobic surface but switched to an 
extremely hydrophilic one when temperature, pH or ionic strength were raised above 50ºC, 11, or 
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1.25 M, respectively. The presence of RGD enhanced the adhesion of SaOs-2 cells, in comparison to 
films ending either in CHI or a nonbioactive RDG analogue. 
CHI/ELR-RGD coatings were extrapolated to the third dimension as spherical microcapsules assembled 
around calcium carbonate particles. Aiming at drug administration, two mechanisms were studied: 
(i) simple diffusion out of the microcapsules, and (ii) cellular uptake. In the first case, release studies at 
25 and 37°C with “bovine serum albumin”-loaded microcapsules demonstrated that they provided a 
sustained release over 14 days, but with reduced capsule permeability at physiological temperature, 
due to the temperature-induced molecular transition of ELRs. Furthermore, a higher numbers of layers 
provided an added barrier to the diffusion of the encapsulated protein. The microcapsules were also 
noncytotoxic towards L929 cells. In the second case, the internalization efficacy and intracellular traffic 
of RGD- or nonbioactive RDG-functionalized microcapsules by human mesenchymal stem cells (hMSCs) 
was assessed. The data suggests that microcapsules were internalized mainly through 
macropinocytosis and that surface functionalization did not play a significant role on this phenomenon, 
although intracellular processing was faster for RGD-functionalized microcapsules. Both microcapsule 
types were noncytotoxic toward hMSCs for microcapsule/cell ratios between 5:1 and 100:1. 
Finally, inspired by the complex hierarchical and compartmentalized structure of cells, liquefied alginate 
macroscopic spheres coated with a chitosan/alginate shell were conceived. Within this liquefied 
environment, rhodamine and multilayer microcapsules were confined, with the latter encapsulating 
further either rhodamine or magnetic nanoparticles (MNPs). At 25 and 37ºC, rhodamine when 
encapsulated within the inner microcapsules showed a sustained release profile, with the diffusion 
kinetics being even more reduced at 25ºC. The release of rhodamine encapsulated in the outer 
liquefied alginate compartment did not show significant differences as a function of temperature. 
Encapsulating MNPs within the microcapsules provided magnetic responsiveness to the whole 
compartmentalized device and guided mobility capability. 
The developed work shows that LbL is a versatile technique that provides the means to develop a wide 
array of systems useful in biomedical applications, from adhesive and cell seeding planar supports to 
three dimensional structures for smart drug delivery, guided therapies and customized microreactors as 
disease models and microtissue production in laboratory. 
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Resumo 
A modificação de superfícies tem sido um aspeto fundamental em biologia e biotecnologia, em 
aplicações como a expansão de células, desenvolvimento de biomateriais e preparação de substratos 
para medicina regenerativa. Neste trabalho, a técnica de camada-a-camada foi utilizada na modificação 
de superfícies para vários fins, como filmes com adesividade e adesão celular melhoradas, cápsulas 
para administração de drogas, e o posicionamento espacial magnético. A hipótese foi a de que esta 
técnica poderia ser utilizada na modificação de superfícies planares ou tridimensionais, usando 
exclusivamente polímeros obtidos de várias origens naturais ou a partir de vias recombinantes. 
O quitosano (CHI), um reconhecido policatião com origens marinhas, foi recorrentemente utilizado 
como ingrediente em várias formulações de multicamadas, impulsionado por forças intermoleculares, 
tais como interações eletrostáticas e hidrofóbicas. Primeiro, revestimentos de CHI e um 
exopolissacarídeo bacteriano adesivo, levano, foram construídos. Como controlo, foram comparados 
com filmes de CHI e alginato – polissacarídeos marinhos considerados bons adesivos naturais. A força 
adesiva de 50 bicamadas de CHI/levano foi determinada como sendo cerca de 3 vezes mais elevada 
do que o controlo. A adesão de células L929 foi também maior em filmes contendo levano. 
Em seguida, CHI foi utilizado juntamente com recombinâmeros tipo-elastina (ELRs), uma classe de 
polímeros tipo-elastina, exibindo a sequência de adesão celular “arginina-glicina-ácido aspártico” (RGD). 
Embora interações eletrostáticas tenham sido invocadas para a construção de multicamadas 
auto-organizadas, estas não foram o único mecanismo de interação entre CHI e ELRs. A construção de 
filmes de CHI e um de nove ELRs diferentes em conteúdo aminoacídico, tamanho e biofuncionalidade 
foi monitorizado in situ a pH 4.0 e 5.5 utilizando uma microbalança de cristais de quartzo. As suas 
espessuras foram estimadas usando o modelo de Voigt para filmes viscoelásticos, revelando que os 
filmes mais espessos foram obtidos na presença de interações hidrofóbicas entre ELRs e CHI 
parcialmente neutralizado, isto é, quando o pH foi ajustado para 5.5, próximo do seu pKa. Filmes de 
ELR/alginato também foram monitorados, completando um total de 36 combinações estudadas. Os 
resultados obtidos estiveram em concordância com os dados dos filmes baseados em CHI: filmes mais 
espessos foram obtidos para alginato parcialmente neutralizado, a um valor de pH de 4.0. 
Através de medições de ângulos de contato, demonstrou-se que os revestimentos bidimensionais de 
CHI e ELR-RGD eram responsivos a estímulos: exibiram uma superfície moderadamente hidrofóbica 
mas converteram-se em extremamente hidrofílicas quando se aumentou a temperatura, o pH ou força 
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iónica acima de 50ºC, 11, ou 1,25 M, respetivamente. A presença de RGD melhorou a adesão de 
células SaOs-2, em comparação com filmes terminados ou em CHI ou num análogo não bioativo, RDG. 
Os revestimentos de CHI/ELR-RGD foram extrapolados para a terceira dimensão sob a forma de 
microcápsulas esféricas construídas em torno de partículas de carbonato de cálcio. Com a finalidade 
de administração de drogas, foram estudados dois mecanismos: (i) a difusão simples para o exterior 
das microcápsulas e (ii) a incorporação celular. No primeiro caso, estudos de libertação a 25 e 37°C 
com microcápsulas contendo albumina do soro bovino demonstraram uma libertação sustentada ao 
longo de 14 dias, mas sendo as cápsulas menos permeáveis a uma temperatura fisiológica, devido à 
transição molecular dos ELRs induzida pela temperatura. Além disso, um número mais elevado de 
camadas proporcionou uma barreira adicional à difusão da proteína encapsulada. As microcápsulas 
foram também não citotóxicas para células L929. No segundo caso, a eficácia de internalização e 
tráfego intracelular de microcápsulas funcionalizadas com RGD ou a sequência não bioativa RDG por 
células estaminais mesenquimais humanas (hMSCs) foi avaliada. Os dados sugerem que as 
microcápsulas foram internalizadas principalmente através de macropinocitose, e que a 
funcionalização da superfície não desempenhou um papel significativo neste fenómeno, embora o 
processamento intracelular tenha sido mais rápido para microcápsulas funcionalizadas com RGD. 
Ambos os tipos de microcápsulas foram não citotóxicas para hMSCs para rácios de 
microcápsula/célula entre 5:1 e 100:1. Finalmente, com inspiração na hierarquia complexa e estrutura 
compartimentada das células, esferas macroscópicas de alginato liquefeito revestidas com camadas de 
CHI/alginato foram concebidas. Dentro deste ambiente liquefeito, rodamina e microcápsulas foram 
confinadas, com estas últimas podendo conter ou mais rodamina ou nanopartículas magnéticas 
(MNPs). A 25 e 37ºC, rodamina quando encapsulada no interior de microcápsulas mostrou um perfil 
de libertação sustentada, sendo a cinética de difusão ainda mais reduzida a 25°C. A libertação de 
rodamina encapsulada no compartimento externo de alginato não exibiu diferenças significativas em 
função da temperatura. MNPs encapsuladas dentro das microcápsulas providenciaram resposta 
magnética a todo o dispositivo compartimentado e capacidade de mobilidade dirigida. 
O trabalho aqui desenvolvido mostra que a técnica de modificação camada-a-camada é uma técnica 
versátil capaz de fornecer meios para desenvolver uma ampla gama de sistemas úteis em aplicações 
biomédicas, desde suportes planos adesivos e para adesão celular até estruturas tridimensionais para 
a administração “inteligente” de drogas, terapias guiadas e microreatores personalizados para o 
desenvolvimento de modelos de doenças e produção de microtecidos em laboratório. 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xi 
Table of Contents 
Acknowledgements............................................................................................................ v 
Abstract ........................................................................................................................... vii 
Resumo ............................................................................................................................ ix 
Table of Contents ............................................................................................................. xi 
List of Abbreviations and Acronyms .............................................................................. xxiii 
List of Figures .............................................................................................................. xxix 
List of Tables ................................................................................................................. xliii 
List of Publications ......................................................................................................... xlv 
Introduction to the thesis format ...................................................................................... li 
 
SECTION I – GENERAL INTRODUCTION 
Chapter 1. Nanostructured devices produced by layer-by-layer self-assembly adsorption 
for tissue engineering applications ................................................................................... 3 
Abstract ............................................................................................................................ 3 
1.1 Introduction ....................................................................................................................... 5 
1.2 Interaction between biomaterials as ingredients for multilayer formulations ......................... 6 
1.2.1 Buildup mechanisms of synthetic and inorganic materials .............................................. 7 
1.2.2 Natural-based polymeric materials ................................................................................. 9 
1.3 Scalability to three dimensions ......................................................................................... 12 
1.3.1 Membranes ................................................................................................................. 12 
1.3.2 Capsules ..................................................................................................................... 13 
1.3.3 Tubes .......................................................................................................................... 14 
1.3.4 Three-dimensional scaffolds ......................................................................................... 15 
1.4 Application of nanostructured multilayer devices in tissue engineering .............................. 15 
1.4.1 Controlling cell adhesion and proliferation .................................................................... 16 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xii 
1.4.2 Controlling cellular metabolism: encapsulation and differentiation ................................. 17 
1.4.3 Biomimetic and “intelligent” and substrates ................................................................. 19 
1.4.4 Multilayers in controlled drug delivery ........................................................................... 21 
1.4.5 Biomineralized multilayers ........................................................................................... 22 
1.5 Conclusion....................................................................................................................... 23 
1.6 References ...................................................................................................................... 24 
Chapter 2. Polyelectrolyte multilayered assemblies in biomedical technologies ............. 37 
Abstract .......................................................................................................................... 37 
2.1 Introduction ..................................................................................................................... 39 
2.2 Fundamentals of the layer-by-layer technique.................................................................... 41 
2.2.1 Layer-by-Layer as a tool for surface modification ........................................................... 41 
2.2.2 Moving LbL toward faster production ............................................................................ 42 
2.3 Surfaces with specialized properties ................................................................................. 44 
2.3.1 Surfaces containing adhesive constituents .................................................................... 44 
2.3.2 Mineralization control ................................................................................................... 45 
2.3.3 Stimuli-responsive surfaces .......................................................................................... 48 
2.4 Coating of implantable devices ......................................................................................... 49 
2.4.1 Coating of synthetic implantable devices ...................................................................... 50 
2.4.2 Cells as supports for the assembly of multilayer coatings .............................................. 53 
2.5 Engineering biomedical devices ........................................................................................ 54 
2.5.1 Construction of films for wound healing ........................................................................ 54 
2.5.1.1 Development of nanostructured substrate-free membranes .................................. 54 
2.5.1.2 Healing of tissue defects in vivo ........................................................................... 56 
2.5.2 Multilayer coatings for enhanced cell adhesion on flat surfaces ..................................... 57 
2.5.3 Multilayer reservoirs for drug loading and delivery ......................................................... 59 
2.5.3.1 Films loaded with active agents ........................................................................... 59 
2.5.3.2 Polyelectrolyte capsules with tunable permeability ................................................ 60 
2.5.3.3 Capsules for the intracellular delivery of encapsulated agents ............................... 63 
2.5.4 Biosensors .................................................................................................................. 65 
2.5.5 Implantable structural devices with tubular shape ......................................................... 68 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xiii 
2.5.6 Compartmentalized environments ................................................................................ 71 
2.5.6.1 Confined enzymatic reactions .............................................................................. 72 
2.5.6.2 Customizable environments with multifunctional components .............................. 74 
2.6 Engineering tissues in vitro ............................................................................................... 75 
2.6.1 Three-dimensional porous structures ............................................................................ 75 
2.6.2 Cells as components in the LbL construction ................................................................ 78 
2.6.3 Production of microtissues in confined environments .................................................... 80 
2.7 Conclusions ..................................................................................................................... 82 
2.8 References ...................................................................................................................... 83 
Chapter 3. Elastin-like macromolecules ........................................................................ 103 
3.1 General introduction ....................................................................................................... 103 
3.2 Materials engineering – an overview on synthetic and natural biomaterials ...................... 104 
3.3 Elastin as a source of inspiration for nature-inspired polymers ........................................ 104 
3.3.1 Genetic coding ........................................................................................................... 105 
3.3.2 Characteristics of elastin ............................................................................................ 106 
3.3.3 Elastin disorders ........................................................................................................ 107 
3.3.4 Current applications of elastin as biomaterials ............................................................ 108 
3.3.4.1 Skin .................................................................................................................. 108 
3.3.4.2 Vascular constructs ........................................................................................... 109 
3.4 Nature-inspired biosynthetic elastins ............................................................................... 110 
3.4.1 General properties of elastin-like recombinamers ........................................................ 110 
3.4.2 The principle of genetic engineering – a powerful tool for engineering materials .......... 111 
3.4.3 From genetic construction to molecules with tailored bio-functionality ......................... 113 
3.4.4 Biocompatibility of ELRs ............................................................................................. 115 
3.5 ELRs as advanced materials for biomedical applications ................................................. 115 
3.5.1 Tissue engineering ..................................................................................................... 115 
3.5.2 Drug- and gene- delivery ............................................................................................. 118 
3.5.3 Surface engineering ................................................................................................... 120 
3.6 Conclusions ................................................................................................................... 122 
3.7 Acknowledgements ........................................................................................................ 123 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xiv 
3.8 References .................................................................................................................... 123 
Chapter 4. Stimuli-responsive surfaces for biomedical applications ............................. 139 
4.1 Introduction ................................................................................................................... 139 
4.2 Surface modification methodologies: how to render substrates with stimuli responsiveness
 140 
4.2.1 Self-assembled monolayers ........................................................................................ 140 
4.2.2 Thin polymer network films ........................................................................................ 142 
4.2.3 Grafting ..................................................................................................................... 143 
4.2.4 Layer-by-layer ............................................................................................................ 144 
4.3 Exploitable stimuli and model smart biomaterials ........................................................... 146 
4.3.1 Physical stimuli .......................................................................................................... 146 
4.3.1.1 Temperature ..................................................................................................... 146 
4.3.1.2 Light ................................................................................................................. 148 
4.3.2 Chemical stimuli ........................................................................................................ 149 
4.3.2.1 pH .................................................................................................................... 149 
4.3.2.2 Ionic strength .................................................................................................... 150 
4.3.3 Biochemical stimuli.................................................................................................... 150 
4.3.3.1 Antigens ............................................................................................................ 150 
4.3.3.2 Enzymes ........................................................................................................... 151 
4.3.3.3 Glucose ............................................................................................................. 151 
4.3.4 Multiple responsive surfaces ...................................................................................... 151 
4.4 Biomedical applications of smart surfaces ...................................................................... 152 
4.4.1 Smart coatings for tissue engineering, regenerative medicine and drug delivery 
applications............................................................................................................................ 152 
4.4.2 Smart biomineralization ............................................................................................. 155 
4.4.3 Cell sheet engineering ................................................................................................ 156 
4.5 Conclusions ................................................................................................................... 157 
4.6 Acknowledgements ........................................................................................................ 157 
4.7 References .................................................................................................................... 158 
 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xv 
SECTION II – EXPERIMENTAL SECTION 
Chapter 5. Materials and methods ............................................................................... 173 
5.1 Materials ....................................................................................................................... 173 
5.1.1 Polysaccharides ......................................................................................................... 173 
5.1.1.1 Microbial levan production ................................................................................. 175 
5.1.1.2 Levan phosphonate modification ........................................................................ 176 
5.1.2 ELR expression and purification ................................................................................. 176 
5.1.3 Synthesis of magnetic nanoparticles ........................................................................... 179 
5.2 Characterization of the materials .................................................................................... 179 
5.2.1 Degree of deacetylation of chitosan ............................................................................ 179 
5.2.2 Phosphonate-levan modification assessment .............................................................. 180 
5.2.3 Elastin-like recombinamers bioproduction assessment ................................................ 181 
5.2.4 Magnetization of MNPs .............................................................................................. 181 
5.2.5 Measurement of charges ........................................................................................... 182 
5.2.6 Temperature responsiveness of the polymers ............................................................. 183 
5.3 Assessment of LbL films’ growth .................................................................................... 184 
5.3.1 In situ monitoring....................................................................................................... 184 
5.3.2 Estimation of films’ thicknesses ................................................................................. 185 
5.4 Assembly and characterization of multilayer films ........................................................... 186 
5.4.1 In planar substrates ................................................................................................... 186 
5.4.1.1 Adhesiveness of the films .................................................................................. 187 
5.4.1.2 Contact angle measurements ............................................................................ 187 
5.4.1.3 Surface topography ........................................................................................... 189 
5.4.2 In three dimensional substrates ................................................................................. 189 
5.4.2.1 Preparation of spherical microparticle templates ................................................ 189 
5.4.2.2 Construction of the multilayer shells .................................................................. 190 
5.4.2.3 Compartmentalized structures ........................................................................... 191 
5.4.2.4 Encapsulation losses and pre-loading efficiency .................................................. 193 
5.4.2.5 Microscopy evaluation of the structures ............................................................. 193 
5.5 In vitro release studies from three-dimensional capsules ................................................. 194 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xvi 
5.6 Mechanical resistance of compartmental units ............................................................... 195 
5.7 Magnetic responsiveness assays .................................................................................... 195 
5.8 In vitro biological studies ................................................................................................ 196 
5.8.1 Cell seeding ............................................................................................................... 196 
5.8.2 Staining of cells adhered to bidimensional surfaces .................................................... 197 
5.8.3 Cellular uptake of three dimensional microcapsules ................................................... 198 
5.8.4 Cell metabolism and viability ...................................................................................... 199 
5.8.5 Alkaline phosphatase assays ...................................................................................... 200 
5.9 References .................................................................................................................... 201 
 
SECTION III – OPTIMIZATION OF LAYER-BY-LAYER STRATEGIES FOR BIOMEDICAL 
APPLICATIONS 
Chapter 6. Adhesive nanostructured multilayer films using a bacterial exopolysaccharide 
for biomedical applications .......................................................................................... 209 
Abstract ........................................................................................................................ 209 
6.1 Introduction ................................................................................................................... 211 
6.2 Experimental section ...................................................................................................... 213 
6.2.1 Materials ................................................................................................................... 213 
6.2.2 Microbial levan production ......................................................................................... 213 
6.2.3 Phosphonate modification of levan ............................................................................. 214 
6.2.4 Measurement of charges ........................................................................................... 214 
6.2.5 Construction of hybrid self-assembled films ................................................................ 214 
6.2.6 Estimation of the films’ thicknesses............................................................................ 215 
6.2.7 Preparation of hybrid multilayer films ......................................................................... 215 
6.2.8 Adhesiveness of the films ........................................................................................... 215 
6.2.9 In vitro cell culture ..................................................................................................... 216 
6.2.10 Nuclei-staining fluorescence assay ............................................................................. 216 
6.3 Results and Discussion .................................................................................................. 216 
6.4 Conclusions ................................................................................................................... 223 
6.5 Acknowledgements ........................................................................................................ 224 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xvii 
6.6 References .................................................................................................................... 224 
Chapter 7. Layer-by-layer film-growth using polysaccharides and recombinant 
polypeptides: a combinatorial approach ....................................................................... 229 
Abstract ........................................................................................................................ 229 
7.1 Introduction ................................................................................................................... 231 
7.2 Experimental section ...................................................................................................... 233 
7.2.1 Materials ................................................................................................................... 233 
7.2.2 Assessment of the ELR compositions ......................................................................... 234 
7.2.3 Measurement of the charges ...................................................................................... 234 
7.2.4 Construction of hybrid self-assembled films ................................................................ 234 
7.2.5 Estimation of the film thicknesses .............................................................................. 234 
7.3 Results and discussion ................................................................................................... 235 
7.3.1 Characterization of the polysaccharides and ELRs ...................................................... 235 
7.3.2 Effect of the charged state by means of the ζ-potential ............................................... 237 
7.3.3 QCM-D data acquisition ............................................................................................. 240 
7.3.4 Data modeling and thickness analysis ........................................................................ 242 
7.3.5 Effect of molecular weight .......................................................................................... 245 
7.3.6 General model for hybrid multilayer growth ................................................................ 247 
7.4 Conclusions ................................................................................................................... 248 
7.5 Supplemental information .............................................................................................. 248 
7.5.1 Neutralization of V84 ................................................................................................. 248 
7.5.2 Amino acid composition ............................................................................................. 249 
7.5.3 Molecular weight........................................................................................................ 251 
7.5.4 ζ-potential and molecular weight effect on thickness: .................................................. 256 
7.5.5 QCM-D acquisition graphics and Voigt-based model fitting result ................................. 256 
7.6 Acknowledgements ........................................................................................................ 266 
7.7 References .................................................................................................................... 266 
Chapter 7 – Appendix. Nanostructured thin coatings from chitosan and an elastin-like 
recombinamer with acute stimuli-responsive behavior.................................................. 271 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xviii 
Abstract ........................................................................................................................ 271 
7A.1 Introduction ....................................................................................................................... 273 
7A.2 Experimental section .......................................................................................................... 273 
7A.2.1 ELRs expression and purification ................................................................................. 273 
7A.2.2 Buildup kinetics monitoring ........................................................................................ 274 
7A.2.3 Contact angle measurements ...................................................................................... 274 
7A.2.4 Topography studies ..................................................................................................... 274 
7A.3 Results and discussion ....................................................................................................... 275 
7A.3.1 ELRs peptide sequence ............................................................................................... 275 
7A.3.2 Buildup monitoring of the films .................................................................................... 275 
7A.3.3 Wettability variations of the films ................................................................................. 277 
7A.3.4 Topography analysis ................................................................................................... 278 
7A.4 Conclusions ....................................................................................................................... 279 
7A.5 Acknowledgements ............................................................................................................ 280 
7A.6 References ......................................................................................................................... 280 
Chapter 8. Layer-by-layer assembly of chitosan and recombinant biopolymers into 
biomimetic coatings with multiple stimuli-responsive properties .................................. 283 
Abstract ........................................................................................................................ 283 
8.1 Introduction ................................................................................................................... 285 
8.2 Experimental section ...................................................................................................... 287 
8.2.1 ELR-RGD expression and purification .......................................................................... 287 
8.2.2 ELR-RGD characterization .......................................................................................... 287 
8.2.3 Buildup and characterization of the self-assembled coatings ....................................... 288 
8.2.4 Contact-angle measurements ..................................................................................... 288 
8.2.5 Atomic force microscopy measurements .................................................................... 289 
8.2.6 Cell culture studies of SaOs-2 osteoblast-like cells ...................................................... 289 
8.3 Results and discussion ................................................................................................... 290 
8.3.1 ELR-RGD characterization .......................................................................................... 290 
8.3.1 Analysis of CHI/ELR-RGD film buildup ........................................................................ 292 
8.3.2 Characterization of the self-assembled coatings .......................................................... 293 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xix 
8.3.3 Cell culture studies of SaOS-2 osteoblast-like cells ...................................................... 300 
8.4 Conclusions ................................................................................................................... 303 
8.5 Acknowledgements ........................................................................................................ 303 
8.6 References .................................................................................................................... 304 
Chapter 9. Nanostructured and thermoresponsive recombinant biopolymer-based 
microcapsules for the delivery of active molecules ....................................................... 309 
Abstract ........................................................................................................................ 309 
9.1 Introduction ................................................................................................................... 311 
9.2 Experimental section ...................................................................................................... 312 
9.2.1 Materials for the microcapsule composition ................................................................ 312 
9.2.2 ELR aggregate-size measurements ............................................................................. 313 
9.2.3 Entrapment of BSA in calcium carbonate particles ...................................................... 313 
9.2.4 Construction of the multilayer shells and microcapsule formation ............................... 313 
9.2.5 Determination of pre-loading encapsulation efficiency ................................................. 314 
9.2.6 In vitro biological performance ................................................................................... 314 
9.2.7 Quantification of FITC-BSA release ............................................................................. 315 
9.2.8 Microscopy characterization of the CaCO3 microparticles and multilayered microcapsules . 
  ................................................................................................................................. 315 
9.3 Results .......................................................................................................................... 316 
9.4 Discussion ..................................................................................................................... 321 
9.5 Conclusion..................................................................................................................... 325 
9.6 Supplemental information .............................................................................................. 325 
9.6.1 Schematic structure of the ELR .................................................................................. 325 
9.6.2 Morphology of the sacrificial CaCO3 templates: .......................................................... 326 
9.6.3 Cumulative losses and encapsulation efficiency .......................................................... 326 
9.6.4 Release kinetics calculation ........................................................................................ 327 
9.6.4.1 Korsmeyer kinetics ............................................................................................ 327 
9.6.4.2 Zero-order release ............................................................................................. 328 
9.6.4.3 First-order release ............................................................................................. 329 
9.6.4.4 Higuchi release model ....................................................................................... 330 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xx 
9.7 Acknowledgements ........................................................................................................ 331 
9.8 References .................................................................................................................... 331 
Chapter 10. Cellular uptake of multilayered capsules produced with biomimetic and 
genetically engineered macromolecules ....................................................................... 337 
Abstract ........................................................................................................................ 337 
10.1 Introduction ................................................................................................................... 339 
10.2 Experimental section ...................................................................................................... 341 
10.2.1 Materials ................................................................................................................... 341 
10.2.2 Measurement of the charges ...................................................................................... 342 
10.2.3 Synthesis of calcium carbonate sacrificial templates ................................................... 342 
10.2.4 Construction of the multilayer shells and microcapsule formation ............................... 342 
10.2.5 Characterization of the hybrid microcapsules .............................................................. 343 
10.2.6 Cell culture ................................................................................................................ 343 
10.2.7 Cell viability assays .................................................................................................... 344 
10.2.8 Statistical analysis ..................................................................................................... 344 
10.2.9 Internalization and intracellular processing experiments .............................................. 344 
10.2.10 Cell analysis by flow cytometry ................................................................................... 345 
10.3 Results and discussion ................................................................................................... 345 
10.4 Conclusion..................................................................................................................... 356 
10.5 Acknowledgements ........................................................................................................ 357 
10.6 References .................................................................................................................... 358 
Chapter 11. Multifunctional compartmentalized capsules with a hierarchical organization 
from the nano- to the macro-scales ............................................................................... 363 
Abstract ........................................................................................................................ 363 
11.1 Introduction ................................................................................................................... 365 
11.2 Experimental section ...................................................................................................... 366 
11.2.1 Materials ................................................................................................................... 366 
11.2.2 Bioproduction of the elastin-like recombinamers ......................................................... 367 
11.2.3 Synthesis of magnetic nanoparticles ........................................................................... 367 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxi 
11.2.4 Characterization of the MNPs ..................................................................................... 367 
11.2.5 Temperature-induced aggregate measurements ......................................................... 368 
11.2.6 Synthesis of the calcium carbonate sacrificial particles, either empty or entrapping 
fluorophores/MNPs ................................................................................................................ 368 
11.2.7 Construction of the microparticle multilayer coating .................................................... 368 
11.2.8 Construction of multilayer coated external subcompartment-containing beads ............. 369 
11.2.9 Characterization of the compartmental units .............................................................. 369 
11.2.10 Mechanical resistance of the external compartments .................................................. 370 
11.2.11 Rhodamine release studies ........................................................................................ 370 
11.2.12 Magnetic-based responsiveness ................................................................................. 370 
11.3 Results and discussion ................................................................................................... 371 
11.4 Conclusion..................................................................................................................... 380 
11.5 Supplemental information .............................................................................................. 381 
11.5.1 Deacetylation degree of chitosan. ............................................................................... 381 
11.5.2 ELR transition temperature ........................................................................................ 381 
11.5.3 Rhodamine encapsulation losses ............................................................................... 383 
11.5.4 Magnetic responsiveness assay .................................................................................. 384 
11.6 Acknowledgements ........................................................................................................ 385 
11.7 References .................................................................................................................... 385 
 
SECTION IV – CONCLUDING REMARKS 
Chapter 12. Major conclusions and future perspectives ............................................... 393 
 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxii 
 
 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxiii 
List of Abbreviations and Acronyms 
0-9 
 
A 
 
 
 
 
 
 
 
B 
 
 
 
 
C 
 
 
 
 
 
 
 
 
 
 
 
D 
2D – two dimensional 
3D – three dimensional 
A – alanine 
AA – acrylic acid 
AFM – atomic force microscopy 
ALG – alginate 
ALP – alkaline phosphatase 
ANOVA – analysis of variance 
ASTM – American Society for Testing 
Materials 
β – beta 
BG – Bioglass® 
BMP – bone morphogenetic protein 
BNP – bioactive nanoparticle 
BSA – bovine serum albumin 
χ2 – chi-square 
CA – contact angle 
CaCl2 – calcium chloride 
CHI – chitosan 
CLSM – confocal laser scanning 
microscopy 
cm – centimeter 
CO2 – carbon dioxide 
cP – centipoise 
CRP – controlled/living radical 
polymerization 
ºC - degree Celsius 
δ – delta 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E 
∆D – variation of dissipation 
∆F – variation of frequency 
∆m – variation of adsorbed film mass 
D – aspartic acid 
D20 – deuterated water 
Da – Dalton 
DAPI – 4',6-diamidino-2-phenylindole 
DCl – deuterated hydrochloric acid 
DD – degree of deacetylation 
DHR 123 – dihydrorhodamine 123 
DIC – differential interference contrast 
DL-1 – delta-like 1 Notch ligands 
DLS – dynamic light scattering 
DMEM – Dulbecco’s modified Eagle’s 
medium 
DMPEI – N,N - dodecyl methyl 
polyethylenimine 
DNA – deoxyribonucleic acid 
DOPA – 3,4-dihydroxy-phenylalanine 
DOX – doxorubicin 
DPBS - Dulbecco's phosphate-buffered saline 
DSC – differential scanning calorimetry 
η – eta 
E – glutamic acid 
EC – external compartment 
ECM – extracellular matrix 
EDAC – 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxiv 
 
 
 
 
 
 
 
 
 
F 
 
 
 
 
 
 
G 
 
 
 
 
 
H 
 
 
 
 
 
 
 
 
EDS – energy dispersive spectroscopy 
EDTA – ethylenediamine tetraacetic acid 
EDX – energy dispersive X-ray 
EFG – epidermal growth factor 
ELP – elastin-like polymers 
ELR – elastin-like recombinamer 
ePTFE – expanded poly(tetrafluoroethylene) 
ES – embryonic stem cell 
ESA – electrostatic self-assembly 
F – phenylalanine 
FBS – fetal bovine serum 
FeCl2∙4H2O – iron(II) chloride tetrahydrate 
FeCl3∙6H2O – iron(III) chloride hexahydrate 
FGF – fibroblast growth factor 
FITC – fluorescein isothiocyanate 
FTIR – Fourier transform infrared 
γ – gamma 
G – glycine 
GAG – glucosaminoglycan 
GEL – gelatin 
GOX – glucose oxidase 
H – histidine (amino acid) 
h – hour (unit) 
1H-NMR – hydrogen-1 nuclear magnetic 
resonance 
H2O – water 
HA – hyaluronic acid / hyaluronan 
HAP – hydroxyapatite 
HCl – hydrochloric acid 
HEPES – 4-(2-hydroxyethyl)-1- 
 
 
 
 
 
 
 
 
 
 
I 
 
 
 
 
 
 
 
K 
 
 
 
 
 
 
L 
 
 
 
piperazineethanesulfonic acid 
hMSC – human mesenchymal stem cell 
HPLC – high-performance liquid 
chromatography 
HRP – horseradish peroxidase 
HSA – human serum albumin 
HSC – hematopoietic stem cells 
HUVECS – human umbilical vein 
endothelial cells 
Hz – hertz 
I – isoleucine 
IC – internal compartment 
IFS – forward-scattering intensity 
Ig – immunoglobulin 
Igreen – green fluorescence intensity 
Ired – red fluorescence intensity 
ISS – side-scattering intensity 
ITT – inverse temperature transition 
K – lysine 
K2HPO4 – dipotassium phosphate 
kDa – kilodalton 
kg – kilogram 
KH2PO4 – monopotassium phosphate 
kOe – kiloOersted 
kV – kilovolts 
λ - lambda 
L – leucine (amino acid) 
L – liter (unit) 
LbL – layer-by-layer 
LCST – lower critical solution temperature 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxv 
M 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N 
 
 
 
 
μ – mu 
µm – micrometer 
µL – microliter 
M – methionine (M) 
m – meter (unit) 
MALDI-TOF – Matrix-assisted laser 
desorption/ionization time-of-flight 
MAPLE – matrix-assisted pulsed laser 
evaporation 
mg – milligram 
MgSO4∙7H2O – magnesium sulfate 
heptahydrate 
MHC – major histocompatibility complex 
MHz – megahertz 
min – minute 
mL – milliliter 
mm – millimeter 
Mn – polymer molecular weight 
MNP – magnetic nanoparticle 
MRI – magnetic resonance imaging 
MSC – mesenchymal stem cell 
MTS – 3-(4,5-dimethylthiazol-2-yl)-5-(3- 
carboxymethoxyphenyl)-2-(4-sulfophenyl)- 
2H-tetrazolium 
mV – millivolt 
ν – nu 
Na2CO3 – sodium carbonate 
Na2HPO4 – disodium phosphate 
NaCl – sodium chloride 
NADH – nicotinamide adenine  
 
 
 
 
 
 
 
 
 
O 
P 
dinucleotide, reduced form 
NaH2PO4 – monosodium phosphate  
NaOH – sodium hydroxide 
NdFeB – neodymium 
NH3 – ammonia 
NH4OH – hydroxide solution 
(NH4)2SO4 – ammonium sulfate 
NIR – near-infrared 
nm – nanometer 
ω – omega 
% (v/v) – percentage of volume/volume 
% (w/v) – percentage of mass/volume 
P – proline 
Pa – Pascal 
PAA – poly(acrylic acid) 
PAH – poly(allylamine hydrochloride) 
PBS – phosphate-buffered saline 
PC – personal computer 
PCl3 – phosphorus trichloride 
PD-PPO-PD/PAA – poly(N,N –dimethyl 
aminoethyl methacrylate)-poly(propylene 
oxide)/poly(acrylic acid) 
PDAAEMA – poly(N,N -dyakylamino 
ethylmethacrylates 
PDADMAC – poly(diallyldimethylammonium) 
chloride 
PDGF – platelet-derived growth factor 
PEG – poly(ethylene glycol) 
PEI – poly(ethyleneimine) 
PEM – polyelectrolyte multilayer 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxvi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q 
 
 
R 
 
 
PGA – poly(glutamic acid) 
Ph-levan – phosphonate-derivatized levan 
pKa – acid dissociation constant 
PLGA – poly(lactic-co-glycolic acid) 
PLL – poly(L-lysine) 
PLLA – poly(L-lactic acid) 
PLLs – poly(L-lysine succinylated) 
PMAc – poly-(methacrylic acid)-co- 
(cholesteryl methacrylate) 
PMEMA-b-PDPA – poly[2-(N -morpholino) 
ethyl methacrylate-block-2- 
(diisopropylamino)ethyl methacrylate] 
PMLC – polymeric multilayer capsules 
PMMA – poly(methyl methacrylate) 
PNIPAAm – poly(N -isopropylacrylamide) 
pNP – p-nytrophenyl 
PS – polystyrene 
PSP – poly(sodium phosphate) 
PSS – poly(styrene sulfonate) 
PTFE – poly(tetrafluoroethylene) 
PVA – poly(vinyl alcohol) 
PVCL – poly(N -vinylcaprolactam) 
PVDF – polyvinylidene difluoride 
PVS – poly(vinyl sulfate) 
QBP – glutamine binding proteins 
QCM-D – quartz-crystal microbalance 
with dissipation monitoring 
ρ – rho 
R – arginine 
RDL – recursive directional ligation 
 
 
 
 
 
 
 
 
 
 
S 
 
 
 
 
 
 
 
 
 
T 
 
 
 
 
 
 
 
 
 
 
rhBMP-2 – recombinant human bone 
morphogenetic protein-2 
Rhod – rhodamine-B isothiocyanate 
rlSECS – rat liver sinusoidal endothelial 
cells 
RMS – root-mean-square 
rpm – rotations per minute 
Ru(dpp) – tris(4,7-diphenyl-1,10- 
phenanthroline)ruthenium(II) dichloride 
complex 
S – serine (amino acid) 
s – second (unit) 
SBF – simulated body fluid 
SAM – self-assembled monolayer 
SD – standard deviation 
SE – standard error 
SEM – scanning electron microscopy 
SNARF-1 – seminaphtho-rhodafluor-1-dye 
STM – scanning tunneling microscopy 
SVAS – supravalvular aortic stenosis 
T – threonine (amino acid) 
T – tesla (unit) 
TB – terrific broth 
TC – thiocoraline 
TCP – tricalcium phosphate 
TCPS – tissue culture polystyrene 
TEM – transmission electron microscopy 
TERM – tissue engineering and 
regenerative medicine 
TFE – trifluoroethanol 
 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxvii 
 
 
 
 
 
 
 
U 
 
 
V 
 
Z 
TGF – tissue growth factor 
TRAP – thermodynamically reversible 
addressing of proteins 
TRITC – tetramethylrhodamine B 
isothiocyanate 
Tt – transition temperature 
U∙mL-1 – units per milliliter 
UCST – upper critical solution temperature 
UV – ultraviolet 
V – valine 
VEGF – vascular endothelial growth factor 
ζ – zeta 
  
 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxviii 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxix 
List of Figures 
SECTION I – GENERAL INTRODUCTION 
Chapter 1. Nanostructured devices produced by layer-by-layer self-assembly adsorption 
for tissue engineering applications 
Figure 1.1. On the left: Individual connections between two paraffin wax particles. On the right: 
Florescence images showing the multilayered 3D assembly after leaching of the core material. 
Reprinted (adapted) with permission from [113]. Copyright 2010 Wiley-VCH. 17 
Figure 1.2. On the left: Light microscopy image of trypan blue-stained islets after encapsulation with 
three pairs of polyelectrolyte layers (PDADMAC/PSS)3. On the right: Electron micrographs of 
PAH/PSS/PAH-coated islets. Reprinted (adapted) with permission from [123]. Copyright 2006 
American Chemical Society. 18 
Figure 1.3. Physical changes induced in ELR modified surfaces. (a) Wettability variations with different 
temperatures. Reprinted (adapted) with permission from [131]. Copyright 2009 Wiley-VCH. (b) 
Topography at distinct pHs. Reprinted (adapted) with permission from [78]. Copyright 2011    Wiley-
VCH. 20 
Figure 1.4. Effect of incubation time on the formation of calcium phosphate crystals using liposome 
and liponano–CHI–DNA templates. Each reaction was carried out at pH 7.0 and pH 10.0 for 18 h, 
using calcium chloride (CaCl2) and disodium phosphate/monosodium phosphate (Na2HPO4/NaH2PO4) 
as ion species. Reprinted with permission from [144]. Copyright 2011 American Chemical Society. 23 
 
Chapter 2. Polyelectrolyte multilayered assemblies in biomedical technologies 
Figure 2.1. Schematics of layer-by-layer adsorption of polyelectrolytes based on an electrostatic 
mechanism deposition. The procedure is based on the contact of the substrate with a solution with an 
oppositely charged polymer. In the depicted example, negatively charged round substrates are 
submerged in an aqueous solution of a polycation, followed by a solution containing a polyanion. Each 
adsorption stage is separated by a rinsing step, to remove loosely adsorbed molecules. 41 
Figure 2.2. Formation of calcium phosphate over the surface of polysaccharide-coated liposomes. (a) 
Liposomes encapsulating phosphate ions (PO4
3-) are coated with polysaccharides. Polycations (orange) 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxx 
and polyanions (green) are adsorbed sequentially over the surface and placed in a medium containing 
calcium ions (Ca2+), which concentrate around the negatively charged molecules. The counter-diffusion 
of ions across the wall leads to the formation of a calcium phosphate mineral interface. (b) Field 
emission TEM image of a liposome coated with CHI and DNA after inducing mineralization at pH 10 for 
18 h, exhibiting a thick wall. (c) Energy dispersive X-ray analysis (EDX) exhibiting calcium and 
phosphate peaks. Adapted with permission from ref. [97] Copyright 2011, American Chemical     
Society. 47 
Figure 2.3. Typical photographs obtained using (heparin/collagen)5-CD34 multilayer-modified stents. 
In (a) and (b), cross-section optical images of rabbit femoral arteries with (heparin/collagen)5-CD34 
multilayer-modified stents. (c) Fluorescence microscopy image of the multilayer on stent, with CD34 
tagged with FITC. Inset shows the optical image of the stent. (d) SEM image of the inner wall of the 
stented rabbit femoral arteries for 48 h, showing the formation of a complete endothelium. Adapted 
with permission from ref. [121] Copyright 2010, Elsevier. 52 
Figure 2.4. Free-standing nanosheets and their various applications. (a) Basic concept of the spin-
coating-assisted LbL fabrication method. Upon polyelectrolyte deposition, a PVA layer is cast allowing 
peeling-off the nanosheet easily, subject to posterior dissolution. (b) CHI/ALG nanosheet securing a 
repaired visceral pleural defect in beagle dogs when pressurized by over 50cm H2O pressure 3 h after 
repair. The region indicated by arrows shows the nanosheet-sealed area. Reprinted with permission 
from ref. [151] Copyright 2009, Wiley-VCH; (c) Macroscopic images after treating a murine cecal 
puncture hole with a tetracycline layer sandwiched between CHI/ALG multilayers and poly (vinyl 
acetate). Reprinted with permission from ref. [153] Copyright 2010, Elsevier; (d) Macroscopic images of 
murine dorsal skin treated with tetracycline-loaded CHI/ALG nanosheets illuminated under UV light, 
remaining at the wound site for 7 days. Reprinted with permission from ref. [154] Copyright 2012, 
Elsevier. 56 
Figure 2.5. Temperature-responsiveness of CHI/ELR microcapsules and size/permeability effects. (a) 
Multilayer coatings were assembled around calcium carbonate sacrificial templates. Confocal laser 
scanning microscopy images of BSA-loaded (CHI/ELR)5 microcapsules with the final layer tagged with 
rhodamine at (b) 25 and (c) 37 °C.  Cumulative release of BSA from (CHI/ELR)1, (CHI/ELR)3 and 
(CHI/ELR)5 microcapsules: ■□, ○●, and ▲Δ, respectively, in PBS (pH 7.4), at (d) 25 °C 
and (e) 37 °C. Adapted with permission from ref. [179] Copyright 2013, Elsevier. 61 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxxi 
Figure 2.6. Enzymatic cleavage of DQ-ovalbumin upon internalization by embryonic NIH/3T3 
fibroblasts. Fluorescent cargo was encapsulated either in (a) nondegradable PSS/PAH or (b) degradable 
dextran sulfate/poly(L-arginine) microcapsules. Images were taken immediately after the addition of the 
capsules to the culture over-time up to 120 h under confocal microscopy in different channels, green, 
red, and transmission, where green corresponds to cleaved DQ-ovalbumin and red corresponds to 
intact cargo. Adapted with permission from ref. [183] Copyright 2009, American Chemical Society. 64 
Figure 2.7. Fabrication and response of biosensors based on BSA-functionalized MNPs. (a) Biotin- and 
avidin-modified HRP layers are assembled on top of bidimensional or three-dimensional surfaces to 
produce (i) flat mono-enzyme, (ii) spherical mono-enzyme or (iii) spherical bi-enzyme sensors. The 
substrate accessibility to inner layer enzymes is more favorable when using the spherical templates. (b) 
Production of multilayer single- and bi-enzyme MNP systems using HRP and GOX. (c) Total HRP activity 
as a function of the number of HRP layers in HRP-MNP systems, showing a linear activity increase with 
increasing number of layers. (d) Schematic of the coupled bi-enzymatic reaction in the GOX-HRP-MNP 
system. (e) Photographs showing the colorimetric detection of glucose with the coupled GOX–(HRP)5–
MNP system after 3 h with increasing concentrations of glucose. The discoloration in vial 6 (highest 
concentration of glucose) is attributed to the protonation of resorufin – which is only absorbing in its 
deprotonated form – due to the decrease of pH from the formation of gluconic acid. Adapted with 
permission from ref. [192] Copyright 2011, The Royal Society of Chemistry. 67 
Figure 2.8. Hollow CHI/ALG multilayer tubes. (a) PEMs are assembled on paraffin-coated tubes, the 
latter being leachable using an organic solvent. (b) SEM image of a crosslinked tube. (c) Variations of 
storage modulus (E’) with or without crosslinking obtained by dynamic mechanical analysis in wet 
conditions and 37°C. (d) L929 fibroblast-like cells seeded on crosslinked tubes at day 7 of culture. 
Adapted with permission from ref. [201] Copyright 2013, Wiley-VCH. 70 
Figure 2.9. (a) General route for the synthesis of shell-in-shell microcapsules. (b) Confocal laser 
scanning microscopy of the shell-in-shell structure and HAS distribution 5 seconds after core dissolution. 
The dashed circle indicates the original position of the inner capsule. (c) Formation and diffusion of 
resorufin in a coupled enzymatic test using GOX and peroxidase. Reprinted with permission from ref. 
[219] Copyright 2007, Wiley-VCH. 73 
Figure 2.10. Biological performance of heparin/CHI multilayer-coated decellularized porcine aortic 
valves. (a) Fluorescence of the multilayers adsorded onto the valves. The polymers’ fluorescence (red 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxxii 
for heparin and green corresponds for CHI) is uniform and non-overlapping. Platelets (b) and leukocytes 
(c) adhered poorly to the multilayer-coated decellularized valves. (d) The developed devices were 
repopulated with endothelial progenitor cells exhibiting a contiguous, flat morphology. Reprinted with 
permission from ref. [229] Copyright 2012, Elsevier. 77 
Figure 2.11. Cell-accumulation technique allows assembling three-dimensional cellular constructs. (a) 
Illustration of the rapid construction of 3D multilayered tissues by cell-accumulation using 
fibronectin/GEL-coated cells. (b) Schematics of a cellular construct consisting on 4+4 layers of human 
dermal fibroblast cells, intercalated with a layer of HUVECs. (c) Confocal laser scanning microscopy 
cross-section image of the construct presented in “b”, showing tubular endothelial structures after 1 
week of incubation. Green cells correspond to human dermal fibroblast cells and red cells to HUVECs. 
Adapted with permission from ref. [235], Copyright 2011, Wiley-VCH. 80 
Figure 2.12. Production and characterization of multilayer-coated liquefied ALG capsules. (a) Cells are 
mixed with solutions of either ALG solely ALG-containing PLLA microparticles. Both solutions are 
extruded separately, originating ALG beads by ionotropic gelation. Upon coating with multilayers of 
diverse polyelectrolytes (CHI, ALG and PLL), the crosslinked ALG core is liquefied by EDTA, originating 
liquefied capsules encapsulating cells (ALG capsules), or encapsulating cells and PLLA microparticles 
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Adapted with permission from ref. [236] Copyright 2013, American Chemical Society. (d) Fluorescence 
assay of PLLA capsules at day 7 of culture, showing cells adhered to the surface of the PLLA 
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ref. [237] Copyright 2013, The Royal Society of Chemistry. 81 
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various applications. Recombination techniques allow obtaining several degrees of complex: the 
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sequences and blocks with distinct properties; (c) the inclusion of a bioactive motif or; (d) the inclusion 
of more than one in the same peptidic formulation. 114 
Figure 3.4. Microscopy assessment of HUVECs seeded in macroporous ELP hydrogels after 48 h of 
incubation in: (a) fluorescence microscopy with phalloidin Alexa Fluor488 and 4',6-diamidino-2-
phenylindole (DAPI) staining; and (b) SEM magnified view. Reprinted (adapted) with permission from 
[133]. Copyright 2009 American Chemical Society. 117 
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temperatures. Reprinted (adapted) with permission from [172]. Copyright 2009 Wiley-VCH. (b) 
Topography at distinct pHs. Reprinted (adapted) with permission from [173]. Copyright 2011  Wiley-
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Figure 4.2. Water drop profiles on ELP-coated substrates at 25 and 50ºC. Reprinted (adapted) with 
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Figure 4.3. Transmission electron microscopy (TEM) images of azido- and acetylene-functionalized 
PNIPAAm microcapsules dried at 25 ºC and 50 ºC. Scale bar: 2 μm. Reprinted (adapted) with 
permission from [131]. Copyright 2009 American Chemical Society. 154 
Figure 4.4. In-situ detachment of SaOs-2 cell sheets after 10 min (A) and 15 min (B) of incubation at 
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Chemical Society. 157 
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Figure 5.3. The molecular biology steps of RDL. (A) A synthetic monomer gene is inserted into a 
cloning vector. (B) The gene is designed to contain recognition sites for two different restriction 
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identically, using products from previous rounds as starting materials. Reprinted with permission 
from [18], Copyright 2002, American Chemical Society. (F) Recombinant bacteria containing the 
desired gene are submitted to fermentation and purified afterwards to extract the bioproduced    
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Figure 5.9. Organization of multilayer compartments, with rhodamine molecules and MNPs found at 
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Chapter 6. Adhesive nanostructured multilayer films using a bacterial exopolysaccharide 
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Figure 6.1. Reaction scheme of phosphonate modification of levan. 217 
Figure 6.2. FTIR spectra of levan samples as-produced (in red) and phosphonate (in black). The Ph-
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phosphonate groups are highlighted with grey background, with the inset showing the augmented 
spectra between 700 and 1000 cm-1. 218 
Figure 6.3. EDS spectrum of a Ph-levan sample. 218 
Figure 6.4. Buildup assessment of (CHI/Ph-levan) films. A: QCM-D monitoring of normalized 
frequency, ∆Fν/ν, and dissipation ∆D, obtained from the 5
th overtone, for a total of 3 bilayers. 
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of thickness of (CHI/Ph-levan) films with the number of layers. An odd layer number represents a film 
ending in CHI and an even number a film ending in Ph-levan. Data represent mean±standard deviation 
(SD). 219 
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column, where ALG and V84 were used at pH 5.5, the ζ-potentials were -15.5 mV and -1 mV, 
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Figure 7.2. Representative QCM-D acquisition graphics depicting the 5th overtone variations of 
frequency (A, B) and dissipation (C, D) for hybrid polysaccharide/ELR films at pH 4.0 and 5.5. The case 
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of H-RGD6 combinations is depicted. Results for CHI40 (□), CHI55 (■), ALG40 (○) and ALG55 (●) are 
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CHI/monoblock and b) CHI/triblock. The dashed lines mark the end of the adsorption of one       
bilayer. 276 
Appendix Figure 7.3. Contact angle variations of (CHI/monoblock)5 (■) and (CHI/triblock)1 (Δ) upon 
temperature changes and evolution with time. 277 
Nanostructured functional multilayer coatings incorporating biomimetic macromolecules for biomedical 
applications 
 
xxxvii 
Appendix Figure 7.4. AFM imaging for (CHI/monoblock)5 films for 1, 3 and 5 bilayers, at 25 and 
50ºC. Similar results were obtained for pH 7.4 and pH 14. Scale bar: 200 nm. 278 
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Figure 8.1. Characterization of the ELR-RGD. a) schematic representation of the featured ELR 
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Figure 8.2. Buildup assessment of CHI/ELR-RGD films. a) QCM-D monitoring of normalized frequency 
(ΔFν/ν, ■) and dissipation (ΔD, □) obtained at the 5
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Figure 8.7. In vitro tests on films ending in CHI, ELR-RGD and ELR-RDG(-). a) Cell viability of SaOs-2 
cells for 4 h, 24 h and 3 days. Data are means±SD (n=3; *p<0.05). b) ALP assays on the studied films. 
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Figure 9.1. Aggregate size profile for a 300 µg∙mL-1 ELR solution in PBS over the temperature range 
25–37°C. Means±standard deviation (SD) are represented. Insets show a transparent solution below 
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Supplemental Figure 9.1. Schematic of the ELR used. The bioactive sequence containing the 
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Supplemental Figure 9.2. Morphology of the sacrificial CaCO3 templates observed by SEM. (A) 
Calcium carbonate microparticles with no entrapped BSA (≈2 μm) can be compared to (B) their 
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Figure 10.1. (A) Representative TEM image of a microcapsule showing a detail of the multilayer shell 
delimited by the dashed lines. (B) CLSM micrograph of several microcapsules with the wall tagged with 
rhodamine. Micrograph is representative of both (CHI/ELR-RGD)2 and (CHI/ELR-RDG
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(C) Fluorescence intensity plot profile of three individual microcapsules depicted in (B). The peaks 
coincide with the capsules’ walls, while the plateau in between corresponds to the hollow interior. SEM 
images of (D) (CHI/ELR-RGD)2 and (E) (CHI/ELR-RDG
(-))2 microcapsules, with a vertical tilt of 20º. 346 
Figure 10.2. Metabolic activity of hMSCs incubated with increasing ratios of (A, B) (CHI/ELR-RGD)2 
and (C, D) (CHI/ELR-RDG(-))2 microcapsules for (A, C) 3 h and (B, D) 72 h. Data represent means of 
four experiments, each performed in quadruplicate, normalized in respect to the positive control. Error 
bars represent one standard error (mean+SE). No significant statistical differences were found (p-value 
higher than 0.05). 348 
Figure 10.3. Estimated metabolic activity of hMSCs incubated with (CHI/ELR-RGD)2 and 
(CHI/ELR-RDG(-))2 microcapsules for 3 and 72 h. Data represent means of the viability results 
performed for microcapsule/cell ratios from 5:1 to 100:1, as compared to the positive control (PC, cells 
cultured without microcapsules). Error bars represent one standard error (mean+SE). No significant 
statistical differences were found (p-value higher than 0.05). 349 
Figure 10.4. Representative microphotographs of LIVE/DEAD® assay of hMSCs incubated with (A, B 
and C) (CHI/ELR-RGD)2 and (D, E and F) (CHI/ELR-RDG
(-))2 microcapsules at 0 (A, D) and 72 h (B, E)  
and 240 h times points. (C, F). 350 
Figure 10.5. Confocal microscopy of hMSCs containing (CHI/ELR-RGD)2 microcapsules within their 
cytoplasm. The nuclei are stained with DAPI (blue) and the microcapsules loaded with DQ-ovalbumin. 
The schematics represent the relative position of each plane in the cell (A, B and C). The arrows in (A) 
point to bright green dots, representing fully processed DQ-ovalbumin. (D) Bright field image was 
merged with the fluorescence-only image in (C). 352 
Figure 10.6. Flow cytometry 2D density plots of hMSCs after a 72 h incubation with (A, B) 
(CHI/ELR-RGD)2 and (C, D) (CHI/ELR-RDG
(-))2 microcapsules. The density of the events is color-coded 
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of each type of capsule for three independent experiments. Data represent means of three independent 
experiments. Error bars represent two standard errors (mean±SE). No significant statistical differences 
were found (p-value higher than 0.05). 353 
Figure 10.7. The scheme (A) depicts the various degradation stages that DQ-ovalbumin undergoes. 
Representative microscopy images of (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules loaded 
with DQ-ovalbumin incubated with hMSCs after (B, D) 3 or (C, E) 72 h of incubation and DAPI staining 
(nuclei of the cells stained in blue). A shift from red/orange to green/yellow indicates a transition 
between fully intact to degraded cargo. Images are of fluorescence and differential interference contrast 
(DIC) microscopy at 40× magnification. 355 
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from the nano- to the macro-scales 
Figure 11.1. Hierarchical organization of the multicompartmental capsules. Liquefied alginate beads, 
delimited by a (CHI/ALG)3 coating, are visible to the naked eye. Multilayer microcapsules of (CHI/ELR)3 
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two standard deviations represented. Some standard deviations are too small to be distinguished from 
the symbol. 377 
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microcapsule (a) containing MNPs and (b) empty. Insets scale: 50 nm. (c) Attraction of (CHI/ALG)3 ECs 
containing MNP-loaded (CHI/ELR)3 ICs by a magnet in a PBS medium. The magnet is placed at a 
height of 1.4 cm on top of a polystyrene cover. The red color is characteristic of the MNPs within the 
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Introduction to the thesis format 
This thesis is organized in 4 sections that include a total of 12 chapters, plus 1 appendix. The first 
section provides the general introduction to the thesis. The second section corresponds to the 
experimental methods and materials used. The third section shows the experimental results obtained in 
the context of this thesis and their discussion, focusing on the optimization of layer-by-layer (LbL) 
strategies for biomedical applications. The fourth section finalizes this thesis with concluding remarks. 
The body of the thesis chapters is based on a series of peer-reviewed papers and book chapters 
published or submitted for publication. Each thesis chapter is presented in manuscript form, i.e., 
abstract, introduction, experimental section, results and discussion (or in two separate sections, results 
plus discussion), conclusion, and some of them with acknowledgements. A list of relevant references is 
also provided as a subsection within each chapter. The contents of each part and chapter are described 
below in more detail. 
 
Section I – General introduction 
Chapter 1, Nanostructured devices produced by layer-by-layer self-assembly adsorption for tissue 
engineering applications: This chapter provides an introduction to the mechanisms behind the 
construction of LbL films and coatings, a technique based on the self-assembly of materials in the form 
of nanolayers, which may belong to distinct classes of materials. This technique served as the basis to 
the whole work described in this thesis. 
Chapter 2, Polyelectrolyte multilayered assemblies in biomedical technologies: In the sequence of 
Chapter 1, which focused primarily on the intermolecular phenomena driving the self-assembly of 
multilayer films, Chapter 2 reviews the state-of-the-art applications derived from LbL strategies focused 
on the technologies with interest in biomedicine. A thorough discussion regarding the current 
applications of LbL is presented, while hypothesizing about the potential of this technique in providing 
better devices for current medicine and for tissue engineering applications. 
Chapter 3, Elastin-like macromolecules: Most of the developed work relied on the use of elastin-like 
recombinamers (ELRs), a class of genetically-engineered polypeptides with stimuli-responsiveness. The 
properties and applications of this class of material are described, as well as their origin and 
resemblance with natural elastin. 
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Chapter 4, Stimuli-responsive surfaces for biomedical applications: The use of ELRs allowed developing 
multilayer devices that exhibited stimuli-responsiveness. In this chapter, the importance of “smart” 
surfaces for biomedical applications – planar and three-dimensional – obtained by numerous 
techniques is reviewed. 
 
Section II – Experimental section 
Chapter 5, Materials and methods: A list of the materials used and methods applied to obtain the 
results described further on is provided. 
 
Section III – Optimization of layer-by-layer strategies for biomedical applications 
Chapter 6, Adhesive nanostructured multilayer films using a bacterial exopolysaccharide for biomedical 
applications: This chapter aims to show that LbL coatings can be constructed using natural-occurring 
materials and retain the original properties of those constituents. Namely, levan, an exopolysaccharide 
produced by extremophilic bacteria, is known to exhibit adhesive properties. Thus, it was used as an 
ingredient for multilayer formulations with enhanced adhesiveness. 
Chapter 7, Layer-by-layer film-growth using polysaccharides and recombinant polypeptides: a 
combinatorial approach: In this chapter, the type of interactions that drive the self-assembly of ELRs 
and polysaccharides into layers – namely chitosan and alginate – was studied. It is based on partial 
findings from the literature, where there has been evidence that not only electrostatic interactions are at 
work during the construction of polymer/protein hybrid films but also hydrophobic ones. 
Chapter 7 – Appendix, Nanostructured thin coatings from chitosan and an elastin-like recombinamer 
with acute stimuli-responsive behavior: This appendix complements Chapter 7 and consists in a 
comparative study between ELR-functionalized films which amino acid sequence is organized either as 
a single or multiple blocks with distinct properties. 
Chapter 8, Layer-by-layer assembly of chitosan and recombinant biopolymers into biomimetic coatings 
with multiple stimuli-responsive properties: In this chapter, polyanionic elastin-like recombinamers 
produced by Escherichia coli strains were used. ELRs appear as an elegant example of how natural 
materials inspire the creation of new and tailored materials using biological processes. Their response 
to external stimuli and genetic nature allows incorporating specific motifs like the cell adhesion motif 
arginine-glycine-aspartic acid (RGD) while retaining the repeating amino acid structure of natural elastin. 
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With this polymer, surfaces with stimuli-responsive properties and enhanced cell adhesion were 
envisaged. 
Chapter 9, Nanostructured and thermoresponsive recombinant biopolymer-based microcapsules for the 
delivery of active molecules: This chapter describes the attempt to extrapolate ELR-polysaccharide 
hybrid films to the third dimension in the form of spherical microcapsules. The mechanism of diffusion 
of an encapsulated protein to the exterior of the capsules was studied for the development of drug 
delivery devices. 
Chapter 10. Cellular uptake of multilayered capsules produced with biomimetic and genetically 
engineered macromolecules: Similarly to Chapter 9, microcapsules are produced for drug delivery. In 
this case, the mechanism of delivery is focused on the internalization of the microcapsules by cells 
rather than diffusion to the surrounding medium. 
Chapter 11. Multifunctional compartmentalized capsules with a hierarchical organization from the nano- 
to the macro-scales: The possibility of using LbL to develop structures with higher degrees of complexity 
is studied in this chapter by assembling compartmentalized spherical structures with hierarchical 
organization and customized stimuli-responsiveness. It constitutes a fine example of inspiration on 
natural living structures such as that of natural cells. 
 
Section IV – Concluding remarks 
Chapter 12. Major conclusions and future perspectives: To finalize this thesis, the conclusions are 
summarized, and current limitations and future potential of LbL-based strategies for biomedical 
applications is reflected upon. 
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 Chapter 1. Nanostructured devices produced by layer-by-layer self-
assembly adsorption for tissue engineering applications1 
Abstract 
Devices prepared by bottom-up strategies have been proposed for several biomedical applications. 
Among various self-assembly techniques, layer-by-layer (LbL) offers ease of preparation, versatility, fine 
control over the materials structure, and robustness under physiological conditions. Due to its self-
assembled nature and use of small masses of material, coatings can be produced using aqueous 
solutions under mild conditions of temperature, pH, and pressure, with minimal energy requirements 
and material waste. Herein, we review the multitude of LbL mechanisms for constructing 
nanostructured devices of relevance to applications such as tunable cell adhesion and metabolism, 
drug delivery, and biomineralized and smart systems. 
 
                                                 
1
 This chapter is based on the following publication: 
Costa R. R., and Mano J. F., Layer-by-layer self-assembly techniques for nanostructured devices in tissue engineering, In 
Gaharwar A. K., Sant S., Hancock M. J., and Hacking A. (eds.), Nanomaterials in tissue engineering: characterization, 
fabrication and applications, United Kingdom, Woodhead Publishing Limited, 2013, ISBN: 978-0857095961. 
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1.1 Introduction 
The modification of surfaces has been a key aspect in biology and biotechnology applications, including 
cell expansion, biomaterials development and preparation of substrates for regenerative medicine [1-3]. 
In the field of implantable biomaterials and tissue engineered constructs, the bulk material properties 
are generally considered to determine the overall properties of a biomaterial. Surface properties, 
however, are of utmost importance as the surface constitutes the first interface between an implant and 
the organism, and will drive subsequent tissue and cellular events including protein adsorption, cell 
adhesion and inflammatory response, all of which are necessary for tissue remodeling [4-6]. Thus, 
surface engineering is highly important for developing devices with improved biological performance. 
Many processing techniques have been suggested and employed for the purpose of modifying 
substrates [7], but in the past two decades alternatives to common surface engineering strategies have 
emerged. Inspired by Nature, scientists and engineers have developed techniques based on biomimetic 
concepts. In Nature, evolutionary processes have constantly improved the design and functionality of 
natural materials. A well-known example is the layered organization of nacre found in the shells of sea 
animals. This layered and hierarchical structure containing calcium minerals is capable of dissipating 
high amounts of mechanical energy[8,9]. Mimicking natural layered structures has been attempted in 
the laboratory. In particular, the alternate adsorption of polyanions and polycations onto solid substrates 
is a reliable, flexible, and simple approach to modify a substrate while allowing the integration of a wide 
range of molecules, including those with biological relevance. As a result, multilayered thin films can be 
constructed with nanometric precision. This technique was first introduced by Decher, Hong and 
Schmitt and has denominated the layer-by-layer (LbL) field [10]. 
LbL is a self-assembly-driven surface modification strategy that allows the construction of 
nanostructured films onto substrates of any geometry, from simple bidimensional surfaces to more 
complex three-dimensional porous scaffolds. The underlying principle lies in the existence of multiple 
intermolecular interactions, such as electrostatic contacts, hydrophobic interactions, and hydrogen 
bonding, where the cooperative effects of multipoint attractions play the most important role. It is a 
technique that is easy to perform, versatile, offers fine control over the materials structure, and 
produces materials that are robust in physiological environments [11-13]. Because this technique may 
be performed using various complementary substances, a vast choice of available materials may be 
added to a multilayer formulation, such as proteins, nucleic acids, polysaccharides, virus particles, 
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organic polymers, molecular assemblies, and inorganic substances, allowing construction of LbL 
assemblies with very specific properties [4]. The buildup can be performed at mild conditions, namely 
standard laboratory temperatures and pressures, and mild pH, and can be tuned by making small 
adjustments in such conditions. Moreover, LbL does not involve the use of organic solvents. The mild 
and non-aggressive processing conditions of LbL make it an appealing technique for tissue engineering 
applications. Molecules with biological relevance may be embedded in the multilayer materials, with 
bioactivity preserved, particularly important for drug delivery applications. Biomaterials and ligands with 
more specific functions, such as cell adhesion enhancers, may be used in order to mimic biological 
structures and functions, rendering a substrate more instructive for cell behavior [14-16]. Exploiting the 
advantages of LbL, multilayer systems have already been proposed for various biomedical applications. 
An example includes biomimetic composite coatings that regulate drug release or manipulate the 
adhesion, differentiation, proliferation, and even function of attached cells. In the following sections, 
these applications and associated multilayer formulations will be reviewed. 
1.2 Interaction between biomaterials as ingredients for multilayer formulations 
One of the key features of LbL adsorption is the ability to use ingredients from distinct classes of 
materials. Usually the most important requirement is that two distinct materials possess 
complementarity, that is, the properties of both materials result in attraction. A well-known example 
most exploited example is the self-assembly driven by electrostatic interactions of oppositely charged 
components, in which polyanions and polycations interact and assemble [17]. Besides electrostatic self-
assembly (ESA), other types of interactions that can drive the construction of multilayers include short-
range interactions, such as van der Waals forces and hydrogen bonding [11]. The strength of these 
interactions may depend on several intrinsic factors, such as the molecular weight of polymers or size 
of inorganic particles, charge density, polarity, and also external factors, like the temperature, the pH of 
the solvent, and ionic strength (see following sections). Importantly, it is now acknowledged that the 
driving force behind multilayer formation is not only mutual interaction, but also by the gain in entropy 
due to the release of counter-ions [13,18]. The variation of one or more of these parameters can lead to 
a more favorable interaction and consequent buildup of a nanostructured coating. The result is, 
however, dependent on the original properties of the materials: for instance, varying the pH of a weak 
polyelectrolyte will greatly affect its overall charge density. Several biomaterials of synthetic and natural 
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origins have been used since LbL was first introduced, many of which capable of being used for 
multilayered constructs while displaying biologically relevant properties. 
1.2.1 Buildup mechanisms of synthetic and inorganic materials 
Many types of charged molecules and nano-objects are suitable for deposition by ESA. So far, the most 
popular deposition materials have been synthetic polyelectrolytes. Synthetic materials are usually man-
made and can be highly functional [19]. With the availability of thousands of monomers and their 
seemingly endless combinations, polymer science has developed a wide array of complex but well-
defined structures with specific properties, such as molecular weight and charge density. Other 
materials suitable for deposition using ESA are inorganic (e.g., calcium-containing or clay mineral 
particles) or metallic materials, usually consisting of a single geometrical charged structure (e.g., 
spheres or platelet-like objects) with natural or artificial origins [20,21]. 
Synthetic polymers, though not often similar to biological structures, have been used to define and 
quantify parameters important for the construction of nanostructured multilayer coatings. The main 
advantages of synthetic polymers are that they are easily chemically modified and they enable certain 
buildup parameters to be precisely adjusted. The pioneers of LbL proved its concept by creating 
ultrathin homogeneous films on solid surfaces [10]. Positively charged aminopropylsilanized fused 
quartz or silicon single crystal substrates served as supports for the ESA buildup. Poly(styrene 
sulfonate) (PSS) and poly(vinyl sulfate) (PVS) served as polyanions and poly(allylamine hydrochloride) 
(PAH) and poly-4-vinylbenzyl-(N, N -diethyl-N -methyl)-ammonium iodide as polycations. Immersing the 
positive support in an aqueous solution of one of the polyanions resulted in the adhesion of the 
polymeric molecules and reversal of charge density of the substrate. A rinsing step followed to remove 
loosely adsorbed molecules. Then the substrate was exposed to a solution of one of the polycations, 
again reversing the charge. By repeating this process, the stepwise construction of a coating was 
achieved. With 39 layers, Decher et al. were able to produce films as thin as 44 nm. 
The striking simplicity of fabricating a wide range of LbL-modified substrates was rapidly recognized by 
the scientific community. Many studies with different materials collectively identified the key parameters 
influencing the fabrication of nanostructured multilayer films and determined how to optimize them. The 
pH of the polyelectrolyte solutions used during buildup has been studied by using poly(acrylic acid) 
(PAA) and PAH to fabricate polyelectrolyte multilayers (PEMs) [22,23]. Varying the pH of the dipping 
solutions considerably changes the charge density of a weak polyelectrolyte when operating above or 
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below the acid dissociation constant (pKa) of the polymer. When adjusting the pH of PAA and of PAH 
above and below their pKa, respectively, a higher degree of ionization could be exploited, favoring ESA-
driven adsorption. In the opposite case, when operating near the acidity constant, the charge density is 
at its lowest. Consequently, fewer charged molecules are available to form a new top layer and more 
polyelectrolyte molecules are needed to interact with the underlying layer for ESA [16,24,25]. This 
affects the internal structure of the fi lm in terms of layer conformation since adjusting the pH modifies 
the charge density of the polyelectrolytes. An additional observation is that increasing the charge density 
of the adsorbing polymer will favor thinner polyelectrolyte layers, whereas increasing the charge density 
at the surface will favor thicker adsorbed layers. The latter enables the production of thicker and 
rougher films, while the former results in thinner and smoother films [23,26]. 
The addition of salts to the adsorbate solutions has been studied since ions can interfere with the 
electrostatic balance of molecules and the internal PEM structure. PAH, PSS and 
poly(diallyldimethylammonium) chloride (PDADMAC) have been used to demonstrate that the addition 
of salt increases the thickness of the layers due to a screening mechanism of charge–charge repulsions 
[27,28]. Basically, the electrostatic repulsion among groups with the same charge sign is reduced by 
the interaction with the salt ions present in solution and allows for a more stable buildup and interaction 
between layers. The adsorption process can be increased with increasing concentrations of salt, but 
since this mechanism is somewhat similar to that of pH, high concentration of salt may render the 
materials uncharged, which may induce desorption or “stripping” rather than adsorption [29,30]. 
Temperature also affects the buildup mechanism of multilayer films. However, while most studies on 
temperature focus on its effect on stability and functionality after construction, few study temperature as 
a buildup variable. A study by Salomäki, Vinokurov and Kankare [31] used films made of PSS and 
PDADMA to verify that temperature has a remarkable effect on the apparent mass of the resulting films. 
In aqueous solutions containing sodium bromide, the mass of adsorbed material at 55 ºC was 
approximately 5 times higher than a construction performed at a room temperature of 25 ºC, along with 
a tendency for the mass to increase exponentially. In the same report, similar results were found for 
PSS and PAH films. The conclusion was that a higher temperature during the deposition increases the 
mobility of the adsorbed molecules, resulting in deeper layer interpenetration deeper through the PEMs 
and a greater likelihood of finding more energetically optimal binding sites at the deposition site. 
Polyelectrolyte multilayers made using synthetic polymers have been extended to applications other 
than simple interface tuning. For instance, a dye may be used as a film ingredient or it may be loaded 
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after film assembly [32]. The latter takes advantage of the swelling properties of multilayer films, in 
which a dye can be loaded – and reversibly unloaded – into the film by immersion in a saturated 
solution. Ideally, a dye may be replaced by a therapeutic molecule or growth factor to act as a drug 
delivery device upon implantation or for use in cell culture. The versatility of LbL is not limited to 
polymers. Other extended functionalities include the use of inorganic particles, such as bioactive 
nanoparticles (BNPs), to develop surfaces that could mineralize into calcium phosphate crystals under 
the presence of a simulated body fluid [33]. Carbon nanotubes have also been used as LbL ingredients 
along with polyelectrolytes for substrates with improved mechanical properties [34-36]. Work with clay 
platelets [37], and graphene [38] has also taken advantage of the LbL methodology, although polymers 
offer more mobility to the internal structure of the film. In summary, LbL can be used as a means to 
coat surfaces and control the interface in almost any fashion desired, due to the several mechanisms 
that influence its thickness, roughness and loading capabilities. Such surface property control makes 
LbL a powerful technique to develop tunable cutting-edge devices whose surfaces influence the fate of 
cells, important for a range of applications in conventional medicine and tissue engineering. 
1.2.2 Natural-based polymeric materials 
Natural materials are intricate structures which have risen from hundreds of millions of years of 
evolution. Comparing to our current technology, natural structures are more multifaceted than 
man-made materials, forming complex arrays and hierarchical structures with multiples functionalities 
[39-41]. The advantage of using natural-based polymers for biomedical and tissue engineering 
applications lies in their similarity with biological macromolecules, thus avoiding triggering chronic or 
immunological reactions and toxicity [42]. They possess more similarity to the extracellular matrix 
(ECM) than synthetic materials and are therefore appropriate multifunctional ingredients for 
constructing multilayer films and coatings with better interface with biological environments. The range 
of potential LbL ingredients spans the gamut from synthetic to natural materials, including 
polysaccharides, polypeptides, proteins, nucleic acids, deoxyribonucleic acid (DNA), and even viruses, 
allowing highly biomimetic surfaces to be engineered [4,12,13,16,27]. 
One of the natural polymers most exploited to construct multilayer films is hyaluronic acid (HA). 
Hyaluronic acid, also known as hyaluronan or hyaluronate, is an important glycosaminoglycan 
component of the connective tissue, synovial fluid and the vitreous humor of the eye [43]. It is a linear 
polysaccharide composed of numerous repelling anionic groups capable of binding cations and water 
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molecules. Solutions of HA exhibit clear viscoelastic properties that make them excellent biological 
absorbers and lubricants. HA may also be obtained through a process of microbial fermentation, 
avoiding the risk of animal-derived pathogens [44]. 
Several authors have focused on the use of HA as a polyanion [45-47]. In particular, HA has been 
combined with poly(L-lysine) (PLL) [48-50]. PLL is a linear polypeptide containing an amino group and 
has been widely used in biomaterial applications to enhance cell adhesion [51-53]. A thorough 
investigation of the PLL/HA system provided a better understanding of the exponential growth 
mechanism of layer thickness, as opposed to the linear growth mechanism introduced by Decher [54-
56]. For this system, the exponential growth mechanism relies on the diffusion of at least one of the 
polymers ‘in-and-out’ of the molecular chains during each bilayer deposition step. In these studies, it 
was PLL that diffused through the film. 
Polysaccharides of marine origin form another important class of natural materials. Chitosan (CHI) is a 
polysaccharide exhibiting cationic properties and solubility under acidic conditions. Its precursor, chitin, 
is the second most important natural polymer in the world and can be extracted from marine 
crustaceans including shrimp and crabs. CHI possesses several characteristics favorable for promoting 
dermal regeneration and accelerated wound healing [57]. Alginate (ALG) is another polysaccharide of 
marine origin, namely from brown algae. Its structure contains carboxyl groups, which makes it 
negatively charged [58]. Both of these polysaccharides possess adhesive, non-toxic, bacteriostatic, 
fungistatic, hemostatic, and anti-microbial properties, making them ideal for tissue engineering 
applications. Because of these unique features, CHI and ALG have been frequently used in biomedical 
applications including burn dressings, drug delivery, and implants [59-61]. They have been used as LbL 
ingredients, both together or in conjugation with other materials. PLL/ALG and CHI/HA systems have 
been shown to possess an internal structure typically produced by the exponential growth mechanism 
[54,62]. Martins et al. [63] demonstrated the loading capability of CHI/ALG films with human serum 
albumin (HSA) which depended on the availability of amino groups to bind the negatively charged 
protein. Crosslinking with glutaraldehyde reduced that availability and HSA adsorption in comparison to 
uncrosslinked films. 
The molecular weight of LbL ingredients is an important property influencing the buildup mechanism. 
However, few studies using natural polymers have systematically investigated the influence of polymer 
molecular weight on the physical properties of polyelectrolyte multilayers, since it is difficult to obtain 
monodisperse polymers from natural sources. As such, studies related to molecular weight have mostly 
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focused on the use of well-characterized synthetic polymers [64-66]. Nevertheless, using CHI and HA 
films, Kujawa et al. [67] found that the thickness increased when the molecular weight of these 
polysaccharides was higher. They demonstrated that the higher the molecular weight the thicker the 
film: a longer polymer tends to adsorb in a “loopier” way, while a smaller molecule adsorbs in an 
extended conformation. Therefore, with longer polymers, there are more anchoring sites available for 
the next layer to adsorb and potentially higher interpenetrating capabilities than with smaller molecules. 
The mechanical properties of multilayer films can affect cell adhesion and differentiation. Increasing the 
Young’s modulus (i.e. stiffness) of multilayer films improves cell adhesion [68-70]. This behavior makes 
LbL substrates suitable as tunable platforms to control cell adhesion. Moreover, LbL substrates with 
varying support stiffness could potentially induce stem cell differentiation. Multilayers can also be used 
as reservoirs for therapeutic molecules (discussed below) and can incorporate naturally occurring smart 
biomaterials. By fabricating a film containing stimuli-responsive ingredients, interface properties could 
be changed on demand. 
All films constructed by ESA from weak polyelectrolytes – synthetic or natural – are inherently pH-
responsive. Properties like Young’s modulus, roughness or wettability may be tailored by varying the 
film assembly conditions, due to the dissociation of the weak acidic and alkaline functional groups on 
the chains. Wood et al. [71] demonstrated the pH controlled degradation of a film, from which 
therapeutic molecules were release to the bulk medium. Ionic strength may also be used as a stimuli-
response mechanism for films made of weak, and, unlike pH, strong polyelectrolytes [27-30]. A 
screening effect caused by the interaction between free counter-ions and charged polymer groups leads 
to a reduction of the electrostatic repulsion between charged groups of the same sign. Such 
mechanisms are potentially useful for drug delivery, because they could provide sustained and 
controlled release with greater effectiveness, lower toxicity, and improved patient convenience over 
conventional formulations. However the sharp variations of pH and ionic strength associated with them 
may be harmful for cells. On the other hand, cells are less sensitive to temperature variations, at least 
for temperatures near 37°C. Therefore, temperature responsive materials could be a more favorable 
choice for use with cells. One of the most popular temperature responsive polymers is poly(N-
isopropylacrylamide) (PNIPAAm). PNIPAAm has a lower critical solution temperature (LCST) around 
32°C enclosing both hydrophobic and hydrophilic domains [72]. Below the LCST, the polymer is 
soluble in aqueous solution, with an expanded or hydrated coil conformation; above it, the polymer 
becomes insoluble, preferring a folded globular structure. PNIPAAm is a synthetic material but 
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combinations with natural polymers are possible. CHI, a weak polycation, has been grafted with 
PNIPAAm to construct films with dual responsiveness [73]. Elastin-like recombinamers (ELRs) are 
another class of temperature-responsive materials; a class of the elastin-like polymers (ELPs) family, 
they are genetically engineered peptide-based macromolecules obtained through the fermentation of 
modified bacterial strains [74]. ELRs are rooted in the peptide sequence of natural elastin present in 
tissues that require elasticity as part of their function, such as skin, tendons and muscles. In an 
aqueous environment they are known to self-assemble and exhibit a transition temperature (Tt): below 
Tt, the free polymer chains adopt random coil conformations; above it, they fold into an organized 
structure known as β-spiral. Although ELRs respond primarily to temperature, the effects of other 
stimuli, such as pH, ionic strength and concentration also affect the transition phenomenon. Their 
genetically-engineered origin also allows motifs to be integrated that have biological relevance, such as 
cell adhesion [75] and mineralization enhancers [76]. In LbL, they have already been suggested as 
suitable ingredients for constructing films with multiple stimuli-responsiveness [77-79]. They are an 
elegant example of how Nature inspires engineers to develop new multifunctional materials for tissue 
engineering applications. 
1.3 Scalability to three dimensions 
LbL was first introduced as a surface engineering technique for planar surfaces. However, this 
technology can be used to coat surfaces on substrates or templates with a variety of shapes and sizes 
beyond planar. As a result, devices such as scaffolds that could only be fabricated through conventional 
methods may now be engineered to exhibit new tunable properties according to the desired application. 
1.3.1 Membranes 
Most polyelectrolyte multilayers may be assembled with up to dozens of layers to a thickness that may 
reach tens of micrometers. However, PEMs are assembled and adhere to underlying substrates and 
cannot be detached without damaging the films. Detached films, usually called “free-standings”, are 
potentially useful for a range of nanostructured membrane based devices for a range of sensing, 
detection, and drug delivery applications [80,81]. 
A typical approach to fabricate free-standings involves a sacrificial layer or substrate that is dissolved 
after buildup [82,83]. Cellulose acetate, for instance, can be used as a substrate and dissolved with 
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acetone after buildup [84]. A potential disadvantage of such an approach is that the films may undergo 
both chemical and physical changes during the post-processing steps to separate the film from the 
underlying substrate and interfere with the internal structure of the multilayers. More recently, other 
strategies have been introduced that avoid using chemicals to remove the template. Hydrophobic 
substrates have been used to assemble free-standing PEMs, exploiting a peeling mechanism of the film 
from the substrate. Larkin et al. [85] used Teflon and polypropylene as planar templates from which 
CHI and HA films could be easily peeled off without damage. Another method consists of assembling 
films virtually “on air without templates”. Mallwitz and Laschewsky [86] prepared ultrathin freestanding 
arrays of LbL films in the holes of electron microscopy grids (100 × 100 µm). The precise mechanism 
was not clear. Apparently, the pores were so small that the multilayer ingredients were suspended 
across the orifices instead of coating their walls, so that thin polymeric lamellae could remain trapped in 
the pores. However, the authors did not develop a strategy to extract the free-standings from the grid. 
1.3.2 Capsules 
LbL has been suggested as a technology to produce capsules as tunable drug carriers for drug delivery 
applications and cell differentiation [87,88]. Typically, the template for a hollow or loaded capsule is a 
nano- or micro-particle. Similarly to some free-standings, the template particle is sacrificial. After 
assembling the multilayers, the core is removed with a solvent. The result is a hollow multilayer shell 
which may encapsulate molecules of interest such as DNA and proteins [35,89]. The sacrificial cores 
were organic microparticles (typically 1–10 mm) such as polystyrene or melamine formaldehyde, which 
were then dissolved by organic solvents or strong acids [90]. The drawback of such an approach is that 
it employs aggressive solvents that could damage the remaining shell and destroy the functionality and 
purpose of the structure. Also, organic residues from the aggressive solvents could affect biological 
environments, making the approach less appealing for tissue engineering. Such drawbacks led to the 
introduction of other templates that could be dissolved under less aggressive conditions, such as 
mesoporous silica (with diameters of 500 nm to 5 µm, dissolved in hydrogen fluoride) and porous 
calcium carbonate (with diameters of 3–5 µm, dissolved in ethylenediamine tetraacetic acid, 
EDTA) [91,92]. 
The concept of permeability after the buildup is of great interest for drug delivery and tissue engineering 
applications: not only must a carrier be able to retain and preserve the drug but also release it when 
necessary and in a controlled fashion. The most obvious way to control such permeability is to vary the 
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number of layers assembled around a template: more layers result in higher resistance to molecular 
[93]. In order to fill the interior of a multilayer capsule with a drug, both pre- and post-loading 
encapsulation mechanisms have been exploited [94]. In pre-loading, the sacrificial core may already 
contain the molecule of interest that will remain upon dissolution, or crystals of the molecule of interest 
that can be used as a template and liquefied after assembly, without removal. In the post-loading 
approach, prefabricated hollow capsules can be loaded by altering the permeability of the capsule shell 
[95,96]. Several mechanisms based on the effect of external variables have been exploited to reversibly 
change the permeability of a multilayer shell. Multilayer capsules are inherently responsive to pH and 
ionic strength due to their interference with the electrostatic balance between layers. The permeability 
of such responsive capsules was studied by Shutava et al. [97] for capsules based on tannic acid and 
PAH. The capsules seemed impermeable to fluorescein isothiocyanate (FITC)-dextrans at neutral pH but 
became permeable at both low and high pH values. Ibarz et al. [98] reported that the permeability of 
hollow PSS/PAH polyelectrolyte capsules sharply improved upon increasing the concentration of salts. 
Temperature has also been suggested as a mechanism for post-loading. It is believed that a 
rearrangement occurs with the increase of temperature due to a tendency of shells to reduce the 
shell/water interface [99]. However it has only been achieved for temperatures as high as 50–70ºC, 
and is thus not suitable for biological applications [100-102]. For drug release, the same mechanisms 
used to post-encapsulate a molecule of interest could also be used to modulate its release in a 
controlled fashion. 
1.3.3 Tubes 
Hollow tubes of micron or submicron diameter and high aspect ratio are interesting for various 
applications. They possess a large specific surface area, making them appealing for catalysis, sensing, 
or as tissue scaffolding [103-105]. Hollow tubes could be used for encapsulation purposes and find 
applications in fields like drug delivery and as transport channels in microfluidics [106]. In biology, 
tubes of submicron dimensions are commonly found, like protein nanotubes or microtubules, and play 
an essential role in providing mechanical reinforcement in cells and small blood vessels [34]. 
Tube-like structures may be fabricated in a similar manner to other shapes templates (cylindrical in this 
case) are coated and subsequently dissolved under conditions that do not destroy the coating, thus only 
tube-like objects remain. To date, this morphology has not been extensively used and only a few reports 
exist of multilayer nanostructured hollow tubes compatible with tissue engineering applications. Tube-
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like structures have previously been fabricated by assembling polyelectrolytes onto micrometric glass 
fibers that were then dissolved by hydrogen fluoride [107]. Another strategy to fabricate tube-like 
structures is to consists in the coat porous membranes (the templates) with polyelectrolytes, which in 
turn adsorb to the wall of the pores, after which the membranes are dissolved [35]. He et al. [108] 
pursued an interesting approach by assembling tubes of PSS and PAH using the porous template 
method and transforming them into capsules by varying temperature. This structural transition from 
tubular to vesicular or vesicle-like systems is often considered for drug delivery, gene delivery, self-
assembled nanoreactors, or biochemical sensors [109]. 
In the future, multilayer tubular structures may be of significant interest in tissue engineering. For 
instance, nanostructured artificial blood vessels could be developed as an alternative to the 
conventional autologous grafting treatment by the incorporation of collagen and elastin to mimic the 
intima, media and adventitia layers [110,111]. 
1.3.4 Three-dimensional scaffolds 
LbL is not limited to the simple geometries shown so far. The technique may be applied to more 
complex geometries by using more intricate structures as templates. Porous agglomerates of particles, 
for instance, can be coated and, similarly to previous structures, the template can be chelated, leaving 
only the multilayer assembly to serve as supports for cell culture. Miranda et al. [112] and Sher, 
Custódio and Mano [113] have developed nanostructured multilayer structures based on agglomerates 
of particles of chitosan (not leachable) and paraffin (leachable), respectively. Their works, which will be 
referred to again, demonstrate that more complex and functional structures may be made using LbL. 
1.4 Application of nanostructured multilayer devices in tissue engineering 
The numerous possibilities for adjusting the chemical, physical, and mechanical properties of multilayer 
films have garnered attention from tissue engineers hoping to develop systems to control protein and 
cell adhesion and release therapeutic molecules and growth/differentiation factors. In addition, 
researchers wish to tune the surface properties by of such microsystems adding specific ligands or 
stimuli-responsive biomaterials. 
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1.4.1 Controlling cell adhesion and proliferation 
When a biomedical device enters in contact with a cell-populated biological environment, adhesion is 
the first event to occur Adhesion is the first cell event that occurs when a cell comes into contact with a 
material’s surface, which will be followed by proliferation and, in the case of stem cell cultures, 
differentiation. 
We have already mentioned that changing the mechanical properties of a multilayer film may affect the 
cellular adhesion. Schneider et al. [69] have studied the cell adhesion of HCS-2/8 human 
chondrosarcoma cells on PLL/HA films with various degrees of crosslinking. The Young’s modulus of 
the film could be varied over two orders of magnitude simply by varying the concentration of a 
crosslinker, carbodiimide, from 3 to 400 kPa for the lowest and highest concentrations, respectively. 
Increasing the film stiffness also increased the roughness and number of attached cells, showing how a 
simple modification to the mechanical properties to multilayer films can affect their response in a 
biological environment. Phelps et al. [114] also applied this concept to selectively crosslink the outer 
region of a PLL and poly(glutamic acid) (PGA) film, resulting in a rigid outer skin to promote cell 
attachment, while leaving the film (and any embedded bioactive species) unaffected. Crosslinked CHI 
and HA films have also been studied in vivo by implantation in a rat oral cavity [115]. Crosslinked films 
demonstrated up to 60% higher resistance to degradation compared to uncrosslinked samples. 
Multilayer films may be engineered with exhibiting anti-fouling properties to control cellular and bacterial 
adhesion by enhanced resistance to serum proteins. A straightforward way to build “stealth” substrates 
of any morphology is to use derivatives of poly(ethylene glycol) (PEG), a highly hydrated polymer 
effective in rendering surfaces non-adsorbent to proteins [116-118]. Another strategy is to add 
antimicrobial agents. Ettiene et al. have added defensin [119] and chromofungin [120] to the films 
constitution and reported growth inhibition up to 98% for Escherichia coli with defensin and 65% for 
Candida albicans with chromofungin. Rendering a surface non-fouling can serve as immuno-
‘‘camouflage’’ to prevent the immune rejection of implanted biomaterials or to enhance the efficiency of 
injected drug delivery vehicles. 
The application of LbL to more complex structures is highly important for tissue engineering 
applications such as cell culture platforms, where higher hierarchical organization better resembles 
native tissues. Besides bidimensional, spherical, and tubular shapes, more complex geometries such as 
agglomerated shapes can be fabricated and used as scaffolds for cell culture. LbL may be used to 
agglomerate beads [112] or to coat free-packet leachable templates [113] leading in both cases to 
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porous structures that may be populated by cells. Recently, Ye et al. [121] coated a decellularized 
porcine aortic valve with CHI and heparin showing anti-thrombotic properties. The device was shown to 
be hemocompatible by reducing platelet adhesion while allowing the proliferation of endothelial 
progenitor cells. The work of Sher, Custódio and Mano [113] introduced an interconnected three-
dimensional porous scaffold using a new drop-wise perfusion technique over a three-dimensional (3D) 
template formed by free-form moldable paraffin wax spheres held together only by the LbL coating 
(Figure 1.1). 
 
 
Figure 1.1. On the left: Individual connections between two paraffin wax particles. On the right: 
Florescence images showing the multilayered 3D assembly after leaching of the core material. 
Reprinted (adapted) with permission from [113]. Copyright 2010 Wiley-VCH. 
 
The paraffin was dissolved by dichloromethane, leaving only the assembled layers as a scaffold. SaOs-2 
human osteoblast-like cells were seeded and showed attachment and proliferation. The authors did not 
characterize the system for its mechanical properties, however. It is possible that the resulting structure 
is not adequate for applications involving high loads, such as bone regeneration, but may be more 
appropriate for regenerating soft tissues, such as cartilage or nerves. 
1.4.2 Controlling cellular metabolism: encapsulation and differentiation 
Multilayer films may be of use for cell encapsulation since the films can coat various cell types and even 
be used to build multilayered cell architectures. Developing a device that provides immune protection 
via microencapsulation as well as enhanced control of both transport and surface physicochemical 
characteristics is an important and ambitious step in the development of an effective encapsulating 
barrier. One approach to encapsulate cells is by using coated liquefied capsules. For example, Costa et 
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al. [122] have used liquefied alginate beads coated with CHI and ALG to immobilize SaOs-2 human 
osteoblast-like cells. Another cell encapsulation approach exploits cell surface charge to assemble 
polyelectrolytes. Krol et al. [123] pursued this surface charge approach with pancreatic islet cells to 
assemble a multilayer shell that effectively encapsulated them for the treatment of diabetes. By 
incubating Langerhans cells with alternating solutions of polycationic PAH or PDADMAC and polyanionic 
PSS, the authors built a barrier that covered and protected the cells. The shell was permeable and the 
cells were immunologically protected and retained their insulin secretion capability (Figure 1.2). The 
coating, however, consisted of synthetic materials which could be cytotoxic in the long term.  
 
 
Figure 1.2. On the left: Light microscopy image of trypan blue-stained islets after encapsulation with 
three pairs of polyelectrolyte layers (PDADMAC/PSS)3. On the right: Electron micrographs of 
PAH/PSS/PAH-coated islets. Reprinted (adapted) with permission from [123]. Copyright 2006 
American Chemical Society. 
 
Veeradabran et al. [53] followed a similar approach to encapsulate individual mouse mesenchymal 
stem cells (MSCs) using PLL and HA. The cells were encapsulated within shells with thicknesses of 
approximately 6–9 nm. Cell morphology and viability were maintained for up to 1 week. Encapsulation 
has tremendous potential for the maintenance and differentiation of stem cells. LbL allows the 
encapsulating shells to be tuned to achieve optimal permeability. Nutrients, waste, and chemical 
differentiation factors could be exchanged between the cell and its external environment and the 
differentiation process triggered on demand. Other approaches have been introduced to drive the 
differentiation of cells by incorporating specific factors in a multilayer formulation. Dierich et al. [124] 
presented a formulation with poly(lactic-co-glycolic acid) (PLGA), PLL and poly(L-lysine succinylated) 
(PLLs), along with bone morphogenetic proteins (BMPs) and tissue growth factors (TGFs). Using this 
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system, they were able to drive the differentiation of embryoid bodies into cartilage and bone. Another 
interesting approach is to embed differentiation factors into spherical shapes, which have a higher 
surface area and improved accessibility compared to planar substrates. Facca et al. [125] created 
capsules templated in silica particles (1 µm) coated with a similar formulation. The incubation with 
embryonic stem (ES) cells led to both in vitro and in vivo bone formation. It is unclear if the delivery of 
BMP was due to the degradation of the capsules or to their internalization by the cells. The latter option 
is a possibility: Rivera-Gil et al. [126] have recently demonstrated the internalization of multilayer 
capsules by embryonic NIH/3T3 fibroblasts. 
These encapsulation methods have proven to be novel approaches to shield cells from certain external 
factors and to controllably differentiate stem cells either by taking advantage of the permeable nature of 
multilayer films or by targeting the intracellular environment directly. Therefore, LbL structures have 
potential use for tissue engineering applications where cell transplantation or damaged tissue 
replacement is necessary. 
1.4.3 Biomimetic and “intelligent” and substrates 
Systems used for biomedical and tissue engineering applications must be biocompatible and not trigger 
toxic, inflammatory, or rejection responses. The structures and properties found in natural materials 
have inspired the development of multilayer systems with higher degrees of functionalization. One 
approach is to incorporate natural materials directly into multilayer systems. For instance, 
nanostructured films containing CHI retain some of CHI’s anti-microbial 
properties [127]. Another approach consists of integrating ingredient molecules, such as bioactive 
ligands, that can drive specific phenomena mimicking their native function. Picart et al. [128] 
incorporated arginine-glycine-(aspartic acid) (RGD) a cell adhesion promoter, with the substrate using 
PLL and RGD-grafted-PGA in the terminating layer. The proliferation of primary human osteoblast cells 
was enhanced on for films containing RGD compared to films without. RGD-enhanced proliferation was 
observed not only for simple adsorbed layers, but also for crosslinked films. To mimic the 
microenvironments of bone marrow and the thymus, Lee and Kotov [129] incorporated delta-like 1 
Notch ligands (DL-1) at the surface of PEM films. The Notch ligands stimulated hematopoietic stem 
cells (HSCs) to differentiate into T-cell lymphocytes and progressively develop their own ECM. 
Adding stimuli-responsive materials to multilayer formulations offers additional functionalization, by 
controlling surface properties and the conformational rearrangement of molecular chains. Stimuli-
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responsive properties have been engineered into several types of systems, such as grafted surfaces and 
hydrogels [130], and are beginning to be used in multilayer systems for controlling biological events 
such as cell attachment/detachment. As mentioned before, pH and ionic strength may be useful stimuli 
response mechanisms for drug delivery applications, but changes of these variables beyond 
physiological conditions may be too aggressive for cell cultures. Temperature changes, on the other 
hand, are usually more tolerated by cells for temperatures up to 37°C. Costa et al. used an ELR 
containing RGD to generate bilayer coatings [131] and multiple stimuli-responsive multilayers [78] with 
enhanced cell adhesion. By varying the pH, ionic strength and temperature of CHI/ELR films, it was 
possible to switch the wettability of the substrates from a moderately hydrophobic character (contact 
angle around 70º) to a superhydrophilic (contact angle of 0º) (Figure 1.3). 
 
 
Figure 1.3. Physical changes induced in ELR modified surfaces. (a) Wettability variations with different 
temperatures. Reprinted (adapted) with permission from [131]. Copyright 2009 Wiley-VCH. (b) 
Topography at distinct pHs. Reprinted (adapted) with permission from [78]. Copyright 2011 Wiley-VCH. 
 
However, the variation was observed for values not suitable for biological studies: pH 11; ionic strength 
0.15 M; and 50 ºC. Nevertheless, at physiological conditions, the cellular adhesion of a SaOs-2 
osteoblast-like cell line was higher than in films ending in CHI or a scrambled non-functional RDG 
sequence. Martins et al. [73] then described a multilayer system of ALG and PNIPAAm-grafted CHI to 
reproduce the cell-sheet technology [132]. SaOs-2 human osteoblast-like cells seeded onto coated 
substrates ending in the modified CHI were allowed to achieve confluence at 37ºC. Upon decreasing 
the temperature to 4ºC, the peeling effect enabled cells to be detached from the surface as a thin layer. 
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Zahn et al. [133] demonstrated a similar approach by using the ion-induced detachment of myoblast 
layers by the eroding effect of ferrocyanide on PLL and HA multilayers. Incorporating biofunctional 
ingredients and bioinspired concepts into multilayer systems has enhanced the functionality of such 
systems and is producing promising results for tissue engineering applications. 
1.4.4 Multilayers in controlled drug delivery 
Current advances in biomedicine have been driven by the need to develop systems that can effectively 
encapsulate, protect and deliver an active agent with specific kinetics [134]. At the same time, distinct 
classes of biomolecules are widely available and related to the treatment of several diseases or the 
development of new biomedical devices. Ideally, a biomolecule carrier should act as a compartment 
with tunable drug permeability. The multilayered capsule systems described above are ideal for such 
drug delivery applications, including the associated methods to load and control the release of 
therapeutic molecules and growth/differentiation factors. The adequate loading efficiency and controlled 
release of the molecules of interest, such as growth factors, are necessary to ensure the survival of cells 
in tissue engineering applications. Erel et al. [135] fabricated hydrogen-bonded multilayers of micelles 
of poly[2-(N  - morpholino)ethyl methacrylate-block-2-(diisopropylamino)ethyl methacrylate] (PMEMA-b   -
PDPA), a dicationic block copolymer, encapsulating pyrene onto a surface with tannic acid. The films 
were dual responsive and released pyrene upon increasing either temperature or pH. Crouzier et 
al. [136] developed crosslinked films of PLL and HA as reservoirs loaded with a recombinant human 
BMP-2 (rhBMP-2) to control the differentiation of myoblasts into fibroblasts. They demonstrated that the 
amount of loaded rhBMP-2 could be regulated by film thickness and assembly conditions. Also, the 
rhBMP-2 loaded in the films retained its bioactivity and was protected for three consecutive cultures. 
Another particular area being targeted for multilayer drug delivery systems is cancer treatment, where 
the uncontrolled systemic administration of chemotherapeutics comes with several drawbacks to the 
patients. Zhao et al. [137] developed CHI/ALG microcapsules loaded with doxorubicin, an effective 
anticancer drug, and demonstrated that the apoptosis of HepG2 tumor cells could be induced in vitro 
by incubating with loaded microcapsules. A suspension of microcapsules was also injected directly to 
tumors induced in mice, inducing a higher tumor inhibition compared to free drug administration. De 
Geest et al. [138] demonstrated that polymeric multilayer capsules (PMLCs) increase antigen delivery 
toward antigen-presenting cells in vivo, enforcing antigen presentation and stimulating T-cell 
proliferation. Poon et al. [139] recently addressed the stability and biodistribution of electrostatic self-
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assembled nanoparticles for systemic administration and off-body tracing by imaging techniques. They 
provided evidence of the importance of a larger number of layers and the role of the terminating layer in 
terms of functional retention. A formulation of PLL and dextran films topped with a final layer of HA 
assembled onto gold nanoparticles or quantum dots. In mice, these coated particles had a blood 
elimination half-life of 9 hours and low liver accumulation. These reports represent a step forward the 
use of LbL systems in in vivo applications such as cancer treatment, and augment the mounting 
evidence that such systems can be designed to have minimal or no negative effects on living organisms. 
1.4.5 Biomineralized multilayers 
Developing systems with LbL technology to facilitate bone regeneration or to improve the mechanical 
properties of substrates is an active area of research. Such research is adding versatility to 
biomineralization processes by developing controlled nanostructured assemblies that tune the kinetics 
of calcium phosphate, apatite formation, and ultimately bone regeneration [140-142]. 
Bioactive coatings on orthopedic implants may create an environment compatible with osteogenesis 
and provide bone-friendly interfaces for forming natural bonding junctions between the implant and host 
bone [143]. Couto, Alves and Mano [33] developed hybrid films of CHI and bioactive glass 
nanoparticles that mimicked the brick-and-mortar layered structured of nacre. They showed that the 
incorporation of BNPs rendered the substrates prone to mineralization upon immersion in simulated 
body fluid (SBF) solution. The mineralization was also more pronounced with an increasing number of 
layers. Fukui and Fujimoto [144] described a hybrid nanocapsule templated in phospholipids that 
encapsulated phosphate ions (Figure 1.4). The phospholipids were coated using CHI, dextran or DNA 
and then incubated in a solution containing calcium ions. They demonstrated that the chemical surface 
change could influence the counter-ion diffusion and therefore the mineralization rate. 
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Figure 1.4. Effect of incubation time on the formation of calcium phosphate crystals using liposome 
and liponano–CHI–DNA templates. Each reaction was carried out at pH 7.0 and pH 10.0 for 18 h, 
using calcium chloride (CaCl2) and disodium phosphate/monosodium phosphate (Na2HPO4/NaH2PO4) 
as ion species. Reprinted with permission from [144]. Copyright 2011 American Chemical Society. 
1.5 Conclusion 
For the past 20 years, the use of LbL as a processing technique has evolved from traditional surface 
modification on two-dimensional (2D) planar surfaces to three-dimensional (3D) environments. The 
procedure can even be performed using mild conditions and in a cell-friendly environment. The most 
recent results show that LbL may be used to encapsulate cells, control cell adhesion and metabolism, 
tune the release of encapsulated molecules, render a substrate with smart responsiveness, and 
enhance mineralization. We believe that the technology will follow two trends in the near future. The first 
trend will involve using existing nanostructured multilayer devices in more in vivo applications that take 
advantage of the spatial organization and bioactivity, adjustable stiffness and chemistry, or adjustable 
stiffness and bioactivity, of multilayer devices. The other trend will involve the development of more 
intricate structures with hierarchical complexity embedded in devices with multiple functionalities, such 
as controlling the diffusion of gases and nutrients to cultured cells. Higher levels of functionalization 
should enable the development of systems exhibiting intelligent responses to external stimuli. For 
example, drug release systems could respond to an external stimulus by releasing encapsulated drugs 
and therefore influencing cellular metabolism on demand. The inclusion of specific ligands or metallic 
particles could enable the development of targeted delivery strategies for cell therapies and transplant. 
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In summary, research on nanostructured multilayer devices will likely result in innovative low-cost 
technologies to meet critical biomedical needs. 
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 Chapter 2. Polyelectrolyte multilayered assemblies in biomedical 
technologies2 
Abstract 
Layer-by-layer (LbL) was first introduced as a surface modification technique based on the sequential 
spontaneous adsorption of at least two distinct materials to planar substrates. In the last two decades, 
this technique has evolved to the coating of more convoluted geometries with high levels of tailored 
functionalization or with structural purposes. In this review, the potential uses of LbL films in biomedical 
engineering based mainly in the assembly of polyelectrolytes are reviewed. Examples of recent 
developments are provided, from the modification of substrates to improve their biointegration or to add 
specialized properties, to the three-dimensional extrapolation of this technique as more complex 
structures for cell seeding, drug delivery devices, biosensors and customizable microreactors. Future 
strategies and opportunities are compared with current medical and laboratorial methodologies. 
Through them, it is expected that LbL will contribute greatly to the development of new functional 
devices with high perspectives of return for the administration of active agents, biosensing and 
construction of microtissues and disease models in laboratory. 
                                                 
2
 This chapter is based on the following publication: 
Costa R. R., and Mano J. F., Polyelectrolyte multilayered assemblies in biomedical technologies, submitted (2013). 
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2.1 Introduction 
Surface modification is a prominent field of engineering of utmost importance for biomedical 
applications. When having in mind the contact of a medical device with the human body – resulting 
from surgical or topical implantation – the reaction to this “foreign body” must be considered. The 
surface of a medical device is the first contact with the biological environment. Upon contact, a series of 
bio-recognition processes (such as protein/cell adhesion and inflammatory response) occur between 
the surface of biomaterials and the biological environment [1-5]. It is evident that such interface defines 
whether the device will be accepted or rejected by the body, and therefore the surface properties play 
an extremely important role in its success. 
Surface engineering has been commonly achieved through techniques such as plasma [6], polymer 
grafting [7], micro/nanofabrication [8] and Langmuir-Blodgett [9]. Each one of them, different as they 
may seem, often aim for the same goal: to modify the characteristics of a selected surface while 
retaining the properties of the bulk materials. Using the example of artificial prosthesis, the surface 
could be improved for better biointegration through the enhancement of its antimicrobial properties, 
biocompatibility, degradation resistance and drug loading capability [10-12], while preserving the native 
mechanical properties. 
It is notable how surface modification in biomedical applications has motivated so much interest in the 
scientific community. Nowadays, modifying a surface is no longer limited to the improvement of an 
implant’s integration. Technological ramifications have allowed producing surfaces that respond to 
stimuli, tune cell adhesion, mineralize and adjust the permeability of active agents’ carriers [13-16]. In 
particular, surfaces containing nano- or micro-scale features in a well-controlled manner have been 
shown to influence cellular adhesion and metabolism [17]. In this sense, surface modification has also 
become a synonym of “control”. 
Taking Nature as the greatest of inspirations, scientists and engineers have developed many biomimetic 
concepts based on the constant evolutionary improvement of designs and functionalities of natural 
occurring materials [18]. One example is the layered organization found in natural materials, such as 
the case of nacre found in the shells of sea animals. Nacre consists in a hierarchical and layered 
structure of calcium minerals capable of dissipating high amounts of mechanical energy [19-21]. In an 
attempt to mimic natural layered structures, a strategy consisting in the alternate adsorption of 
polyelectrolytes onto solid surfaces – polyanions and polycations – was introduced. In this process, two 
or more constituents can be added on top of a substrate sequentially with nanometric precision as 
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many times as desired, until stacks of numerous layers give rise to multilayered thin films. This concept 
was first introduced by Iller [22] in 1966, who assembled alternate layers of positively and negatively 
charged colloidal particles (such as silica and alumina) onto solid smooth surfaces. Later, Decher and 
Hong [23] expanded this concept using anionic and cationic bipolar amphiphiles containing rigid 
biphenyl cores, and adsorbed them alternately onto a positively charged planar surface. They 
demonstrated the construction of a film with 35 amphiphile layers accounting for a total thickness of 
170 nm. After completion of their follow-up work [24,25] this strategy became known as layer-by-layer 
(LbL). Since its introduction, it has become one of the most prominent surface engineering strategies in 
materials science, capable of providing a reliable, easy, versatile and cost-effective way of tuning 
interfaces. Furthermore, a wide variety of constituents can be selected. The only requirement is that 
multipoint interactions – such as electrostatic contacts, van der Walls forces, and hydrogen bonding – 
exist between each of them to enable their sequential adsorption [1,26-30]. It is a simple and versatile 
technique that allows producing robust coatings, even in substrates with convoluted and three 
dimensional geometries. Harmful solvents (e.g., crosslinkers, organic solvents) and harsh processing 
conditions (e.g., high temperatures, extreme pH values) are seldom required, making LbL an attractive 
technique for biological-based applications. Specialized biomaterials and ligands, such as cell adhesion 
enhancers, may be used in order to mimic biological structures and functions, rendering a substrate 
more instructive for cell behavior [27,31]. Multilayered films can also act as drug reservoirs: active 
agents may be embedded in the multilayer constitution while preserving their bioactivity, especially 
when the protection of drugs until their delivery is desired [32,33]. 
Due to the broad scope and fast development of LbL, dozens of review articles have contributed to this 
topic in the last decade. In 2006, Kotov and coworkers [30] focused on a comprehensive review about 
the bioactivity of multilayer films for biomedical applications, such as superhydrophobic surfaces, 
biosensors, drug delivery, protein/cell adhesion, mediation of cellular functions and implantable 
materials. These authors estimated that LbL could be extrapolated to the third dimension in the 
following years in order to conceive scaffolds with specific embedded growth factors, receptors, or 
ligands. Their expectations have been met as several works have showed the production of complex 
geometrical structures using this technology. Another review by Picart and coworkers [1] in 2010 
reminded us of the fundamentals of LbL and how the experimental conditions affect the final properties 
of a multilayer films. Namely, the mechanism of exponential growth, which describes an alternative non-
linear model of thickness growth per layer, was reflected upon. In 2012, Tong, Song and Gao [34] 
reviewed the construction of spherical containers (namely capsules) for drug delivery, biosensing and 
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confining chemical reactions, showing how LbL has surpassed the simple idea of improving interfaces 
and creating functional surfaces. 
In this review, we intend to discuss the state-of-the-art developments of LbL-based strategies, especially 
those with applicability in the biomedical field. Through selected recent examples from the literature, we 
will discuss how LbL has been established as a conventional surface modification technique in little 
more than 20 years thanks to this technique’s capability to address a wide range of biomedical 
applications. Simultaneously, it is our intention to open the question of whether LbL, as it stands now, 
surpasses other existent technologies and what potential is still reserved for the future development of 
multilayered biomedical devices with value for biomedical applications. 
2.2 Fundamentals of the layer-by-layer technique 
2.2.1 Layer-by-Layer as a tool for surface modification 
LbL adsorption relies in the interaction between two or more distinct materials that possess 
complementary interactions, i.e. that the properties of both materials result in their mutual attraction. 
The most exploited buildup mechanism of multilayer films is the assembly driven by electrostatic 
interactions of oppositely charged components, as depicted in Figure 2.1.  
 
 
Figure 2.1. Schematics of layer-by-layer adsorption of polyelectrolytes based on an electrostatic 
mechanism deposition. The procedure is based on the contact of the substrate with a solution with an 
oppositely charged polymer. In the depicted example, negatively charged round substrates are 
submerged in an aqueous solution of a polycation, followed by a solution containing a polyanion. Each 
adsorption stage is separated by a rinsing step, to remove loosely adsorbed molecules. 
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Besides electrostatic assembly, constructing multilayer films may rely on short-range interactions, such 
as van der Walls forces and hydrogen bonding [35-37]. Nowadays it is acknowledged that the gain in 
entropy due to the release of counterions plays a key role in the LbL adsorption process. Its outcome is 
often the organization of the layers in a more coiled and interdigitated conformation, leading the 
polyelectrolyte molecules to lose degrees of freedom [38-40]. 
Many types of charged molecules and nano-objects are suitable for deposition by electrostatic 
interactions, from nanoparticles [41-43], carbon nanotubes [44,45], clay platelets [46], 
dendrimers [47,48], polysaccharides [49-51], polypeptides [52-54], nucleic acids [55,56] and viral 
components [57,58]. Special emphasis has been given to synthetic polyelectrolytes, such as the widely 
investigated poly(styrene sulfonate)/poly(allylamine hydrochloride) (PSS/PAH) system – considered so 
far as a model of multilayered thin films [1]. Synthetic materials are usually highly versatile materials 
with well-defined structures with tailored properties, such as molecular weight and charge density [59]. 
Thanks to their tailored properties these systems have been used as a means to determine the 
influence of several construction conditions involved in the LbL buildup. For example, it is known that 
varying the pH of weak polyelectrolytes also varies the protonation state of their ionizable groups, this 
way influencing the availability of charged groups; additionally, a moderate ionic strength can help 
reducing electrostatic repulsion between charged groups and favor electrostatic assembly [60-62]. 
Another parameter is temperature, which increases the mobility of the adsorbed molecules and the 
chances of finding more energetically optimal binding sites at the deposition site [63]. 
Synthetic materials have served their purpose, but for biomedical applications materials that exhibit 
biological features should be more appropriate. Natural materials are intricate structures which have 
risen from hundreds of millions of years of evolution. Comparing to our current technology, Nature was 
able to conceive structures more multifaceted than man-made materials, forming complex arrays, 
hierarchical structures and multifunctionality [11,64,65]. Natural materials often avoid triggering 
chronic or immunological reactions and toxicity, and are therefore appropriate multifunctional 
ingredients for constructing multilayer films and coatings with improved interface with the biological 
environment [66]. 
2.2.2 Moving LbL toward faster production 
The number of parameters that may influence the buildup of multilayer films is broad: LbL requires 
complementarity between the multilayer constituents, but the strength of the forces driving the 
assembly may be influenced by other parameters. Intrinsic properties – such as the molecular weight of 
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polymers or size of inorganic particles, charge density and polarity – and external properties – such as 
temperature, pH of the solvent and ionic strength – may facilitate or hinder a constituent’s adsorption. 
The result depends on the original properties of the materials. For instance, varying the pH of a weak 
polyelectrolyte above or below its acidic constant (pKa) will greatly impact on its overall charge density 
and ultimately electrostatic interactions [67,68]. Therefore, the construction of multilayer films based on 
new and not much used constituents may require a thorough preliminary screening process. 
Nonetheless, as soon as this temporal hardship is overcome, the optimal conditions will be determined 
and they can be applied in the mass-production robust nanostructured coatings. 
Despite all the presented advantages of LbL, this technique has one fundamental drawback: it is 
generally a time-consuming process. To construct a multilayer film, the adsorption time to assemble a 
single layer may vary with the nature of the constituents. A standard time of 10 minutes is usually 
acceptable, plus a rinsing step that may take an equivalent time scale. Surprisingly, the effect of 
reducing the processing times (sacrificing some mass deposition) was never properly addressed as a 
way to accelerate the fabrication of the films. In a scale-up perspective, and when large numbers of 
layers are required, automated devices have been proposed for the production of multilayer films. The 
most common devices are dipping machines, which allow parallel construction of several films at once. 
They function similarly to manual dipping in every aspect but its automated nature permits not only the 
repetition of multiple adsorption cycles over long construction times but also the parallel assembly of 
multiple films. This way, thicker multilayer films with several micrometers can be obtained in high 
quantities [69-71]. 
One could argue that, although many films can be fabricated in parallel, the fabrication time is still too 
long. An alternative procedure is a sputtering-based strategy which, rather than dipping, sprays the 
surface. The fabrication time of the latter has been reported to be greatly shortened due to enhanced 
adsorption by the spray pressure. Schlenoff, Dubas and Farhat [72] showed the construction of 
poly(diallyldimethylammonium) chloride/poly(styrenesulfonate) (PDADMAC/PSS) multilayer films by 
spraying the respective solutions onto silicon wafers. For that purpose, they used a sprayer as simple as 
a hand-operated “plant mister”, making it possible for each layer to be adsorbed in a matter of seconds. 
Their morphology, uniformity, and chemical composition were similar to coatings made by dipping. 
Izquierdo et al. [70] followed a similar spraying strategy for the assembly of PSS/poly(allylamine) 
hydrochloride (PAH) multilayers, where they reiterated the findings of the previous authors. 
Although the process of LbL started as being an inherently slow processing method that requires a 
lengthy preliminary screening stage, these drawbacks have been addressed and reduced to a minimum 
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in the last decade [73]. Furthermore, the use of automated devices, including unconventional 
sputtering-based approaches, have made it possible to construct multilayers a lot faster (about a factor 
of 250 in the latter example) and are appropriate for future industrial mass-production with low risk of 
stock shortage. 
2.3 Surfaces with specialized properties 
2.3.1 Surfaces containing adhesive constituents 
Multilayer films and coatings can exhibit higher forms of specialized properties by selecting functional 
materials as their components. One such example is the use of polymers that are known to exhibit 
adhesive properties in nature. Without much effort, a great source of adhesive natural materials can be 
found in the sea, such as the polysaccharides chitosan (CHI) and alginate (ALG). CHI is derived from 
chitin, found in the exoskeleton of shellfish or crustaceans, like shrimp and crabs, and ALG is a 
structural component found in brown algae. These two polysaccharides share a marine origin and 
exhibit important properties for biomedical applications – biocompatible, adhesive, nontoxic, 
bacteriostatic, fungistatic, antimicrobial and hemostatic [66,74] – which proved to be useful in drug 
delivery, implants and wound dressings [75-77]. Another strategy to obtain adhesive materials is to 
produce synthetic analogues based on natural systems, such as the adhesive proteins rich in 3,4-
dihydroxy-phenylalanine (DOPA). DOPA, also a precursor of dopamine, can be found in the threads 
expressed by mussels, which have been shown to attach to many types of inorganic and organic 
surfaces thanks to the exhibition of catechol hydroxyl groups [78,79]. Catechol-modified biomimetic 
polymers can be used to aid in the construction of the multilayer film itself. As demonstrated by 
Lee et al. [80] catechol-functionalized poly(ethylenimine) (PEI) and hyaluronic acid (HA) adsorbed could 
be adsorbed onto any sort of substrate, namely poly(tetrafluoroethylene) (PTFE), silicon and gold. 
Karabulut et al. [81] exploited the iron(III) (Fe3+) crosslinking mechanism of catechol groups to tune the 
mechanical properties of films made of carboxymethylated cellulose nanofibrils modified with dopamine. 
The adhesive forces were measured using a silica probe demonstrating that, in the presence of Fe3+, 
dopamine-functionalized films are more resistant to deformation than films prepared from unmodified 
nanofibrils. Wu et al. [82] prepared multilayers of PAH and poly(acrylic acid) (PAA), the latter modified 
with dopamine, and crosslinked the films by an oxidation reaction mediated by sodium periodate for 
better stability. These coatings could be peeled by a sodium hydroxide solvent, providing undamaged 
free-standing membranes. Curiously, DOPA and its analogues have been used as a mechanism to 
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improve the construction of LbL films, rather than increasing adhesiveness to surrounding tissues. It is 
however expectable that the adhesiveness of such films is indeed augmented, judging by how catechol-
modified gels and membranes behave.[83-85] 
Adhesive materials can be found in places other than the sea. For instance, Costa et al. [86] assembled 
multilayer films made of CHI and phosphonate-modified levan, a fructan exopolysaccharide produced by 
the halophilic bacterium Halomonas smyrnensis sp. nov. AAD6T. The adhesiveness of this polymer 
comes from their hydroxyl groups that form strong adhesive bonds with various substrates [87,88]. The 
adhesiveness of these films was verified by lap shear bonding stress between two overlapped films with 
100 bilayers assembled onto glass slides, meaning that no peeling was attempted. In comparison to 
CHI/ALG films used as controls – two polysaccharides often regarded as good natural adhesives – the 
detachment force of the levan-functionalized surfaces was about 3 times higher than the control 
(2.5±0.3 MPa and 0.9±0.1 MPa, respectively). The cell adhesion for 24 h conducted using a fibroblast 
cell line also showed that cells were sensitive to the incorporation of levan and adhered mostly to these 
coatings (110 cells∙mm-2 in comparison to 20 cells∙mm-2 in the control). 
The technology of LbL films using adhesive materials has the potential to address issues related to 
wound healing, namely in the performance of medical adhesives. Many synthetic adhesives currently 
approved present limitations, which include poor adhesion in the presence of biological fluids, allergic 
response and inflammation [89]. Therefore, the use of natural adhesive constituents may help in the 
development of wound healing dressings and surgical biomaterials with improved adhesiveness to 
organs and tissues. 
2.3.2 Mineralization control 
Bone regeneration and integration is probably one of the most researched areas in biomedical 
engineering and a variety of systems have been proposed for this purpose [90-92]. Using the recurrent 
example of orthopedic bone implants, coatings that exhibit biomineralization capability may provide a 
favorable environment for osteogenesis and a bone-friendly interface between the implant and host’s 
bone [93,94]. 
Biomineralization can be achieved following two strategies: (i) addition of inorganic components (e.g. 
silicate-based particles), or (ii) incorporation of osteoinductive molecules (e.g. polymers and proteins). 
An example of (i) are bioactive glasses. These materials have been subject of much research in the last 
decades because when in contact with physiological or simulated body fluids they form a surface 
apatite layer.  Such apatite layer permits an adjusted bonding of the implant to bone in vivo, preventing 
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the formation of a fibrous capsule and promoting a stronger osseo-integration. Ultimately, this layer can 
bind to the collagen of connective tissue cells, like osteoblasts [95]. In the case of (ii), bone 
morphogenetic proteins (BMPs) are well-known growth factors which have been widely used for bone 
repair and are known to stimulate the proliferation, migration and differentiation of stem cells [96]. 
One would not expect LbL devices to be used as systems aimed to integrate or regenerate a hard tissue 
such as bone, since most polymeric multilayer films do not exhibit mechanical properties equivalent to 
the bone. However, it may be used to engineer an appropriate interface between an implantable device 
and bone, since LbL allows incorporating distinct classes of materials in their structure. Thus, strategies 
can be devised to convert a “soft” multilayer to the purpose of triggering biomineralization. 
Couto, Alves and Mano [41] constructed multilayer films that contained bioglass nanoparticles as an 
inorganic ingredient that provided biomineralization capability in vitro. The synthesized nanoparticles 
had a charge of -25 mV, which enabled them to interact with the polycationic CHI via electrostatic 
interactions. Using a quartz-crystal microbalance (QCM), they demonstrated that films up to 10 bilayers 
could be successfully assembled. Using a simulated body fluid (SBF), they showed that it was possible 
to induce the formation of apatite crystalline layers, similar to the ones found in the inorganic 
component of bone. The mineralization was also more pronounced with increasing number of layers. 
Fukui and Fujimoto [97] described the conception of a nanocapsule templated in phospholipids that 
encapsulated phosphate ions. The phospholipids were coated using CHI, dextran sulfate or DNA and 
then incubated in a solution containing calcium ions. They demonstrated that changes in the surface 
chemistry could influence the counterion diffusion and therefore the biomineralization rate (Figure 2.2). 
Despite the efforts made so far, biomineralization-inducing multilayers still remain a largely unexplored 
approach. Most likely the reason lies within the fact that immobilizing particles inside a multilayer 
structure is not an easy task. While a polymeric film may have only a few nanometers but an 
interpenetrated structure, a nanoparticle can be very large in comparison. Thus, it is likely that the 
production of biomineralizing surfaces will be limited to the loading of osteoconductive agents. 
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Figure 2.2. Formation of calcium phosphate over the surface of polysaccharide-coated liposomes. (a) 
Liposomes encapsulating phosphate ions (PO4
3-) are coated with polysaccharides. Polycations (orange) 
and polyanions (green) are adsorbed sequentially over the surface and placed in a medium containing 
calcium ions (Ca2+), which concentrate around the negatively charged molecules. The counter-diffusion 
of ions across the wall leads to the formation of a calcium phosphate mineral interface. (b) Field 
emission TEM image of a liposome coated with CHI and DNA after inducing mineralization at pH 10 for 
18 h, exhibiting a thick wall. (c) Energy dispersive X-ray analysis (EDX) exhibiting calcium and 
phosphate peaks. Adapted with permission from ref. [97] Copyright 2011, American Chemical Society. 
 
For instance, Hu et al. [98] took another approach by adding bone morphogenetic protein-2 (BMP-2) 
and fibronectin to a CHI/gelatin (GEL) multilayer formulation. Disks and rods of a titanium alloy were 
first subjected to the adsorption of a layer of GEL conjugated with dopamine – a fine example of how 
dopamine and its analogues can be used as the starting layer of any substrate, as previously 
demonstrated by Lee et al. [80] Next a combination of CHI, unmodified GEL, recombinant human bone 
morphogenetic protein-2 (rhBMP-2) and fibronectin was used. The in vitro release of rhBMP-2 showed 
that 30% of the initial adsorbed amount was released within 2 hours and around 50% after 6 days. After 
2 weeks, around 20% was still retained at the surface. Mesenchymal stem cells (MSCs) were seeded 
onto these substrates up to 21 days and showed higher production levels of alkaline phosphatase (ALP), 
mineralization and expression of osteogenic genes compared to a control of bare titanium substrate. In 
vivo studies using a rabbit femur model were carried out up to 12 weeks and were shown to increase 
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the density and formation of bone. More examples of multilayered systems containing BMPs will 
provided later in this review, in the context of drug delivery systems (Section 2.5.3). 
2.3.3 Stimuli-responsive surfaces 
Higher degrees of functionalization can be achieved by introducing stimuli-responsive constituents. 
Usually, a surface – modified or not – is perceived as a static interface, that is, no structural changes 
occur upon switching environmental parameters. However, stimuli-responsive surfaces are dynamic and 
undergo conformational changes upon variations of specific external factors. An elegant example found 
in Nature exhibiting such mechanism is skin. Skin is the largest organ of the human body and it can be 
perceived as the ideal multifunctional membrane that responds to every variation in its environment – 
heat/cold, humidity, chemical/mechanical stress and even light [99]. Exploiting external stimuli has 
been extensively researched for several devices, such as grafted surfaces and hydrogels [100], but not 
as much in multilayer systems for controlling biological events, like cell attachment/detachment 
mechanisms. Some works described films made of CHI and elastin-like recombinamers (ELRs), a 
recombinant class of elastin-like polymers (ELPs). ELRs are genetically modified polypeptides that 
undergo a phase transition when in solution dependent on temperature: below a critical transition 
temperature, the free polymer chains adopt random coil conformations; above it, they fold into an 
organized structure known as β-spiral [101]. Using this polysaccharide/polypeptide formulation, both 
bilayer coatings [102] and multiple responsive multilayers [27] were made. In the latter, variations of 
pH, ionic strength and temperature triggered a transition of wettability between a moderately 
hydrophobic character (contact angle around 70º) to a superhydrophilic surface (contact angle of 0º). 
These variations were observed above pH 11, ionic strength 1.25 M in NaCl, and temperature of 50ºC. 
The genetic nature of ELRs permitted the inclusion of the cell adhesion sequence arginine-glycine-
aspartic acid (RGD), the minimal sequence required for recognition by cell membrane integrins [103]. 
The adhesion of osteoblast-like cells was higher in these films than in films ending in CHI or a 
scrambled nonfunctional RDG analogue. Although cell adhesion was influenced by the exhibition of 
specialized bioactive groups, the possibility to use external stimuli to control the attachment or 
detachment of cells was not explored. The reason lies in the fact that the variation of the surface 
properties evaluated in terms of wettability variations only occurred at values that are simply not 
suitable for biological experiments. However, in another report from the same group [104], a multilayer 
film made of ALG and CHI modified with poly(N - isopropylacrylamide) (PNIPAAm) was developed to 
reproduce the cell-sheet technology developed by Okano and coworkers [105], which allows a thin layer 
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of cells to be harvested for reculture, transplantation or differentiation. Human osteoblast-like cells were 
seeded until confluence was achieved at 37ºC and the temperature was lowered afterwards to 4ºC. 
Cells started to peel and detached from the surface as a thin layer, which occurs due to the extension 
of the PNIPAAm chains and increase of hydrophilicity. These cell-sheets could be harvested and seeded 
again in a different culture support to demonstrate their viability. A similar approach was demonstrated 
by Zahn et al. [106] who used an ion-induced detachment of myoblast cell layers through the eroding 
effect of ferrocyanide on PLL/HA multilayers. 
Temperature, ionic strength, and pH can be easily manipulated to influence the response of 
“intelligent” materials contained within the LbL formulation. However, sharp variations of the last two 
may be aggressive to cells as they are not capable of withstanding hypotonic/hypertonic and extreme 
acid/alkaline conditions. Temperature changes, on the other hand, are usually more tolerated by cells 
for temperatures up to 37ºC,  and the example of cell-sheet technology is a fine example of that [107]. 
Another stimulus that may be exploited is light. The use of light would be a convenient way of 
controlling a surface’s properties since it can be easily emitted or blocked on demand. Moreover, 
biomedical applications could benefit from its noninvasive character, capability of deep tissue 
penetration and fine spatial control over its intensity [108]. One example of light-responsive films is the 
work of Ahmad, Saqib and Barret [109], who developed films containing anionic azobenzene-
functionalized polyelectrolytes. The polyelectrolytes were distinct and exhibited different 
hydrophilicity/hydrophobicity character, which ultimately reflected upon the ultraviolet (UV)-visible 
absorption spectrum of each film. Azobenzenes linked to hydrophilic groups exhibited higher absorption 
maxima (423–440 nm) than azobenzenes linked to hydrophobic groups (407–414 nm), in both cases 
values slightly higher than the maximum UV wavelength of 400 nm. Multilayer systems that respond to 
light are seldom referred in the literature. This may be related to the fact that most light-sensitive 
molecules respond mostly to light in the UV spectrum, which is harmful to biological cells. Nevertheless, 
the presented example shows how the inclusion of light-responsive groups linked to distinct radical 
groups may help shifting the maximum absorption wavelengths toward the visible spectrum. 
2.4 Coating of implantable devices 
The modification of implantable medical devices is perhaps the most evident application resulting from 
LbL strategies in the biomedical field. The versatility of LbL and the possibility of developing surfaces 
with specialized properties have already been applied as a means to improve the integration and to 
adjust the biorecognition of implantable devices, such as prosthesis and stents. Currently, most of the 
Chapter 2. Polyelectrolyte multilayered assemblies in biomedical technologies 
 
50 
improvements in the performance of an implant are possible thanks to the development of more 
anatomically-shaped geometries. This is particularly evident in the case of bone implants, which are 
increasingly easier to attach to the bone and provide more comfort for the patients [110-112]. Besides 
design, it is known that an efficient integration is determined mainly by the surface characteristics of the 
implantable device (surface microstructure and chemical/biochemical nature), which influence the 
subsequent adhesion of proteins and cells. It is common to find metallic implants (e.g. steel or titanium) 
during surgical interventions [3,10,113]. However, it is difficult to assume that a metal with no 
resemblance to biological materials provides appropriate integration and recognition by the body. 
Therefore, LbL constitutes an adequate methodology to modify the surface of implantable devices, as it 
could be employed regardless of their geometry. 
2.4.1 Coating of synthetic implantable devices 
Most metallic alloys are negatively charged, like other common materials found outside the medical 
field (e.g., glass), and thus provide support for the formation of a multilayer coating by adsorbing a 
primer polycationic layer [30]. Zhankovich et al. [114] proposed to coat a titanium alloy using multilayer 
coatings of either CHI/GEL or CHI/HA to improve osseo-integration. Their study was based on prior 
conclusions by the same group that had shown showed that while CHI/GEL coatings stimulated the in 
vitro adhesion and proliferation of human osteoblasts, CHI/HA coatings reduced it [115]. So, using a 
rat tibia model, shear strength analysis did not show any biomechanical difference between the coated 
implants and a control of uncoated implants after 3 weeks. However, after 8 weeks, compared to the 
titanium alloy control, shear strength was increased up to 1.84-fold and 1.86-fold for CHI/GEL and 
CHI/HA, respectively, indicating improved osseo-integration of the implant to the surrounding tissue. 
Interestingly, these results contradicted their expectation to observe significantly higher integration with 
GEL-coated implants. The explanation to this similar osseo-integration observed in the rat tibia model 
could be due to the long-term exposure of the coating to a biological environment. This exposure could 
have led to the partial dissolution of the outer HA layer and its inhibitory effect decreased. CHI would 
then come in contact with the biological tissue and promote osteoblast proliferation. Both works 
demonstrate the potential of LbL modified implants in orthopedic implant surgery, even using very 
simple biopolymers, where a regulated osteointegration is desirable to avoid early loosening, especially 
when osteoporotic fractures are involved. 
Aiming for the treatment of coronary artery diseases, stents have been coated with polymeric 
films [116,117]. Stents with no modification can trigger thrombosis and cytokines secretion, leading to 
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in-stent restenosis – a particular refractory form of neointimal hyperplasia [118]. Schweizer et al. [119] 
coated nitinol stents with a multilayer formulation of CHI and heparin, a well-known glucosaminoglycan 
with anticoagulant properties. First, tubes made of the stent bulk material were coated and bent in a 
37º angle, showing that the LbL coating could be maintained and withstand mechanical loading. Then, 
they conducted a mineralization study by immersion in a calcium nitrate and ammonium phosphate 
bath in agitation for one week. The formation of calcium phosphate particles with less than 100 nm was 
observed in the coated stents, while in the control large microcrystals were formed. Large calcium 
phosphate crystals may be dangerous if released and transported into the blood stream, but 
nanocrystals are not expected to trigger high thrombogenicity. Furthermore, they may help to increase 
the mechanical stability of the assembled multilayers. In the same study, titanium samples were coated 
and studied simultaneously. Surprisingly, crystals on the order of 10 μm were observed on coated 
samples, much larger than in the case of coated nitinol ones. This conclusion alerts to the role of the 
substrate used, since it is likely that synergistic effects occur between not only the coating constituents 
but also between the assembled coating and the substrate’s chemistry. The use of CHI/heparin films 
may also result in antibacterial activity and suppression of blood clot formation, respectively. In fact, 
Meng et al. [120] had previously shown that stainless steel coronary stents with the same coating has a 
better hemocompatibility and more efficient re-endotelyzation than bare metallic samples, using a 
porcine coronary injury model. 
Lin et al. [121] tested the hypothesis that a stent that promotes the adhesion of endothelial cells – 
either circulating in the blood or migrating from neighbor tissues – facilitates its integration and reduces 
risk of stent failure. Stainless steel stents were coated with heparin/collagen multilayers, which could be 
or not be further functionalized with an anti-CD34 antibody. Both types of samples and a control of 
uncoated stents were implanted in rabbit femoral arteries. While no significant difference of neointimal 
hyperplasia was observed between uncoated metal stents and heparin/collagen multilayer modified 
stents, neointimal hyperplasia on the anti-CD34 antibody-functionalized multilayer coated stents was 
significantly inhibited and provided an accelerated adhesion of both vascular and endothelial cells 
(Figure 2.3). 
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Figure 2.3. Typical photographs obtained using (heparin/collagen)5-CD34 multilayer-modified stents. 
In (a) and (b), cross-section optical images of rabbit femoral arteries with (heparin/collagen)5-CD34 
multilayer-modified stents. (c) Fluorescence microscopy image of the multilayer on stent, with CD34 
tagged with FITC. Inset shows the optical image of the stent. (d) SEM image of the inner wall of the 
stented rabbit femoral arteries for 48 h, showing the formation of a complete endothelium. Adapted 
with permission from ref. [121] Copyright 2010, Elsevier. 
 
Post-surgical infection due to bacterial contamination constitutes another major issue that leads to 
implant failure. Bacteria can form biofilms on the surface of implants, therefore compromising the 
performance of the device [122]. Therefore, it is crucial that initial bacteria adhesion to an implant’s 
surface is prevented. Building multilayer films that exhibit antifouling properties is a possible solution for 
this problem. Rendering a surface non-fouling can serve as immuno-‘‘camouflage’’ to prevent immune 
rejection of implanted biomaterials or to enhance the efficiency of injected drug delivery vehicles [123-
125]. Reisch et al. [126] demonstrated that films containing PAH and a PAA containing 
phosphorylcholine side chains resisted the adsorption of albumin, which served as an estimation of 
cellular adhesion. Caruso and coworkers [127] demonstrated that PSS/PAH multilayer films with a 
terminal layer of PSS-b- poly(ethylene glycol) (PEG) were up to five-fold more resistant to bovine serum 
albumin (BSA) adsorption than PSS-terminated films. Moreover, the binding of coated polystyrene 
particles to human colorectal cancer cells was reduced 6.5-fold in comparison to native PSS-terminated 
particles. However, since LbL allows the inclusion of active agents to the formulation of a multilayer 
coating, the most straightforward strategy to avoid deleterious effects caused by microorganisms is 
perhaps the addition of antimicrobial agents. For instance, Hammond and coworkers [128] coated 
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silicon substrates with N,N - dodecyl,methyl-poly(ethylenimine) (DMPEI) as a polycation with microbicidal 
activity and a polyanion, such as PAA. The surfaces proved to be lethal against airborne and waterborne 
bacteria (Escherichia coli and Staphylococcus aureus) and viruses (influenza virus, strain H1N1). 
2.4.2 Cells as supports for the assembly of multilayer coatings 
Cell therapies based on bioencapsulation strategies have recently found utility in the treatment of 
numerous pathologies, such as for diabetes, bone and cartilage defects, and cancer. Usually, ALG is 
the most frequently employed biomaterial for the encapsulation of cells due to its abundance, water 
solubility, mild gelling properties, high biocompatibility, and resemblance to the natural extracellular 
matrix (ECM). However, the diffusion of essential molecules in hydrogels is usually less efficient than in 
liquefied environments, which may compromise cell survivability [129,130]. 
Developing a device that provides immune protection and selective permeability is an important and 
ambitious step in the development of an effective encapsulating barrier [131-133]. In the field of LbL 
implantable devices, cells or cell agglomerates can be used as suitable substrates for the buildup of 
multilayers. Therefore, cell surface engineering offers great potential to improve clinical outcomes 
associated with this promising class of therapeutic devices. 
An application that would benefit greatly of such approach would be the treatment of diabetes. The 
widespread clinical solution for this disease is that of islet transplantation, but this brings problems such 
as immune rejection, inflammation, thrombosis, hypoxia and weakened revascularization [134-136], 
leading ultimately to the destruction of the encapsulated cells. Krol et al. [137] demonstrated that 
Langerhan cells could be effectively coated with the polycations PAH or PDADMAC. Coating pancreatic 
cells with multilayers is an alternative to the conventional microencapsulation approaches within highly 
viscous ultrapure alginate droplets [138-140]. By taking advantage of the negative charge provided by 
the peri-islet capsule, polycations could be adsorbed to the membrane of the cells, followed by the 
polyanionic PSS. The multilayer coating succeeded in providing immunological protection to the cells. 
They also retained their insulin secretory function in vitro up to 4 days and diffusion was allowed 
through the coating. Furthermore, insulin release increased when high quantities of glucose were 
present. This is a very promising approach of LbL for the development of effective cellular therapies, 
which seemed promising to solve diabetes related problems, and their application in vivo was most 
anticipated. 
Recently, Wilson et al. [141] presented a polyelectrolyte multilayer (PEM) comprised of ALG and 
poly(L-lysine) (PLL)-g-PEG to coat the surface of pancreatic islet cells. The surface engineered islets 
Chapter 2. Polyelectrolyte multilayered assemblies in biomedical technologies 
 
54 
were introduced through the portal vein and into the liver microvasculature in diabetic mice. Two weeks 
after transplantation, 47% of the mice receiving the coated islets converted from a diabetic to an 
euglycemic state, while 25% of mice that received uncoated cells showed improvements. 
Given these examples, one can see that LbL-based strategies have the potential to improve the 
integration of diverse types of implants. It can be easily applied to existing biomedical devices implants 
and even to biological materials like cells for transplantation purposes. The possibility to introduce 
functionalized and bioactive materials to a surface may lead ultimately to a good integration in a living 
system and constitutes an advantage in comparison to other conventional techniques (e.g., temperature 
and plasma treatments). The possibility to coat biological structures directly is unusual and may have a 
great impact in the management of cellular viability prior and after implantation. This technology may 
be extended to develop cellular strategies, for instance in the form of cell infusions that may be injected 
intravenously for delivery to targeted tissues, such as the heart, or with other therapeutic functions, 
such as immunoregulation or systemic production of growth factors. 
2.5 Engineering biomedical devices 
2.5.1 Construction of films for wound healing 
With LbL, one can develop films with just a couple of layers or hundreds, with obvious implications in 
the films’ thickness. Thin coatings with several nanometers or membranes that may reach tens of 
micrometers can be obtained this way. When considering the production of membranes, film casting 
and hot-melt extrusion are the most recurrent used techniques [142]. However, these techniques are 
not completely compatible with biological applications: the use of organic solvents in film casting and 
the addition of plasticizers in hot-melt extrusion may cause adverse reactions when introduced in a 
biological environment. Since LbL-based strategies disregard the use of such agents, thick multilayer 
films appropriate for biological applications can be constructed. 
2.5.1.1 Development of nanostructured substrate-free membranes 
Multilayers adhere strongly to the underlying substrate and usually cannot be harvested without risk of 
damaging the film. Thus, many strategies were developed to produce films that could be detached, 
which are usually referred to as free-standing films. These free-standing films resemble membranes but, 
unlike conventional membranes, they are nanostructured and exhibit nanoscale precision thanks to 
their organization in layers. Such a device offers all the advantages of multilayered coatings and is 
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useful for applications such as wound healing and drug delivery, with the added benefit of manual 
handling [143-145]. 
A typical approach to fabricate free-standings is through the use of sacrificial layers or substrates that 
can be dissolved after the buildup [42,146,147]. Ott et al. [147] used silicon wafers precoated with PEI 
to assemble chemically polymerized polyanions bearing aldehyde groups and polycations with 
4-methylpyridinium moieties. After crosslinking, the film could be detached easily from the substrate by 
salty solutions. The salt weakened the PEI interactions with the silicon wafers, after which robust free-
standing films could be harvested. 
Using salty solutions is preferable to chemical solvents, since the latter may cause both chemical and 
physical changes to the film during this stage. However, even salt may interfere in the internal 
structures of the multilayers [68,148,149]. Consequently, other strategies have been introduced as 
alternatives to the solvent-assisted detachment of multilayer films more recently. Larkin et al. [145] 
used planar substrates of Teflon and polypropylene to assemble polymeric free-standing films. 
Polymeric constituents and these substrates form weak van der Waals interactions, which make it 
possible to peel the films safely without risk of damage. The proof-of-concept was demonstrated for 50 
bilayers of CHI/HA, crosslinked by glutaraldehyde to increase their stability in aqueous solutions. A 
unique feature of these detachable free-standing films was their optical transparency. The transmission 
of light is critical for microscopy observations and makes them suitable to be used as cell culture 
substrates. Indeed, in that work fibroblasts were seeded and could be observed under light microscopy. 
Caridade et al. [150] recently developed CHI and ALG free-standing films assembled on distinct low 
surface energy substrates. In comparison to the work of Larkin et al. [145] no crosslinking was made. 
Instead, 100 bilayers were assembled (around 35 μm). They also exploited the possibility to produce 
free-standing films exhibiting asymmetrical properties, that is, distinct properties in each face of the 
membrane. After the assembly was concluded, one side of the membrane was effectively made of ALG 
and the other of CHI. This property is useful if one envisages having two distinct properties in distinct 
faces of the same membrane. In this regard, the in vitro adhesion of myoblasts showed that cells 
adhered more to the ALG face (200 cells∙mm-2) than to the CHI face (40 cells∙mm-2), showing how the 
simple selection of the starting and ending constituents can significantly influence the biological 
performance of free-standing films. 
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2.5.1.2 Healing of tissue defects in vivo 
Free-standings may also result from hybrid approaches using LbL together with other techniques. Not 
only that, they can be associated with an additional substrate that helps in the posterior application of 
the membrane to a wound. In this sense, free-standings may serve as protective coating for wounds, 
requiring ultimately that a film is harvested and used independently of the substrate. 
The group of Takeoka and coworkers has developed a LbL-assisted strategy involving spin-coating and 
casting for the purpose of healing wounds in animals. One of their first works reported the use of a 
“spin-coating”-assisted-LbL subsequently followed by casting [151]. Shortly, CHI and ALG were 
sequentially adsorbed onto spinning silica substrates to obtain a film 75 nm thick. Poly(vinyl alcohol) 
(PVA) was cast over the bilayered films and left at room temperature during a cure time of 12 hours. 
Together with this PVA layer, with a thickness around 70 μm, the CHI/ALG film could be easily peeled 
from the silica substrates, making it easier to carry and place over a tissue defect (Figure 2.4a). 
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Figure 2.4. Free-standing nanosheets and their various applications. (a) Basic concept of the spin-
coating-assisted LbL fabrication method. Upon polyelectrolyte deposition, a PVA layer is cast allowing 
peeling-off the nanosheet easily, subject to posterior dissolution. (b) CHI/ALG nanosheet securing a 
repaired visceral pleural defect in beagle dogs when pressurized by over 50cm H2O pressure 3 h after 
repair. The region indicated by arrows shows the nanosheet-sealed area. Reprinted with permission 
from ref. [151] Copyright 2009, Wiley-VCH; (c) Macroscopic images after treating a murine cecal 
puncture hole with a tetracycline layer sandwiched between CHI/ALG multilayers and poly (vinyl 
acetate). Reprinted with permission from ref. [153] Copyright 2010, Elsevier; (d) Macroscopic images of 
murine dorsal skin treated with tetracycline-loaded CHI/ALG nanosheets illuminated under UV light, 
remaining at the wound site for 7 days. Reprinted with permission from ref. [154] Copyright 2012, 
Elsevier. 
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The authors performed a minimally invasive procedure to repair a visceral pleural defect in beagle dogs: 
the PVA/(CHI/ALG)n complex was placed in contact with the defect. Next PVA was dissolved using non-
aggressive aqueous solvents, such as phosphate-buffered saline (PBS). Over a period of 24 hours after 
the defect repair, this thin membrane resisted the pressure of respiration and blood circulation, and 
was able to sustain the stress due to ventilation (Figure 2.4b). Problems such as the reduction in the 
pulmonary tissue volume due to suture, and pulmonary air leakage could benefit from the use of 
multilayer thin films as protective membranes and sealants [152].  Later, this hybrid LbL technique and 
ingredient formulation was used to develop tetracycline-loaded films with antimicrobial effects in a 
murine cecal punctured model (Figure 2.4c) [153] and nanosheets as a protective membrane for full-
thickness burn-wound infection in a murine model (Figure 2.4d) [154]. Their production differed slightly 
from the first proposed strategy, in the fact that tetracycline was cast in the opposite face to that of the 
PVA, followed by a spin-coated layer of poly(vinyl acetate) and dissolution of PVA. 
These two last examples are particularly important for the translation of such approach to humans. 
Burn injuries are perhaps one of the most common skin defects. Such an injury creates a large skin 
area which is susceptible to bacterial colonization, leading ultimately to infections, systemic sepsis, 
severe septicemia and, if left untreated, death [155,156]. Full-thickness burn wounds may require 
tissue grafting [157]; thus it is important to have an effective protective barrier that protects the wound 
until grafting is carried out. The necessity for bacterial protection takes greater proportions when 
considering gastro-intestinal lesions, where the presence of multiple microorganisms may lead to 
bacterial peritonitis [158]. The presented examples were able to circumvent such problems and have 
great potential for future wound treatments in human patients. 
Although the technology of LbL membranes has the potential to act as wound healing dressings, there 
has been little research on LbL coatings in vivo. Based on the existing animal tests with hybrid “spin 
coating-LbL-casting” technology and on the robustness of films made purely with LbL, its broad 
application may be a matter of time. Additionally, this evolution may benefit from the use of biomimetic 
approaches and natural sources of adhesive ingredients (as mentioned in Section 2.3.1) for dressings 
with improved mechanical and biological performances. 
2.5.2 Multilayer coatings for enhanced cell adhesion on flat surfaces 
The surface of an implant is the first contact with the biological environment, and its modification – if 
any – will dictate the extent of its integration and long-term stability. Modifying surfaces is not limited to 
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devices currently used in surgical practice but also to more sophisticated ones for tissue engineering 
and regenerative medicine. 
The versatility of LbL can help achieving better cellular attachment by tuning a variety of factors. One of 
those is the stiffness of the multilayer film. It was demonstrated by Schneider et al. [159] how films of 
PLL and HA were assembled and crosslinked with increasing concentrations of a water-soluble 
carbodiimide. Higher concentrations of carbodiimide allowed achieving higher crosslinking degrees and, 
consequently, higher elastic moduli, as well as higher surface roughness. The cellular adhesion was 
affected by the stiffness: human chondrosarcoma cells adhered and spread preferentially in stiffer films. 
Using the same mechanism, Phelps et al. [160] assembled films of PLL and polyglycolic acid (PGA) and 
selectively crosslinked it by exposing only the outermost layers to carbodiimide. This interface was 
turned into a rigid external skin that promoted the adhesion of pre-osteoblast cells, while leaving the 
interior of the film unaffected. Although unexplored, this structure could be useful to encapsulate an 
active agent within. Because the crosslinking is selective and not fully uniform, the deactivation of 
embedded bioactive species due to crosslinking may be avoided. 
Martins et al. [161] used CHI/ALG films crosslinked with glutaraldehyde, to study the adhesion and 
proliferation of osteoblast- and fibroblast-cell lines during 1 week. In the first case, the cells proliferated 
in a rate similar to cells seeded onto CHI-ending films, but appeared as more elongated and with a 
higher metabolic activity. In the case of fibroblast-like cells, the proliferation was inhibited in crosslinked 
films. The results of these authors show that films with higher stiffness are not always clearly beneficial 
to cells and that different cell types may behave differently when contacting with different substrates. In 
fact, the authors justified that the reduction of positive charges due to CHI crosslinking affected both the 
attachment and adhesion of this cell line – L929 human fibroblast-like cells – which are known to favor 
their adhesion. 
The addition of bioactive compounds is another form of tuning the adhesion and metabolism of cells in 
a surface. Lee and Kotov [162] incorporated delta-like 1 Notch ligands (DL-1) at the surface of PEM 
films. The Notch ligands stimulated hematopoietic stem cells (HSCs) to differentiate into T-cell 
lymphocytes and progressively develop their own ECM. Gribova et al. [31] developed PLL/PGA films to 
study the effect of the stiffness and the exhibition of RGD-modified PGA on muscle cell differentiation. It 
was shown that uncrosslinked films exhibiting RGD were the most appropriate to induce the 
differentiation of myoblasts, while crosslinked films – with and without RGD – inhibited it and exhibited 
an excessive cell confluence that led to detachment. 
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Aiming to use multilayer coatings in living organisms, Picart et al. [163] tested the performance of 
CHI/HA coatings – either crosslinked with a carbodiimide or uncrosslinked – in vitro and in vivo. By 
using a QCM and fluorimetry, degradation of the films in situ was followed upon their contact with an 
enzyme solution containing lysozyme, chitosanase and hyaluronidase. The in vivo degradation was 
studied by implanting both types of films in mouse peritoneal cavity for 1 week. In both cases, 
crosslinked films were more resistant to degradation in comparison to native films, which showed 
almost complete degradation by the end of the studies. 
The use of LbL-based substrates for cell expansion is an ever-evolving field. In contrast to the case of 
implantable devices, which consist on the improvement of already existing devices, the reviewed works 
pushed forward toward new ways of improving cell adhesion. Most of the times it involved the 
development of new types of substrates, such as the example of ligand-functionalized surfaces. It is 
debatable whether the modification of 2D surfaces using LbL is a solution or an alternative to already 
existing approaches. For the simple purpose of cell adhesion, conventional techniques such as grafting 
or plasma can achieve the same result, usually with much faster processing times. As will be debated 
in Section 2.6.1, the future innovations brought by LbL may lie in the coating of substrates with 
increasingly complex geometry and the addition of bioactive or smart constituents that may further 
extend the functionality of 3D multilayer cell substrates. 
2.5.3 Multilayer reservoirs for drug loading and delivery 
The technological advances in drug delivery have been driven by the need to develop systems that can 
effectively encapsulate, protect and deliver an active agent with specific kinetics, such as micelles, 
liposomes, polymersomes, and polymer particles/capsules [164-168]. Such wide availability of delivery 
systems – not to mention the quantity of drugs available in the market – are proof enough that there is 
need to develop drug delivery strategies capable of improving the efficacy and bioavailability of bioactive 
agents. 
2.5.3.1 Films loaded with active agents 
Picart and coworkers have performed several works consisting on the assembly of PEMs loaded with 
BMPs. First, PLL/HA films crosslinked with carbodiimide were doped with rhBMP-2 after 
construction [169]. Myoblast cells were seeded on these films and showed differentiation into 
osteoblasts, as evidenced by the increasing secretion of ALP. Consecutive in vitro cultures showed that 
rhBMP-2 retained its bioactivity for the length of 3 successive experiments. Recent works using the 
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same formulation assembled onto tricalcium phosphate/hydroxyapatite (TCP/HAP) macroporous 
granules [170] and titanium [171] demonstrated the osteoinductive character of the BMP-loaded 
multilayers in a rat ectopic model. Furthermore, these coatings could be stored up to 1 year without 
significant loss of bioactivity. By studying the secondary structure of rhBMP-2, Gilde et al. [172] showed 
that this growth factor retained its bioactivity when the films were stored in the hydrated and, to a lesser 
extent, in the dry state. 
Hammond and coworkers also developed a series of multilayer formulations for the loading and release 
of various growth factors. They constructed a multilayer composition of polycationic poly(β-amino-
esters) and noncytotoxic polyanions – heparin sulfate and chondroitin sulfate – intercalated with 
fibroblast growth factor 2 (FGF-2, negatively charged below pH 9.6) [173]. Assembling more layers 
equaled to more FGF-2 loaded and also a faster release. The bioactivity of the growth factor was 
retained, as revealed by in vitro biological assays. Using films built with distinct constituents, the 
released FGF-2 promoted the proliferation of a preosteoblastic cell line up to 12 days in culture. Loading 
multiple growth factors is a strategy that may help, for instance, to accelerate joint implant integration 
and reduce recovery time and failure rates by delivering active agents that intervene in the multiple 
biological events. In another report [174], multiple growth factors – rhBMP2 and a recombinant human 
vascular endothelial growth factor (rhVEGF) – were loaded by adsorption into multilayers assembled in 
macroporous polycaprolactone/β-tricalcium phosphate. The release of rhBMP-2 was sustained over a 
period of 2 weeks, while it took 8 days for rhVEGF to elute from the films. Using a rat ectopic bone 
model, films loaded with both growth factors were able to potentiate the formation of de novo bone, to 
an extent 33% higher than films loaded solely with rhBMP-2 was introduced.  
2.5.3.2 Polyelectrolyte capsules with tunable permeability 
From all the 3D shapes that can be coated with LbL, the simplest is the sphere. When coated, spherical 
multilayer shells surround particles that can often be dissolved to produce hollow capsules. Multilayer 
capsules present several advantages that are not coupled so often in other conventional fabrication 
techniques: (i) they can be prepared under mild conditions of pH and temperature, avoiding the 
denaturation of sensitive species and thus allowing encapsulation in high quantities [175]; (ii) a wide 
variety of drugs can be encapsulated, regardless of their water solubility [176]; (iii) they allow tuning the 
release kinetics of an encapsulated agent to the external environment simply by adding a variable 
number of layers and selecting the shell constituents [177]; and (iv) specialized functions can be 
attributed by using stimuli-responsive or biofunctional materials with relevant biological interest [178]. 
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Combining distinct ingredients in the coating provide different properties to the shell, such as controlled 
permeability and, if smart materials are included, stimuli-responsive behavior. Costa et al. [179] 
constructed microcapsules of CHI/ELR bilayers adsorbed onto inorganic calcium carbonate sacrificial 
microparticles (around 5 µm in diameter) preloaded with BSA (Figure 2.5a).  
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Figure 2.5. Temperature-responsiveness of CHI/ELR microcapsules and size/permeability effects. (a) 
Multilayer coatings were assembled around calcium carbonate sacrificial templates. Confocal laser 
scanning microscopy images of BSA-loaded (CHI/ELR)5 microcapsules with the final layer tagged with 
rhodamine at (b) 25 and (c) 37 °C.  Cumulative release of BSA from (CHI/ELR)1, (CHI/ELR)3 and 
(CHI/ELR)5 microcapsules: ■□, ○●, and ▲Δ, respectively, in PBS (pH 7.4), at (d) 25 °C 
and (e) 37 °C. Adapted with permission from ref. [179] Copyright 2013, Elsevier. 
 
After the assembly, the template was dissolved by ethylenediamine tetraacetic acid (EDTA), resulting in 
a hollow multilayer microcapsule encapsulating BSA. The inclusion of such a temperature responsive 
polypeptide was expected to provide smart-responsiveness, and so, by changing the temperature 
between 25 and 37ºC, the mean diameter of the microcapsules varied between 5.5 and 3.2 µm, 
respectively (Figure 2.5b and Figure 2.5c). The release of BSA was also affected by temperature: the 
release of this protein was more sustained in the latter case due to the temperature response of the 
ELRs, which in the case resulted in a permeability decrease of the multilayer shells. The influence of the 
number of layers was also studied. As expected, having more layers resulted in an added barrier to the 
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protein diffusion, that is, a high number of layers reduced the shell permeability (Figure 2.5d and Figure 
2.5e). 
Kainourgios et al. [180] developed PSS/PDADMAC multilayer shells using silica nanoparticles (around 
500 nm in diameter) as templates. Following the dissolution of the template by ammonium fluoride and 
hydrofluoric acid, hollow spheres were obtained. After chelation, two additional layers (PAA and 
methoxy-polyethylene glycol amine) were deposited on their surface and crosslinked. Daunorubicin was 
loaded and released at distinct pHs, showing a high quantity release at acidic pH values (pH=4, around 
70%) in comparison to pH 7.4 (around 15%). The reduced release at pH 7.4 was attributed to the 
electrostatic interactions between the sulfonate group of the PSS – which is negatively charged at this 
pH value – and the amino group of the daunosamine sugar of daunorubicin, which is positively charged. 
The cytotoxicity of these structures towards breast cancer cells was dose-dependent and higher for 
increasing daunorubicin content. 
Recently, Shen et al. [181] fabricated BSA-gel capsules via a two-step procedure. First, calcium 
carbonate microparticles entrapping BSA were coated with PAH/PSS bilayers, followed by removal of 
the sacrificial core. Afterwards, a heat treatment at 80ºC converted BSA into gel. By exploiting the 
isoelectric point of BSA (pI=4.8), loading and releasing doxorubicin (DOX) as a model drug could be 
tuned. At a pH higher than 4.8, the negatively charged BSA allowed a favorable loading of the 
polycationic DOX and its release upon lowering the pH below 4.8. Thus, rather than exploiting the 
permeability of the LbL shell to load and release bioactive agents, as described by Kainourgios and 
coworkers [180], they relied on the jellified interior to retain DOX. Melanoma models were created in 
the lungs of mice and after injection of DOX-loaded BSA-gel capsules they were more effective in the 
reduction of the number of melanoma metastatic nodules than injected free DOX. 
Ingredients other than polymers can be used to render capsules stimuli-responsive. For instance, 
Liu et al. [182] used an emulsification method to produce magnetic alginate microspheres with around 
600 nm in diameter and coated them with PAH/PSS multilayer coatings. After the assembly, the 
emulsified alginate was liquefied by EDTA but remained entrapped within the coatings, along with the 
iron oxide nanoparticles. DOX (cationic) was post-loaded by diffusion from concentrated solutions to the 
interior and was immobilized by electrostatic interaction with alginate (anionic), with an entrapment 
efficiency of about 56%. Applying a high-frequency magnetic field resulted in an increase of the internal 
temperature, resulting in an increase in shell permeability and DOX release with higher kinetics. 
Furthermore, increasing times of exposure to the magnetic field resulted in increased released 
quantities. 
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2.5.3.3 Capsules for the intracellular delivery of encapsulated agents 
Multilayer microcapsules have been demonstrated to be suitable carriers for drugs and to deliver them 
either by conventional mechanisms of diffusion to the surrounding environment or by delivering them 
directly to the intracellular environment. The latter possibility is particularly interesting. In theory, the 
delivery of an active agent directly to the cells ensures that higher drug quantities will be available at the 
targeted cell or tissue. Szarpak et al. [168] constructed microcapsules using HA and either PAH or PLL. 
The microcapsules were labeled with fluorescein isothiocyanate (FITC) and co-incubated for 2 hours 
with mouse macrophages, being both types internalized, deformed, and excreted by lysosomes. Caruso 
and coworkers [167] reported that the shape of the capsules influences the internalization rate: 
spherical capsules were more prone to undergo cellular uptake by human cervical cancer cells than 
cylindrical ones. 
Parak and coworkers [183] demonstrated the internalization of degradable dextran sulfate/poly(L-
arginine) and non-degradable PSS/PAH by embryonic fibroblasts for a period of 5 days. The 
intracellular degradability of each capsule type could be followed thanks to the encapsulation of a 
fluorescent compound, DQ-ovalbumin. Due to a characteristic self-quenching mechanism, this 
compound exhibits a red fluorescence characterized by the close proximity of the fluorescent dyes, but 
it shifts to a bright green upon proteolysis. After a culture time of up to 5 days, the biodegradable 
capsules exhibited a green fluorescence, while the PSS/PAH capsules were in their majority red (Figure 
2.6). This results showed that, although both types of microcapsules could be delivered to cells, the 
availability of DQ-ovalbumin was higher when encapsulated within dextran sulfate/poly(L-arginine) 
microcapsules. 
The results from Parak and coworkers suggest that it is not enough to ensure that a drug is delivered to 
cells: after delivery, the encapsulated agent needs to be available to the cellular machinery. Moreover, 
with this strategy the release of the drug is mediated by the degradation of the capsule inside the cell, 
making external control over this process not possible. In this regard, Palankar et al. [184] devised a 
strategy to release an encapsulated agent on demand upon cellular uptake using infrared light. A 
peptide ligand of the major histocompatibility complex (MHC) class I molecules was encapsulated 
within PDADMAC/PSS microcapsules (around 2 μm in diameter) doped with gold nanoparticles. 
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Figure 2.6. Enzymatic cleavage of DQ-ovalbumin upon internalization by embryonic NIH/3T3 
fibroblasts. Fluorescent cargo was encapsulated either in (a) nondegradable PSS/PAH or (b) degradable 
dextran sulfate/poly(L-arginine) microcapsules. Images were taken immediately after the addition of the 
capsules to the culture over-time up to 120 h under confocal microscopy in different channels, green, 
red, and transmission, where green corresponds to cleaved DQ-ovalbumin and red corresponds to 
intact cargo. Adapted with permission from ref. [183] Copyright 2009, American Chemical Society. 
 
Upon internalization by monkey kidney epithelial cells and chinese hamster ovary cells, an infrared 
laser was irradiated over cells individually. This caused the disruption of the microcapsules’ walls due to 
heating release by the gold nanoparticles and consequently the release of the encapsulated peptide. 
Moreover, contrary to what occurs with UV light, infrared light did not result in any adverse 
consequence to the cells. With this strategy, bioactive agents may be encapsulated in nondegradable 
microcapsules that protect them until their release is desired and triggered on demand. 
The stability and biodistribution of electrostatic self-assembled nanoparticles for systemic administration 
and off-body tracing was recently addressed by Poon et al. [185] by imaging techniques. They 
evidenced the importance of a larger number of layers and the role of the terminating layer in terms of 
functional retention. A formulation of PLL and dextran films capped with a final layer of HA assembled 
onto gold nanoparticles or quantum dots showed a blood elimination half-life of 9 hours and low liver 
accumulation could be observed in mice. 
A lot of effort has been done in the context of drug delivery devices made with LbL. This approach has 
potential for the construction of nano- and micro-carriers that provide tunable release by varying not 
only the number of layers but also external parameters, such as temperature and pH. It is even possible 
to exploit mechanisms of delivery directly to the intracellular environment. Judging by the reviewed 
works, multilayer microcapsules can be inherently uptaken by cells without requiring specific 
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functionalization wit bioactive materials. However, the intracellular degradation kinetics should be taken 
into account since capsules made of nondegradable materials may limit the bioavailability of the 
encapsulated agents. Much research has been carried out using DOX as a model drug. These reports 
represent a step forward the usage of LbL systems in actual in vivo applications, such as in cancer 
treatments, and their low or even absent negative impact in a living organism. Given the extensive 
knowledge of such systems using chemotherapeutics to target cancerous cells, it is likely that cancer 
treatments will be the most studied application using this class of carriers in the short term. 
2.5.4 Biosensors 
Biosensors are analytical devices that incorporate biological sensing elements. Screening metabolites 
present in biological fluids and in the human body is of growing importance for medical analysis, rapid 
disease diagnosis and drug discovery [186-188]. This concept has been transcribed to the LbL 
technology, mainly in the form of capsules, where metabolite-sensitive fluorophores are immobilized 
inside a carrier, resulting in a measurable response upon contact with a specific biological agent. Parak 
and coworkers [189] developed microcapsules delimited by PSS/PAH multilayers and magnetite 
nanoparticles that encapsulated seminaphtho-rhodafluor-1-dye (SNARF-1)-dextran conjugate as mobile 
pH sensors. The purpose of using magnetite particles was to enable a magnetic separation of capsules 
during their construction. SNARF-1 exhibits a pH-responsive fluorophore that emits green fluorescence 
under acidic conditions and red under alkaline ones. Using this combination, they exploited the 
mechanism of cellular intracellular uptake by fibroblasts and breast cancer cells. First, due to the 
alkaline properties of the culture medium, the microcapsules exhibited red fluorescence. After 30 
minutes of incubation, capsules internalized by lysosomal/endosomal compartments turned from red to 
green, due to the acidic pH found inside the intracellular environment. The cells retained their viability 
and capacity to divide and proliferate. Although two types of cells were used to study this biosensor, 
there seemed to be no difference in the fluorescence response observed upon cellular uptake. In the 
future, it could be interesting to have a biosensor of this class capable of measuring physiological 
parameters in distinct types of cells with clear distinct signals. 
This simple formulation is one of the pioneer works of LbL microcapsules that act as biosensors, 
namely toward physical physiological parameters like pH. However, different approaches may allow 
identifying other parameters such as biochemical signals. Pan, Zhang and Li [190] presented films 
made of single-walled carbon nanotubes and CHI-dispersed tin disulfide nanoparticles assembled onto 
glassy carbon electrodes by electrostatic interactions. While bare electrodes did not provide a clear 
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distinct electrochemical signal for individual compounds – dopamine hydrochloride and uric acid, in the 
presence of ascorbic acid – the multilayer coating enabled the identification of clear separate 
electrochemical voltammetric signals. Thus, the assembly of the coating allowed identifying 
simultaneously two distinct compounds. This strategy could be useful for the fabrication of tailored 
electrodes in a rapid and simple way that allow detecting and quantifying multiple specific metabolites 
present in biological fluids. 
Yu et al. [191] presented gold substrates coated with multiple dendritic stars of opposite charge 
finished with an ending layer containing negatively charged carboxyl groups. These groups could be 
functionalized with by carbodiimide and N - hydroxysuccinimide which allowed binding covalently 
fluorophore-amino-modified single stranded DNA via amidation. Using this strategy, it was possible to 
distinguish and quantify DNA hybridization behaviors between one mismatch and complementary target 
DNA molecules, showing that such devices could be interesting DNA biosensor platforms. 
Another approach is the use of reservoirs made by LbL that encapsulate sensing molecules. One such 
example is the encapsulation of enzymes as sensing molecules. Enzymes are versatile biocatalysts 
which have a wide range of important catalytic and sensing applications [192]. Kazakova et al. [186] 
presented PSS/PAH microcapsules that acted as multilayer biosensors and as reservoirs of (i) glucose 
oxidase, (ii) lactate oxidase or (iii) both enzymes. PSS was labeled with tris(4,7-diphenyl-1,10-
phenanthroline)ruthenium(II) dichloride complex (Ru(dpp)) –  a well-known dye used in luminescence-
based oxygen sensors – and dihydrorhodamine 123 (DHR123) – a non-fluorescent molecule that yields 
rhodamine123 which, in the presence of peroxidase, emits green fluorescence upon oxidation by 
hydrogen peroxide. Oxygen-, glucose- and lactate-dependent spectrofluorimetric assays dependent on 
concentration were conducted, showing reliable detection at the millimolar range in all cases. 
The problem with enzymes is that they lack long-term stability and limited reusability for biosensing 
purposes [193,194]. We described before how Parak and coworkers [189] introduced magnetite to 
allow separation and harvesting during microcapsule production, but this concept could be used to 
retrieve and reuse enzyme-encapsulating devices until the enzymatic content is depleted. 
Garcia et al. [192] presented a thorough study in which they developed BSA-functionalized magnetic 
nanoparticles (MNPs) coated with biotin- and avidin-modified horseradish peroxidase (HRP) layers 
(Figure 2.7a and Figure 2.7b). The enzymatic activity of peroxidase adsorbed as a single layer was 
compared to that of peroxidase in solution, revealing that the enzymatic activity was similar in both 
cases. However, peroxidase activity increased linearly with the number of layers, exhibiting a four-fold 
total activity upon the assembly of 5 layers in respect to the solution control (Figure 2.7c). 
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Figure 2.7. Fabrication and response of biosensors based on BSA-functionalized MNPs. (a) Biotin- and 
avidin-modified HRP layers are assembled on top of bidimensional or three-dimensional surfaces to 
produce (i) flat mono-enzyme, (ii) spherical mono-enzyme or (iii) spherical bi-enzyme sensors. The 
substrate accessibility to inner layer enzymes is more favorable when using the spherical templates. (b) 
Production of multilayer single- and bi-enzyme MNP systems using HRP and GOX. (c) Total HRP activity 
as a function of the number of HRP layers in HRP-MNP systems, showing a linear activity increase with 
increasing number of layers. (d) Schematic of the coupled bi-enzymatic reaction in the GOX-HRP-MNP 
system. (e) Photographs showing the colorimetric detection of glucose with the coupled GOX–(HRP)5–
MNP system after 3 h with increasing concentrations of glucose. The discoloration in vial 6 (highest 
concentration of glucose) is attributed to the protonation of resorufin – which is only absorbing in its 
deprotonated form – due to the decrease of pH from the formation of gluconic acid. Adapted with 
permission from ref. [192] Copyright 2011, The Royal Society of Chemistry. 
 
These results suggest that LbL-immobilized enzymatic molecules do not block any active site in the 
enzyme, since the enzymatic activity increased with the number of layers, and is therefore adequate for 
biosensing activities. The authors studied this system further. They showed that these biosensors could 
be retrieved by magnetic-assisted harvesting and reused up to 10 consecutive cycles without loss of 
enzymatic activity. Then, this system was turned into a bi-enzymatic system by the incorporation of 
biotin-activated glucose oxidase (GOX) as the ending layer. Two enzymatic reactions could then be 
exploited for the detection of glucose. Shortly, the degradation of glucose by GOX results in gluconic 
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acid and hydrogen peroxide, which is a colorless reaction (Figure 2.7d). In the presence of peroxidase, 
Amplex red reacted with hydrogen peroxide producing resorufin, a pink-colored product observable in 
the visible spectrum. Increasing concentrations of glucose could be detected and measurable by the 
increasing absorbance of pink in the retrieved samples (Figure 2.7e). This work presents potential for 
applications concerning the detection of glucose, namely to diagnose and follow diabetes, which 
account for approximately 85% of the world market for biosensors [187]. 
 
The use of colorimetric biosensors is particularly interesting. A patient could use it for rapid screening 
purposes conveniently at home without any specific operation training. Colorimetric changes could 
provide a quick indication of whether a person suffers from a specific disease. In a recent highlight from 
McShane and Ritter [195] the potential of colorimetric biosensors was discussed. With the advent of 
portable devices, such as smartphones and tablet PCs, it would be possible to install multiple 
diagnostic software tools that permitted to identify and rate a response from a biosensor based on 
colorimetric scales. Smart tattoos – color changing particles intended for a minimally invasive dermal 
implantation – could react to the metabolites present in the interstitial fluids, resulting in measurable 
shifts of their optical properties. Then, an external device could read that response, give a diagnostic 
and even send it directly to a physician. Given the potential of LbL devices for biosensing and the 
present technological advances, it is likely that this concept will grow, accompanied by a miniaturization 
of biosensors, commodity and ease of use. LbL will contribute to this evolution since this technique 
allows achieving higher levels of functionalization, customization and measurement of multiple 
metabolites at once. 
2.5.5 Implantable structural devices with tubular shape 
LbL allows coating substrates with distinct geometries to obtain devices from thin coatings to 
membranes and three-dimensional objects. Those could have adequate anatomic shapes that could be 
used to replace or regenerate tissues or organs. Particular interesting examples of such devices are 
tubular structures, which constitute another three-dimensional shape that can be obtained by LbL 
besides spheres. 
One typical approach to construct tubular structures is to coat the interior of cylindrical pores, which 
usually lead to the fabrication of tubes with low caliber, in the order of nanometers. Liang et al. [196] 
were able to conceive hybrid polyelectrolyte/nanoparticle tubes templated on the pores of 
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polycarbonate membranes, each pore with around 400 nm in diameter and maximum pore length of 
10 μm. The membrane was first functionalized with a PEI solution that acted as the primer layer and as 
support for the assembly of PAA and PAH layers. The membrane was then dissolved with 
dichloromethane, leaving intact only the coatings of the inner pores with tubular shape. To give 
mechanical stability to these structures, the tubes were crosslinking with high temperatures (160ºC) or 
in alternative they could be assembled with gold or cadmium telluride nanoparticles intercalated 
between bilayers. Their inclusion could play an essential role in providing mechanical reinforcement, 
affecting the properties of small blood vessels substitutes and the structure of cells. In both cases, 
hollow tubes could be formed with an outer diameter similar to the size of the pore and wall thickness 
ranging from about 50 to 80 nm. Yang et al. [197] studied the in vitro biological properties of CHI/ALG 
tubes with around 400 nm of diameter and estimated wall thickness of 80 nm (thickness for 16 
bilayers), fabricated using polycarbonate porous membranes. Their biodegradability in pancreatin 
carried out overnight resulted in a diameter reduction to 160 nm, attributed to the CHI degradation due 
to lipase present in pancreatic fluids. Cellular assays using human cervical cancer cells or breast cancer 
cells demonstrated their low cytotoxicity. They also carried out cellular uptake experiments with each 
cell type, showing that after 24 h the tubes could be found inside the cells. Due to the small size of 
these nanotubes, such tubular structures could be useful as drug carriers for the intracellular delivery of 
active agents. 
Another approach for construction tubular structures is by coating sacrificial templates with cylindrical 
shape to assemble multilayer coatings. Since this approach relies on the use of physical shapes, it is 
possible to develop tubes with larger calibers that could be useful as blood vessel substitutes. Mueller, 
Daehne and Fery [198] used tubular templates for the fabrication of hollow LbL tubes instead of porous 
membranes. Glass fibers ranging from 5 to 10 μm were coated with PDADMAC and PSS, after which 
the fibers were dissolved by hydrogen fluoride. However, the authors warned for the possibility of 
pearling instability, that is, the deterioration of a liquid cylinder into a series of droplets, also known as 
the Rayleigh instability. This effect results from the tension of the wall surface provoked by a high ionic 
strength at the time of template dissolution. To solve this issue, they added an additional layer of PAH, 
which is known to withstand high concentrations of salt. Indeed, the addition of this material eliminated 
pearling instability, resulting in the formation of stable hollow tubes. The tubes were dried and shown to 
be resistant, with a Young’s modulus of around 200 MPa. Curiously, He et al. [199] took advantage of 
the pearling instability to construct tubes that transform into capsules. They used the polycarbonate 
porous membrane template to assemble PSS/PAH multilayer tubes. Then, by increasing temperature 
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up to 138ºC, tube segments separated, closed and formed capsules. This interesting tubular-derived 
capsular formation strategy can be useful for other applications, such as delivery of drugs or genes and 
for the preparations of reactors or biochemical sensors [200]. 
In the work of Silva et al. [201] CHI/ALG hollow tubes were developed using glass tubes (around 1 mm) 
as templates. Glass was first coated with a thin sacrificial layer of paraffin, which served as the 
substrate to adsorb 100 bilayers. Upon assembly, the paraffin was dissolved by dichloromethane, 
resulting in hollow cylindrical structures with a caliber comparable to the template (Figure 2.8a). 
Afterwards, some tubes were crosslinked by genipin (Figure 2.8b) which provided structures with 
storage and Young’s moduli about twice the uncrosslinked tubes when immersed in PBS (Figure 2.8c), 
an important property for implantable devices. In vitro biological studies up to 7 days using a fibroblast-
like cell line demonstrated that the cells adhered preferentially to crosslinked films, showing a more 
elongated and spread morphology (Figure 2.8d) in comparison to native films. 
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Figure 2.8. Hollow CHI/ALG multilayer tubes. (a) PEMs are assembled on paraffin-coated tubes, the 
latter being leachable using an organic solvent. (b) SEM image of a crosslinked tube. (c) Variations of 
storage modulus (E’) with or without crosslinking obtained by dynamic mechanical analysis in wet 
conditions and 37°C. (d) L929 fibroblast-like cells seeded on crosslinked tubes at day 7 of culture. 
Adapted with permission from ref. [201] Copyright 2013, Wiley-VCH. 
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The synthesis of hollow tubular structures has the potential to mimic the structure of blood vessels. The 
tuned permeability of the multilayered walls potentiates the control of gas and nutrient exchanges from 
and into circulating fluids. They could help in cases of coronary artery and peripheral vascular diseases, 
which are still a cause of high mortality in western societies. Usually, autologous vessel grafts are the 
standard treatment when small diameter vessels are involved. However, to many patients this option is 
limited due to the lack of suitable vessels or because of a previous harvest [202,203]. Moreover, their 
large surface area makes them appealing for other applications such as catalysis, sensing or tissue 
growth supports [204-206]. 
Tubular LbL structures still remain a largely unexplored area. A possible reason for this is the difficulty 
associated with their fabrication: collapsing of the internal wall and pearling instability, which are 
phenomena not encountered for simpler structures, such as the 2D films and 3D spheres and scaffolds. 
Most of these studies also focus on the morphological, mechanical and in vitro biological 
characterization, but, to our knowledge, attempts of cellular colonization of multilayer tubes’ interior has 
yet to be attempted. Indeed, LbL tubular structures may be envisaged as blood vessels, but one must 
be aware that blood vessels – artery, vein, capillary – have different calibers, with capillaries being 
suggested to have a mean diameter of 5 μm [207]. 
The possibility of LbL to control the constituents with each adsorbing layer may be used to mimic the 
structure of blood vessels, which is organized in three layers: intima, media and adventitia. In each 
layer, distinct percentages of collagen and elastin are found to supply the arterial wall matrix with 
strength and elasticity [203,208]. Furthermore, besides the conventional approaches of sacrificial 
templates coated with PEMs described herein, tubular multilayer structures may be produced with new 
strategies that disregard the dissolution of templates and may even incorporate natural constituents of 
blood vessels. In respect to the latter, as we will be discussed in Section 2.6.2, Akashi and coworkers 
have been exploring hybrid multilayers containing cells and ECM components to fabricate tissue 
analogues in vitro, including analogues of blood vessels. 
2.5.6 Compartmentalized environments 
With the successful extrapolation of LbL to 3D, multilayer films have started to be perceived not as 
coatings but as boundaries that delimit and confine an internal environment. One can find such analogy 
in Nature in the elegant example of cells. Cells are unique for their hierarchical and compartmentalized 
organization. Delimited by the phospholipidic membrane, the cytoplasm provides a balanced 
intracellular environment where the organelles are maintained and execute various specialized functions 
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such as the transport of numerous compounds, synthesis of proteins and regulation of enzymatic 
reactions. Thus, besides compartmentalization, cells also exhibit multifunctionality thanks to the 
specialized structures confined within [209-211]. 
Although cells may seem a complex inspiration to follow, some strategies have already been proposed 
to mimic their structure using multi-shelled organic and inorganic capsules prepared by template-
assisted strategies [212-214]. However, as they are often accompanied by harsh processing conditions, 
compartmentalized assemblies of polymeric multilayer nano/microcapsules within larger partitions have 
been achieved by using non-aggressive bottom-up strategies [215], among them LbL [216,217]. In a 
simplistic structural organization, cells can be transcribed to a compartmental model, where a large 
compartment confines a liquefied environment in which subcompartments are suspended. Each 
compartment exhibits a distinct function and is delimited by its own membrane. In any case, 
multilayered or not, compartmentalization has allowed combining properties and confining reactions 
that could not be achieved simply with single-component assemblies [218]. 
2.5.6.1 Confined enzymatic reactions 
The concept of multilayered multicompartments was first demonstrated by Sukhorukov and 
coworkers [219] who developed concentric shell-in-shell nanostructured microcapsules. They used 
calcium carbonate microparticles produced by co-precipitation of calcium chloride and sodium 
carbonate, during which fluorescent-tagged human serum albumin (HSA) and magnetite nanoparticles 
were entrapped. As observed in Figure 2.9a, the microparticles were coated with PSS/PAH multilayers 
and, instead of dissolving this sacrificial template afterwards, they submitted the coated particles to a 
second coprecipitation stage. At this stage, HSA tagged with another fluorophore was also present. This 
way, a second calcium carbonate inorganic layer was assembled around the first one while entrapping 
HSA separated from the underlying core by the PSS/PAH multilayers. In this formulation, the magnetite 
was used for magnetic separation and harvesting of ball-in-ball structures. After chelation of both 
inorganic sections, fluorescence microscopy confirmed the presence of a shell-in-shell structure, each of 
them containing HSA tagged with the distinct fluorophores (Figure 2.9b). Following the same procedure, 
the authors used this concept to encapsulate also GOX in the outer compartment and peroxidase in the 
inner compartment. Upon the addition of glucose to the surrounding medium, the enzymatic reaction 
could be detected by the Amplex Red fluorescence in the inner compartment due to the formation of 
resorufin (Figure 2.9c). This is a similar situation to that reported previously by Garcia et al. [192] in 
single-compartment capsules, where an identical enzymatic reaction was identified by the visible optical 
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properties of Amplex Red, but with the added advantage of confining the whole enzymatic reaction in a 
confined and controlled environment. 
 
(a) b
c
 
Figure 2.9. (a) General route for the synthesis of shell-in-shell microcapsules. (b) Confocal laser 
scanning microscopy of the shell-in-shell structure and HAS distribution 5 seconds after core dissolution. 
The dashed circle indicates the original position of the inner capsule. (c) Formation and diffusion of 
resorufin in a coupled enzymatic test using GOX and peroxidase. Reprinted with permission from ref. 
[219] Copyright 2007, Wiley-VCH. 
  
Other complex structures can be obtained through similar approaches. Instead of concentric 
compartments, Tong et al. [220] produced PAH/PSS coatings around calcium carbonate microparticles 
pre-doped with polystyrene-block-poly(acrylic acid) (PS-b-PAA) micelles. After chelation with EDTA, it was 
possible to observe the free micelles (around 30 nm) suspended inside the PEM microcapsules (around 
3 μm). In contrast to Sukhorukov and coworkers [219], in this work not just one “ball” was 
encapsulated inside a larger one. Instead, several smaller containers were suspended within the larger 
multilayer compartment. They also demonstrated the loading capability of water soluble and water 
insoluble drugs. Namely, the hydrophobic triclosan was encapsulated in the micelles’ cores and the 
water soluble DOX in the microcapsule’s interior by association with the negatively charged PAA corona 
of the micelles. This strategy has clear potential for the simultaneous delivery of hydrophobic and 
hydrophilic drugs. 
Hosta-Rigau et al. [221] constructed LbL-based capsosomes – polymer capsules containing liposomal 
subcompartments – as carriers of therapeutic molecules. Silica microparticles (around 3 μm) were 
coated with a precursor PLL layer followed by the adsorption of liposomes containing thiocoraline (TC), 
a hydrophobic antitumoral drug. Two liposome layers were assembled, each separated by a PEM of PLL 
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and poly-(methacrylic acid)-co-(cholesteryl methacrylate) (PMAc) and this structure was then protected 
by adding additional polymer layers to hold the liposomes in place. In comparison to the other 
described works, this approach was developed to show compartmentalization organization at an 
interfacial level, rather than in the interior of the microcapsules. Incubation with colon cancer cells 
showed an increased anti-carcinogenic activity of capsosomes containing TC-loaded liposomes, when 
compared to capsosomes without TC. In the presence of the former, cells exhibited a reduction of 
viability as high as 43%. 
2.5.6.2 Customizable environments with multifunctional components 
Compartmental devices are useful in fields such as catalysis, sensors, multiple drug delivery, disease 
models, energy storage and microreactors,  which often require complex phenomena to occur 
simultaneously [34,222,223]. In particular, this technology permits adding materials that respond to 
external stimuli either in the composition of the coatings or in the interior of three dimensional 
structures. This opportunity opens chances for customization of compartmentalized devices rather than 
being limited to the confinement of enzymatic reactions and drug encapsulation. Costa et al. [224] used 
a hybrid ionic gelation strategy assisted by LbL to fabricate temperature and magnetic responsive 
compartmentalized capsules with hierarchical organization from the nano- to the macro scales. First, 
CHI/ELR multilayers coated calcium carbonate microparticles (3 μm) entrapping superparamagnetic 
nanoparticles (MNPs, 10 nm). Afterwards, they were encapsulated within ALG beads (2 mm) by ionic 
gelation, which were further coated with CHI/ALG films. EDTA was then used to chelate the calcium 
carbonate that served as template for the microcapsules and liquefy the jellified ALG. The result was a 
multilayer-confined liquefied alginate environment encapsulating smaller microscopic compartments 
with both temperature and magnetic responsive materials. Each of the capsular compartments was 
loaded with rhodamine. Release studies at 25 and 37ºC showed that the rhodamine release was more 
sustained at physiological temperature (71%, in comparison to 84% at room temperature), being this 
behavior in accordance with the previous work of the same group with BSA-loaded microcapsules [179]. 
MNPs, which were confined within the microcompartments, were shown to attribute magnetic 
responsiveness towards external magnetic fields to the whole compartmentalized device, allowing their 
spatial mobilization and immobilization. One could think that a millimetric device delimited with a 
nanometric coating would be unable to withstand the stress of carrying a cargo. The authors, however, 
also showed that the millicapsules were capable of withstand centrifugal stress and handling without 
rupturing the LbL external membrane. This is a useful and convenient property, which makes it easy to 
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transport and transfer these devices between different containers if necessary (e.g., well-plates, Petri 
dishes). This class of customizable hierarchical systems can be envisaged to control the release of 
several biomolecules simultaneously, their spatial immobilization in targeted therapies and the control 
over a multitude of cellular in controllable reactors. The authors studied the two stimuli in separate and 
did not explore the mixed influence of temperature and magnetic response in the release of 
encapsulated molecules. Nonetheless, it may be possible to explore their combined effect for amplified 
hyperthermia treatments such as those found in cancer treatments [225] and studying its effectiveness 
in killing cancer cells inside such a millimetric model reactor for drug discovery and screening. 
Compartmentalized systems inspired on cells are still in an early infancy but their future potential as 
drug delivery and enzymatic reactors has already been proved. The potential of such devices may allow 
for this technology to advance in terms of functionality and customization by coupling functionality that 
is not found together in Nature. In Section 2.6.3, we will show that mammalian cells may be 
encapsulated and form microtissues inside such liquefied capsules that could be explored in tissue 
engineering applications. 
2.6 Engineering tissues in vitro 
Presently, when a patient’s organ fails the only treatment available is transplantation. However, organ 
availability for transplantation is limited and in many cases the waiting leads to the patient’s death. As a 
response, tissue engineering has appeared as a multidisciplinary field that applies principles of biology, 
chemistry, physics and engineering, culminating in life and health sciences [226]. The ultimate 
objective of this field is not only to help biological structures to regenerate for themselves but also to 
produce tissues and organs in lab that could serve as functional substitutes for damaged tissues and 
organs. For that purpose, it is typical for tissue engineering strategies to combine cells, scaffolds that 
provide a three-dimensional environment and biochemical signals, such as growth factors. 
2.6.1 Three-dimensional porous structures 
LbL can be used to coat substrates with complex and convoluted geometries other than simple planar 
surfaces. Three-dimensional substrates may be coated and eventually provide a porous structure to be 
populated by cells for the development of alternative cell growth platforms for tissue engineering 
applications. This feature is particularly important when considering the development of environments 
resembling the spatial arrangement of cells in native tissues and organs as much as possible. 
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It is possible to construct convoluted three-dimensional structures made exclusively with LbL 
constituents with porosity for cell seeding. For example, Sher, Custódio and Mano [227] developed 
porous scaffolds using leachable PEI-functionalized paraffin wax particles as template. Aggregates of 
paraffin wax particles were packed together and coated with CHI/ALG films using a perfusion-assisted 
LbL strategy. Afterwards, the particles were dissolved by dichloromethane, leaving only the PEM 
structure with porosity and interconnectivity. They served as substrates to seed human osteoblast-like 
cells, which adhered and proliferated within 7 days. Following an identical approach to produce 
scaffolds, Silva et al. [228] developed 3D structures of CHI and chondroitin sulfate multilayers for 
bovine chondrocytes and multipotent bone marrow derived stromal cells. Both types of cells were able 
to proliferate significantly and retain their viability for as long as 35 days. Histology on scaffolds seeded 
with bovine chondrocytes showed that the number of cells per section increased with the time of culture 
and started to show a more homogeneous dispersion after 14 days of culture. Lacunae formation was 
also observed in the matrix surrounding these cells, indicating the maintenance of the chondrogenic 
phenotype. Similar results were obtained for scaffolds seeded with the stromal cells, accompanied by 
the deposition of glucosaminoglycans (GAGs), an indicator of chondrogenic differentiation. 
Instead of a 3D template, it is possible to modify pre-existing structures with LbL to improve the 
biological performance upon contact with the cells. Ye et al. [229]  used a decellularized porcine aortic 
valve that acted as support for heparin and CHI multilayers (Figure 2.10a). In comparison to uncoated 
matrices, they exhibited lower platelet adhesion and activation, lower adhesion of leukocytes and 
significantly higher whole-blood clotting time (Figure 2.10b and Figure 2.10c). Human blood derived 
endothelial progenitor cells were seeded into the coated matrix for 5 days and showed almost full 
coverage of the available surface with a well-spread morphology and maintenance of the endothelial 
phenotype (Figure 2.10d). Therefore, a matrix with anti-thrombotic properties and good repopulation 
capability by endothelial cells was obtained and it constitutes a viable alternative to current valve 
transplantation alternatives. 
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Figure 2.10. Biological performance of heparin/CHI multilayer-coated decellularized porcine aortic 
valves. (a) Fluorescence of the multilayers adsorded onto the valves. The polymers’ fluorescence (red 
for heparin and green corresponds for CHI) is uniform and non-overlapping. Platelets (b) and leukocytes 
(c) adhered poorly to the multilayer-coated decellularized valves. (d) The developed devices were 
repopulated with endothelial progenitor cells exhibiting a contiguous, flat morphology. Reprinted with 
permission from ref. [229] Copyright 2012, Elsevier. 
 
The internal structure of a porous scaffold can also be modified using LbL to create new hierarchical 
microstructures. Oliveira et al. [230] presented a strategy in which the formation of fibrillar structures is 
was induced across the pores’ walls of diamine-modified poly(ε-caprolactone) scaffolds. Using a 
custom-made dipping robot, the pores were coated with ALG/CHI multilayers from solutions with 
different concentrations (0.5–5 mg∙mL-1) and rinsing times (5–40 minutes). After the assembly, the 
scaffolds were frozen at -80ºC, which led to the formation of ice crystals that caused localized 
compression, shear and stretching on the assembled layers. Consequently, the coating would 
experience displacement from the walls toward the center of the pores, resulting in fibrillar structures of 
ALG/CHI multilayers. High rinsing times inhibited the formation of such structures: a lengthy washing 
step did not allow excess polyelectrolyte solution to remain inside the pores which would lead to the 
formation of complexes and fibrillar structures. Moreover, the use of the most concentrated solutions 
led to an increase in the formation fibrillar structures and more uniformly spread than with more diluted 
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solutions. With these structures, it could be possible to increase the surface available area for cell 
growth. In fact, using osteoblast-like cells, they demonstrated that cells adhered and proliferated 
preferentially in scaffolds containing fibrils that resulted from shorter rinsing times and concentrated 
polyelectrolyte solutions. 
2.6.2 Cells as components in the LbL construction 
Akashi and coworkers have followed an elegant LbL-based approach to develop hybrid polymeric and 
cellular constructs capable of providing a three-dimensional environment and simulate the hierarchical 
organization of tissues. In an early report [231], they started by seeding a monolayer of fibroblasts on a 
fibronectin-functionalized cover glass, followed by the adsorption of seven fibronectin and GEL bilayers. 
Fibronectin is a well-known ECM glycoprotein related to the adhesion, migration and differentiation of 
cells. They are also known to interact with materials of the collagen class, like GEL, which was exploited 
to drive the LbL assembly between these two materials. The preparation of this multilayer was expected 
to provide an interface similar to the natural ECM to seed a second layer of cells. Following this pattern, 
they were able to construct 4 cell layers intercalated by fibronectin/GEL bilayers with controlled 
thickness (around 6 nm). More recently, using a similar multilayer construct, they intercalated human 
primary dermal fibroblasts and umbilical vascular endothelial cells to evaluate their stability and 
function, including after a heat shock of 45ºC [232]. They observed that the layered structure provided 
a protective and biologically suitable environment for the cells in comparison to the ones seeded in 
culture dishes. Using a similar approach, Kim and Rajagopalan [233] focused on hepatic-related 
applications by seeding a rat hepatocyte monolayer over a collagen gel-coated substrate, followed by a 
coating of CHI/HA multilayers. Afterwards, a layer of rat liver sinusoidal endothelial cells (rLSECs) was 
added. The CHI/HA served as an analogue of the Space of Disse, a separator between the endothelium 
and the epithelium which helps in the diffusion of nutrients to the hepatocytes. Its role helps 
maintaining the hepatic functions of the liver cells and their differentiation state. It was expected that 
such construct would provide hepatocytes with a hepatic three-dimensional adequate environment that 
would prevent their dedifferentiation. Thus, in comparison to a cultured monolayer of rLSECs, rLSEC-
PEM-hepatocyte cultures maintained their differentiated state over 12 days, whereas in the former case, 
rLSECs lost their phenotype within 3 days. 
The use of ECM components and cells opens the way for LbL to be used in the fabrication of tissues in 
vitro by allowing cells to be stratified in a 3D environment. Akashi and coworkers have been very active 
in the development of devices that could help achieve such a three-dimensional cell organization for 
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transplantable constructs or angiogenesis models. Recently [234], they presented layered 
polyelectrolyte/cell structures as blood vessel analogues. To achieve this purpose, hydrogels of γ-PGA 
containing spatially arranged silica tubes (up to 620 μm in diameter) were used. The tubes were 
removed afterwards, thereby resulting in a gel containing uniaxial pores with inner diameter of around 
700 μm. Fibronectin/GEL films were then assembled by perfusion, followed by a suspension of human 
umbilical artery smooth muscle cells, another polymeric film, and finally human umbilical vein 
endothelial cells. With these two types of cells, the typical composition of blood capillaries and the 
intima and media layers – containing endothelial and smooth muscle cells, respectively – could be 
mimicked. The permeability of this capillary analog was assessed by following the perfusion of BSA 
from the capillary lumen to the hydrogel template. The coating of the microchannels was able to act as 
a barrier to the diffusion of this high molecular weight protein (around 66 kDa) with a diffusion rate 
constant about 7 times inferior to uncoated microchannels. In contrast with the conventional approach 
of tubular constructs involving sacrificial templates, this work did not take such an approach. Instead, 
they demonstrated that LbL can be used to construct blood vessel analogues within three-dimensional 
porous hydrogel networks. This way, it may be possible to develop a three-dimensional device with 
enhanced perfusion of nutrients, oxygen and also delivery of bioactive molecules to cells confined within 
the gel. 
Another strategy to construct 3D multilayer structures consists in the rapid cell-accumulation technique. 
This approach consists in the assembly of ECM components directly at the surface of cells and the 
consequent cell self-organization into layers. For this purpose, Akashi and coworkers [235] assembled 
fibronectin and GEL layers (with an estimated total thickness of 6 nm) onto the membrane of various 
types of cells (Figure 2.11a). Coated mouse fibroblast cells were able to organize themselves into 8 
dense and homogeneous layers (around 35 μm), in comparison to a tattered and porous structure 
obtained using noncoated cells. The authors justified that since fibronectin/GEL films assembled on 
individual cell surfaces provide an interactive property with the α5β1 integrin receptor of the cell 
membrane, the cell-cell adhesion of all seeded cells in three-dimensions can be induced at the same 
time. Their study proceeded with an attempt to produce 3D cell structures with in which endothelial 
tube networks could be formed. The cell accumulation technique allows “sandwich” structures 
containing different cell types to be made. A cellular construct consisting of 8 layers of human dermal 
fibroblast cells divided by 1 intermediate layer of human umbilical vein endothelial cells (HUVECs) was 
constructed in a controlled manner by adjusting the number of cells that were incubated simultaneously 
(Figure 2.11b). After 7 days of incubation, a highly-developed capillary networks and a tubular 
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morphology of the HUVECs were observed, occupying an area of around 63% of the construct (Figure 
2.11c). 
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(c)
 
Figure 2.11. Cell-accumulation technique allows assembling three-dimensional cellular constructs. (a) 
Illustration of the rapid construction of 3D multilayered tissues by cell-accumulation using 
fibronectin/GEL-coated cells. (b) Schematics of a cellular construct consisting on 4+4 layers of human 
dermal fibroblast cells, intercalated with a layer of HUVECs. (c) Confocal laser scanning microscopy 
cross-section image of the construct presented in “b”, showing tubular endothelial structures after 1 
week of incubation. Green cells correspond to human dermal fibroblast cells and red cells to HUVECs. 
Adapted with permission from ref. [235], Copyright 2011, Wiley-VCH. 
 
The presented examples show that LbL has made a step toward the engineering of tissues in vitro by 
mimicking the ECM composition and 3D organization of tissues, effectively creating tissue analogues 
such as blood vessels and liver. This technology may be adapted to produce analogues for other kinds 
of tissues with interest in tissue engineering, such as the pancreas and heart. 
2.6.3 Production of microtissues in confined environments 
In tissue engineering, the use of alginate as templates for the fabrication of millimetric capsules permits 
the incorporation of cells for the formation of microtissues, drug discovery, and to conduct fundamental 
studies using complex cellular microenvironments. Mano and coworkers used liquefied ALG 
environments delimited by coatings made of CHI, ALG and PLL for cell encapsulation 
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purposes.[236,237] The encapsulation of fibroblasts was achieved by suspending them in the ALG 
solution prior to ionic gelation (Figure 2.12). 
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Figure 2.12. Production and characterization of multilayer-coated liquefied ALG capsules. (a) Cells are 
mixed with solutions of either ALG solely ALG-containing PLLA microparticles. Both solutions are 
extruded separately, originating ALG beads by ionotropic gelation. Upon coating with multilayers of 
diverse polyelectrolytes (CHI, ALG and PLL), the crosslinked ALG core is liquefied by EDTA, originating 
liquefied capsules encapsulating cells (ALG capsules), or encapsulating cells and PLLA microparticles 
(PLLA capsules). Optical microscopy of (b) liquefied capsules encapsulating (c) PLLA microparticles. 
Adapted with permission from ref. [236] Copyright 2013, American Chemical Society. (d) Fluorescence 
assay of PLLA capsules at day 7 of culture, showing cells adhered to the surface of the PLLA 
microparticles. Cell nuclei were stained blue and actin filaments red. Reproduced with permission from 
ref. [237] Copyright 2013, The Royal Society of Chemistry. 
 
The subsequent ionic gelation of alginate in calcium chloride solution was not harmful for the cells, 
making it an appropriate technique for cell encapsulation. However, it is known that often cells require 
anchorage points that allow them to attach, spread and proliferate, otherwise risking cellular 
death [238]. To increase available surface area inside the capsules, plasma-functionalized poly(L-lactic 
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acid) (PLLA) microparticles were co-encapsulated in the ALG medium along with fibroblasts, which 
ensured that cells survived up to 28 days. In principle, such devices could be adapted to include more 
complex features such as microparticles, they could be able to deliver bioactive agents inside the 
capsules or the combination of multiple cellular populations. 
2.7 Conclusions 
The multitude of multilayer devices developed so far show how LbL-based strategies have surpassed 
the simple purpose of modifying surfaces. It is clear that LbL permits achieving high degrees of 
functionalization and complexity, both in bioactivity and geometry, for various biomedical applications. 
We summarized the factors that influence the construction of PEMs, with pH and ionic strength being 
the factors most often manipulated to improve the assembly output. Also, we described the efforts 
made to minimize the lengthy construction times that are necessary to obtain not only thicker films but 
films in sheer quantity, an important feature when envisaging future mass production of multilayered 
biomedical devices. 
Emphasis was given to discussing an exhaustive list of potential biomedical applications that may 
benefit from LbL-based approaches. Implantable devices, such as coated prosthesis cells, may have 
facilitated biointegration in a living organism. Surfaces may be modified to exhibit “special” properties 
that result in improved mechanical properties, or with stimuli-responsiveness that may help tuning the 
adhesion of cells or tissues to PEMs. Moreover, being LbL a versatile technique, convoluted three-
dimensional PEM arrangements can be obtained throughout all dimensional scales: 0D (nanoparticles 
and fibers), 1D (nanotubes), 2D (thin coatings and membranes) and 3D (tubes, capsules, scaffolds). 
Free-standing membranes may act as wound healing dressings, porous scaffolds as novel cell 
expansion supports for tissue engineering, and tubular structures as analogues for blood vessels. Also, 
the use of cells as multilayer constituents may allow building hybrid constructs that resemble tissues 
both in function and structure. From all 3D devices explored, spherical capsules have been by far the 
most studied. They offer possibilities of drug delivery and biosensing either by diffusion or by targeting 
cells, while degradation and cargo release/reactivity can be finely controlled by a variety of mechanisms. 
Finally, structures mimicking natural structures, such as that of biological cells, can be constructed in 
the form of compartmentalized structures exhibiting organization at distinct size scales. Although 
generally limited to confining enzymatic reactions, they may be customized and act as multifunctional 
microreactors to simulate specific events, such as disease models and microtissue production. It is 
expected that LbL will continue to contribute to technological advancements in the biomedical field. 
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Both in conventional medicine and in tissue engineering and regenerative medicine, the possibilities 
opened by LbL will allow developing devices with superior performance when compared to the 
technology currently in use. 
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 Chapter 3. Elastin-like macromolecules3 
3.1 General introduction 
Scientists have long discovered that macromolecules are the best option for obtaining highly functional 
and complex materials. Hierarchical organization, self-assembly, or “intelligence” are common to many 
natural macromolecules and desirable for several applications in biology and biotechnology. Proteins, 
nucleic acids, and polysaccharides are fine examples of structures that have been employed in many 
biomimetic concepts displaying such properties. 
In biomedicine, several advances have been made in the last decades regarding the design and 
conception of new state-of-the-art devices with great potential for future in-depth studies and, ultimately, 
use in human healthcare services. Some of them emerged from the increasing use of elastin-derived 
materials, consisting in viable and functional protein-based molecules as alternatives to the conventional 
polymers used in biomedical applications, including in tissue engineering and regenerative medicine 
(TERM). 
Elastin-like macromolecules are genetically engineered materials rooted in the repeating sequence of 
natural elastin, a vital protein component of the extracellular matrix (ECM) found in various mammalian 
tissues [1]. As biomaterials, they became popular for exhibiting excellent mechanical properties [2-6] 
and biocompatibility [7-10]. They have also shown potential to self-assemble and respond to changes of 
the environment or under physiological conditions [11-14]. 
Because of their genetic-engineered origin, they are often called elastin-like polymers or, more recently, 
elastin-like recombinamers [15]. This class of materials can be modified to virtually include any desired 
peptide sequence, especially functional sequences with relevant biological role [16-18], and has already 
been studied extensively for applications in drug delivery [19-21], and cell and tissue engineering [22-
24]. In the following sections, a comprehensive discussion of the importance of elastin-like 
macromolecules in the conception of TERM devices will be presented. Here, not only their properties 
will be presented but also their origin and natural inspiration. 
                                                 
3
 This chapter is based on the following publication: 
Costa R. R., Martín L., Mano J. F., and Rodríguez-Cabello J. C., Elastin-like macromolecules, In Mano J. F. (ed.), Biomimetic 
approaches for biomaterials development, Germany, Wiley-VCH, 2012, DOI:10.1002/9783527652273.ch5. 
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3.2 Materials engineering – an overview on synthetic and natural biomaterials 
Biomaterials have been applied in Medicine since the early 1950’s and expanded in four traditional 
directions: metals, polymers, ceramics, and combinations thereof – composites [25,26]. More recently, 
biological or natural materials, found in animals and plants, were added as a fifth direction. Natural 
materials are intricate structures which have risen from hundreds of millions of years of evolution. 
Comparing to our current technology, Nature was able to conceive structures more complex than 
man-made materials, forming complex arrays, hierarchical structures and multi-functionality [26,27]. 
According to Wegst and Ashby [28], natural materials can be categorized into four groups: (i) ceramics 
and ceramic composites – shells, bones or any material where the mineral component is prevalent; (ii) 
polymer and polymer composites – e.g. ligaments and silk; (iii) elastomers – elastic soft tissues in the 
body which undergo large stretches or strains; and (iv) cellular materials – typically light-weight 
materials prevalent for example in feathers, wood and cancellous bone. 
Upon implantation, natural-based biomaterials can be recognized by the body and process it through 
established metabolic pathways [29,30]. The metabolic products end up being simple sugars, amino 
acids or minerals. This eliminates the possibility of cytotoxic and inflammatory response from the host, 
a situation occurring with wear particles of long-term orthopedic joint prostheses made of metal or 
synthetic polymers [31]. In this regard, inspiration was found in Nature to develop new materials and 
new methods of processing. In particular, the scientific community has been exploiting biological 
systems to produce tailored materials. Such synergy between the idealized material and its final 
construction is the basis of Biomimetism [32,33]. This principle has already started to be applied 
through genetic engineering, through the construction of specific deoxyribonucleic acid (DNA) 
sequences in order to obtain a desired peptide [34]. Elastin-like macromolecules are one successful 
example of this methodology, mimicking natural elastin, which will be discussed in the following 
sections. 
3.3 Elastin as a source of inspiration for nature-inspired polymers 
Elastin is a vital biopolymer with elastic properties. It can be found in the structures that require 
elasticity as part of their function, stretching and relaxing more than a billion times during life [1]. For 
instance, the content of elastin in skin is 5–10%, in ligaments is 10–15% and in the aorta it is as high 
as 40–50% [35]. 
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3.3.1 Genetic coding 
The elastin gene is a single copy gene found in chromosome 7 in humans [36]. Tropoelastin is the 
product of this gene and the precursor of human elastin. It is a 72 kDa soluble precursor with 760 
residues [37,38], and is expressed by various cell types during the pre- and neonatal stages of 
development, including smooth muscle [39] and endothelial cells [40], fibroblasts [41] and 
chondrocytes [42]. Currently, the full amino acid composition of tropoelastin is known for several 
species besides humans, like rats and bovines. Although some variations exist, there is still a similarity 
of 70% among the different tropoelastin species [36,43-46]. 
The elastin gene possesses 36 exons, encoding two major alternating domains: hydrophobic 
(responsible for elasticity) and hydrophilic crosslinking domains. The composition of the hydrophobic 
domains is a combination of glycine (G), valine (V), proline (P), alanine (A), leucine (L) and isoleucine (I) 
residues – being the first two the most abundant – often repeated in sequences of (GVGVP), (GVPGV) 
and (GVGVAP). The hydrophilic domains contain several lysine (K) and A residues, which show an 
important role in the crosslinking of tropoelastin.[1,36,47] 
In order to synthesize the mature elastin, the precursor must undergo a process called elastogenesis 
(Figure 3.1), a highly complex phenomenon comprising all the events that lead to the synthesis of a 
fully functional elastic fiber [48]. The process starts with the synthesis of tropoelastin itself, in the rough 
endoplasmic reticulum. As soon as they are formed, a galactolectin – an elastin-binding protein – acts 
as a chaperone that prevents premature intracellular aggregation [48]. This association lasts until the 
complex is excreted into the extracellular medium. The binding protein has a higher affinity for 
galactosugars of the microfibrilar component of the extracellular medium. Outside the cells, the 
microfibrils act as scaffolds for the deposition and alignment of tropoelastin molecules, which end up 
cross-linked to each other in K-containing sites [49,50]. Crosslinking is the culmination of elastogenesis, 
resulting in mature elastin, which is insoluble but extremely stable. In fact, it is one of the most stable 
proteins known and has a half-life of from 40 to 70 years [51,52]. 
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Figure 3.1. The elastogenesis phenomenon, starting by the translation of the elastin gene and 
proceeding to its alignment by microfibrils. 
3.3.2 Characteristics of elastin 
Mature elastin is an insoluble polymer composed by several or more tropoelastin molecules covalently 
bound to each other by crosslinks. Despite its essential hydrophobic nature, elastin can be highly 
hydrated by water molecules from both hydration and solvent water. In between the very rigid 
crosslinking domains, the hydrophobic segments exhibit a considerable mobility [36,53]. 
Despite several decades of research, elastin’s own nature has hindered the study of its properties and 
structure, mostly due to the insolubility in water and backbone mobility. Nevertheless, scientists were 
able to obtain important knowledge regarding this polymer. For example, calorimetric studies have 
shown that entropy is the primary source of its remarkable elasticity and swelling capability in vivo [54-
56]. 
There are two main models that attempt to explain elastin’s behavior: the single-phase model (also 
known as random-chain model) and the two-phase model. The latter can be further divided into the 
liquid-drop and the oiled-coil models. The single-phase model considers elastin to be like a typical 
rubber with randomly distributed polymeric chains in any solvent system [55,57]. The two-phase 
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models state that water-swollen elastin is composed of hydrophobic domains between cross-linked 
proteins and the aqueous solvent is driven to the spaces between its domains. Specifcally, the liquid-
drop model [58] assumes that the peptide segments between the crosslinks are globular domains. The 
oiled-coil model [59] is similar to the liquid-drop model, but assumes that the so called “oiled-coils” are 
broader in comparison and composed of a series of β-turns between the crosslinking domains. 
Unfortunately, none of the models described provide sufficient insight regarding the molecular basis for 
its elastomeric properties at atomic level. The groups of Urry and Tamburro carried out a variety of 
physical-chemical studies using synthetic elastin-based pentapeptides to investigate the relationship 
between its structure and function [4,56,60,61]. Their studies led to the conception of yet another two-
phase perspective: the β-spiral or fibrillar model, stating that there is one type II β-turn per pentameric 
unit, stabilized by intra-spiral, inter-turn, and inter-spiral hydrophobic contacts. The repetition of this 
conformational unit results in an organized helical arrangement called the β-spiral, hence the name of 
the model. 
3.3.3 Elastin disorders 
Mutations involving elastic fibers are important for understanding the function of elastin and the process 
of elastogenesis and associated disorders. Congenital supravalvular aortic stenosis (SVAS) is a 
pathological condition associated with a mutation in the elastin gene. The symptom is the obstruction of 
the outflow from the left ventricle narrowing of the arterial lumen, due to a failure to regulate cellular 
proliferation and matrix deposition of elastin [62-64]. At the molecular level, the cause is a lack of some 
crosslinking domains or deficient coacervation of tropoelastin molecules [62,65]. SVAS can be inherited 
as an autosomal dominant trait or as part of the Williams’ syndrome, a developmental disorder 
involving the central nervous system and the connective tissues [66]. Another pathology linked to the 
elastin gene is cutis laxa, a rare autosomal dominant disease caused by abnormally branched and 
fragmented elastic fibers with reduced tropoelastin deposition in the elastic fibers and few microﬁbrills 
in the dermis. The symptoms are inelastic loose-hanging skin, hernias, and emphysema [67,68]. 
Changes in other molecules found in elastic fibers may also result in deficient elastogenesis or 
abnormal structures. Marfan’s syndrome, for example, is an autosomal dominant disorder associated 
with mutations in the gene encoding fibrillin-1, characterized by pleiotropic manifestations in the ocular, 
skeletal, and cardiovascular systems [69]. 
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3.3.4 Current applications of elastin as biomaterials 
Elastin can be used as a biomaterial in different forms. It can be found in its insoluble form in puriﬁed 
elastin preparations, or it can be hydrolyzed to obtain soluble elastin ones. One problem associated with 
elastin use in biomedical devices is calcification because it serves as a nucleation site for mineralization, 
a problem to be considered especially in cardiovascular implants. Fortunately, it can be controlled by 
using molecules that prevent calcification, like ethanol/ ethylenediamine tetraacetic acid (EDTA) 
treatments or the addition of glycosaminoglycans or basic fibroblast growth factor [70-72]. 
Naturally, elastin can be found also in autografts, allografts, xenografts and decellularized ECM’s. Well-
known examples are split-skin autografts for burn wounds, autologous saphenous veins and umbilical 
vein allografts for coronary artery bypass graft surgery, and aortic heart valve xenografts. Incorporation 
of elastin in biomaterials is especially significant when its elasticity or biological effects can be exploited. 
3.3.4.1 Skin 
Skin is the largest organ of the human body. It is composed by two layers: epidermis and the dermis, 
which lay on subcutaneous fat. The epidermis consists mainly of layers of keratinocytes scattered with 
other cell types, among them melanocytes and Langerhans cells. It is separated from the dermis by the 
basement membrane. The dermis is comprised of papillary and reticular compartments which contain 
an ECM made of collagen, reticulum fibers, elastin, and glycosaminoglycans. The cellular constituents 
are mainly fibroblasts [73,74]. 
Skin substitutes are usually applied to treat either burn or chronic wounds. There are several 
commercial solutions currently available, like Apligraf®, among others [75]. Apligraf® is a type I collagen 
gel cultured with human neonatal foreskin dermal fibroblasts and keratinocytes, and has been used for 
the treatment of venous leg [76] and diabetic foot ulcers [77]. Like others, it contains little elastin, so 
autologous skin grafting is still the gold standard for skin substitutes. Other solutions have still been 
investigated. Hafemann et al. [78] developed a membrane of collagen and elastin of porcine origin to 
serve as a matrix for neo-dermis growth with acceptable morphology and function. Using rats as animal 
models, these membranes showed complete vascularization and colonization with fibroblasts and cells 
from the immune systems within three weeks. 
More recently, Nillesen et al. [79] designed an acellular double-layered skin construct, both cross-linked, 
to improve wound regeneration. The epidermal layer was essentially made of collagen containing 
heparin and a fibroblast growth factor (FGF) 7 to stimulate the proliferation of keratinocytes. The dermal 
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layer was porous and consisted of type I collagen fibrils, solubilized elastin from equine ligamentum 
nuchae, dermatan sulfate, heparin, FGF-2 and vascular endothelial growth factor (VEGF). Using a rat 
model, and in comparison to another commercial skin substitute, Integra®DRT, the double-layered 
construct showed more cell influx, significantly less contraction and increased blood vessel formation at 
early time points. As late as 112 days, it also contained the most elastic fibers and hair follicle- and 
sebaceous gland-like structures could be identified. This work addressed a current problem of wound 
closure, which requires minimal contraction, vascularization, and elastogenesis in the early stages. 
3.3.4.2  Vascular constructs 
Type I collagen and elastin are the main components present in the arterial wall matrix supplying the 
artery with strength and elasticity, respectively. Blood vessels are structured in three layers: intima, 
media and adventitia. In the typical three-layered architecture, elastin is found in the intimal and medial 
layers. Collagen is also found in the media and adventitia sites [80,81]. 
Coronary artery and peripheral vascular diseases cause high mortality in western societies. The 
conventional treatment is surgery to restore blood ﬂow using autologous vessels or valves [80,82]. 
Although autologous vessels remain the standard for small diameter grafts, many patients do not have 
a vessel suitable for grafting because of vascular disease, amputation, or previous harvest. Artificial 
grafts made from expanded poly(tetrafluoroethylene) (ePTFE) or Invista Dacron® are an alternative 
option [83,84], but for smaller vessels (diameter less than 5 mm) the possible formation of clots from 
thrombotic events may rapidly close them. In the past two decades, tissue-engineered solutions have 
emerged, using elastin as a crucial ingredient. Stitzel et al. [85] have developed vascular graft scaffolds 
fabricated by electrospinning using polymer blends of type I collagen from calf skin, elastin from bovine 
neck ligament, and poly (D,L-lactide-co -glycolide) (PLGA). The scaffolds were tested both in vitro and in 
vivo, using a mice model, and showed an absence of elicit local and systemic toxic effects. They also 
possessed a tissue composition and mechanical properties similar to that of native vessels. Koens et 
al. [80] developed a triple layered construct consisting of an inner layer of elastin fibers, a middle 
(porous) ﬁlm layer of collagen fibrils and an outer scaffold layer, also made of collagen. The substitute 
did not evoke platelet aggregation in vitro. The structure could also be sutured and was considered 
adequate for in vivo application. 
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3.4 Nature-inspired biosynthetic elastins 
Typically, aggressive methods of extraction are used to isolate elastin from tissues. Those can comprise 
the use of 0.1 M sodium hydroxide (NaOH) at 98ºC, or autoclaving [86,87]. More recent approaches 
follow stepwise protocols under mild conditions by peptide-bond cleavage [88]. However, the yield of 
these approaches is usually low. Based on the exploitation of biological systems, one was developed 
that helps addressing this problem by the production of tailored molecules mimicking natural elastin 
through genetic engineering. The pentapeptide poly(VPGVG) was the first to be extensively studied, for 
being the most abundant sequence in natural elastin, but variations of this model soon followed. It was 
possible to produce recombinant peptides with precision over the primary amino acid content, being 
able to introduce relevant functional sequences, for example to improve cell adhesion, trigger 
biomineralization and vascularization.  Due to their characteristics and peptide sequence, these 
molecules are known as elastin-like recombinamers (ELRs), a recombinant class of elastin-like polymers 
(ELPs) [15]. 
3.4.1 General properties of elastin-like recombinamers 
ELRs are a promising class of biocompatible protein-based polymers inspired in the mammalian elastin 
protein sequences, or modifications thereof [4,34,89]. In aqueous solution and below a certain 
transition temperature (Tt), the free polymer chains are disordered, consisting in fully hydrated random 
coils, mainly by hydrophobic hydration. This kind of hydration is characterized by ordered clathrate-like 
water structures surrounding the nonpolar moieties of the polymer with a structure somewhat similar to 
that described for crystalline gas hydrates, although a more heterogeneous one that varies in terms of 
perfection and stability [4,13]. When the temperature is increased above Tt, the structure loses the 
water molecules from hydrophobic hydration and the chains fold and assemble. A phase-separated 
state is formed, consisting of 63% water and 37% polymer, in weight. In this self-assembled separated 
state, the chains adopt a regular non-random structure known as β-spiral conformation [60,61,90]. 
Urry studied this phenomenon and stated that a polypeptide with a correct balance of polar and 
nonpolar amino acids can be soluble in water at low temperatures, yet undergoing a phase separation 
from the aqueous medium upon raising temperature [91]. In the latter case, the structures assemble 
into anisotropic fibers due to hydrophobic associations between the β-spirals. This folding is completely 
reversible if the temperature of the sample is decreased again below Tt [4,34]. This transition 
phenomenon is called inverse temperature transition (ITT) and has become the key issue in the 
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development of new peptide-based polymers as molecular machines and materials [92]. Although the 
phenomenology of ELRs is similar to that of amphiphilic polymers with a lower critical solution 
temperature (LCST), the presence of an ordered state above the Tt led to the usage of the term “inverse 
temperature transition” as a descriptive term for these polymers’ behavior [92,93]. 
The self-assembly of ELRs is also dependent on others factors and external stimuli besides temperature. 
There is a strong dependence of the Tt on concentration in the range of 0.01 to 5–10 mg.mL
-1, 
showing a decrease in Tt with increasing macromolecule concentration, due to the facilitated 
aggregation of molecules in higher number [13,34]. Above this range, the Tt does not show further 
significant changes with increasing concentrations up to 150–200 mg.mL-1 [13,94]. Increasing the 
ionic strength of an ELR solution also influences the Tt and is particularly useful to trigger the ITT 
phenomenon when its concentration is low. Reguera et al. [95] suggested that an increase in the salt 
concentration increases the polarity of the solvent. This creates a higher difference in polarity with 
respect to the hydrophobic moieties of the polymer, recruiting more and more ordered water molecules 
to surround the polymer chains. Increasing the molecular weight of the ELR has also been 
demonstrated to decrease the Tt [96,97]. ELRs can be modified in order to exhibit smart behavior 
towards other stimuli. By modifying the composition of the polymer it is possible to conceive materials 
that react to stimuli like pH, redox reactions and even light [90,98,99]. 
Some ELR systems have been developed, being successful in maintaining some of the main 
characteristics of natural elastin. For example, the cross-linked matrices of these polymers retain most 
of the mechanical properties of elastin [100,101], which becomes important when this behavior is 
accompanied by other interesting properties, such as biocompatibility, stimuli-responsive behavior, and 
the ability to self-assemble. 
3.4.2 The principle of genetic engineering – a powerful tool for engineering 
materials 
In the last decade protein biosynthesis showed the ability to directly produce high molecular weight 
polypeptides of exact amino acid sequence with high fidelity. Its usefulness to biosynthesize ELRs 
proceeds with near-absolute control of their macromolecular architecture in size, composition, 
sequence, topology, and stereochemistry [102,103]. There are a few limitations, however, in respect to 
the sequence and its final properties. In the general model (VPGXG), X does not support 
proline.[15,104] Substitution of amino acids in other positions is also limited. For example, 
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poly(APGVG) becomes an irreversible granular precipitate instead of a reversible viscoelastic coacervate 
upon increasing the temperature [105]. 
Recombinant DNA technology and bacterial protein expression have been employed for the biosynthesis 
of repetitive polypeptides based on the 20 naturally occurring amino acids with no direct parallels in 
Nature [91,102,106]. It is a technology that clearly opens infinite possibilities, with far more potential 
than most common synthetic ways of production, limited only by the living molecular machinery itself. 
Urry has presented five essential axioms to conceive protein-based macromolecules capable of 
undergoing hydrophobic folding and assembly due to inverse temperature transitions, presented in 
Figure 3.2. Shortly, the axioms describe that the ITT depends on an ELR aminoacid composition and 
that external factors can also influence its conformation and Tt. 
 
The manner in which a guest aminoacid, alters the transition temperature, Tt, of a 
hydrophobic folding and/or assembly transition is a functional measure of its
hydrophobicity.
Raising the temperature above Tt results in hydrophobic folding and assembly and
can be used to perform useful mechanical work – thermomechanical transduction.
At a constant temperature, lowering the Tt to below an operating temperature, by
decreasing its hydrophobicity, also results in hydrophobic folding and assembly.
Temperature, pressure, chemical concentrations, charged state of functional side
chains, redox states and light-elicited changes in the structure can be used to alter Tt. 
Distinct functional groups sensitive to any of the above mentioned factors can be
coupled by being part of the same hydrophobic folding and assembly domain.
All the mentioned energy conversions can be demonstrated to be more efficient
when carried out using more hydrophobic protein-based polymers.
Axiom 1
Axiom 2
Axiom 3
Axiom 4
Axiom 5
 
Figure 3.2. The five axioms of elastin-like recombinamers, according to Urry [10]. 
 
Typically, ELRs are produced by Escherichia coli strains through bacteria fermentation, accounting for 
nearly 80% of the cell’s volume by the end of the process within cytoplasmatic inclusion bodies. It can 
achieve low production costs by producing an elastin sequence via the machinery of living cells, 
independently of its complexity. The production cost of those materials is not related to their complexity 
since the most costly task in terms of both time and money is the gene construction. However, once the 
plasmid is inserted in the microorganism genetic information, the fast and cheap production of the 
polymer rapidly compensates for the costs associated with the molecular biology steps. This intrinsic 
advantage also has environmental benefits, since recombinant protein-based materials are obtained by 
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an easily scalable technology fermentation that uses only moderate amounts of energy and 
temperatures, with water as the only solvent [15,91,107,108]. 
3.4.3 From genetic construction to molecules with tailored bio-functionality 
The design of an appropriate strategy at the gene level is critical for the efficient synthesis of the protein 
encoding sequence and to produce a uniform protein product with an optimal quality and yield. The 
biosynthesis of any artificial protein generally includes: (i) design and construction of a coding synthetic 
gene for the protein of interest in a plasmid with close transcription control; (ii) the cloning of a 
recombinant gene with the necessary transcriptional regulatory elements into competent host cells; (iii) 
the screening of plasmids containing the desired clones and verification of their DNA sequence; (iv) 
transformation of the chosen plasmids into expression-competent host cells; (v) the growth of 
appropriate volumes of host cells and induction of protein expression; and (vi) purification of the protein 
of interest from cell lysates [109]. 
Molecular biology techniques are typically employed to self-ligate monomer DNA fragments in an 
oligomerization process that relies on restriction-enzyme-based approaches when designing genes that 
encode repetitive recombinamers. In this case, the monomeric fragments must be oligomerized in a 
“head-to-tail” orientation and can either be seamless in sequence or contain intervening linkers between 
the desired repeats. Approaches to oligomerization can be classified as: (i) iterative, where a DNA 
segment is oligomerized in a series of single, uniform steps. Each step extends the oligomer by one unit 
of length of the monomer gene; (ii) random method or “concatemerization”, where an uncontrolled 
number of monomer DNA segments are oligomerized in a single step to create a population of 
oligomerized clones with different lengths. This method creates a library of genes of different lengths 
that encode oligomeric polypeptides with the same repeat sequences but sacrifices the precision of the 
oligomerization process; finally, (iii) recursive directional ligation (RDL), an alternative method in which 
DNA segments with two different restriction sites flanking the insert are joined in sequential steps, with 
the length of the ligated segments growing geometrically in each step. This approach is suitable for the 
synthesis of repetitive polypeptides with a specific and predetermined chain length as it seamlessly 
joins the two monomeric inserts and also eliminates the restriction sites placed at either end of the 
dimerized gene [110]. 
An obvious disadvantage of oligomerization would seem to be the incapability to generate biopolymers 
with unnatural aminoacids, such as those not encoded by conventional codons or ones containing 
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chemical modifications, cyclic aminoacids, aromatic amino acids or β-amino acids, amongst others. 
Fortunately, this problem can be resolved by native chemical ligation [111,112]. Recently, Liu et 
al. [113]  have developed a new approach that allows incorporating unnatural amino acids to be 
genetically encoded in mammalian cells.  
One of the main goals in the materials field is to develop materials with an increasing and 
programmable degree of complexity which is closely related with the application. More complex 
materials are capable to perform more complex and tailored functions (Figure 3.3). 
 
Tissue Engineering
Drug and Gene-Delivery
Surface Engineering
Hybrid Materials
Fusion Protein Purification
a)
b)
d)
c)
 
Figure 3.3. Schematic diagram of increasing complexity of ELRs with different functionality for use in 
various applications. Recombination techniques allow obtaining several degrees of complex: the 
schematic represents (a) a simple model of recombinant elastin; (b) the introduction of specific peptide 
sequences and blocks with distinct properties; (c) the inclusion of a bioactive motif or; (d) the inclusion 
of more than one in the same peptidic formulation. 
 
The primary sequence of ELRs is responsible for the formation of well-defined secondary structures, 
such as α-helices, β-sheets or β-turns, assembling into supramolecular structures. Furthermore, they 
can be switched by several factors, such as temperature, pH and light in aqueous solution and can 
include crosslinking or self-assembling domains and diverse bio-functionalities along the polypeptide 
chain. Those may include targeting ligands, cell adhesion or specific biodegradation sequences, 
fluorescent or contrast agents. Combined with their good expected biocompatibility and favorable 
degradation rate and products, they constitute promising materials for multiple applications, with 
particular emphasis in biomedical and nanotechnological applications [114,115]. 
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3.4.4 Biocompatibility of ELRs 
The biocompatibility feature of ELRs, which is relevant for their use in advanced biomedical applications, 
was evaluated by the complete series of the American Society for Testing Materials (ASTM) generic 
biological tests for materials and devices in contact with tissues, tissue fluids and blood [101,116,117]. 
Regarding these biopolymers, it has not been possible to obtain monoclonal antibodies against them; it 
would seem that the immune system cannot distinguish them from the natural elastin. In a more 
detailed interpretation of this effect, Urry et al. [118] have suggested that the β-spiral strongly 
contributes to prevent the identification of these foreign materials by the immune system. Additionally, 
the secondary products of its biodegradation are just simple and natural amino acids that can be 
metabolized by the body to produce non-toxic degradation products. More detailed examples of their 
biocompatibility and multifunctional possibilities will be discussed in the next section. 
3.5 ELRs as advanced materials for biomedical applications 
ELRs have found widespread use due to their good biocompatibility and non-immunogenicity in the 
fields of drug delivery and tissue engineering. As they can be genetically synthesized, the precisely-
defined molecular weight is ideal for drug delivery, because the molecular weight is a key parameter in 
the route of clearance from the body and in vivo half-life of the polymer [104]. The ability to display 
stimuli-driven variations in their structure as consequence of their self-assembling behavior in aqueous 
solution has been exploited into useful functional structures and devices combining these properties, 
with an adequate arrangement of specific building blocks and physicochemical and mechanical 
properties. 
3.5.1 Tissue engineering 
New classes of materials with additional tissue-specific properties or ones which could be tailored to 
several tissue systems are required for TERM. The ECM is an important model for the design of 
biomaterials. The goal of mimicking the ECM structure and biological functions requires the design of 
artificial scaffolds that reproduce one or, preferably, more properties and functionalities of the natural 
tissue [119,120]. The scaffold must be biocompatible and biodegradable and it should own properties 
that support tissue morphogenesis. This generally requires a multifunctional artificial ECM that can 
supply temporary mechanical support until the engineered tissue has sufficient mechanical integrity to 
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support itself. Future advances in tissue engineering will depend on the development of biomimetic 
materials that actively participate in the formation of new functional tissues [27]. 
Recombinant DNA technologies allow designing and expressing artificial genes to prepare artificial 
analogues of ECM proteins with controlled mechanical properties that incorporate domains to modulate 
cell behavior. Crosslinked ELRs of poly(VPGVG) resulted in a matrix showing a mechanical response 
similar to the natural elastin [116], which is an important factor to provide a structural basis that 
properly transmits the forces from the environment to the growing tissue. However, these cross-linked 
matrices showed anti-fouling properties limiting cell adhesion. Although lacking bio-functionality that 
would promote unspecific cell adhesion, the poly(VPGVG) concept matrix was used as starting material 
with good mechanical and biocompatible properties, and short peptides having specific bioactivities 
were inserted into the polymer chain, even though by chemical synthesis. Once genetic engineering 
techniques became the production method of choice, the molecular design started to increase in 
complexity. To increase the complexity of ELRs, a simple substitution of the amino acid X in the elastin 
repeated unit (VPGXG) results in the addition of cross-linking domains to obtain more stable substrates, 
which are usually based on lysine residues [2,121-123]. 
Several modular ELRs have been designed to include bioactive peptides into the polymer chain such as 
the well-known, general purpose cell-adhesion sequence RGD [124], found in several ECM proteins 
[18,125-127], and arginine-(glutamic acid)-(aspartic acid)-valine (REDV) [128], included in the CS5 
domain of fibronectin and specific for endothelial cells [17,129]. An extra feature – namely degradation 
responsiveness – has been included into more advanced versions of ELRs for tissue repair to allow the 
renovation and replacement of natural ECM by living tissue [17,130]. In this regard, ELR-hydrogels have 
been obtained by different cross-linking methods such as photo-initiation [131], irradiation [132], or 
enzymatic cross-linking [121]. The physical properties can be tuned by the cross-linking conditions and 
degree, while retaining the stimuli-responsive behavior. This way, appropriate bioactive substrates can 
be obtained for a wide range of applications. Highly porous hydrogels have been conceived by chemical 
cross-linking of ELRs containing REDV sequence: a salt leaching/gas foaming was performed to obtain 
suitable 3D scaffolds promoting infiltration of human umbilical vein endothelial cells (HUVECs) inside 
the porous network (Figure 3.4) [133]. 
Chapter 3. Elastin-like macromolecules 
 
117 
 
Figure 3.4. Microscopy assessment of HUVECs seeded in macroporous ELP hydrogels after 48 h of 
incubation in: (a) fluorescence microscopy with phalloidin Alexa Fluor488 and 4',6-diamidino-2-
phenylindole (DAPI) staining; and (b) SEM magnified view. Reprinted (adapted) with permission from 
[133]. Copyright 2009 American Chemical Society. 
 
Another potential application of these bioactive ELRs is the preparation of films to be used for ocular 
surface tissue engineering [134,135]. Recently, Srivastava et al. [135] have successfully investigated 
the use of ELRs as a substrate to maintain the growth, phenotype, and functional characteristics of 
retinal pigment epithelial cells in vitro to obtain a suitable carrier for transplantation in the treatment of 
age-related macular degeneration. 
Hybrid scaffolds composed of collagen and different proportions of this ELR-REDV have been obtained 
by enzymatic cross-linking by tissue transglutaminase, affecting physical properties such as porosity, 
thermal behavior and mechanical strength. Such approach led to a differential colonization of the 
scaffolds with diverse cell lines, which is very useful for vascular-tissue and skin-wound healing [121]. 
Other complex hybrid scaffolds were created to obtain an acellular arterial substitute as artificial vessel-
like platforms: they were produced by the combination of several layers of an ELR matrix reinforced with 
collagen microfibers, resulting in constructs with appropriate mechanical properties, such as 
compliance or suture retention strength [136]. Other types of smart bilayer scaffolds of an ELR 
containing RGD and collagen have also been investigated – foams, fibers and foam-fiber bilayer 
scaffolds [137]. The study of the structural and mechanical properties indicated that the incorporation 
of ELRs into the scaffold improved the uniformity of the pore network and decreased the fiber diameter. 
The culture of human fibroblasts and epithelial cells in these scaffolds showed the positive contribution 
of the bioactive ELR on the proliferation of both cell types, compared to a collagen foam. These results 
were promising for the reconstruction of full-thickness skin and oral mucosa equivalents. 
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Other strategies consist in the incorporation of ELR coatings onto different materials to improve cell 
attachment or stimuli-responsiveness. Barbosa et al. [138] developed chemically cross-linked chitosan 
hydrogels with an ELR coating containing an osteoconductive sequence inducing precipitation of 
calcium phosphate when the gels were soaked in simulated body fluid. More recently, an ELR 
incorporating octaglutamic acid with well-defined charged backbone has been used to design 
multifunctional bone cements resulting in materials with hydroxyapatite binding ability and improved 
mechanical strength [139]. Prieto et al. [140] have designed a set of ELRs containing the SNA15 
statherin analog domain. In vitro mineralization showed interesting results in the effect of the ELR 
composition as a key parameter to control the calcium phosphate nucleation. These studies show the 
high potential of ELRs for biomedical hybrid materials development. 
Another attractive alternative is based in the thermal behavior of modular amphiphilic ELRs to form in 
situ stable gels under physiological conditions [141,142]. They constitute low viscosity solutions below 
their Tt and form physically cross-linked hydrogels by self-assembling that are suitable for fixing 
materials and biological elements in specific sites in the body through minimally invasive procedures. 
When greater mechanical integrity is desired, the mechanical properties can be enhanced by including 
additional chemical crosslinking domains in the ELR chain [117,143]. Sallach et al. [144] have also 
highlighted the good biocompatibility of these ELR physical gels showing a minimal inflammatory 
response and robust in vivo stability for periods exceeding 1 year. These self-gelating materials offer the 
possibility to obtain multifunctional bioactive versions, which can be also used as carriers for controlled 
drug release or as biocompatible surface coatings. Oliveira et al. [145] used an ELR containing the RGD 
cell adhesion domain to fabricate cell-induced microparticle aggregates as scaffolds for TERM. Using a 
SaOs-2 osteoblast-like cell line and microparticles with varying degrees of crosslinking, they have shown 
that for higher degrees of crosslinking the cell proliferation was more favorable and formed cell-induced 
aggregation scaffold. 
3.5.2 Drug- and gene- delivery 
Drug delivery carriers have several advantages over free drug delivery systems such as specific site 
targeting, sustained release, minimized systemic exposure and reduced toxicity. In order to be effective, 
systemic drug delivery carriers must be biocompatible and have controllable composition and molecular 
weight. Although a wide range of materials have been employed for controlled and targeted drug 
release, the most common carriers are polymeric-based systems [146,147]. 
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ELRs exhibit several properties that can be useful for drug delivery purposes, such as precise control 
over molecular weight and composition, self-assembly and stimuli-responsive behavior, as well as 
biocompatibility, non-toxic properties and efficient pharmacokinetics. In addition, their genetic nature 
allows incorporating targeting ligands, cell membrane fusion sequences or reactive sites for drugs 
conjugation [21,148,149]. Their self-assembly can also be designed in response to an extrinsic 
temperature stimulus, such as the local application of heat, ultrasound or light, or intrinsic to the site 
environment, such as low extracellular pH or up-regulated protease expression for cancer drug 
delivery [150]. 
The ability of ELRs to form stable micro- and nano-particles that are able to trap active substances has 
facilitated the development of smart systems for therapeutic release. Poly(VPAVG) was shown to form 
stable particles in water solution with a size below 3 µm above its Tt. They exhibited hysteresis behavior 
and were capable of encapsulating significant amounts dexamethasone phosphate with a sustained 
release profile for about 30 days.[151] Later, two bone morphogenetic proteins (BMP-2 and BMP-14) 
were encapsulated for combined release in a sustained way for 14 days, promising for bone tissue 
engineering [19]. Electrospraying has been used by Wu et al. [152] to generate stimuli-responsive ELR 
nanoparticles (300–400 nm in diameter) that can encapsulate drugs. The molecular weight and 
solution concentration of the ELRs were found to have a significant influence on the morphology and 
size distribution of the nanoparticles. Doxorubicin, a cancer chemotherapeutic agent, was released by 
the ITT-driven solubility of the particles at 37ºC. In other recent report, Dash et al. [153] have fabricated 
tunable monodispersed cross-linked ELR hollow spheres ranging from 100 nm to 1000 nm by using a 
template-based method. Plasmid DNA and polyplexes were efficiently loaded inside hollow spheres by 
diffusion and charge interactions. These polyplex-loaded spheres displayed controlled release and 
transfection ability in their use as gene transfection agents, with the possibility to include future 
functionalities to the spheres for targeted gene delivery applications. 
Some of the recent studies are more focused on controlling the size and monodispersity of ELR 
particles, since these are two key factors in improving therapeutic efficacy. Genetic engineering of 
protein-based block copolymers is a suitable way to program defined polypeptide block sequences to 
study the influence of macromolecular architecture in the hierarchical structural organization and 
morphology. ELR-based amphiphilic block copolymers undergo ordered nanoscale self-assembly 
forming protein-like micellar systems with controlled structure and function. Strategies that describe 
stable monodispersed ELR particles include those of Chilkoti and co-workers [150,154,155] who 
fabricated sub-100 nm sized micelles conjugated to diverse hydrophobic molecules and 
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chemotherapeutics. The goal of these studies was to investigate the design rules for tuning the self-
assembly of different ELRs forming multivalent spherical micelles within the clinically relevant 
hyperthermic temperature range 37 to 42ºC and target cancer cells. Similarly, Kim et al. [156] 
improved the stability of micelles from ELR-diblock copolymers incorporating cysteine residues at the 
core-shell interface, which undergo covalent cross-linking through disulfide bond formation. Most of 
these studies involve diblocks, although there are some examples based on triblocks, such as one that 
relies upon a reversible switch of secondary structures [157]. The triblock-ELR copolymer can form 
monodispersed temperature-responsive micelles in dilute solutions below its Tt and an abrupt increase 
in the micelle compacticity with a reduction in particle size occurs upon raising the temperature. 
3.5.3  Surface engineering 
In the field of biomaterials science the control and modification of surfaces and interfaces has opened 
novel frontiers for developing advanced materials and devices with distinct and specific features for 
biomedical applications [158,159]. Surfaces can be functionalized by multiple approaches involving 
physical or chemical modifications, such as coatings and grafts. They allow introducing small biological 
ligands, like peptides or proteins with fouling/anti-fouling features, specific groups for cell-material 
interactions, smart behavior (stimuli responsive or environmentally sensitive), or micro- and nano-
patterns [160-162]. 
Surfaces modified with stimuli-responsive polymers, called “smart surfaces”, undergo physical and 
chemical changes in response to external variations [163-165]. In this regard, ELRs exhibit some 
additional advantages that make them excellent candidates for the development of smart surfaces: their 
stimuli-responsive behavior can depend on other factors such as pH, light, or ionic strength, amongst 
others. Genetic engineering also allows for a precise control of the reactive sites on the polypeptide 
chain for use in surface grafting, leading to an extensive potential of the self-assembly exhibited by 
these polymers. Biosensing surfaces displaying topologically modified self-assembly with ELRs have 
been developed by Chilkoti’s group. The “thermodynamically reversible addressing of proteins” (TRAP) 
technology obtained by covalent micro-patterning of ELRs onto glass surfaces against an inert 
background allows a reversible, spatio-temporal modulation of ligand-binding triggered by the phase 
transition of the ELR at a solid-liquid interface. Such technology can be applied in different systems for 
bio-analytical sensors in order to detect single biomolecules [159,164]. Fluorophore-labeled glutamine 
binding proteins (QBPs) and derivatives - which can be coupled to a designed hydrophobic polypeptide - 
can be constructed and adhered onto solid surfaces [166]. Another novel fusion protein for controlling 
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cellular functions combines the RGD sequence, epidermal growth factor (EFG), and a hydrophobic 
sequence into a single molecule: it was shown to exhibit both cell-adhesive and growth-factor activity. In 
addition, the hydrophobic sequence contributed to self-assembly of the RGD, retaining its activity on a 
solid-phase surface and proving its use for wound healing [167]. 
For tissue engineering, novel temperature-responsive culture surfaces coated with ELR has been 
developed for cell harvesting. By reducing the temperature using a polyvinylidene difluoride (PVDF) 
membrane, the cell sheet was detached from the coated surface and subsequently transferred to new 
surfaces, suggesting its potential for the fabrication of multilayer cell sheets for transplantation.[24] For 
bone tissue engineering, an ELR-RGD has been adsorbed onto micro-patterned poly(N -isopropyl 
acrylamide) films displaying a positive maintaining of the cell attachment in the scaffolds under dynamic 
culture conditions [168]. Na et al. [169] have also developed a lysine-containing ELR conjugated onto 
aldehyde-glass surface by micro-patterning. The sharp and controllable phase transition of ELR enabled 
reversible cell adhesion on the surface by changing the temperature or salt concentration, 
demonstrating potential applications for cell-based micro-devices. 
Other techniques using ELRs include the alternating adsorption of polyelectrolytes. This is a simple 
technique for generating bioactive surfaces, driven by complementary forces occurring between two 
distinct materials [170]. These ultra-thin nanoscale coatings promote cell adhesion and proliferation 
and the results show that the thickness and mechanical integrity of the multilayer assembly modulates 
the cell response. Swierczewska et al. [170] have reported the use of ELRs – modified either with 
poly(ethyleneimine) (PEI) or poly(acrylic acid) (PAA) to provide positive or negative charge, respectively – 
to conceive films in a sequential fashion. Another similar work described a similar approach but with 
ELRs containing negatively charged residues [171]. Costa et al. also reported the construction of thin 
coatings [172] and nanostructured multilayers [173] made of chitosan and RGD-containing ELRs with 
smart properties towards temperature and pH (Figure 3.5) and also improved cell adhesion. These 
examples opened up a field where polymeric coatings include specific biofunctional responses. 
Progress in the last few years combining surface chemistry with microfabrication techniques has 
provided new tools to study cell-material interactions with their environment. Using lithography and 
patterning techniques, peptides and proteins can be deposited with absolute spatial control on specific 
regions of a surface [174,175]. 
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Figure 3.5. Physical changes induced in ELR modified surfaces. (a) Wettability variations with different 
temperatures. Reprinted (adapted) with permission from [172]. Copyright 2009 Wiley-VCH. (b) 
Topography at distinct pHs. Reprinted (adapted) with permission from [173]. Copyright 2011 Wiley-VCH. 
 
The ability to obtain nano- and micro-structured surfaces of patterned biomacromolecules is of great 
importance for several applications, including biological assays, miniaturized biosensors, and 
biomedical diagnostics. In this regard, ELRs have been employed in the design and development of 
biosensors and microfluidic bioanalytical devices, as reported by Nath and Chilkoti [176]. 
Nanostructured surfaces taking advantage of the self-assembly properties of ELRs have been obtained 
for capturing and releasing proteins by combining ELRs and dip-pen nanolithography. 
Recently, the replica molding method has been adapted to obtain 3D micro-structured thermo-
responsive ELR hydrogels by Martín et al. [123]. In this study, the thermally responsive behavior of 
macroscopic and micro-patterned features with different dimensions and spacing was studied, showing 
dimensional changes with no alteration of the topography. This feature could be used during cell culture 
adjusting the Tt in the correct range to study cell behavior by changing the dimensions of the micro-
pattern and subsequent mechanical properties. 
3.6 Conclusions 
Elastin is the root of inspiration for a class of versatile materials with physical and biological properties 
of great interest for TERM applications. The cumulative studies of elastin and elastin-like 
macromolecules now provide the required background for understanding in more detail structure-
related aspects of such biomaterials from a functional point of view. 
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Taking advantage of genetic recombination approaches, one can easily “engineer” a peptide-based 
macromolecule exhibiting characteristics that can be tuned for specific fields: skin substitutes, vascular 
constructs, drug delivery devices and functional interfaces. Their functionality can be further expanded 
by adding sequences with biological relevance to the common elastin structure, like cell adhesion-, 
tissue-specific- and degradation-motifs. Complex, well-defined and tailored polymers can be obtained 
with a wide range of properties and possibilities for new devices. One could say that such degree of 
complexity is only limited by the imagination of the scientist: it still needs to be faithful to the original 
properties of elastin-like macromolecules, though, since an unfavorable modification can lead to a non-
functional polypeptide. 
The study and use of elastin-like macromolecules is leading to the design of new cutting-edge and more 
complex ones emerging as promising candidates for future treatments. Their smart behavior and self-
assembly properties may be exploited for further tuning and ultimate control of the performance of an 
elastin-based system, like how a specific cell phenotype will bind to a substrate, or how an active agent 
will be released under stimuli variations and biological conditions. 
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 Chapter 4. Stimuli-responsive surfaces for biomedical applications4 
4.1 Introduction 
Surface engineering is a field of expertise dealing with the modification and improvement of interfaces. 
In conventional medicine, the surface properties of an implantable device are regarded with the utmost 
importance since the first contact with the organism is mediated by the interface with the organism. 
This interaction is what drives the subsequent tissue and cellular events, including protein adsorption, 
cell adhesion, and inflammatory response [1-3]. 
A device which surface is modified is often perceived as a static product that gives rise to an improved 
interface while retaining the mechanical bulk properties. However, specific applications may require that 
such interface is dynamic. In these cases, a surface should be able to respond towards external factors 
and considered as a step forward when developing systems with increasing complexity in healthcare, 
biomedicine and tissue engineering applications. An example of such a dynamic system is our own skin. 
Skin can be perceived as a multifunctional membrane that responds to its environment. Its reaction is 
different when exposed to distinct conditions – heat/cold, humidity, chemical/mechanical stress and 
light – and constitutes an elegant example of a sensorial stimuli-responsive structure found in 
Nature [4]. Such mechanism can be found in many other living processes: they can use 
macromolecules as construction elements or parts of cell machinery, including proteins/enzymes, 
polysaccharides and nucleic acids that typically exhibit a clear non-linear and reversible behavior. Some 
are stable along wide ranges of some external variables and undergo drastic conformational changes 
upon narrow variations around given critical points [5-7]. 
Inspired by natural examples, stimuli-responsive surfaces have been developed in the past two decades, 
often recurring to materials that exhibit reversible property switchability. These surfaces are capable of 
reversibly changing their properties depending on the environmental conditions, such as temperature, 
pH, ionic strength, light, electrical fields and biomolecules [8-10]. Thanks to their properties, stimuli-
responsive materials have been used to develop “smart” surfaces with significant potential in the fields 
                                                 
4
 This chapter is based on the following publication: 
Costa R. R., Alves N. M., Rodríguez-Cabello J. C., and Mano J. F., Stimuli-responsive surfaces for biomedical applications, In 
Taubert A., Mano J. F., and Rodríguez-Cabello J. C. (eds.), Biomaterials surface science, Germany, Wiley-VCH, 2012, DOI: 
10.1002/9783527649600.ch4. 
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of material science and biotechnology for the spatial and temporal control of the attachment of cells, 
microorganisms or biomolecules, biosensor or diagnosis, or to control de diffusion of encapsulated 
molecules for drug delivery and bioseparation [4,11-14]. 
4.2 Surface modification methodologies: how to render substrates with stimuli 
responsiveness 
Many processing techniques have been suggested and employed for the purpose of modifying 
substrates. Most of them often rely on the use of physical or chemical methods, such as plasma and 
ion-beam sputtering [15]. However, in most cases, they are not suitable to produce stimuli-
responsiveness. Meanwhile, other techniques were introduced with capability of rendering a substrate 
with smart properties and will discussed in the following sections. 
4.2.1  Self-assembled monolayers 
Self-assembled monolayers (SAMs) are ordered molecular assemblies formed by the self-assembly of 
an active surfactant onto a solid surface. In these two-dimensional systems, order is achieved by a 
spontaneous chemical synthesis at the interface [16]. The self-assembling molecules consist generally 
of three groups: (i) a head group, (ii) an alkyl chain and (ii) a terminal end group. The head group is 
responsible for the anchoring of the molecules onto the substrate (see Figure 4.1a). The alkyl chain, or 
spacer group, provides the stability of the monolayer, through van der Waals interactions. The terminal 
end group introduces chemical functionality into the monolayer system and is important for the overall 
properties of surfaces [17]. 
Surface chemistry represents an important tool for the preparation of a large variety of differently 
functionalized SAMs bearing a diversity of functional groups. There are three main approaches one can 
follow to obtain a suitable functional surface: (i) nucleophilic substitution, (ii) click chemistry and (iii) 
supramolecular modification. The first is a process through which a nucleophile (such as hydroxide, 
cyanide and ammonia) attacks an atom with a positive or partially positive charge connected to a 
negative or neutral leaving group [18]. Click chemistry generates substances by joining small units 
together with heteroatom links. Kolb, Finn and Sharpless [19] first introduced click chemistry as a 
technique that uses C–C bonds as a “currency”. Finally, the supramolecular modification is achieved by 
the functionalization of surfaces with tailor-made supramolecular binding motifs through specific 
interactions with the surface [20]. 
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Figure 4.1. Schematic structure of interfaces formed by (a) self-assembled monolayer, (b) thin 
polymer network films, (c) grafting and (d) layer-by-layer. 
 
SAMs can be assembled by adsorption of a variety of functional organic molecules onto suitable solid 
substrates. For instance, long-chain alkanethiols bearing a terminal functional group spontaneously 
assemble onto gold to form densely packed and ordered monolayers [21]. They are the most commonly 
used materials for SAMs and – besides gold – can be assembled onto noble metals, such as silver and 
platinum [22,23]. Other combinations of adsorbates and substrates include silane compounds onto 
silicon oxide and titanium [24,25], and phosphonic acids onto titanium [26]. 
Unfortunately, the specificity of SAMS is a shortcoming: they can only be fabricated upon the adsorption 
of specific molecules onto specific surfaces. Furthermore, the resulting monolayers show generally a 
limited stability under ambient and physiological conditions, leading to facile exchange and “stripping” 
of the adsorbates [27]. Nonetheless, SAMs have thrived because they are easy to prepare as they do 
not require any specialized equipment for their preparation and can be constructed on objects of 
different size and shape such as thin films, nano-particles/wires/cages in colloids, with clear impact in 
nanoscience and nanotechnology. In particular, SAM-modified surfaces have been constructed to exhibit 
smart properties towards external stimuli such as electrical fields (due to the desorption of 
alkanethiolates) [28], light (by the inclusion of azobenzenes or spiropyrans) [29], redox reactions (by the 
inclusion of supramolecular rotaxanes) [30] to obtain surfaces for protein separation, diagnostic and 
with switchable wettability. 
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4.2.2  Thin polymer network films 
Nanostructured thin network films are structures in which surface confinement brings a range of 
opportunities for engineering stimuli-responsive properties. These are polymeric networks – in many 
cases very thin hydrogel films prepared from water-soluble polymers chemically linked to a surface, 
resulting in a soft surface with well-defined mechanical, physical and biochemical properties (see Figure 
4.1b) [31]. This kind of polymer network provides a soft three-dimensional scaffold similar to that of 
macroscopic hydrogels, capable of hosting a wide-array of functionalities, ranging from proteins to 
inorganic nanoparticles, but typically produced at the nano- and micro- scales. They can undergo 
substantial swelling and contraction in response to external stimuli, making them excellent candidates 
for “smart” surfaces with sensing and actuating characteristics [13]. 
The advantage towards their macroscopic counterparts is that gel thin films exhibit a fast swelling and 
shrinkage kinetics. In fact, this behavior was predicted by the Tanaka and Fillmore’s model which states 
that the characteristic time of the swelling transition is directly proportional to the square of the linear 
size of the gel [32]. A critical issue for understanding and predicting the properties of surface-attached 
polymer networks is the impact of confinement on their swelling behavior. Chemical linkage of the thin 
gel to a surface prevents swelling in the parallel direction to that of the substrate, effectively confining 
the volume change to one dimension. Such an effect has an impact in properties such as the structure, 
mechanical properties, dynamics, and permeability of the network [33]. Additionally, the swelling 
behavior of the polymer network is also influenced by the crosslinking degree of the film, as well as the 
nature of the polymer, e.g. if it is stimuli-responsive. 
An interesting property of thin gel polymer networks is that they are not limited to surfaces: they can 
also be processed in the form of freestanding films if neither adhesion or covalent bonding to the 
surface is triggered [4]. Therefore, it is possible to synthesize thin responsive membranes that can be 
used in the selective separation of molecules and particles. While traditional membranes can perform 
this function based on parameters like size and charge, responsive membranes can demonstrate a 
gating function controlled by external stimuli. For instance, pores in the membrane can be switched 
between an “open” or “closed” state and allow the passage of specific solution components at a 
specific time in function of one or more stimuli [34,35]. 
Summarizing, thin polymer networks have a fast swelling/shrinking response and can accommodate in 
their bulk various chemicals, biomolecules and nanoparticles. These properties make of thin gel 
polymer networks attractive systems in microtechnology, namely as selective membranes, intelligent 
drug delivery devices and biosensors [36-38]. 
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4.2.3  Grafting 
Grafting is a technique by which a polymer is attached to a substrate, usually solid [39]. The bound 
polymer chains are often called “grafts” or “brushes” and lend their properties to the substrate (see 
Figure 4.1c). There are two major approaches of grafting that can be applied: “grafting-to” and 
“grafting-from” [40-42]. 
The “grafting-to” method refers to a chemical reaction between an end-functionalized polymer and a 
suitable surface containing complementary functional groups, and requires that the polymer is modified 
beforehand. Reactive end-functionalized polymers can be obtained through techniques such as 
controlled/living radical polymerization (CRP), group transfer and ring opening metathesis 
polymerizations [43-45]. A drawback of the “grafting-to” approach is the low density yield of the grafted 
chains: steric repulsions between polymer chains hamper the formation of dense polymer brushes [46]. 
Another drawback is that with increasing molecular weight of the polymer’s the reaction between the 
polymer end-group and the complementary group on the substrate becomes less efficient [47]. 
Nevertheless, “grafting-to” is simple to perform and, thanks to the covalent bond formed between 
surface and polymer, the brushes are robust and capable of withstanding both chemical and physical 
efforts. 
The “grafting-from” method refers to the preparation of polymer brushes in which the polymerization is 
triggered by initiator-functionalized surfaces. The immobilization of initiators on the surface can be 
achieved by treating the substrate with plasma or glow discharge in the presence of a gas or forming 
initiator-containing SAMs on the substrates. It can produce tethered layers of higher grafting densities 
than the “grafting-to” approach since the active centers (radicals, ions, and ion pairs) of the growing 
chains at the surface are easily accessible for monomer molecules in the swollen brush during the 
course of polymerization [48,49]. 
Regardless of the method – “to” or “from” – the principles are common to both: (i) the grafting 
techniques imply chemical attachment of polymers to the surface; (ii) the reaction occurs under 
appropriate reactive conditions, which are usually specific for the kind of materials and substrates 
involved; (iii) the polymers can be grafted to distinct types of surfaces, e.g. metals, glasses and silica, 
and not limited to planar substrates but also applied to spherical ones; and (iv) the substrates often 
assume the properties of the grafted polymer, with stimuli-responsive grafts rendering a smart-
responsive surface. 
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A grafted polymer brush can be composed of chains from a single homopolymer – single-component 
homopolymer brushes – two or more different homopolymers – mixed brushes – or block-copolymers – 
block-copolymer brushes. In the first case, when dealing with smart surfaces, the responsive behavior 
originates from the inherent properties of the grafted polymer chains, their grafting densities, or by 
changes in the balance between polymer–polymer and polymer-solvent interactions [50]. In mixed 
polymer brushes, response comes from phase segregation, which causes the switching of the spatial 
distribution of the functional groups that are exhibited by the brush exterior. Consequently the materials’ 
properties can be switched between among the ones of the constituent polymers [51]. The responsive 
behavior of block copolymer brushes (as in mixed brushes) is based on the phase segregation of the 
different blocks. The combination of different polymeric blocks in the responsive film broadens the 
range of properties upon switching, so that the surface changes from the property of one polymer to the 
property of the second polymer, or is locked in some intermediate state [52]. Graft-modified surfaces 
with stimuli-responsive behavior have been extensively used in biology and nanotechnology. The cell-
sheet technology achieved through the attachment of poly(N -isopropyl acrylamide) (PNIPAAm), a 
thermoresponsive polymer, is one of the most representative examples of the grafting approach in 
tissue engineering [50]. Other applications based on other and stimuli (e.g. pH and ionic strength) have 
also been addressed, such as the switchable wettability of substrates, controlled release of drug delivery 
devices and sensors. 
4.2.4  Layer-by-layer 
Layer-by-layer (LbL) is a self-assembly-driven surface modification strategy that allows the construction 
of nanostructured films onto distinct geometries, from simple bidimensional surfaces to more complex 
three-dimensional porous structures. The principle behind it lies in the existence of multiple 
intermolecular interactions where the cooperative effects of multipoint attractions play the most 
important role (see Figure 4.1d) [11,53,54]. Constructing a multilayer film usually has two 
requirements: (i) a reactive surface as the assembly support and (ii) a combination of two or more 
ingredients for the constitution of the film that can interact with each other. The buildup process is 
initiated by dipping the substrate in a solution of one ingredient that shows complementary interactions 
with the surface, forming therefore the first layer. Then another ingredient follows, interacting with the 
preformed layer, assembling a second one. Between each dip, a rinsing step is performed to remove 
excess of non-adhered material from the interface. In comparison with SAMs and polymer brushes, 
usually neither the surface nor the ingredients require modification prior to the LbL construction since 
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assembling the layers rely on the intrinsic properties of each counterpart and their spontaneous 
assembly. 
Usually the most important requirement is that two distinct materials possess complementarity, i.e. that 
the properties of both materials result in attraction. In other words, LbL is a generic surface 
modification technique with which (in theory) any material and surface can be used for this end, in 
opposition to the methods described in the previous sections. The most representative buildup 
mechanism relies on electrostatic interactions among surface/ingredient and ingredient/ingredient. For 
instance, a polycation can be adsorbed to a negatively charged surface to form a layer. A polyanion can 
then adsorb to the now positively charged interface, rendering it with a negative charge [55]. This 
process can be repeated as many times as necessary under aqueous conditions to construct films with 
thickness at the order of a few nanometers to tens of micrometers. Although electrostatic self-assembly 
(ESA) is the most exploited mechanism, other interactions can be present, such as hydrophobic 
interactions and hydrogen bonding [53,56]. 
LbL offers ease of preparation at mild conditions of temperature, pressure and pH, versatility, fine 
control over the materials structure and robustness under physiological conditions. Additionally, the 
mild and non-aggressive processing conditions of LbL make of it an appealing technique for tissue 
engineering applications. There is a vast choice of available materials that one can add to a multilayer 
formulation, such as proteins, nucleic acids, polysaccharides, and virus particles, as well as various 
organic polymers, molecular assemblies [57-59]. and inorganic substances (e.g. clay platelets [60], 
grapheme [61] and glass nanoparticles [62]). Furthermore, although LbL has been first introduced as a 
surface engineering technique of planar surfaces [63], the concept has been extrapolated to 3D. The 
sequential mechanism of layer adsorption can be extrapolated to construct thick membrane-like films 
with tens of micrometers assembled on non-adhesive substrates (e.g. through van der Waals 
interactions with polypropylene) to produce freestanding films [64]. Other types of complex geometries 
with distinct shapes and sizes and as a result, devices such as porous scaffolds and drug delivery 
capsules can now exhibit new properties with the option of further tuning by varying the nature of the 
LbL ingredients and number of layers [65,66]. 
LbL films and shells can contain stimuli-responsive ingredients in order to render a system with a smart 
response. Exploiting the advantages of LbL and intelligent multilayer systems have already been 
proposed for different biomedical applications, including for biomimetic composite-like coatings, to 
control the release of drugs, or to manipulate the adhesion of attached cells. In particular, systems 
assembled using weak polyelectrolytes (e.g. chitosan and alginate) are inherently responsive towards 
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ionic strength and pH responsive, since they interfere with the electrostatic balance within the internal 
structure of the film [58,67,68]. In similarity with polymer brushes, multilayer films with temperature 
responsive properties have also been fabricated to control the cell attachment/detachment to a surface 
for cell sheet technology, and to fabricate surfaces with acute wettability transitions [69,70]. 
4.3 Exploitable stimuli and model smart biomaterials 
4.3.1  Physical stimuli 
4.3.1.1  Temperature 
Among the stimuli used to control the response, temperature has been extensively studied in the 
biomedical field as certain diseases manifest temperature changes and this factor can be easily 
controlled and applicable both in vitro and in vivo conditions. Thermo-responsive systems have a critical 
solution temperature at which the phase of the polymer and solution is discontinuously changed 
according to their composition.[8] PNIPAAm is the thermo-responsive polymer most used for conferring 
thermo-responsiveness to surfaces. It exhibits a lower critical solution temperature (LCST) at about 
32ºC in aqueous solution, changing sharply from a hydrophilic to a hydrophobic state upon heating [71]. 
It is believed that this transition involves the breakage of intermolecular hydrogen bonds between the 
water molecules and the amide groups in the polymeric chains, which are replaced, above the LCST, by 
intramolecular hydrogen bonds amongst the dehydrated amine groups. PNIPAAm has been 
copolymerised with hydrophilic or hydrophobic monomers in order to control the kinetics of the 
response [72,73]. 
Typically, above the LCST of PNIPAAm based surface-grafted polymers, surface wettability decreases 
and the thickness of the grafted layer decreases (deswelling). The work of Shi and co-workers [74] 
illustrates this behavior for bioactive composites of poly(L-lactic acid) (PLLA) reinforced with Bioglass® 
(BG) and grafted with PNIPAAm through the use of plasma activation. The water contact angle for the 
PNIPAAm modified PLLA+10% BG composite was 51.9±2.4º, at 25ºC and at 37ºC it changed to 
58.8±2.4º, being consistent with the increase in the surface hydrophobicity above the LCST. The range 
of wettability can be further amplified to the super- hydrophobic/hydrophilic regimen by using 
substrates with increasing roughness [75], which is also predicted in the Wenzel model [76]. 
Besides the grafting of PNIPAAm-based polymers on distinct substrates, LbL assembling has also been 
used to confer temperature-responsiveness to surfaces. Serpe et al. [77] were the first to apply the LbL 
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technique to produce temperature-responsive PNIPAAM/-co-acrylic acid (AA)/polyallylamine coatings. 
Since then, LbL surfaces containing PNIPAAm have already been suggested for cell sheet 
engineering [70]. 
Other thermo-responsive polymers may be used instead of PNIPAAm. Poly(N-vinylcaprolactam) (PVCL) 
is another thermo-sensitive polymer that can be deposited onto surfaces, which possesses very 
interesting properties for biomedical applications such as solubility in water, biocompatibility, a 
transition temperature around 31ºC and its cytoxicity has been referred as being much lower than the 
one of PNIPAAm.[78,79] Thermo-sensitive films based on triblock copolymers have also been 
prepared [80]. 
Nature also houses inspiration for the development of new polymers. Elastin-like recombinamers (ELRs) 
– a recombinant class of elastin-like polymers (ELPs) – are genetically engineered peptide-based 
materials that mimic the structure of natural elastin [81]. By exploiting microorganism systems, tailored 
recombinant elastins based on the pentapeptide poly(VPGVG) can be produced and, thanks to their 
recombinant nature, recombinant peptides with precision over the primary aminoacid content is 
possible, being able to introduce relevant functional sequences, for example to improve cell adhesion, 
trigger biomineralization and vascularization [82-84]. 
In aqueous solution, and below a certain transition temperature (Tt), the free polymer chains are 
disordered, consisting in fully hydrated random coils. When the temperature is increased above Tt, the 
structure loses the water molecules from hydrophobic hydration and the chains fold and assemble into 
a β-spiral conformation [85-87]. Although often associated with temperature-responsive polymers, the 
fact is that such transition phenomenon can occur due to other stimuli, such as pH, ionic strength, 
redox reactions and in specific modifications even due to light. In this perspective, ELRs could be 
classified as a multiple-responsive material, and surfaces modified with this kind of macromolecules 
have already been demonstrated to respond towards temperature, pH and ionic strength at the same 
time [69]. 
Biosensing surfaces displaying topologically modified self-assembly with ELRs have been developed by 
Chilkoti’s group. The “thermodynamically reversible addressing of proteins” (TRAP) technology obtained 
by covalent micropatterning of ELRs onto glass surfaces against an inert background allows a reversible, 
spatio-temporal modulation of ligand-binding triggered by the phase transition of the ELR at a solid-
liquid interface. Such technology can be applied in different systems for bio-analytical sensors in order 
to detect single biomolecules [88,89]. 
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Smart thin coatings using an ELR containing RGD sequences are also a new and interesting example of 
thermo-responsive surfaces. These coatings can be fabricated through simple deposition of the ELR 
dissolved in aqueous-based solutions onto chitosan membranes [82]. It was shown that the 
conformational changes suffered by the ELR at its inverse temperature transition modified the 
topography at the nanoscale and the wettability of the polymeric substrate, which could be potentially 
used to control cell adhesion and protein adsorption (see Figure 4.2). 
 
 
Figure 4.2. Water drop profiles on ELP-coated substrates at 25 and 50ºC. Reprinted (adapted) with 
permission from [82]. Copyright 2009 Wiley-VCH. 
4.3.1.2  Light 
Light could be an interesting stimulus in the context of stimuli-responsive surfaces, as it is widely used 
in Nature as a source of energy. Photo-responsive polymers change their properties when irradiated 
with light, due to light-induced structural transformations of specific functional groups (e.g. 
chromophores) along the polymer backbone or side chains [90-92]. An important aspect of photo-
sensitive polymer systems is that using irradiation as a stimulus is a relatively straightforward, non-
invasive mechanism to induce a responsive behavior. The most well studied examples of photo-
responsive polymers are those that contain azobenzene groups. Azobenzene is a well-known 
chromophore with an irradiation-induced cis -to-trans isomerization that is accompanied by a fast and 
complete change in electronic structure, geometric shape, and polarity. By incorporating azobenzene 
derivatives into polymer structures, materials with variable shape, polarity, and self-assembly behavior 
can be obtained [91].  Azochromophores have been incorporated into a variety of polymeric 
systems [10,91]. Other chromophores, namely spiropyran and its derivatives have been incorporated 
terminally or pendantly to confer light sensitivity [93,94]. Spiropyran groups are relatively non-polar, but 
irradiation with the appropriate wavelength of light leads to the zwitterionic merocyanine isomer that has 
a larger dipole moment. 
Illustrative works where photo-responsive LbL films were prepared can be found elsewhere [91,95]. The 
studies related with photo-responsive LbL systems have shown that the photoresponsive cis –trans -
isomerization rates in the layers are highly dependent on the functional groups attached to the 
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chromophores [91]. Most of the works regarding photo-responsive polymers require isomerization 
induced by ultraviolet (UV) radiation or visible light. Recent years have also seen a growing interest in 
employing near-infrared (NIR) radiation as a trigger to activate delivery of encapsulated material from 
LbL systems [96]. The use of NIR light is particularly attractive in biomedical applications because of 
the weak absorption of NIR radiation by most tissues. 
Photo-isomerizable monolayers applied to surfaces can also be used to control surface properties, such 
as wettability [97]. In this case, the water contact angle was found to be lower for the spiropyran-
modified surfaces after irradiation with UV light, when compared with the contact angle found for visible 
light. This was ascribed to the changes in the surface energy of the surfaces correlated to the switching 
of the surface-bound spiropyran molecules between polar, zwitterionic and nonpolar forms. 
4.3.2  Chemical stimuli 
4.3.2.1  pH 
“pH” has also been extensively studied in the biomedical field because this factor can be easily 
controlled and applicable both in vitro and in vivo conditions. It is well-known that there is a pH change 
along the gastrointestinal tract from the stomach (pH=1–3) to the intestine (pH=5–8) and chronic 
wounds and tumor tissue are also slightly acidic. So, for example, pH-responsive systems can be used 
for releasing drugs in the intestine in order to avoid their degradation in the environment of the 
stomach [8]. They have also been investigated for gene delivery and gene therapy. “pH”-responsive 
polymers contain ionizable groups that can accept and donate protons in response to a pH change. 
Examples of pH-responsive polymers are chitosan, alginate, hyaluronic acid, PAA, poly(ethyleneimine) 
(PEI), poly(N,N-dyakylamino ethylmethacrylates (PDAAEMA) and poly-lysine [98]. Grafting of pH-
responsive polymers has been used to confer pH-responsiveness to a surface. For example, chitosan 
was grafted onto the surface of PLLA/BG composites [99]. In an acidic medium, chitosan becomes 
positively charged due to the protonation of the free amine groups. The pH-responsive behavior of the 
PLLA/BG composites modified with chitosan was confirmed by contact angle measurements. After 
modification, the contact angle changed from 88.9±4.05º at pH 7.4 to 67.6±2.3º at pH 5.4. The 
unmodified PLLA/BG composites revealed a hydrophobic character, presenting a contact angle of 82º, 
independently of the pH. 
In LbL, the growth of polyelectrolyte-based coatings is dependent on pH [100,101]. For instance, for 
chitosan/alginate films, a value of 56 nm was obtained for the final thickness of the films built at a pH 
Chapter 4. Stimuli-responsive surfaces for biomedical applications 
 
150 
of 7.0 and 34 nm for the multilayers assembled at a pH of 5.5 [101]. When the charge density of the 
adsorbing species decreases (i.e., chitosan at a pH of 7.0), more polyelectrolyte chains are needed to 
overcompensate and invert the surface charge, explaining the higher thickness associated with the 
deposition of polymers at pH 7.0. Also, LbL coatings of polyelectrolytes respond intrinsically to pH. 
Multilayer films conceived with chitosan and ELRs were demonstrated to be pH-responsive [69]. At high 
pH values, the roughness of the substrates increased due to the triggering of the ELR self-assembly 
mechanism into aggregates, besides the variation of the internal electrostatic interactions. 
Micro- and nano-scale porosity can be introduced in LbL films by pH variations, thus allowing to control 
film permeability [102,103]. 
4.3.2.2  Ionic strength 
Polymers that contain ionizable groups are typically sensitive to ionic strength. In fact, due to the 
attractive Coulombic interactions between oppositely charged species, such polymers may be insoluble 
in deionized water but soluble in the presence of a determined oncentration of added electrolytes where 
the attractive charge/charge interactions are shielded, as higher ionic strength solutions reduce the 
range of electrostatic interactions [104]. So, changes in the ionic strength can lead to changes in the 
polymer solubility and, therefore, in the length of the deposited polymer chains. Ionic strength is also an 
important parameter that allows controlling film swelling. In the case poly-lysine/hyaluronic acid LbL 
films prepared at an ionic strength of 0.15 M in NaCl, reversible swelling and deswelling occurs when 
the ionic strength is cycled between 0.15 and 0.225 M [105]. Ionic strength has also been used to 
control the permeability of LbL films as ionic variations can introduce porosity [106]. 
4.3.3  Biochemical stimuli 
4.3.3.1  Antigens 
Antigen-antibody interactions have been also explored under the scope of stimuli-responsive surfaces. 
Such interactions are quite specific and associated with the complex immune responses that help 
recognize and neutralize foreign infection-causing objects in the body. 
Ai and co-workers [107] showed that platelets coated with anti-“immunoglobulin G” (IgG) multilayers 
could be targeted to IgG-coated surfaces. An antigen responsive membrane based on dextran grafted 
with both a fluorescent fluorescein isothiocyanate (FITC) antigen and anti-FITC IgC antibody was 
proposed by Zhang and co-workers [108]. When free sodium fluorescein was added to the membrane, 
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antibody-antigen crosslinks were broken by competitive binding of the free antigen. The disruption of the 
crosslinks caused the reversible swelling of the membrane. So, such membranes could be used as 
gates for selective diffusion controlled by the presence of an antigen. 
4.3.3.2  Enzymes 
Bacteria located mainly in the colon produce reductive enzymes (e.g. azoreductase) or hydrolytic 
enzymes (e.g. glycosidases) capable of degrading various types of polysaccharides, such as pectin, 
chitosan, amylase/amylopectin, cyclodextrin and dextrin [109-111]. For example, polymer systems 
based on alginate/chitosan are responsive to chitosanase and azoaromatic bonds are sensitive to 
azoreductase [112,113]. Enzyme responsive polymers present the advantage of not requiring an 
external trigger for decomposing, exhibit high selectivity and work under mild conditions, although is not 
straightforward to determine the beginning of degradation. An interesting example regarding enzyme-
responsive surfaces are the ones developed by Todd and co-workers, which present cell adhesive 
arginine-glycine-aspartic acid (RGD) sequences on-demand, that is, by enzymatic hydrolysis of inactive 
RGD containing precursors that carry cleavable steric blocking groups [114]. 
4.3.3.3  Glucose 
Glucose-responsive polymers can be specifically used in the controlled relase of insulin and for glucose 
sensing. Typically, glucose oxidase (GOX) is conjugated to a pH-sensitive polymer [115]. GOX oxidizes 
glucose to gluconic acid, inducing a pH change and the corresponding release of the insulin 
encapsulated in the pH-system. For example Imanashi and co-workers [116] grafted GOX-conjugated 
PAA onto a cellulose film. At neutral and high pH the PAA chains were extended due to the negative 
charged of the carboxylate groups, occluding the pores of the cellulose membrane. The gluconic acid 
that resulted from the addition of glucose led to a local pH decrease, protonation and subsequent 
collapse of the PAA chains, leading to the insulin release. 
4.3.4  Multiple responsive surfaces 
Smart surfaces that respond simultaneously to more than one stimulus could be particularly interesting 
regarding biomedical applications and could be used, for instance, to control in a more effective way 
drug release or cell response. Some representative works where this type of surfaces was developed will 
now be given. For example, dual responsive coatings of chitosan-graft-NIPAAm and alginate were 
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built [70]. AFM analysis confirmed that PNIPAAm is able to reconform upon temperature swaps even 
when combined with other layers in a polyelectrolyte multilayer, demonstrating that the nano-
assemblies are thermo-responsive. In another work, a smart and stable polymer brush interface based 
on PNIPAAm, PAA and poly(NIPAAm-co-AA) was able to reversibly respond to temperature, ionic 
strength and pH, independently or simultaneously [117]. 
Thermo- and pH- sensitive films of poly(N,N -dimethyl aminoethyl methacrylate)-poly(propylene oxide)-
poly(N,N -dimethyl aminoethyl methacrylate)/PAA ((PD-PPO-PD)/PAA) were prepared by Tan and co-
workers [80]. These films present a thickness of 2150 nm at 6ºC and of 941 nm at 20ºC, when they 
were deposited from distilled water at pH 7. This volumetric transition does not occur any more when 
the same films were prepared from water at pH 4 because PPO already forms hydrogen bonds with 
PAA (mostly in the protonated, neutral form) which are not available any more for water molecules. 
Other interesting example of multi-responsive coatings are the PNIPAAm-co-AA copolymers sensitive to 
pH and temperature that were prepared by Xia and co-workers [75]. The combination of this dual 
stimuli-responsive coating combined with surface micro and nanostructure enabled the water contact 
angle (CA) of the surface to be controlled over a range of 150º. On a flat surface, however, the CA 
change was only 13º and 9.6º for a temperature range of 21–45ºC and a pH range of 2–11, 
respectively. 
4.4 Biomedical applications of smart surfaces 
4.4.1  Smart coatings for tissue engineering, regenerative medicine and drug 
delivery applications 
Smart coatings can be used to control the properties of the surface of a substrate, such as an implant, 
by changing the surface chemistry, topography and/or hydrophobicity, and therefore modifying protein 
adsorption and cell adhesion. These coatings can be simultaneously used to release a drug or bioactive 
compound in a controlled way. Some representative examples of smart biomaterial coatings will now be 
presented. 
Protein adsorption on PNIPAAm coatings has been investigated by distinct authors, showing that 
adsorption is typically unfavorable below the LCST, being stronger above the LCST [118-120]. For some 
proteins and some conditions, protein adsorption might become irreversible, inhibiting repeated 
switching. It was found that protein adsorption reversibility on PNIPAAm coatings depends whether the 
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phase transition back to the hydrated protein resistant state is energetically more favorable than the 
interactions formed between chains and the protein in the collapsed state [119]. 
Several studies have focused on the influence of the LbL film composition on protein 
adsorption [121,122]. For instance, the adsorption of human serum albumin (HSA) onto 
chitosan/alginate multilayer assemblies was assessed in situ using QCM-D [123]. It was found that the 
behavior of human serum albumin (HAS) on biomaterials surface can be tuned by adjusting parameters 
of the polyelectrolyte system such as pH, layer number, crosslinker and polymer terminal layer. The key 
role of electrostatic interactions during HSA adsorption was evidenced in that work, since oppositely 
charged surfaces were more effective in promoting protein adhesion. Also, novel protein-based systems 
have been developed by self-assembly, introducing the possibility to prepare, in a controllable way, thin 
reservoirs of proteins [124] and, by embedding biologically active proteins, film functionalization can be 
achieved [125]. The LbL approach has enabled protein encapsulation to release active proteins in a 
way that is applicable to objects of any desired geometry and size scale [126]. Moreover, microcapsules 
with a hierarchical shell-within-shell structure of different proteins entrapped in polymeric layers have 
been developed [127]. 
In the field of active molecule release, it is also very interesting to develop LbL films in which one of the 
components hydrolyses above a critical pH value leading to film erosion and release of the active 
molecule. This concept has been used for the pH triggered release of anionic polysaccharides and of 
deoxyribonucleic acid (DNA) from poly-(β-amino ester)-DNA films [67,128]. The decomposition or 
release of active compounds can also occur through enzymatic hydrolysis [129]. For example, DNA and 
non-activated DNAase were co-encapsulated in hollow polyelectrolyte capsules. The enzyme can be 
activated by a chemical trigger which diffuses through the polyelectrolyte membrane, activating the 
enzyme, the subsequent hydrolysis of DNA and the diffusion of small oligonucleotides through the 
capsule wall [130]. LbL can also be used to coat inorganic microspheres to conceive smart 
microreservoirs. Huang and Chang [131] developed multilayer microcapsules made of azido- and 
acetylene-functionalized PNIPAAm that shrunk upon increasing the temperature from 25 to 50ºC 
(Figure 4.3). These microcapsules were also permeable to low-molecular weight substances, such as 
dextran. 
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Figure 4.3. Transmission electron microscopy (TEM) images of azido- and acetylene-functionalized 
PNIPAAm microcapsules dried at 25ºC and 50ºC. Scale bar: 2 μm. Reprinted (adapted) with 
permission from [131]. Copyright 2009 American Chemical Society. 
 
There are many other interesting examples related with the field of active molecule release. For 
instance, pH-responsive polymers may be used to deliver fragile biomolecules such as peptides or 
oligonucleotides to the cytoplasm of macrophages, as the work of Murthy and co-workers 
evidenced [132]. They used pH cleavable acetal linkages to remove poly(ethylene glycol) (PEG) grafts 
that mask the delivery vehicle and disrupt the endosome causing the delivery of biomolecules into the 
cytoplasm before they are degraded in the lysosomes. PNIPAAm/-co-AA microgels/polyallylamine 
coatings retained their thermo-responsiveness within the multilayer and allowed their use for thermally 
triggered release of insulin [133]. An antimicrobial coating that can simultaneously discourage bacteria 
attachment to the implant surface and release, in a tuneable dosage and rate, antibiotics into the 
surrounding tissues has also been developed [134]. 
Regarding the use of smart surfaces to control cell response, several works can also be found in 
literature. For example, Picart et al. [135] investigated the effect of grafting an RGD peptide onto distinct 
LbL films on the adhesion of primary cells, and observed an enhanced cell proliferation for the 
functionalized films. Boura et al. [136] evaluated the adhesion properties of endothelial cell on two 
types of polyelectrolyte films ending either by polylysine, or poly(allylamine hydrochloride) (PAH), and 
compared them to data obtained on polylysine  or PAH monolayers, glass and fibronectin-coated glass. 
They found that the cells seeded on the LbL films showed a good morphology and resisted to 
physiological shear stress better, when compared to the cell seeded on glass or fibronectin. 
Photo-responsive layers composed of made of PNIPAAm and spiropyrans have been used to tailor cell 
adhesion by switching light on or off [95]. Cell adhesion has also been photo-chemically controlled 
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using RGD-functionalized azobenzene poly(methyl methacrylate) (PMMA) surfaces [137]. It was found 
that azobenzenes enhanced cell adhesion but, upon UV-irradiation-induced trans -cis isomerization, 
which shortened the distance of the RGD-containing peptides from the surface, cell adhesion decreased. 
Nakanishi et al. [138] built self-assembled monolayers having photo-cleavable 2-nitrobenzyl groups that 
could be used to template cell adhesion. Bovine serum albumin (BSA), inert to cell adhesion, was 
adsorbed over this monolayer. Upon exposing defined regions with UV light, BSA was released from 
such regions. Finally, fibronectin, a protein promoting cell adhesion, was then incubated and covered 
the irradiated regions. This method allowed producing patterned regions for cell adhesions and by 
subsequent illumination it could be also possible to induce cell migration and proliferation. 
4.4.2  Smart biomineralization 
In medical devices for orthopaedic applications, either under traditional replacement concepts or 
regeneration strategies, such as tissue engineering, it is important to promote the production of 
bonelike apatite onto the biomaterial’s surface. It has been shown that surface biomimetic 
mineralization may be triggered by either temperature or pH [74,99]. For PNIPAAm modified composite 
PLLA film with 10% BG, it was found that the conformational changes occurring at the surface affect the 
mineral formation below and above the LCST [74]. No mineral phase could be observed at 25ºC after 2 
weeks in simulated body fluid (SBF). However, at 37ºC the treated film could form dense precipitates 
with the typical cauliflower morphology, containing needle-like nanometric structures, characteristic of 
biomimetic-formed apatite. Moreover, by exposing some regions of the surface to the plasma treatment, 
a patterning could be made to combine stimuli and spatial control of biomimetic apatite [74]. This 
allowed the insertion of PNIPAAm in specific chosen areas. Again, no apatite formation was observed 
for these modified films at 25ºC. On the other hand, apatite aggregates were formed at 37ºC, with a 
circular shape and randomly distributed over the composite surface, being consistent with the 
PNIPAAm patterning generated during the plasma activation step. These apatite patterned surfaces 
could be used in fundamental studies on differentiation, adhesion, proliferation and cell-cell signaling of 
bone-related cells. These surfaces could also be used in fundamental co-culture studies involving bone 
cells and other cell types [139,140]. 
For chitosan-modified PLLA/BG composites no apatite formation was found at pH 5.4 [99]. On the 
other hand, a dense apatite layer of a carbonated apatite mineral similar to the major mineral 
component of vertebrate bone tissue was formed at pH 7.4. For the unmodified substrates an apatite 
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layer was formed at both pH. Temperature and pH were chosen in the above mentioned works, but this 
concept of smart apatite formation can be extended for other source of responsiveness and for other 
type of mineral deposition. 
4.4.3  Cell sheet engineering 
The use of smart surfaces, specifically thermo-responsive surfaces, has been applied to the so-called 
“cell sheet engineering”. This technology has been proposed to construct ideal transplantable tissues 
composed exclusively of cells [141]. Initially, Okano and co-workers proposed temperature-responsive 
cell culture polystyrene substrates prepared by the grafting of PNIPAAm onto these surfaces, which 
allow the culture of confluent cell monolayers at 37C and their recovery as single cell sheets when the 
temperature is below the LCST of PNIPAAm. Afterwards, they have combined these smart surfaces with 
patterning, with the aim of producing complicated three-dimensional tissues [142-145]. For instance, 
micropatterned dual thermo-responsive surfaces that enable the culture and recovery of patterned 
heterotopic cell sheets were proposed [142,143]. 
Okano and co-workers have shown that it is possible to obtain cell sheet constructs with five layers, 
where the viability of the transferred cells and the adequate organization of the functional cell-cell 
junctions were demonstrated [144]. Direct transplantations of cell sheets have been already 
successfully applied to corneal epithelia, mucosal epithelia, periodontal ligament cells, bladder epithelia 
and esophageal epithelia [141]. Cell sheets have also been layered in order to successfully recreate 
thicker tissue-like constructs such as cardiac and more recently bone [146]. 
The LbL approach has also been explored as a potential alternative to the traditional grafting techniques 
employed for cell sheet engineering. It was shown that (chitosan-graft-NIPAAm)/alginate LbL films 
enabled the attachment and proliferation until confluence of cells at 37ºC and the spontaneous 
detachment of cell sheets along with their deposited extracellular matrix by simple temperature 
modulation (Figure 4.4) [70]. Thus, these multilayered thermo-responsive surfaces could potentially be 
used in cell sheet engineering. The mild conditions and the absence of harmful solvents, the simplicity 
of the method and the ability to modulate cellular adhesiveness by controlling the “nanometric” 
thickness of the coatings are some of the advantages of this novel strategy. A completely new strategy 
for cell culture focusing on the design of three-dimensional smart surfaces by supercritical fluid 
technology has also been recently proposed based on supercritical carbon dioxide [147]. This approach 
might overcome the limitations on cell expansion and harvesting of currently existing techniques. 
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Figure 4.4. In-situ detachment of SaOs-2 cell sheets after 10 min (A) and 15 min (B) of incubation at 
4ºC from (GRAFT/ALG)5GRAFT films. Reprinted with permission from [70]. Copyright 2011 American 
Chemical Society. 
4.5 Conclusions 
The latest advancements in healthcare have emphasized the need to develop dynamic devices that can 
adjust themselves to a specific situation. Although many of these concepts are still under development 
in the lab bench, substrates modified with stimuli-responsive properties have already been proposed for 
controlling the adhesion of cells or proteins, microfluidics and biosensors. 
From the literature, it is clear that such advances are owed to the variety of methods that one can use 
to modify an interface and to the wide array of materials that can be used to build it. Thus substrates 
that respond to distinct physical, chemical and biochemical stimuli can be made with potential for new 
cutting-edge applications in biology and biotechnology. In the next decade, we expect to assist to the 
rise of dynamic smart systems with new designs and complexity moving further into the third dimension. 
Switchable surfaces exhibiting alternating biological active signals will be used to develop new cell 
culture protocols. Substrates with dynamic molecular conformation upon the contact with a specific 
biochemical agent will be used as biosensors for rapid diagnostic. Stimuli-responsive interfaces built 
onto drug reservoirs will be further optimized to tune and control better the release of encapsulated 
therapeutic molecules. With such nature, smart surfaces offer opportunities for a wide array of 
applications in medicine and tissue engineering where an interface with switchable properties is needed. 
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 Chapter 5. Materials and methods 
Many of the materials used in this thesis – both polymeric constituents and reactives – were either 
purchased or obtained by biological processes. The detailed specifications of the suppliers can be found 
in the experimental subsections of each chapter of Section III. Likewise, equipment suppliers are also 
discriminated in those subsections. 
5.1 Materials 
5.1.1 Polysaccharides 
Several polysaccharides were used for the conception of multiple layer-by-layer (LbL) constructs. 
Namely, chitosan (CHI) was used in every experimental work, throughout chapters 6 to 11. CHI is a 
biodegradable linear polysaccharide composed of randomly distributed N -D-glucosamine and N -
acetyl-D-glucosamine, linked by β-(1-4) glycosidic bonds (Figure 5.1a). It is obtained by partial 
deacetylation of chitin – which is found in the exoskeleton of shellfish, like shrimp and crabs – in the 
solid state under strong alkaline conditions or by enzymatic hydrolysis in the presence of a chitin 
deacetylase. In this process, named N - deacetylation, the acetyl functional groups of chitin are removed. 
Conventionally, the compound is called “chitosan” when the degree of deacetylation of chitin reaches 
about 50%. CHI undergoes a conformational transition in solution around a pH value of 6. Its amine 
groups, as is characteristic of polybases, are protonated at pH below the pKa and deprotonated at 
higher pH values [1-3]. 
Levan is a linear β-(2-6)-linked fructose polymer (fructan) exhibiting hydroxyl groups that form strong 
adhesive bonds with various substrates (Figure 5.1b). This polymer – which was used along CHI in 
Chapter 6 – can be produced by almost every fructan synthesizers: one particular example is levan 
produced by extremophilic and halophilic bacteria Halomonas smyrnensis (Figure 5.2). They are found 
in highly saline environments to provide adhesion and protection. The fact that superior 
bioadhesiveness can be achieved under such harsh conditions points to the excellent adhesive 
properties that levan and its derivatives can provide. In comparison to petrochemically-derived 
adhesives, levan is biodegradable, biocompatible, nonallergic, nontoxic and water-soluble, useful 
properties for high-value biomedical applications [4-6]. 
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Occasionally, alginate (ALG) was also used as a multilayer constituent, in Chapters 6, 7 and 11. ALG is 
a linear anionic copolymer composed of two monomers: β-D-mannuronic acid, α-L-guluronic acid 
(Figure 5.1c). It can be obtained from the cellular wall, accounting for up to 45% of the dry weight of 
these seaweeds. ALG has stimuli-responsiveness toward pH. The carboxylic acid groups from the 
guluronate and mannuronate monomers can be deprotonated above pH values of 3.2 and 4, 
respectively. Thus, alginate behaves as polyacid and exhibits polyanionic behavior above these pKa 
values [7-10]. ALG and also CHI, which share a marine origin, both show biocompatibility, adhesiveness, 
nontoxicity, as well as bacteriostatic, fungistatic, antimicrobial and hemostatic activities [10-12]. These 
properties make of these polysaccharides suitable constituents for multilayer formulations that resort to 
natural materials. 
 
(a) (b)
(c)
 
Figure 5.1. Molecular structure of (a) chitosan, (b) levan, and (c) alginate. 
 
2 μm
 
Figure 5.2. Scanning electron microscopy image of a preparation of Halomonas sp. strain. Source: 
http://commtechlab.msu.edu/sites/dlc-me/zoo/zdx0283.html, September 10th 2013. 
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All materials used in the present thesis were bought from specialized commercial distributors. Among 
the purchased materials were CHI and ALG: medium molecular weight chitosan (Brookshield viscosity 
200-800 cP, molecular weight 190-310 kDa) and alginic acid sodium salt from brown algae (molecular 
weight 100-200 kDa). The sodium salt group enabled ALG to solubilize in water more easily, in 
comparison to its unmodified form. Levan was obtained by biological processes, as described below. 
Chitosan as-received often contains impurities and debris resulting from the deacetylation process of 
chitin and requires a purification procedure. Purification of CHI exploits the fact that it undergoes a 
conformational transition in solution around a pH value around 6, making it soluble below this value 
and precipitate above it. For purification a method described by Signini and Filho [13] was adapted. A 
CHI solution at 1% (w/v) using acetic acid at 1% (v/v) as solvent was prepared. The solution was 
vacuum-filtered twice through filter papers with 20–25 μm of pore size, to remove impurities. The 
filtered solution was neutralized using sodium hydroxide (NaOH) at a molar concentration of 1 M and 
was added drop-wise until pH was 8. The precipitated chitosan was then repeatedly rinsed in distilled 
water until the pH of the residual waters meets the same value of distilled water (around pH 7). CHI 
was rinsed with ethanol, vacuum-filtered and stored at -80 ºC before being lyophilized. 
5.1.1.1 Microbial levan production 
For Chapter 6, levan was produced by halophilic Halomonas smyrnensis AAD6T batch cultures using 
pretreated sugar beet molasses as substrate. For this, molasses subjected to tricalcium phosphate, 
sulphuric acid and activated carbon pre-treatment was added to sterile production medium (7 g∙L-1 
dipotassium phosphate (K2HPO4); 2 g∙L
-1 monopotassium phosphate (KH2PO4); 0.1 g.L
-1 magnesium 
sulfate heptahydrate (MgSO4∙7H2O); 1 g.L
-1 ammonium sulfate ((NH4)2SO4); 0.5 g∙L
-1 peptone; 
137.2 g∙L-1 sodium chloride (NaCl) to 30 g∙L-1 final carbohydrate concentration and after inoculation, 
cells were incubated in an orbital shaker set at 37ºC and 180 rotations per minute (rpm) agitation rate. 
Afterwards, cells from the stationary phase cultures were harvested by centrifugation at 11000g for 20 
minutes and the supernatant phases were treated with an equal volume of ethanol, held at -18ºC 
overnight, and then centrifuged at 16000g and 4ºC for 30 min using a refrigerated centrifuge. The 
pellets were dissolved in hot distilled water, dialyzed against several runs of distilled water for 3 days 
and lyophilized. The typical results of this procedure is a levan polymer with a molar mass of at least 
1000 kDa [14]. 
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5.1.1.2 Levan phosphonate modification 
Levan as-produced does not possess groups exhibiting electrostatic charge. For the purpose of 
producing multilayer films with CHI driven by electrostatic interactions, phosphonate groups were 
introduced in the structure of levan. This way, it was expected that the introduced groups provided 
negative charge for interaction with the polycationic CHI. For the production of phosphonated levan 
(Ph-levan), 4 g of levan was dissolved in 100 mL of pyridine by vigorously mixing on a magnetic stirrer 
for 48 hours at ambient conditions and then the solution was cooled down to 0ºC. In an ice bath, 4 mL 
of phosphorus trichloride (PCl3) was added slowly in a drop-wise manner to the well-stirred solution. 
After stirring for 30 min under ambient conditions, 100 mL of saturated sodium carbonate (Na2CO3) 
was added. The aqueous phase containing the modified polymer was separated and freed from pyridine, 
and then subjected to dialysis against distilled water for at least 4 consecutive days with frequent 
exchanges of the solvent (3–5 times per day). The polymer was freeze-dried and an overall recovery 
yield of about 50% was achieved. 
5.1.2 ELR expression and purification 
Elastin-like recombinamers are genetically-engineered polypeptides that can exhibit precise amino acid 
length and sequence, and stimuli-responsiveness toward external stimuli, such as temperature, pH, 
ionic strength, and some toward light. An exhaustive description of elastin-like macromolecules has 
already been provided in Section I, as Chapter 3. 
From Chapter 7 to Chapter 11, ELRs were used as one of the constituents of the multilayer films and 
coatings. Expression conditions and purification protocols were adapted from Meyer and Chilkoti [15] 
and Girotti et al. [16]. ELRs were obtained by the induced gene expression from a stock of recombinant 
Escherichia coli strains containing the desired expressing gene. This stock of recombinant bacteria had 
been previously obtained. The artificial nature of ELRs means that it is necessary to design and 
synthesize their genes de novo in order to obtain them. It is impossible to obtain a complete synthetic 
gene, through an approach involving genetic engineering. The repetitive structure of recombinamers 
implies that a monomer deoxyribonucleic acid (DNA) segment or “monomeric gene” encoding a 
specific polypeptide sequence can be created and subsequently seamlessly joined independently of the 
presence of restriction sites in the target DNA to generate multimerized genes that express the whole 
recombinamer. Three strategies can be employed to obtain the polymeric genes. One is 
concatemerization method, a random, directional concatenation of the monomeric gene. This method 
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allows multimeric genes with a defined distribution and discrete lengths to be obtained in a single 
cloning cycle. The other is the iterative-recursive method, which allows complete control of the size and 
distribution of the individual blocks that play central roles in formation of the supramolecular structures. 
Finally, recursive directional ligation (RDL), an alternative method in which DNA segments with two 
different restriction sites flanking the insert are joined in sequential steps, with the length of the ligated 
segments growing geometrically in each step (Figure 5.3) [17]. 
 
Transformation
Recombinant
bacteria
Fermentation
∞
F
Purification
 
Figure 5.3. The molecular biology steps of RDL. (A) A synthetic monomer gene is inserted into a 
cloning vector. (B) The gene is designed to contain recognition sites for two different restriction 
endonucleases, RE1 and RE2, at each of the coding sequence. (C) An insert is prepared by digestion of 
the vector with both RE1 and RE2 and subsequently ligated into the vector that has been linearized by 
digestion with only RE1. (D) The product contains two head-to-tail repeats of the original gene, with the 
RE1 and RE2 sites maintained only at the ends of the gene. (E) Additional rounds of RDL proceed 
identically, using products from previous rounds as starting materials. Reprinted with permission 
from [18], Copyright 2002, American Chemical Society. (F) Recombinant bacteria containing the 
desired gene are submitted to fermentation and purified afterwards to extract the bioproduced polymer. 
 
Nine distinct ELRs were produced, differing in their amino acid sequence, length and, in most cases, 
bioactivity. Table 5.1 lists the desired ELR sequences produced throughout this thesis. The acronyms 
were given in accordance to their specific amino acid sequence. Gene expression was induced in 12 L 
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of terrific broth medium (TB) with 0.1% of carbenicilin and 0.1% of glucose, under controlled conditions 
of temperature (37ºC) and pH (7.00). The fermentation was stopped after registering an optical density 
variation at 600 nm inferior to 0.25, within 1 h. Subsequent to fermentation, the culture was harvested 
by centrifugation, resuspended and lysed by ultrasonic disruption. Insoluble debris was removed by 
centrifugation and the cleared lysate was subjected to several cycles of cold and warm centrifugations, 
of 4 and 40ºC, respectively. All the purification steps were carried out in a sodium chloride (NaCl) 
solution at 0.5 M. The polymer in solution was then frozen at -24ºC and freeze-dried. 
 
Table 5.1. List of ELRs and corresponding amino acid sequence used throughout the various 
subsequent chapters. 
ELR acronym Sequence 
3K-VRDG(-)V MGKKKP-(VPGVG)14[(VPGIG)10AVTGRD GSPASS(VPGIG)10]2(VPGVG)14-V 
3K-VRGDV MGKKKP(VPGVG)14[(VPGIG)10AVTGRGDSPASS(VPGIG)10]2 (VPGVG)14-V 
HAP3 
MESLLP[[(VPGIG)2(VPGKG)(VPGIG)2]2 DDDEEKFLRRIGRFG[(VPGIG)2 
(VPGKG)(VPGIG)2]2]3-V 
GEG15 MD[(VPGVG)2(VPGEG) (VPGVG)2]15IGSG 
H3A20 
MESLLP[[(VPGIG)2VPGKG(VPGIG)2]2DDDEEKFLRRIGRFG[(VPGIG)2VPGKG 
(VPGIG)2]]3-(VPAVG)20-V 
IK24 MESLLP[(VPGIG)2(VPGKG)(VPGIG)2]24-V 
H-RGD6 
MGSSHHHHHHSSGLVPRGSHMESLLP[[(VPGIG)2(VPGKG)(VPGIG)2]2 
AVTGRGDSPASS[(VPGIG)2(VPGKG) (VPGIG)2]2]6-V 
H3A20H3 
MESLLP[[(VPGIG)2(VPGKG)(VPGIG)2]2DDDEEKFLRRIGRFG[(VPGIG)2(VPGKG) 
(VPGIG)2]2]3(VPAVG)20[[(VPGIG)2(VPGKG)(VPGIG)2]2DDDEEKFLRRIGRFG 
[(VPGIG)2(VPGKG)(VPGIG)2]2]3-V 
V84 MGKKKP-(VPGVG)84-V 
 
All ELRs exhibited groups that could undergo protonation and exhibit electrostatic charge, except for 
V84. This polypeptide was submitted further to a chemical modification to neutralize its three lysines (K), 
in order to use a neutral ELR in LbL formulations. For that, V84 was modified by amidation of the 
γ-amine group of the biopolymer with pentynoic anhydride as an acylating agent. The reaction was 
performed in trifluoroethanol (TFE) with 10 equivalents of pentynoic anhydride per γ-amine group and 
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1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC; 5 equivalents) as catalyst. Pentynoic anhydride 
was synthesized previously from pentynoic acid in a 1:1 (v/v) mixture of dichloromethane and diethyl 
ether in the presence of dicyclohexylcarbodiimide. The reaction mixture was stirred for 3 days at room 
temperature. After this time, the functionalized polymer was precipitated into increasing fractions of 
diethyl ether and dried in a vacuum oven at room temperature for 24 h. Once dry, the modified V84 
was solubilized in cold water and the crude product purified by exhaustive dialysis against water, then 
frozen and finally freeze-dried. 
5.1.3 Synthesis of magnetic nanoparticles 
For the purpose of constructing LbL-based systems with magnetic response in Chapter 11, magnetic 
nanoparticles (MNPs) were first synthesized. MNPs are structures susceptible to magnetic fields, often 
used to enhance medical imaging diagnosis of soft tissues (e.g., magnetic resonance imaging, MRI) and 
temperature-mediated treatments such as hyperthermia and tissue ablation [19-21]. Their magnetic 
responsiveness also allows spatial mobilization/immobilization dependent on the application of a 
magnetic field on demand. In a typical synthesis of spherical iron oxide MNPs, 10 mL of a solution 
containing 1.2 g of iron(III) chloride hexahydrate (FeCl3∙6H2O) and 0.6 g of iron(II) chloride tetrahydrate 
(FeCl2∙4H2O) was added drop-wise to 25 mL of ammonium hydroxide solution (NH4OH, made of 33% 
ammonia, NH3, in H2O) over 4 h under an inert nitrogen atmosphere. The products of the reaction 
were collected by magnetic separation and washed three times with ethanol and water. The last 
washing step was made with ethanol, after which the products were left to dry at room temperature. 
5.2 Characterization of the materials 
Many characterization techniques were specific for each of the materials used: CHI, Ph-levan, ELRs and 
MNPs. 
5.2.1 Degree of deacetylation of chitosan 
After the purification of CHI – which was recurrently used in every experimental work – it was necessary 
to determine the precise degree of deacetylation (DD) of the obtained stock. For that purpose, 
hydrogen-1 nuclear magnetic resonance (1H-NMR) spectra were recorded for a sample of purified CHI. 
NMR is a common technique used to determine the structure of unknown organic structures, by 
applying a nuclear magnetic resonance with respect to hydrogen-1 nuclei within the molecules of a 
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substance. Among other things, it allows determining the number of protons in a molecule, different 
types of hydrogen atoms (e.g., protons bonded to carbon atoms that are attached to different functional 
groups), and the number of “neighbor” hydrogen atoms a proton has [22]. Thus, 10 mg of chitosan 
was dissolved in 1 mL of deuterated water (D2O) and 20 µL of deuterated hydrochloric acid (DCl) to 
form a viscous solution. An aliquot of this solution was placed in a 5 mm NMR tube and the spectrum 
recorded at 60ºC. The calculation of the DD, in percentage (%), was based on the report of Hirai, Odani 
and Nakajima [23] and is presented in equation 5.1: 
100
6
1
3
1
1(%) 

























c
e
I
I
DD   (5.1) 
where Ie represents the integral intensity of the CH3 resonance band and Ic the integral intensity of the 
H2 to H6 resonance bands (Figure 5.4). 
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Figure 5.4. Typical structure of the N -D-glucosamine monomer in chitosan molecules. Each distinct 
hydrogen atom is identified from 1 to 6. 
5.2.2 Phosphonate-levan modification assessment 
To assess if the modification of levan into Ph-levan was successful in Chapter 6, two techniques were 
used: energy dispersive spectroscopy (EDS) analysis, for the elemental analysis of phosphorous, and 
Fourier transform infrared (FTIR) spectra, by comparing both modified and unmodified levan samples 
within wavelength values of 400–4000 cm-1. EDS is performed using a scanning electron microscope 
(SEM) which, besides the morphology and surface of a sample, allows determining its elemental 
composition. When the electron beam bombards a sample, X-rays are produced as a result of the 
ionization of an atom by high-energy radiation. Consequently, an inner shell electron is removed. To 
return an ionized atom to its ground state, an electron from a higher energy outer shell fills the vacant 
inner shell and, in the process, releases an amount of energy equal to the potential energy difference 
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between the two shells. The excess energy is unique for every atomic transition and allows determining 
the atomic element in analysis [24]. In FTIR, infrared radiation passes through a sample: some of this 
radiation is absorbed by the sample some of it is transmitted through. The detected infrared spectrum 
is the result of transitions between vibrational energy states, which can range from simple coupled 
motion of two atoms in a diatomic molecule to a more complex atomic motion in a large polyfunctional 
molecule. Thus, it is possible to detect functional groups, for instance, in a modified polymer by 
measuring characteristic absorption spectra, in respect to an unmodified sample [25]. 
5.2.3  Elastin-like recombinamers bioproduction assessment 
ELRs used throughout Chapters 7 to 11 were characterized following a multitude of techniques. To 
assess that the desired ELR was appropriately synthesized and produced, amino acid composition 
analysis and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectroscopy 
were used. The amino acid composition was determined according to the AccQTag Waters method and 
the derivatized amino acids analyzed by high-performance liquid chromatography (HPLC). In general, 
an ideal derivatizing reagent must consist of an appropriate reactive group and a strong fluorophore. 
Typically, the protocol of the manufacturer requires the use of 6-aminoquinolyl-N -hydroxysuccinimidyl 
carbamate to react with primary and secondary amines to produce unsymmetrical urea derivatives that 
are highly fluorescent. Such conjugates can be separated in chromatographic columns and be detected 
sensitively using ultraviolet fluorescence detectors [26,27]. MALDI-TOF mass spectroscopy was used to 
determine the molecular weight of the produced ELRs. In MALDI-TOF, proteins are liberated in an 
ionized form from a target surface by firing a laser pulse at crystallized proteins. The ionized proteins 
are accelerated through a vacuum tube by an electrical field and reach a detector. Smaller proteins are 
accelerated to higher velocities than heavier proteins, and the “time-of-flight” is proportional to “m/z”. 
The charge “z” of ionized proteins is often 1, making the m/z value equal to the mass value [28]. 
5.2.4 Magnetization of MNPs 
Magnetic particles can be classified as ferromagnetic and paramagnetic/superparamagnetic. Whereas 
the former exhibit a permanent magnetic dipole moment, with a paramagnetic particle a magnetic 
dipole moment is induced only when an external magnetic field is applied [29-32]. The magnetization of 
the MNPs was therefore measured as a function of an applied external magnetic field. Typically, a 
vibrating sample magnetometer is used, which is capable of generating a magnetic field and detect the 
magnetization exhibited by a tested material. 
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The shape and morphology of the magnetite nanoparticles were determined using high resolution 
transmission electronic microscope (TEM). TEM is a microscopy technique that detects a beam of 
electrons transmitted through a specimen. A microscope of this class is capable of imaging at a 
significantly higher resolution than conventional light microscopes, thus it was appropriate to observe 
such nanometric structures [33]. The samples were prepared by dropping a dilute aqueous solution 
(1 mg∙mL-1) of the nanoparticles onto a 200-mesh copper grid and allowing the solvent to evaporate. 
5.2.5 Measurement of charges 
The charge exhibited by each polymer in aqueous solution was determined by the measurement of zeta 
(ζ)-potentials using laser Doppler electrophoresis. When a solid surface is in contact with an aqueous 
solution, the formation of an interfacial charge causes a rearrangement of the local free ions in the 
solution to produce a thin region of nonzero net charge density near the interface. The arrangement of 
the charges at the solid-liquid interface and the balancing counter-ions in the liquid is usually referred to 
as the electrical double layer. This region consists in a thin layer of counter-ions immediately next to the 
charged solid surface, called the compact layer, or Stern layer. The counter-ions in the compact layer 
are immobile due to the strong electrostatic attraction, while counter-ions outside the compact layer are 
mobile. This last part of the electrical double layer is called the diffuse layer. The ζ-potential is the 
electrostatic potential at the boundary dividing the compact layer and the diffuse layer [34]. This 
potential may depend on the polymer concentration, pH and ionic strength. Thus, solutions of each 
polymeric material were prepared considering one of two situations: (i) the conditions that would be 
used afterwards for the construction of the LbL films and coatings, in an attempt to relate both charge 
and successful or unsuccessful multilayer construction, or (ii) the conditions in which the developed 
coatings are placed after their construction, to determine their behavior at, e.g., physiological conditions. 
Aqueous solutions of each ingredient were tested all the times at 25ºC, 0.15 M of sodium chloride 
(NaCl), with varying concentrations and pH values. Regarding (i) they were: 1 mg∙mL-1, pH 5.5 for 
Ph-levan and CHI (Chapter 6); 100 μg∙mL-1, pH 5.5 for ELR-RGD (herein corresponding to 3K-VRGDV) 
and CHI (Chapter 8); 100 μg∙mL-1, pH 4.0 or 5.5 for all 9 ELRs, CHI and ALG (Chapter 7). Regarding 
(ii), they were: 300 μg∙mL-1, pH 7.4 for ELR-RGD and ELR-RDG(-) (herein corresponding to 3K-VRGDV 
and 3K-VRDG(-)V, respectively). 
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5.2.6 Temperature responsiveness of the polymers 
Differential scanning microscopy (DSC) and dynamic laser scattering (DLS) were used to evaluate the 
stimuli-responsiveness. DSC was used in Chapter 8 to determine the transition temperature of a sample 
of 3K-VRGDV. This technique measures the change of the difference in the heat flow rate to a sample 
and to a reference sample while they are subjected to a controlled temperature program. It provides 
direct, model-independent determinations of the transition properties, such as enthalpy, entropy, and 
transition temperature, and is an appropriate technique to study the inverse temperature transition of 
ELRs [35,36]. Experiments were performed with water solutions of 3K-VRGDV at 50 mg∙mL-1 were 
prepared at pH 7.4. In a typical DSC run, 20 μL of the solution were placed inside a standard 40 μL 
aluminum pan hermetically sealed. The same volume of water was placed in the reference pan. All 
samples were equilibrated for 5 minutes at 5°C inside the sample chamber just before the beginning of 
each experiment. A heating rate of 5ºC∙min-1 was used. 
Dynamic laser scattering (DLS) consists in the emission of a laser light over particles, emulsions or 
molecules dispersed or dissolved in a liquid. The interaction of this laser with the particles causes the 
light to be scattered at different intensities. The light intensity measured at the other end of the 
detectors in then interpreted and provides an estimation of the size of the samples dissolved or 
dispersed in solution [37]. It was used to determine the formation of polymeric aggregates in various 
solutions at various temperatures. In Chapter 9, 3K-VRGDV aggregate sizes were measured in the 
temperature range 25–37°C after stabilization for 5 minutes, to determine the transition temperature of 
the polypeptide. Samples were prepared at 300 µg∙mL-1 in phosphate-buffered solution (PBS, pH 7.4). 
A total of 20 runs were performed for each sample to obtain a final average value at constant 
temperature. In Chapter 11, the reversibility of the temperature-induced phase transition of the same 
ELR-RGD was evaluated. For solutions prepared under the same conditions, measurements were 
performed first at 25ºC, then 37 ºC and finally back at 25ºC. A total of 20 runs were performed for 
each sample to obtain an average value at stabilized temperature. In the same chapter, ALG and CHI 
were also submitted to the same measurements, although CHI – due to this polybase’s pKa – had to be 
tested at pH 5.5. Nonetheless, it was not expected that temperature influenced significantly the 
response of CHI, regardless of the pH value. 
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5.3 Assessment of LbL films’ growth 
5.3.1 In situ monitoring 
In order to determine if a set of ingredients can be used to construct multilayer films and coatings, a 
quartz-crystal microbalance with dissipation monitoring (QCM-D) was used in Chapters 6, 7 and 8, a 
technique that is able to detect adsorbed surface density changes in the order of ng.cm-2 and measure 
the viscoelastic properties of the resulting surface in real time. In this technique, a sensor is composed 
of a thin AT-cut quartz disk sandwiched between a pair of electrodes. Quartz allows exploiting the 
piezoelectric which makes it possible to convert an electric AC voltage across its electrodes into 
mechanical motion, exciting the quartz to oscillation at a fundamental frequency of 5 MHz. Therefore, 
the use of quartz sensors for QCM requires the use of “chips” that are coated by the electrode material, 
which can be one of a number of metals but being gold the one mostly used. An AT-cut quartz crystal 
can be excited at its fundamental frequency (5 MHz) and at several overtones: 1, 3, 5, 7, 9, 11 and 13, 
corresponding respectively to 5, 15, 25, 35, 45, 55 and 65 MHz, although different overtones can be 
monitored, depending on the equipment’s supplier. When a thin film is deposited onto the sensor 
crystal the frequency decreases. If the film is thin and rigid, the decrease in frequency (ΔF) is 
proportional to the mass of the film. However, when using polymers, the adsorbed film is not rigid and 
this relation is not valid. At the same time, monitoring of ∆D gives an indirect indication of the film’s 
viscoelastic properties. An increase in ∆D represents a shift towards a film with a higher viscous 
component and damping properties typical of “soft” polymeric LbL films. The dissipation values for a 
soft film are higher due to increased energy loss from the crystal, whereas smaller dissipation values 
are obtained for a rigid film. It is this dampening to the crystal’s oscillation that is registered as 
dissipation, ∆D [38-42]. 
The adsorption of polymeric layers was studied onto gold-coated quartz crystals in situ, cleaned with 
acetone, absolute ethanol and 2-propanol prior to the experiments. The quartz crystals were excited at 
multiple overtones: 1, 3, 5, 7, 9, 11 and 13. For all monitoring experiments, adsorption took place at 
25ºC, using solutions at 0.15 M NaCl. Each multilayer constituent was flushed sequentially to the inside 
of the chamber where the sensor was immobilized at a constant flow rate of 50 mL∙min-1, being each 
adsorption step separated by a 10-minute intermediate rinsing step with 0.15 M NaCl, as depicted in 
Figure 5.5. 
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Figure 5.5. Schematic representation of LbL adsorption on top of gold-coated quartz crystal sensors. 
 
The adsorption time and polymer concentration varied for each experiment performed: 10 min, 
1 mg∙mL-1 for CHI (starting layer) and Ph-levan films (Chapter 6); 10 min, 100 μg∙mL-1 for CHI 
(starting layer) and 3K-VRGDV films (Chapter 8); 15 min, 100 μg∙mL-1 for CHI/ELR and ELR/ALG films 
(Chapter 7), being CHI and ALG always adsorbed first and second, respectively. Except for the latter 
chapter, the frequency of each overtone was normalized to the fundamental resonant frequency of the 
quartz crystal, by dividing it by ν (where ν is the number of the overtone). In the specific case of 
Chapter 7 – Appendix, CHI/monoblock and CHI/triblock films (herein designated as HAP3 and 
H3A20H3, respectively) were assembled at a pH value of 4.5, with the rest of the solution parameters 
being similar to the ones in the main chapter. 
5.3.2 Estimation of films’ thicknesses 
The Voigt-based viscoelastic model was used to estimate the thickness of the films from the QCM-D 
monitoring data. The obtained frequency and dissipation values were converted to their estimated 
thickness using the Voigt-based viscoelastic model [43], which is integrated into the QTools software 
from Q-Sense (supplier of the equipment), based on equations 5.2 and 5.3: 
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where, considering a total of k thin viscoelastic layers, ρ0 and h0 are the density and thickness of the 
quartz crystal, η3 is the viscosity of the bulk liquid, δ3 is the viscous penetration depth of the shear wave 
in the bulk liquid, ρ3 is the density of liquid, μ is the elastic shear modulus of an overlayer and ω is the 
angular frequency of the oscillation. 
Iterations of the model were performed using at least three overtones. The model requires three 
parameters, namely solvent density, solvent viscosity and film density, to be fixed. The solvent viscosity 
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was therefore fixed at 0.001 Pa∙s (same as water) and the film density at 1200 kg.m-3 (often assumed 
to return the lowest calculation error) [44-46]. The solvent density was varied by trial and error until the 
total error, χ2, was minimized. The solvent density values that allowed obtaining the minimum error was 
determined to be within 1000–1015 kg∙m-3 for levan-based films (Chapter 6) and 1000–1060 kg∙m-3 
for ELR-based films (Chapters 7 and 8). The area density, a rough approximation of the mass adsorbed 
on top of a gold-coated quartz sensor was calculated by multiplying the thickness by the films density 
(1200 kg.m-3). 
5.4 Assembly and characterization of multilayer films 
5.4.1 In planar substrates 
After determining if a set of constituents provided a favorable multilayer construction, they were 
reproduced outside of the QCM-D. Hybrid multilayer films based on the diverse polymeric materials 
used herein were constructed by dipping alternately glass substrates into the polyelectrolyte solutions 
for 10 min, with an intermediate rinsing step of 5 (Chapter 6) or 10 min (Chapter 7 - Appendix and 
Chapter 8) in NaCl 0.15 M. In similarity to most metallic alloys, glass is negatively charged, and thus 
provided support for the formation of a multilayer coating by adsorbing CHI as a polycation primer 
layer [47]. 
In Chapter 6, fresh CHI and Ph-levan polyelectrolyte solutions were prepared (1 mg∙mL-1, 0.15 M NaCl, 
pH 5.5). Commercial glass from a local store were acquired and cut into 100×20 mm2 slides and 
cleaned thoroughly by immersion in a sequence of absolute ethanol, 2-propanol and chromosulfuric 
acid for 24 h. The construction was assisted by an in-house developed dipping robot that allowed the 
automated assembly of each layer in a programmed manner. The construction proceeded until 100 
layers (50 bilayers) were adsorbed. Films consisting of CHI and ALG were produced in parallel under 
the same experimental conditions for control purposes. In Chapter 7 – Appendix, films of CHI and 
either HAP3 or H3A20H3 were assembled onto glass pieces (1 cm2). The number of CHI/HAP3 and 
CHI/ H3A20H3 bilayers assembled was defined based on the results from the QCM-D screening stage. 
In Chapter 8, five pairs of CHI and ELR-RGD were prepared by manual dipping at the surface of regular 
glass microscopy slides cut into 1 cm2 pieces after undergoing a cleaning stage with acetone, absolute 
ethanol and 2-propanol.  
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5.4.1.1 Adhesiveness of the films 
In Chapter 6, the adhesiveness of “Ph-levan”-based films was studied by measuring the lap shear 
adhesive strength between two individual films. This technique determines the force that causes an 
adhesive to slide on a surface in the direction parallel to the plan of contact [48], as depicted in Figure 
5.6. 
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Figure 5.6. Experimental setup for the measurement of the lap shear adhesive strength. 
 
As soon as the construction of the films was concluded, two coated glass slides were put in contact 
face-to-face with an overlapping area of 20×10 mm2. To promote better adhesion, a weight of 6 kg was 
applied perpendicularly to the joint area and after a curing time of 24 h, the weight was removed. The 
bonded glass slides were placed in a universal mechanical testing machine according to the ASTM 
D1002-05 standard method and fixed by one binder grip in each extremity. A crosshead speed of 
5 mm∙min-1 was employed and the samples were stressed until enough force was applied to trigger 
their detachment and pull them apart. The same setup was used to evaluate the adhesiveness of 
CHI/ALG films for the purpose of comparison. The lap shear bonding strength was then determined 
from the maximum of the force-deformation curve obtained. The average and standard deviations were 
determined using the results from five bonded substrates. Values reported reflect means±standard 
deviation (SD) of three independent experiments, and analyzed using t-student test. All results were 
considered to be statistically significant at p-value less than 0.05. 
5.4.1.2 Contact angle measurements 
The wettability of a surface can be quantified by the measurement of contact angles. The contact angle 
of a liquid drop on a solid surface is the angle at which a liquid/vapor interface meets a solid surface. It 
is defined by the mechanical equilibrium of the drop under the action of three interfacial tensions and 
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allows quantifying the wettability of a solid surface by a liquid via the Young equation. Surfaces with high 
energy typically exhibit a low contact angle, whereas hydrophobic surfaces exhibit low surface 
energy [49].   
In Chapter 7 – Appendix, PBS-contact angles were measured for coatings of CHI/HAP3 and 
CHI/H3A20H3 at 4 and 50ºC. The number of layers was defined based on the results from the QCM-D. 
The coatings were immersed in PBS placed under each temperature condition. After periods of 10 min 
of immersion in each temperature condition, the samples were withdrawn and contact angles were 
measured. If wettability did not change significantly, the samples were placed in immersion for an 
additional period of 10 min at the same temperature. 
In Chapter 8, coatings up to 10 layers – 5 pairs of CHI and 3K-VRGDV – were characterized for their 
wettability for each layer assembled using the sessile drop method, at 37ºC and pH 7.4. These 
measurement conditions were chosen to simulate the behavior of the films under physiological 
conditions of temperature and pH for each assembled pH. An approach described by Park et al. [50] 
was used to measure contact angles dependent on several temperature, pH and ionic strength 
conditions: the samples were immersed in a beaker of PBS placed under each condition. After 1 hour, 
the samples were withdrawn and contact angles were measured (Figure 5.7). The time of 1 h was 
determined to be enough to have a stable surface. Therefore, measurements were performed for a pH 
range from 4 to 12, ionic strength from 0 to 1.5 M of NaCl, and three relevant temperatures: 25, 37 
and 50ºC. Upon determining the wettability transition parameters, three cycles were performed by 
changing the transition values above and below each transition value. 
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Figure 5.7. Schematics of contact angle measurements. The dotted surface symbolizes a modified 
glass substrate. 
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5.4.1.3 Surface topography 
Atomic force microscopy (AFM) measurements were performed in LbL-coated glass slides cut into 
pieces of 1×1 cm2, in Chapter 7 – Appendix and Chapter 8, following a similar protocol to that of 
contact angle measurements, in both cases scanning an area of 1×1 µm2. This technique is a 
synthesis of the mechanical profilometer, using mechanical springs to sense forces, and the scanning 
tunneling microscopy (STM), using piezoelectric transducers for scanning. In force microscopy, a 
probing tip is attached to a cantilever-type spring. In response to the force between tip and sample, the 
cantilever is deflected. This deflection is then translated into a visual image [51]. 
In Chapter 8, 5 pairs of CHI/3K-VRGDV were immersed in PBS for 30 min. To assess the influence of 
pH in the coatings, the samples were immersed in PBS at two pH values: 7.4 and 11. To avoid the 
formation of crystals during the acquisition, the samples were immersed shortly in ultrapure water for 
removing excess of saline solution. The samples were then retrieved and introduced in the device. 
Values reported reflect means±standard deviation (SD) of three independent experiments, and analyzed 
using t-student test. All results were considered to be statistically significant at p-value less than 0.05. 
In Chapter 7 – Appendix, CHI/monoblock and CHI/triblock samples were immersed in PBS at room 
temperature and 50ºC and then retrieved and introduced in the device. “pH” was also analyzed, for 
values of 7.4 and 12. 
When a multilayer film is rough, viscous and/or thick, AFM may not be appropriate technique to scan 
its topography. In these cases, scanning electron microscopy (SEM) – a technique that allows observing 
the surface of an object by bombarding it with an electron beam – presents itself as a viable alternative. 
SEM was used in Chapter 6 to evaluate the topography of CHI/Ph-levan and CHI/ALG films. The 
surfaces to be observed were left to dry overnight at room temperature and sputtered with gold prior to 
SEM observations. 
5.4.2 In three dimensional substrates 
5.4.2.1 Preparation of spherical microparticle templates 
Multilayer combinations made of CHI and 3K-VRGDV were extrapolated to the third dimension in the 
form of capsules. For this purpose, microparticles of calcium carbonate (CaCO3) served as spherical 
templates, which are easily obtained and provide a very simple three-dimensional structure to perform 
LbL. Microcapsules made of these constituents were constructed in Chapters 9, 10 and 11. Prior to the 
shell assembly, the template microparticles were produced. Typically, aqueous solutions of sodium 
Chapter 5. Materials and methods 
 
190 
carbonate (Na2CO3) and calcium chloride (CaCl2) were prepared at 1 M. Co-precipitation of both 
solutions was performed by adding a volume “V” of Na2CO3 followed by a volume “V” of CaCl2 to a 
variable volume of a precipitation medium/bath under rapid stirring for 30 seconds. The volume of the 
precipitation medium was of “2V” (Chapters 9 and 11) or “4V” (Chapter 10). Stirring was then stopped 
and the suspension of newly synthesized CaCO3 microparticles left to react and precipitate for 15 min. 
The supernatant was then removed and the particles washed twice or three times with ultrapure water 
to remove residual salts. 
The co-precipitation could occur in a precipitation medium that, besides water, contains an agent for 
encapsulation. The encapsulation is achieved due to the physical entrapment of such agent in the newly 
formed solid microparticles. In Chapter 9, a the entrapment of a “fluorescein isothiocyanate”-tagged 
bovine serum albumin (FITC-BSA) entrapment was achieved following the method described by 
She et al. [52], by preparing a precipitation medium with a FITC-BSA concentration of 5 mg∙mL-1. In 
this work, SEM was used to evaluate the morphology of the sacrificial templates. Specimens were pre-
coated with a conductive layer of sputtered gold and micrographs recorded at 10 kV. In Chapter 10, 
DQ-ovalbumin was entrapped from a medium at 160 μg∙mL-1. DQ-ovalbumin is a protein chemically 
saturated with BODIPY dyes. The close proximity of the dye molecules causes a self-quenching 
mechanism characterized by the exhibition of red fluorescence. However, upon enzymatic degradation, 
their proximity is revoked and dye-labeled peptide fragments are released, exhibiting a fluorescence shift 
from red to green [53]. It is therefore an excellent agent that can be used to follow cellular uptake and 
intracellular traffic by monitoring the changes in the fluorescence emitted. Finally, in Chapter 11, a 
precipitation medium containing either rhodamine-B isothiocyanate or MNPs was prepared at 
500 μg∙mL-1 using the same method. 
5.4.2.2 Construction of the multilayer shells 
The templates – either doped or empty – were immersed alternately in CHI and 3K-VRGDV solutions 
(300 µg∙mL-1, pH 5.5, 0.15 M of NaCl) for 10 min each, then washed with 0.15 M NaCl (pH 5.5). 
Centrifugation was avoided to avoid damage and aggregation of the particles each time the samples 
were to be retrieved from solution; simple precipitation of the suspension was used instead (3 to 5 min). 
In Chapter 10, where the internalization by cells was to be studied, each adsorption step was followed 
by three washing steps with 0.15 M NaCl, pH 5.5, with the first being accompanied by 4 sequential 
ultra-sound pulses of 3 seconds each to disaggregate the substrates. This extra step was performed in 
order to ensure a more thorough washing, microcapsule separation and therefore avoiding major 
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biological shock due to undesired residues and aggregation. This construction process was repeated to 
increase the number of bilayers until the desired coating had been obtained. In Chapter 9, the effect of 
the number of layers in the multilayer shell permeability was object of study, thus samples with 1, 3 
and 5 bilayers were constructed. In Chapters 10 and 11, the coatings were constructed with 2 and 3 
bilayers, respectively. After construction, three approaches were followed: (i) in Chapter 9, the CaCO3 
core was immediately dissolved with ethylenediamine tetraacetic acid (EDTA, 0.2 M, pH 5.5), which is a 
known chelating agent of metal ions, like calcium ions, and washed twice PBS; (ii) in Chapter 10, the 
microcapsules followed a washing procedure with EDTA (0.2 M, pH 7.4) and four with ultrapure water, 
with centrifugation at 1000 rpm for 25 min in between and ultrasound pulses timed as described above. 
Although centrifugation should ideally be avoided, the extra washing steps to which the microcapsules 
were submitted could lead to increased losses in microcapsules’ number. In the case of microcapsules 
intended for cellular contact rather than microscopic observations, Dulbecco's modified Eagle medium 
(DMEM) was used for the washings instead of water. The result is a batch of hollow multilayer shells 
entrapping a desired agent inside. A schematic of this procedure can be found in Figure 5.8; (iii) in 
Chapter 11, the coated particles were left intact for the time being to be employed further in the 
construction of compartmentalized devices. 
5.4.2.3 Compartmentalized structures 
Following point (iii) of the previous paragraph, in Chapter 11 a 1% (w/v) solution of ALG was prepared. 
In a typical experiment, the (CHI/3K-VRGDV)3-coated microparticles were suspended in 1 mL of ALG 
solution and the resulting suspension extruded through a 25G needle, at a rate of 0.33 mL∙min-1, into a 
0.75% (w/v) solution of CaCl2 under mild stirring. ALG beads containing coated microparticles were 
formed by calcium-mediated ionic gelation of alginate (Figure 5.9). The beads were coated with a 
Chi/ALG multilayer shell. They were immersed alternately in CHI and ALG solutions (300 µg∙mL-1, pH 
5.5, 0.15 M NaCl) for 10 min each, then washed with 0.15 M NaCl (pH 5.5 at 0.15 M) and this 
process was repeated until three bilayers were assembled, (CHI/ALG)3. After the coating was 
assembled, the beads were immersed in EDTA. At this point, the CaCO3 sacrificial templates were 
chelated simultaneously with the liquefied alginate bead. 
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Figure 5.8. Scheme depicting the formation of multilayer hollow microcapsules encapsulating a 
desired agent. 
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Figure 5.9. Organization of multilayer compartments, with rhodamine molecules and MNPs found at 
the nanolevel, the smallest scale of the proposed hierarchy. 
 
Liquefied alginate beads coated with (CHI/ALG)3 multilayers loaded with not only empty microcapsules 
and rhodamine in the ALG medium were also constructed. Rhodamine was suspended alongside 
microcapsules without any content and encapsulated in the ALG bead compartment instead of in the 
inner microcapsules. The mass of encapsulated rhodamine at this stage was determined by first 
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calculating the construction losses resulting from the rhodamine-loaded microcapsules within the 
external alginate macrocapsule. 
5.4.2.4 Encapsulation losses and pre-loading efficiency 
It should be noted that for drug delivery studies in Chapters 9 and 11, described below, all 
supernatants were collected during the diverse construction stages of the multilayer microcapsules, 
from the synthesis of the sacrificial templates to the chelation stage. This was necessary in order to 
calculate the BSA or rhodamine losses during each construction stage and determine the pre-loading 
efficiency. 150 μL of sample was pipetted into a white, opaque 96-well plate in triplicate. Distilled water 
was used as blank. The excitation (λexc) and emission (λem) wavelengths used for the calibration curve 
and FITC-BSA mass calculations were 485 and 528 nm, respectively. All supernatants collected during 
entrapment, construction and chelation were measured and quantified. The percentage of FITC-BSA 
mass lost was plotted both for each stage and cumulatively. The encapsulation efficiency was 
calculated by subtracting the cumulative losses of each architecture (i.e., microcapsules with distinct 
number of layers) from the initial FITC-BSA mass. A similar approach was followed for rhodamine, for 
which the excitation (λexc) and emission (λem) wavelengths were 530 and 590 nm, respectively. 
5.4.2.5 Microscopy evaluation of the structures 
Confocal laser scanning microscopy (CLSM) was used to evaluate the structure of the produced 
capsular microstructures. This is a technique that allows observing optical and fluorescence images 
with depth sensitivity, i.e., a sample can be scanned plane-by-plane in the z-axis. CHI/3K-VRGDV shells 
with 5 layers capped with a final layer of rhodamine B (assembled from a solution at 10-6 M) and 
encapsulating FITC-BSA (Chapter 9) or 3 layers encapsulating FITC (Chapter 11) were produced. In the 
first case, in the intent of evaluating morphological changes dependent on temperature, all samples 
were stabilized at either 25 or 37ºC and observed under hydrated conditions. In the second case, 
samples were observed only at 25ºC. 
The morphology of the produced microcapsules in Chapter 10 consisting in 2 bilayers of 
CHI/3K-VRGDV or CHI/3K-VRDG(-)V was determined using an environmental scanning electron 
microscopy (ESEM). With this technique, it is possible to observe a sample without a coating of 
sputtered gold.  A number of 2.2×104 microcapsules suspended in 200 μL of H2O was placed on top 
of a silicon wafer (1 cm2) and dried overnight at 37ºC before the analysis. The samples were placed 
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inside the equipment in a platform with a 20º tilt. Transmission electron microscopy (TEM) was used to 
obtain images of the multilayer coating. Prior to the observation, a number of 104 microcapsules 
suspended in 60 μL of H2O was pipetted onto a TEM grid and left to dry overnight at room temperature. 
TEM was also used in Chapter 11 to determine the distribution of MNPs within the microcapsules. Prior 
to the observation, a volume of 60 μL of microcapsule suspension was pipetted onto a TEM grid and 
left to evaporate overnight. Both MNP-loaded and empty microcapsules were observed. Fluorescence 
microscopy was used to evaluate the morphology of the coated liquefied ALG beads. In contrast to 
CLSM, this technique scans the fluorescence exhibited by the surface. If translucid, the interior can also 
be observed. Based on this consideration, (CHI/ALG)3-coated liquefied beads were observed using 
transmitted light and fluorescence microscopy for rhodamine-loaded external compartments. The latter 
also containing FITC-loaded microcapsules were observed to assess the distribution of the 
subcompartments within the macrocapsules. 
5.5 In vitro release studies from three-dimensional capsules 
The microcapsules in Chapter 9 were resuspended in PBS at either 25 or 37°C. The upper limit of five 
bilayers for the microcapsule architecture was chosen to study the effect of temperature along with 
small changes in the number of different layers. This study was conducted over 14 days, removing the 
surrounding PBS from each container every 24 h. An additional sample was taken after 12 h from the 
start of the study. PBS was fully refreshed at each time point, and 100% FITC-BSA was considered to be 
the total mass remaining in the microcapsules after their construction. The release experiments were 
performed under mild agitation to improve the diffusion of FITC-BSA through the incubating medium. All 
experiments were performed in triplicate (n=3), with each sample containing the number of capsules 
resulting from the attempted encapsulation of 1 mg of BSA. To determine the type of release profile for 
each condition, the release kinetics were determined using the Korsmeyer kinetic model (equation 5.4): 
nKt/M
t
M 

 (5.4) 
where Mt /M∞ is the fraction of protein released at time t, K is the rate constant for the Korsmeyer 
model, and n is the exponent that characterizes the release mechanism [54]. The Korsmeyer model is 
used when the release mechanism from a swellable polymeric device is not well-known or when more 
than one type of release phenomenon could be involved. The latter was a possibility since the phase 
transition of these ELRs is a complex phenomenon, allied to a similarly complex hybrid and three-
dimensional shell. The fitting was performed for all architectures and for each temperature. As a means 
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of comparison, fitting with other models was also made: zero-order (equation 5.5), first-order (equation 
5.6) and Higuchi (equation 5.7): 
tKQQt 00   (5.5) 
where Qt is the cumulative amount of protein released at time t, Q0 is the initial amount of protein and 
K0 is the rate constant for the zero-order model; 
303.2/)()( 0 KtQLogQLog t   (5.6) 
where Qt is the cumulative amount of protein released at time t, Q0 is the initial amount of protein and 
K is the rate constant for the first-order model; 
2/1tKQ H  (5.7) 
where Q is the cumulative amount of protein released at time t and KH is the rate constant for the 
Higuchi model. 
The compartmentalized systems from Chapter 11 were suspended in PBS at either 25 or 37ºC, with 
rhodamine being encapsulated in one of two hierarchical locations: the internal (CHI/3K-VRGDV)3 
microcapsules (with rhodamine added during the co-precipitation stage) or the external liquefied 
alginate (CHI/ALG)3-coated macrocapsules (with rhodamine added to the initial alginate solution). The 
study was conducted for 2 h to assess the early release profile in 3 mL of PBS, with 600 μL of 
surrounding PBS being removed every 10 min and the container being refilled with the same volume of 
PBS pre-stabilized at the corresponding temperature. 100% of Rhod was considered to be the total 
mass remaining in the compartmental systems after taking construction losses into account. The 
studies were performed three times (n=3). 
5.6 Mechanical resistance of compartmental units 
A centrifugal rotation test was performed with the samples suspended in PBS to measure the 
mechanical resistance of the (CHI/ALG)3 macrocapsules (Chapter 11). 100 samples were placed in 
centrifuge tubes and rotated at a starting centrifugal load of 500g. After 5 min, the number of intact 
beads was counted. Those that remained intact were submitted to incremental centrifugal loads (500g 
incremental steps) up to a maximum of 5000g. This experiment was performed three times. 
5.7 Magnetic responsiveness assays 
Macrocapsules containing MNP-loaded microcapsules were suspended in a PBS-filled square 
polystyrene Petri dish placed upon a 1×1 cm2 grid (Chapter 11). A 1.3 T permanent neodymium 
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(NdFeB) bar magnet (diameter: 4 mm; length: 2.5 cm) was used to apply the external magnetic field. 
Ten samples were placed 3 cm away from the magnet, with the latter placed at a height of 1.4 cm from 
the PBS surface. The movement was recorded on video and the mean normalized distance traversed by 
the samples plotted as a function of time. 
5.8 In vitro biological studies 
5.8.1 Cell seeding 
The biological response of cells to biomaterials in vitro is critical to estimate if a harmful reaction is 
triggered upon contact of a newly developed system with a living organism, common when biomedical 
applications are envisaged. Herein, cells were either seeded onto a substrate modified with multilayers, 
or seeded first onto a cell culture support and incubated in the presence of microcapsules in 
suspension in the culture medium. 
In Chapter 6, L929 cells – a murine fibroblast cell line – were routinely cultured with DMEM 
supplemented with 3.7 g∙L-1 sodium bicarbonate, 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin at pH 7.4. Cells were grown in 75 cm2 tissue culture flasks and incubated at 
37ºC in a humidified air atmosphere of 5% carbon dioxide (CO2). Every 3–4 days fresh medium was 
added. At 90% of confluence, L929 cells were washed with PBS and subsequently detached by 
trypsin-EDTA at 37ºC. To inactivate the trypsin effect, cell culture medium was added. Cells were then 
centrifuged at 300g for 5 minutes and the medium was decanted. A 50 µL cell suspension with 2×104 
cells was added to glass slides with 1×1 cm2 modified with 50 (CHI/Ph-levan) or 50 (CHI/ALG) bilayers 
(in triplicate), previously sterilized by ultraviolet (UV)-radiation for 30 min. Surfaces were then incubated 
at 37ºC in a humidified air atmosphere of 5% CO2 and after 4 h culture medium was added. The 
experiment was maintained for 24 h, after which the cellular adhesion was quantified. 
In Chapter 8, cell adhesion was studied using SaOs-2 cells – a human osteosarcoma cell line – 
envisaging the use of these coatings in orthopedic applications in order to improve host integration. Cell 
studies were performed onto coatings of 5 pairs of layers, ending in 3K-VRGDV, CHI or 3K-VRGD(-)V 
(negative control), assembled at the surface of glass coverslips with 1 cm in diameter. Tissue culture 
polystyrene (TCPS) was used as a positive control. Cell adhesion was studied using the SaOs-2 
osteoblast-like osteosarcoma cell line. Cells were seeded on the surfaces (5×104 cell∙mL-1) and 
incubated in serum free Dulbecco’s modified Eagle’s medium (DMEM), loaded with 1% 
antibiotics/antimicotics at 37ºC, 5% CO2. The substrates were analyzed at different time points: 4 h, 24 
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h and 3 days. At each time point, cells on the coated surfaces were washed with PBS twice and fixed in 
formalin (3.7%). 
In Chapter 9, L929 cells were used for the biological assays. They were cultured in DMEM with phenol 
red supplemented with 10% of FBS and 1% antibiotic/antimicotic in a humidified atmosphere with 5% 
CO2 at 37°C. For the cell viability test, 2×10
3 cells were seeded on 48-well plates and incubated at 
37°C, 5% CO2. After 24 hours, microcapsules were added to the culture medium in a ratio of 40 
microcapsules per cell. The incubation was maintained for 24 h, 3 days, and 7 days. 
In Chapter 10, human mesenchymal stem cells (hMSCs) were used for the purpose of evaluation the 
cellular uptake of CHI/ELR microcapsules. Mesenchymal stem cells are hypoimmunogenic and 
pluripotent able to differentiate in in vitro, ex vivo and in vivo, into multiple cells types such as 
osteocytes, adipocytes, chondrocytes, neurocytes, hepatocytes, myocytes, and hematopoietic-
supporting stroma. The option to use hMSCs in this work a model of internalization of CHI/ELR 
microcapsules have the potential to be applied in transplantation, local implantation, gene therapy, drug 
delivery and stem cell differentiation [55,56]. “hMSCs” were cultured in DMEM supplemented with 10% 
FBS and 100 U∙mL-1 penicillin, 0.1 mg∙mL-1 streptomycin replaced every two days and maintained at 
37ºC in a 5% CO2 humidified environmental chamber. Near-confluence cells (passages 2–6) were 
harvested after enzymatically treatment with trypsin/EDTA or AccutaseTM and suspended in culture 
medium. Cell counts were evaluated using a standard Trypan Blue exclusion assay and seeded at 
3×103 cell∙cm-2 on numerous circular cover glasses (diameter: 10 mm) and then incubated during 24 
hours in standard conditions. Afterwards, the culture medium was refreshed by serum-free medium 
containing CHI/ELR microcapsules, either functionalized with 3K-VRGDV or 3K-VRDG(-)V. After 3 h of 
CHI/ELR microcapsules co-incubation, the cultures were maintained for longer times (3 days and 10 
days), by supplementing the microcapsule suspension with additional fresh medium to reach the final 
serum concentration of 2% FBS. 
5.8.2 Staining of cells adhered to bidimensional surfaces 
In Chapters 6, 8 and 9, the cells adhered to the respective films were prepared for 4',6 diamidino-2-
phenylindol (DAPI) staining. DAPI stains preferentially double-stranded deoxyribonucleic acid (DNA). 
DNA-DAPI complexes emit strong blue fluorescence when excited by ultraviolet light so that even very 
small amounts of DNA [57]. After each cell culture time-point, the films seeded with L929 cells were 
prepared for DAPI fluorescence assay. Briefly, samples were washed with PBS and formalin (3.7–10% 
concentration range) was added to each well. After 15–30 min at 4ºC, formalin was removed and 
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samples were washed with PBS. Then, a solution of PBS containing DAPI (1:1000) was added to each 
well and let to react for 5 min at room temperature and protected from light. Ultimately, samples were 
washed with PBS and visualized in the dark by fluorescence microscopy. For the specific case of 
Chapter 6, the nuclei were counted to quantify L929 cells adhered to CHI/Ph-levan and CHI/ALG films: 
adhered cells were assessed by analyzing fluorescence pictures in triplicate using the software ImageJ 
(provided by NIH). Values reported reflect means±standard deviation (SD) of three independent 
experiments, and analyzed using t-student test. All results were considered to be statistically significant 
at p-value less than 0.05. 
Additionally, SaOs-2 (Chapter 8) and L929 (Chapter 9) cells were also stained with 
(tetramethylrhodamine B isothiocyanate)-phalloidin (TRITC-phalloidin). Phalloidin binds tightly to 
polymerized actin filaments and, when conjugated with a fluorophore (like rhodamine), they can be 
observed under fluorescence microscopy [58]. After fixation, cells were incubated with TRITC-phalloidin 
(10 μg∙mL-1) for 45 min and washed three times with PBS. Cells were observed under fluorescence 
microscopy. 
5.8.3 Cellular uptake of three dimensional microcapsules 
For the assays regarding the internalization of microcapsules in Chapter 10, hMSCs were seeded onto 
deposited in a 48-well plate and incubated during 24 h in standard conditions. (CHI/3K-VRGDV)2 and 
(CHI/3K-VRDG(-)V)2 microcapsules pre-loaded with DQ-ovalbumin were added to the culture. After 3 or 
72 h of incubation, samples were washed with Dulbecco's phosphate-buffered saline (DPBS) three 
times. Samples for microscopy analysis – confocal, phase-contrast, epifluorescence, and differential 
interference contrast (DIC) microscopy – were fixed in 4% paraformaldehyde for 10 min, permeabilized 
with 0.2% Triton X-100, and stained with DAPI following a similar protocol as described above. A 
confocal microscope was used for analyzing microcapsules inside the cells. Z-series were performed 
with a Z-step of 1 µm. The images of each fluorophore and phase contrast were overlaid to obtain a 
multilayer image using ImageJ software. Bright field and fluorescence microscopy were performed 
using blue, green and red fluorescence filters in order to determine the distribution and intracellular 
degradation of each multilayer microcapsule type. 
To quantify microcapsule internalization, 1.5×105 hMSCs were seeded in a 25 cm2 flasks and cultured 
as described above. (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules were added at a 
microcapsule-to-cell ratio of 10:1 and incubated during 72 h. The cell cultures dissociated by 
AccutaseTM treatment – specially developed for gentle and effective cell dissociation – were washed, 
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counted, suspended in DPBS, 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5% 
FBS and analyzed in a flow cytometer. Flow cytometry is a technique for making rapid measurements 
on particles or cells as they flow in a fluid stream through a sensing point one by one. It is routinely 
employed in cell counting, cell sorting, biomarker detection and protein engineering [59]. The assay 
was repeated three times. Values reported reflect means±standard error (SE) of three independent 
experiments. The influence of microcapsules/cell ratio on cell viability was analyzed using one-way 
analysis of variance (ANOVA) and the post test of Bonferroni, considered to be statistically significant at 
p-value less than 0.05. All data was analyzed using GraphPad Prism. 
5.8.4 Cell metabolism and viability 
In Chapter 8, to access cell viability, (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) (MTS) assay was performed. MTS and other tetrazolium dyes are 
bioreduced in cells by nicotinamide adenine dinucleotide, in its reduced form (NADH), in the cytosolic 
compartment. This reduced product can be detected for by measuring the absorbance at 490 nm, and 
is therefore directly proportional to the number of living cells in the substrates [60]. After each culturing 
period, samples were washed twice with PBS. A 250 μL aliquot of FBS-free culture medium and 50 μL 
of MTS reagent were added to each well. A cell-free well was used as control. Plates were incubated for 
3 h at 37°C, 5% CO2, protected from light. After incubation, 100 μL of this solution was transferred to a 
96-well plate and the plate read using a microplate reader in 490 nm absorbance mode. In Chapter 9, 
for the cell viability test, 2×103 L929 cells were seeded on 48-well plates and incubated at 37ºC, 5% 
CO2. After 24 h, microcapsules were added to the culture medium in a ratio of 40 microcapsules per 
cell. After each culturing period, the MTS method was performed as described above. In both chapters, 
values reported reflect means±standard deviation (SD) of three independent experiments, and analyzed 
using t-student test. All results were considered to be statistically significant at p-value less than 0.05. 
In Chapter 10, metabolic activity was evaluated by Alamar Blue® and cell viability by LIVE/DEAD® 
assays. Similarly to the MTS assay, Alamar Blue® is reduced in living cells, after which it yields not only 
a colorimetric product but also a very strong fluorescent one, which can be more than ten times as 
sensitive as the colorimetric assay [61]. The relative number of hMSCs metabolically active within each 
experimental condition was evaluated by the Alamar Blue® assay according to the manufacturer 
guidelines. 24 hours after cells seeding, cells culture was washed and then (CHI/ELR-RGD)2 and 
(CHI/ELR-RDG(-))2 microcapsules in serum-free culture medium were added in incremental ratios of 5 
to 100 microcapsules per cell. After 3 and 72 h of microcapsules co-incubation, the fluorimetric 
Chapter 5. Materials and methods 
 
200 
reduction of 10% Alamar Blue® reagent in culture medium was measured with a microtiter plate reader. 
Non-treated cells were employed as positive control and their fluorescence was considered as the 100% 
of cells viability. Values reported reflect means±standard error (SE) of four samples of four independent 
cell culture viability experiments at 3 or 72 hours of incubation. The influence of microcapsules/cell 
ratio on cell viability was analyzed using one-way analysis of variance (ANOVA) and the post test of 
Bonferroni. All treatment-related effects were considered to be statistically significant at p-value less 
than 0.05. All data was analyzed using GraphPad Prism. 
The viability of cells co-incubated with CHI/ELR was also examined by a LIVE/DEAD® assays. Ten 
microcapsules per cell of both CHI/ELR microcapsule types were added to the cell culture. The ratio of 
microcapsules per cell was selected after obtaining the results of the cell viability assays. In this assay, 
the co-incubation with calcein AM and ethidium homodimer-1 allows distinguishing the cytoplasm of live 
cells (with esterase cleavage of calcein accompanied by green fluorescence), and dead cells (which 
compromised membranes enable to stain nucleic acids with red fluorescence) [62]. LIVE/DEAD® 
assays was carried out at different time points (0, 72 and 240 h) according to the manufacturing 
specifications. 
5.8.5 Alkaline phosphatase assays 
The activity of alkaline phosphatase (ALP) is evaluated using a p-nitrophenol assay. Paranitrophenyl 
phosphate, which is colorless, is hydrolysed by alkaline phosphatase at pH 10.5 and 37ºC to form free 
paranitrophenol, which is colored yellow. The expression of the enzyme ALP by osteoblasts, whether in 
a membrane form or in secretory form, is a characteristic of these cells and therefore its expression can 
be a strong indicator of these cells in culture [63]. For alkaline phosphatase (ALP) assays, samples 
collected on each time point were washed with PBS and immersed in 1 mL of ultra-pure water to lyse 
the cells. To each well of a 96-well plate were added 20 µL of sample plus 60 µL of substrate solution 
(0.2% (w/v) p-nytrophenyl (pNP) phosphate/1 M diethanolamine hydrochloric acid (HCl), at pH 9.8). 
The plate was then incubated in the dark for 45 min at 37ºC. After the incubation period, 80 µl of a 
stop solution (2 M sodium hydroxide (NaOH)/0.2 mM ethylenediaminetetraacetic acid (EDTA)), was 
added to each well. The absorbance was then measured at 405 nm using p-nitrophenol as standard. 
For each experiment, a standard curve was constructed from reference suspensions at known cell 
concentrations. Values reported reflect means±standard deviation (SD) of three independent 
experiments, and analyzed using t-student test. All results were considered to be statistically significant 
at p-value less than 0.05. 
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 Chapter 6. Adhesive nanostructured multilayer films using a 
bacterial exopolysaccharide for biomedical applications5 
Abstract 
Medical adhesives and sealants often require that long-term adhesiveness is achieved. In this work, 
nanostructured coatings consisting of chitosan and the adhesive bacterial exopolysaccharide levan are 
fabricated using layer-by-layer (LbL) assembly. Taking advantage of the electrostatic self-assembly 
mechanism of LbL, the charges of both chitosan and a phosphonate-derivatized levan (Ph-levan) are 
measured and the feasibility to construct hybrid films is monitored and confirmed using a quartz crystal 
microbalance with dissipation monitoring (QCM-D). The adhesive properties between two identical 
bonded films with a total of 100 layers are compared to control films in which Ph-levan is replaced by 
alginate, revealing that the detachment force of the former is about 3 times higher than the control. 
Scanning electron microscopy of the films surface shows that the surface of Ph-levan films is smooth 
and homogeneous. Cell adhesion tests were conducted using a L929 cell line. Early cell adhesion is 
significantly higher in chitosan/Ph-levan films when compared to chitosan/alginate controls. These 
findings establish levan derivatives as bioinspired ingredients for conceiving medical adhesive devices 
that allow achieving enhanced mechanical and biological performance. 
                                                 
5
 This chapter is based on the following publication: 
Costa R. R., Neto A. I., Calgeris I., Correia C. R., Pinho A. C. M., Fonseca J., Öner E. T., and Mano J. F., Adhesive 
nanostructured multilayer films using a bacterial exopolysaccharide for biomedical applications, Journal of Materials 
Chemistry B 2013, 1: 2367-2374, DOI:10.1039/c3tb20137f. 
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6.1 Introduction 
Wound healing, robust adhesion and protection towards external physical and pathological harm are 
essential characteristics of medical adhesives and sealants, especially when long-term performance of 
such devices is required [1-3]. However, many synthetic adhesives currently approved present 
limitations, which include poor adhesion in the presence of biological fluids, allergic response and 
inflammation [4]. Overcoming these shortcomings requires the use of materials that can provide 
sufficient cohesive strength and trigger adequate biological response to cells and tissues. 
Nature gives us a wealth of resources that can be exploited in biomedicine and tissue engineering 
applications. In contrast with synthetic materials, natural-based polymers are similar to biological 
macromolecules, avoiding triggering chronic or immunological reactions and toxicity [5]. 
Macromolecular compounds such as collagen, cellulose, and fibrin are used as ingredients for 
adhesives and sealants [4,6-8]. Namely, chitosan (CHI) and alginate (ALG) have been widely used in 
biomedical applications including burn dressings, drug delivery and implantation [9-11]. These two 
polysaccharides share a marine origin derived from materials existing in shells of crustaceans and in 
algae, respectively, and show biocompatibility, adhesiveness, non-toxicity, as well as bacteriostatic, 
fungistatic, antimicrobial and hemostatic activities [5,11]. 
While the sea is a good source of natural bioadhesive materials, it is possible to find interesting 
materials in other less conventional sources such as extremophilic environments. An elegant example is 
levan, a linear β(2-6)-linked fructose polymer (fructan) exhibiting hydroxyl groups that form strong 
adhesive bonds with various substrates [12-14]. It has many advantages over petrochemically derived 
adhesives, including that it is biodegradable, biocompatible, non-allergic, non-toxic and water-soluble. 
Levan is also a bioactive polymer mainly associated with high-value biomedical applications [15,16] and 
has been credited together with xanthan, curdlan and pullulan as the most promising microbial 
exopolysaccharides for various industrial sectors [12]. Though microbial levan is produced 
extracellularly from sucrose-based substrates by various microorganisms, of special interest is the 
halophilic bacterium Halomonas smyrnensis sp. nov. AAD6T which was reported as the first 
extremophilic producer of levan [17,18]. Excreting high molecular weight levan by this halophile to a 
highly saline environment for adhesion and protection points to the superior bioadhesive properties of 
levan that were retained under such unusual conditions. Besides its potential use as a bioflocculating 
agent [19] and in drug nanocarrier systems [20], levan produced by Halomonas smyrnensis, as well as 
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its aldehyde-activated derivative, were successfully deposited by matrix-assisted pulsed laser 
evaporation (MAPLE) resulting in uniform, homogeneous, nanostructured, biocompatible, thin films [14]. 
In light of the properties of levan, we intend to demonstrate that this exopolysaccharide can be used as 
a promising ingredient to conceive new adhesive devices for biomedical applications. 
Film casting and hot-melt extrusion are common techniques for manufacturing adhesive membranes, 
with the former being undoubtedly the most widely used [21]. However, the use of organic solvents in 
film casting and the addition of plasticizers in hot-melt extrusion are common concerns when 
considering the use of such membranes in biological environments. The layer-by-layer (LbL) sequential 
assembly of macromolecules is an approach with the potential to address these issues. LbL techniques 
are perhaps the most versatile and easy-to-apply of the numerous surface modification tools currently 
available as they are based on the spontaneous adsorption of ingredients – generally a polymer, 
biomolecule or inorganic particle – onto a substrate. For instance, the adsorption of charged 
macromolecules (polyelectrolytes) is driven by electrostatic self-assembly (ESA) between two ingredients 
and allows the sequential formation of a multilayer film [22-26]. Furthermore, this technique allows 
robust nanostructured coatings to be produced on substrates with complex geometries and, as it does 
away with the need for harmful organic solvents, it is of great interest in tissue engineering applications, 
such as biomimetic composite-like coatings, controlled drug release or manipulation of adhesion, 
differentiation, proliferation and even function of attached cells [25,27-29]. Because this technique is so 
versatile, it is possible to synthesize adhesive films by proper selection of its ingredients. 
The objective of this work is to demonstrate that a phosphonate-modified levan – henceforth referred to 
as Ph-levan – can be used in electrostatic LbL adsorption to construct nanostructured films with 
adhesive properties. For the proof-of-concept, Ph-levan and chitosan were sequentially assembled onto 
glass using an in-house developed dipping robot and their adhesiveness was studied by measuring the 
shear strength necessary for two adhered films to detach. Their cell adhesion properties were evaluated 
in vitro, as well as the surface morphology. We hypothesized that these nanostructured hybrid films 
could have superior adhesive properties when compared to similar films made of the commonly 
regarded adhesive polysaccharides CHI and ALG. 
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6.2 Experimental section 
6.2.1 Materials 
Medium molecular weight chitosan was purchased from Sigma-Aldrich (ref. 448877, Brookshield 
viscosity 200-800 cP, molecular weight 190-310 kDa) and purified by a series of filtering steps and 
precipitation in water and ethanol, followed by freeze-drying. Alginate – alginic acic sodium salt from 
brown algae – was purchased from Fluka (ref. 71238, molecular weight 100-200 kDa). 
Phosphate-buffered saline (PBS), low glucose Dulbecco’s Modified Eagle’s Medium (DMEM), sodium 
bicarbonate and 4’,6-diaminidino-2-phenylindole-dilactate (DAPI, 20 mg∙mL-1) were purchased from 
Sigma-Aldrich. Fetal bovine serum (FBS), penicillin-streptomycin and trypsin- ethylenediamine 
tetraacetic acid (EDTA) solution were purchased from Invitrogen. The immortalized mouse lung 
fibroblast cell line (L929) was purchased from the European Collection of Cell Cultures. 
6.2.2 Microbial levan production 
Microbial levan production was performed with the halophilic Halomonas smyrnensis AAD6T batch 
cultures [18,30] using pretreated sugar beet molasses as substrate [31]. For this, molasses subjected 
to tricalcium phosphate, sulphuric acid and activated carbon pre-treatment was added to sterile 
production medium (7 g∙L-1 dipotassium phosphate (K2HPO4); 2 g∙L
-1 monopotassium phosphate 
(KH2PO4); 0.1 g.L
-1 magnesium sulfate heptahydrate (MgSO4∙7H2O); 1 g.L
-1 ammonium sulfate 
((NH4)2SO4); 0.5 g∙L
-1 peptone; 137.2 g∙L-1 sodium chloride (NaCl)) to 30 g∙L-1 final carbohydrate 
concentration and after inoculation, cells were incubated in a Certomat BS-1 orbital shaker (B. Braun, 
Germany) set at 37ºC and 180 rotations per minute (rpm) agitation rate. For the purification of levan, 
cells from the stationary phase cultures were harvested by centrifugation at 11000g for 20 minutes and 
the supernatant phases were treated with an equal volume of ethanol, held at -18ºC overnight, and then 
centrifuged at 16000g and 4ºC for 30 min using a refrigerated centrifuge. The pellets were dissolved in 
hot distilled water, dialyzed against several runs of distilled water for 3 days and lyophilized. The 
resultant high molecular weight polymer has a molar mass of at least 1000 kDa [17]. 
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6.2.3 Phosphonate modification of levan 
For the production of phosphonated levan, 4 g of levan was dissolved in 100 mL of pyridine by 
vigorously mixing on a magnetic stirrer for 48 hours at ambient conditions and then the solution was 
cooled down to 0ºC. In an ice bath, 4 mL of phosphorus trichloride (PCl3) was added slowly in a drop 
wise manner to the well-stirred solution. After stirring for 30 min under ambient conditions, 100 mL of 
saturated sodium carbonate (Na2CO3) was added. The aqueous phase containing the modified polymer 
was separated and freed from pyridine and then subjected to dialysis against distilled water for at least 
four consecutive days with frequent exchanges of the solvent (3–5 times per day). The polymer was 
freeze-dried and an overall recovery yield of about 50% was achieved. Fourier transform infrared (FTIR) 
spectra of levan samples were obtained with Nicolet 6700 Spectrometer within (400–4000) cm-1. 
Elemental analysis of phosphorous was estimated by energy dispersive spectroscopy (EDS) analysis 
performed on the JEOL JSM-5910 LV electron microscope. 
6.2.4 Measurement of charges 
The ζ-potentials of the polysaccharides were determined using a Nano-ZS from Malvern (United 
Kingdom), at 25ºC. Aqueous solutions of each ingredient were used, at 1 mg∙mL-1, 0.15 M NaCl and 
pH value of 5.5. 
6.2.5 Construction of hybrid self-assembled films 
A Q-Sense E4 quartz-crystal microbalance (Q-Sense AB, Sweden) with dissipation monitoring system 
was used to monitor the adsorption of chitosan and phosphonated levan onto gold-coated quartz 
crystals in situ. The quartz-crystal was excited at multiple overtones: 1, 3, 5, 7, 9, 11 and 13, 
corresponding respectively to 5, 15, 25, 35, 45, 55 and 65 MHz. Adsorption took place at 25ºC, using 
solutions at 1 mg∙mL-1, 0.15 M NaCl and at a constant flow rate of 50 mL∙min-1, with an adsorption 
time of 10 min (starting with chitosan) and an intermediate rinsing step of 10 min. The frequency of 
each overtone was normalized to the fundamental resonant frequency of the quartz crystal, by dividing 
it by ν (where ν is the number of the overtone). 
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6.2.6 Estimation of the films’ thicknesses 
The Voigt model contained in the software QTools from Q-Sense (version 3.0.15.553) was used to 
estimate the thickness of the films from the QCM-D monitoring data. Iterations of the model were 
performed using at least 5th, 7th and 9th overtones. The model requires three parameters, namely 
solvent density, solvent viscosity and film density, to be fixed. The solvent viscosity was therefore fixed 
at 0.001 Pa∙s (same as water) and film density at 1200 kg∙m-3. The solvent density was varied by trial 
and error between 1000 and 1015 kg∙m-3 until the total error, χ2, was minimized. 
6.2.7 Preparation of hybrid multilayer films 
Fresh polyelectrolyte solutions were prepared by dissolution of chitosan and phosphonated levan in the 
same conditions as the ones prepared for the QCM-D. Commercial glass from a local store were 
acquired and cut into 100×20 mm2 slides. The slides were cleaned thoroughly by immersion in a 
sequence of absolute ethanol, 2-propanol and chromosulfuric acid for 24 h. Hybrid multilayer films of 
the two polysaccharides were constructed by dipping alternately the glass substrate into the 
polyelectrolyte solutions for 10 min, with an intermediate rinsing step of 5 min in NaCl 0.15 M. The 
construction was assisted by an in-house developed dipping robot that allowed the automated assembly 
of each layer in a programmed manner. The construction proceeded until 100 layers (50 bilayers) were 
adsorbed. Films consisting of chitosan and alginate were produced in parallel under the same 
experimental conditions for the purpose of comparison. 
6.2.8 Adhesiveness of the films 
As soon as the construction of the films was concluded, two glass slides were put in contact face-to-face 
with an overlapping area of 20×10 mm2. To promote better adhesion, a weight of 6 kg was applied 
perpendicularly to the joint area and after a curing time of 24 h, the weight was removed. The bonded 
glass slides were placed in a universal mechanical testing machine (Instron model 5540, USA) 
according to the ASTM D1002-05 standard method and fixed by one binder grip in each extremity. A 
crosshead speed of 5 mm∙min-1 was employed and the samples were stressed until enough force was 
applied to trigger their detachment and pull them apart. The lap shear bonding strength was then 
determined from the maximum of the force-deformation curve obtained. The average and standard 
deviations were determined using the results from five bonded substrates. 
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6.2.9 In vitro cell culture 
L929 cells were routinely cultured with DMEM supplemented with 3.7 g∙L-1 sodium bicarbonate, 10% 
FBS and 1% penicillin-streptomycin at pH 7.4. Cells were grown in 75 cm2 tissue culture flasks and 
incubated at 37ºC in a humidified air atmosphere of 5% carbon dioxide (CO2). Every 3–4 days fresh 
medium was added. At 90% of confluence, L929 cells were washed with PBS and subsequently 
detached by trypsin-EDTA at 37ºC. To inactivate the trypsin effect, cell culture medium was added. 
Cells were then centrifuged at 300g for 5 minutes and the medium was decanted. Prior to cell seeding, 
the surfaces were sterilized by ultraviolet (UV)-radiation for 30 minutes. A 50 µL cell suspension with 
2×104 cells was added to glass slides with 1×1 cm2 modified with 50 (CHI/Ph-levan) or 50 (CHI/ALG) 
bilayers (in triplicate). Surfaces were then incubated at 37ºC in a humidified air atmosphere of 5% CO2 
and after 4 h culture medium was added. 
6.2.10 Nuclei-staining fluorescence assay 
After 24 h of incubation, the film samples seeded with L929 cells were prepared for DAPI fluorescence 
assay. Briefly, samples were washed with PBS and 10% formalin was added to each well. After 30 min 
at 4ºC, formalin was removed and samples were washed with PBS. Then, a solution of PBS containing 
DAPI (1:1000) was added to each well and let to react for 5 min at room temperature and protected 
from light. Ultimately, samples were washed with PBS and visualized in the dark by fluorescence 
microscopy. DAPI stains preferentially double-stranded deoxyribonucleic acid (DNA) by delineating cells 
nuclei in blue. Adhered cells were assessed by analyzing fluorescence pictures in triplicate using the 
software ImageJ (NIH, version 1.46r). 
6.3 Results and Discussion 
Phosphorylation is a feasible method for modifying the dissolution properties and bioactivities of 
polysaccharides. Phosphorylated polysaccharides have found use in various applications as flame 
retardant additive, cation exchanger, thickener and binder for biomolecules [32-34]. As such, a wide 
range of potential applications were also proposed for phosphorylated derivatives of the levan 
polysaccharide [16]. Considering these facts and the limited literature on levan derivatives, Ph-levan has 
been chosen as a promising biopolymer and its suitability for the fabrication of adhesive multilayer 
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coatings has been investigated within the scope of this study. The protocol used to modify levan 
followed the reaction scheme is shown in Figure 6.1. 
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Figure 6.1. Reaction scheme of phosphonate modification of levan. 
 
The obtained Ph-levan was then characterized by FTIR and EDS. In the FTIR spectrum (Figure 6.2), 
several stretching vibration bands were detected: the hydroxyl (OH) stretching vibration bands around 
3200 cm-1, two bands around 2900 cm-1/2930 cm-1 corresponding to carbon-hydrogen (C-H) stretching 
vibration of fructose residues, bands in the region of 1430 cm -1 that were assigned to C-H plan 
deformation vibration combined with aromatic skeletal vibrations, bands at 1120 cm-1 and 1000 cm-1 
that were dominated by the stretching vibrations of the glycosidic linkage contributions of C-O-C and C-
O-H, as well as the 920 cm-1 band resulting from the stretching vibration of pyran ring. These bands 
are all characteristic of levan polysaccharides reported earlier [31]. By comparison, in the FTIR 
spectrum of Ph-levan, more bands could be identified: a band at 2360 cm-1 corresponding to the P–H 
bond, another one at 1200 cm-1 corresponding to the P=O bond, a shoulder at 1045 cm-1 attributable 
to the P–OH bond and bands around 875 cm-1 corresponding to the P–O–C bonds [32-34]. 
EDS was performed to further evaluate the efficiency of the modification. From the spectrum in Figure 
6.3, a peak of phosphorus was detected and the EDS analysis resulted in an atomic ratio of 
C:O:P=44:51:3. Thus, both FTIR and EDS pointed towards the production of a Ph-levan stock to be 
used in the construction of the intended multilayer films. 
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Figure 6.2. FTIR spectra of levan samples as-produced (in red) and phosphonate (in black). The Ph-
levan spectrum is represented with an offset of +0.04 of absorbance. The bands respective to 
phosphonate groups are highlighted with grey background, with the inset showing the augmented 
spectra between 700 and 1000 cm-1. 
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Figure 6.3. EDS spectrum of a Ph-levan sample. 
 
Prior to the QCM-D study, the ζ-potential of CHI and Ph-levan was measured, showing values of 
+16.8±0.8 mV and -13.1±0.3 mV, respectively. CHI is a well-known polycation due to the protonated 
state of amine groups in acidic conditions [3]. The negative charge of Ph-levan is possible thanks to the 
introduction of phosphonate groups to a macromolecule that is otherwise uncharged in nature.  This 
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modification allows the reaction with CHI via electrostatic interactions. The ability of CHI and Ph-levan to 
adsorb in a sequential fashion by relying on ESA was monitored by QCM-D. This technique is able to 
detect mass changes in the order of nanograms per square centimeter and measure the viscoelastic 
properties of the resulting surface [35]. Figure 6.4A shows the normalized frequency, ∆Fν/ν (where ν is 
the overtone) and dissipation (∆D) variations for the 5th overtone (25 MHz) after the construction up to 
6 layers onto gold-coated quartz sensors. During QCM-D, a favorable and successful construction is 
usually identified by a decrease in ∆F caused by mass adsorption at the top of the sensor. The ∆Fν/ν 
decreased upon flushing the substrate with the sequence of polyelectrolytes, due to the deposition of 
polymer on the surface of the crystal, to an approximate absolute value of 38 Hz. At the same time, 
monitoring of ∆D gives an indirect indication of the film’s viscoelastic properties. For instance, an 
increase in ∆D represents a shift towards a film with a higher viscous component and damping 
properties that characterize a “softer” film. As observed in Figure 6.4A, the ∆D increased to around 
17×10-6. Therefore, the assembled multilayer film is not rigid and exhibits the typical viscoelastic 
behavior, a typical situation when using macromolecular systems. 
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Figure 6.4. Buildup assessment of (CHI/Ph-levan) films. A: QCM-D monitoring of normalized 
frequency, ∆Fν/ν, and dissipation ∆D, obtained from the 5
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ending in CHI and an even number a film ending in Ph-levan. Data represent mean±standard deviation 
(SD). 
 
Chapter 6. Adhesive nanostructured multilayer films using a bacterial exopolysaccharide for biomedical 
applications 
 
220 
The QCM-D data was used to estimate the thickness variations of the film with each adsorption cycle. 
Figure 6.4B shows how the thickness varied with each deposition cycle calculated using the Voigt 
model [36]. After the deposition of 6 layers, the film had a mean thickness of 50±7 nm, corresponding 
to an approximate total area density of 6.0±0.9 μg.cm-2 (obtained by multiplying the thickness by the 
layer density, 1200 kg∙m-3). The results obtained through QCM-D measurements demonstrate that 
Ph-levan can be used successfully with CHI to conceive a viscoelastic polymeric thin coating using the 
LbL approach. 
Afterwards, films of 50 bilayers were assembled onto glass slides – henceforth referred to as (CHI/Ph-
levan)50 – for the characterization of their surface and adhesive properties. For the sake of comparison, 
multilayer films consisting of 50 bilayers of CHI and ALG, (CHI/ALG)50, were also constructed and 
tested under the same experimental conditions. The formulation of this control film consists of well-
known adhesive materials which properties were compared with those of (CHI/Ph-levan)50 films. 
Additionally, it was seen before that this multilayer film can be easily assembled using the experimental 
parameters utilized in this work.[37,38] 
The surface of (CHI/Ph-levan)50 and (CHI/ALG)50 films was evaluated by scanning electron microscopy 
(SEM). Figure 6.5 demonstrates that the former presented a flat surface with few morphological 
features (Figure 6.5A) in comparison to the (CHI/ALG)50 control (Figure 6.5B). In both cases it is clear 
that the multilayer films completely coated the surface of the substrates. 
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200 µm
 
Figure 6.5. SEM images of (A) (CHI/Ph-levan)50 and (B) (CHI/ALG)50 films assembled onto glass. 
Inset scale bar: 50 µm. 
 
It is noteworthy that the more flat surfaces are the ones exhibiting the best adhesive properties. For 
solid/viscoelastic contacts, it has been reported that if a surface – either the adhesive or the substrate 
– is rough, the contact between the two surfaces may be incomplete (i.e., the real contact area is lower 
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than the apparent contact area) and evolve with contact time, leading to surfaces to unbind [39,40]. For 
elastic surfaces, surface roughness is also known to decrease adhesion [41]. The current work is a 
case of contact between viscoelastic surfaces, a known property of polymer-based multilayer films [35]. 
Fitting only partially on the described roughness/adhesiveness models, the roughness observed in 
Figure 6.5 may have little influence in the adhesion mechanism of these films which, due to their 
viscous nature, will depend mainly on the strong adhesive bonds formed by the hydroxyl groups. 
Most in vitro methods for screening the adhesiveness rely on the measurement of either tensile or 
shear strengths. The first usually tests the perpendicular force necessary to separate two surfaces, 
while the second determines the force that causes an adhesive to slide on a surface in the direction 
parallel to the plan of contact [42]. Although the first is the most commonly used, an adhesive or 
sealant in contact with a biological tissue is more prone to undergo shear stress than tensile, due to 
inherent muscular movements. In light of this, two glass slides bearing either (CHI/Ph-levan)50 or 
(CHI/ALG)50 hybrid films were overlapped as soon as the adsorption of the layers was concluded. After 
a cure of 24 h, the lap shear adhesive strength was tested. Figure 6.6 shows that the lap shear strength 
necessary to separate two (CHI/Ph-levan)50 films was 2.5±0.3 MPa. (CHI/ALG)50 films required a lap 
shear strength of 0.9±0.1 MPa until detachment was observed. 
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Figure 6.6. Lap shear stress for detachment of (CHI/Ph-levan)50 and (CHI/ALG)50 multilayers 
assembled onto glass slides (A) as a function of extension (representative curves). (B) Lap shear 
strength for the two multilayer films (mean±SD; n=3; *p<0.05). 
 
In comparison, (CHI/Ph-levan)50 films exhibited a value about 3 times superior to that of the control. 
Also, notice that the shear modulus (estimated from the slope of the graphics in Figure 6.6A) of both 
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multilayer films is similar, but the final displacement of (CHI/Ph-levan)50 is higher, giving rise to a 
higher adhesive strength compared with the control, (CHI/ALG)50. For clinical procedures, 
cyanoacrylates have been shown to provide a strong adhesiveness, appropriate for wound closure 
(around 68 kPa). Fibrin-based materials are weaker (around 13 kPa) are applied as sealants combined 
with suturing. Hydrogels and other polymer-based devices are also considered weak (ranging from 4 to 
17 kPa) and often used as topical wound dressings or as sealants when mechanical properties are of 
less concern [43]. Independent studies on adhesive and sealant products available in the market have 
been made. For instance, TisseelTM – a fibrin-based sealant – and DermabondTM – a cyanoacrylate-
based glue – showed shear adhesive strengths around 20 kPa [44] and 180 kPa [45], respectively. 
However, the authors used actual bovine tissues and not glass substrates, although other works 
describe experimental conditions similar to the presented herein. Yamada et al. [46] showed that the 
shear stress between two glass slides overlapped together with dopamine-modified chitosan was over 
400 kPa, while unmodified chitosan conferred no adhesive strength. Ishihara et al. [47] also developed 
a photocrosslinkable chitosan hydrogel with a shear adhesive strength around 3 kPa. (Ph-levan)-
containing multilayer coatings adhesives surpass these examples. In comparison with the product 
exhibiting the highest adhesive properties (dopamine-modified chitosan, 400 kPa) the lap shear 
strength is about 6 times higher. Thus, levan derivatives provide an enhanced adhesive character to 
these multilayer films that could be useful in applications where strong adhesiveness to a substrate is 
necessary. 
In order to understand how cells interact with films containing Ph-levan, the biological performance was 
evaluated in vitro using L929 cells. In biological applications, an adhesive film could be useful to readily 
provide fixation to a tissue either externally as a wound healing bandage or internally as a surgical 
sealant for tissues and organs. In order to study the early cell adhesion on (CHI/Ph-levan)50, we 
investigated the density of cells adhered onto the films after 24 h of culture and compared it to the 
(CHI/ALG)50 case. A noticeable difference could be observed: cells adhered mostly to (CHI/Ph-levan)50 
than to (CHI/ALG)50 (Figure 6.7). 
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Figure 6.7. A: L929 cell density after 24 h of culture (n=3; p<0.05). DAPI staining of adhered cells on 
(B) (CHI/Ph-levan)50 and (C) (CHI/ALG)50 substrates. 
 
Quantitatively, the mean cell area on the former was around 110 cells∙mm-2, a high value when 
compared to the latter, with only around 20 cells∙mm-2. The results demonstrated that the biological 
process of L929 cells adhesion was sensitive to the incorporation of Ph-levan into the LbL surfaces. In 
order to optimize biomaterials/cellular interactions this effect is of great importance, since those 
interactions are based on cell surface receptor/substrate ligand binding, which influence different 
cellular responses. We believe that levan surfaces will lead to new findings in cell/materials interactions, 
contributing to promote and control speciﬁc cellular responses. 
6.4 Conclusions 
In this work, the feasibility to construct nanostructured multilayer films containing an exopolysaccharide 
from an unconventional source, namely from extremophile microorganisms, was demonstrated. Relying 
on electrostatic interactions, hybrid films containing this fructan along with chitosan were compared 
with a formulation of chitosan and alginate, two natural ingredients widely regarded as good adhesives: 
the incorporation Ph-levan led to the conception of films that required higher strength for detachment to 
occur due to shear stress. Furthermore, cells were sensitive to this polysaccharide and adhered in 
higher number. In the context of biomedical and tissue engineering, these films could provide enhanced 
adhesiveness and protection to a new generation of wound healing bandages or to surgical sealants 
and also surfaces with optimized cell/substrate interactions, fabricated by a versatile and cost-effective 
multilayer technology. 
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 Chapter 7. Layer-by-layer film-growth using polysaccharides and 
recombinant polypeptides: a combinatorial approach6 
Abstract 
Nanostructured films consisting of polysaccharides and elastin-like recombinamers (ELRs) are 
fabricated in a layer-by-layer manner. A quartz-crystal microbalance with dissipation monitoring (QCM-D) 
is used to follow the buildup of hybrid films containing one polysaccharide (chitosan or alginate) and 
one of several ELRs that differ in terms of amino acid content, length and biofunctionality in situ at pH 
4.0 and pH 5.5. The charge density of the ingredients at each pH is determined by measuring their ζ-
potential, and the thickness of a total of 36 different films containing five bilayers is estimated using the 
Voigt-based viscoelastic model. A comparison of the values obtained reveals that thicker films can be 
obtained when working at a pH close to the acidity constant of the polysaccharide used (near-pKa 
conditions), suggesting that the construction of such films is more favorable when based on the 
presence of hydrophobic interactions between ELRs and partially neutralized polysaccharides. Further 
analysis shows that the molecular weight of the ELRs plays only a minor role in defining the growth 
tendency. When taken together, these results point to the most favorable conditions for constructing 
nanostructured films from natural and distinct recombinant polypeptides that can be tuned to exhibit 
specialized biofunctionality for tissue-engineering, drug-delivery, and biotechnological applications. 
                                                 
6
 This chapter is based on the following publication: 
Costa R. R., Testera A. M., Arias F. J., Rodríguez-Cabello J. C., and Mano J. F., Layer-by-layer film-growth using 
polysaccharides and recombinant polypeptides: a combinatorial approach, The Journal of Physical Chemistry B 2013, 17: 
6839-6848, DOI:10.1021/jp4028518. 
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7.1 Introduction 
Surface engineering is a field of expertise concerned with the modification and improvement of 
interfaces [1-3]. In the past decades, this technique has been widely applied in the field of biomedical 
and tissue engineering, where the properties of substrate surfaces need to be tuned to promote cell 
expansion, improve the interface between an implantable device and its biological environment, and 
add stimuli-responsiveness for on-demand surface property switching [4-7]. Layer-by-layer (LbL) 
techniques are perhaps the most versatile and easy-to-apply of the numerous surface-modification tools 
currently available as they are based on the spontaneous adsorption of ingredients onto a substrate, 
generally a polymer, biomolecule or inorganic particle, and allow the sequential formation of a 
nanostructured film. This technique allows robust coatings to be produced on substrates with complex 
geometries and, as it does away with the need for harmful organic solvents, it is of great interest in 
tissue-engineering applications [5,8-10]. As such, LbL methods have already been employed in cell-
sheet technology [11,12], for drug delivery [13-15] and for the creation of three-dimensional scaffolds 
for cell culture [16]. 
Exploiting strong, long-range electrostatic interactions (e.g., attraction between oppositely charged 
polyelectrolytes) [17] is by far the most widely used LbL construction mechanism, often referred to as 
electrostatic self-assembly (ESA). LbL synthesis is not restricted to this mechanism: this technique relies 
on the existence of multiple complementary intermolecular interactions that allow the LbL concept to be 
widened to include hydrogen bonding and hydrophobic interactions (often referred to as secondary or 
nonelectrostatic interactions) [18-20]. Nowadays, it is assumed that the gain in entropy is also a key 
phenomenon for LbL construction which results from the release of counter-ions. The outcome of such 
a mechanism is often the organization of the layers in a more coiled and interdigitated conformation 
and loss of degrees of freedom from the polyelectrolyte molecules [19-21]. 
Herein we intend to demonstrate the feasibility of LbL synthesis using natural marine-based 
polysaccharides [chitosan (CHI) and alginate (ALG)] and nature-inspired polypeptides, in this case 
elastin-like recombinamers (ELRs), which are the recombinant analogs of elastin-like polymers (ELPs). 
The polycationic chitosan and polyanionic alginate are well-known polysaccharides derived from marine 
crustaceans and brown algae, respectively [22]. Both polymers are non-toxic and exhibit adhesive, 
bacteriostatic, fungistatic, hemostatic and antimicrobial effects that make them suitable for use in 
wound dressings and drug-delivery systems [23-25]. ELRs are genetically modified biocompatible and 
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stimuli-responsive polypeptides that mimic natural elastin, the extracellular elastic protein found in 
higher classes of animals [26-28]. These polypeptides exhibit a transition temperature (Tt) in aqueous 
solution above which free polymer chains adopt random coil conformations and separate from the 
solvent. ELRs follow the standard repeating structure of elastin, namely valine-proline-glycine-valine-
glycine (VPGVG), a sequence with no electrostatic charge. Besides their smart nature, the most 
attractive property of ELRs is their ability to be engineered to contain amino acid sequences with charge 
and even bioactivity. Indeed, it has proven possible to construct ELRs containing sequences that 
enhance cell adhesion [29,30] or biomineralization [31]. One could thus consider that such materials 
may be able to act as versatile and fine-tuned models for protein systems, including nanostructured 
coatings for highly specific tissue-engineering applications. 
A great deal of time and effort has been dedicated to the widely investigated poly(styrene 
sulfonate)/poly(allylamine hydrochloride) (PSS/PAH) system, which is currently considered to be a 
model of how multilayered thin films are built, over the past 20 years [5]. The fact that most studies in 
this field have been based on the application of ESA interactions to synthetic materials with controllable 
properties has hindered a more in-depth understanding of the secondary construction mechanism. As a 
consequence, extrapolation to new tailored materials that are more suitable for tissue-engineering 
applications, as is the case for ELRs or proteins in general, has been limited. In this regard, classical 
ESA has been unable to explain fully the formation of multilayer thin films and the role of secondary 
interactions has been brought into question. A report from Cini and co-workers [32] – to which also 
contributed Decher, one of the pioneers of LbL – have also proposed that the construction of 
poly(allylamine hydrochloride) (PAH) and poly(sodium phosphate) (PSP) “violates almost all the rules” 
of LbL, thereby suggesting a possible contribution from hydrophobic interactions. Our group has also 
considered that the formation of an ELR-containing multilayer film is almost certainly driven, at least in 
part, by hydrophobic interactions [29]. However, to the best of our knowledge, studies that could 
systematically and extensively confirm the role of such interactions in the construction of multilayered 
films have yet not been reported. 
In this work we intended to study the conditions needed to successfully obtain a hybrid, biomimetic LbL 
film that combines the properties of natural and genetically modified polymers. We resorted to a quartz-
crystal microbalance with dissipation monitoring (QCM-D), a technique that is able to detect adsorbed 
surface density changes in the order of ng∙cm-2 and measure the viscoelastic properties of the resulting 
surface in real time. Based on the piezoelectric effect, QCM has proven to be a powerful technique for 
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evaluating the growth of multilayer films as well as for monitoring the effect of factors such as 
concentration, molecular weight and pH during or after their assembly [33-37]. Thus, our objectives 
were (i) to study the influence of ESA and secondary interactions in the buildup mechanism of the 
proposed hybrid films by means of charge variations dependent on pH, (ii) study the influence of 
distinct ELR molecular weights (Mn), (iii) compare the feasibility of the construction when using two 
distinct polysaccharides, CHI and ALG, and (iv) extend the knowledge of LbL mechanisms to the class 
of ELRs. 
7.2 Experimental section 
7.2.1 Materials 
Medium molecular weight chitosan was purchased from Sigma-Aldrich (reference 448877, Brookshield 
viscosity 200-800 cP, molecular weight 190-310 kDa) and purified by a series of filtering steps and 
precipitation from water and ethanol, followed by freeze-drying. To determine the degree of 
deacetylation (DD) of chitosan, hydrogen-1 nuclear magnetic resonance (1H-NMR) was performed using 
a Varian MR-400 spectrometer. 10 mg of chitosan was dissolved in 1 mL of deuterated water (D2O) and 
20 µL of deuterated hydrochloric acid (DCl). An aliquot of this solution was placed in a 5 mm NMR tube 
and the spectrum recorded at 60°C. The calculation method of DD was described elsewhere [38] and 
was determined to be 82%. Alginate (alginic acid sodium salt from brown algae) was purchased from 
Fluka (reference 71238, molecular weight 100-200 kDa). ELRs were obtained by the induced gene 
expression of recombinant Escherichia coli strains containing the expressing gene. Each ELR was 
induced in a 12 L Applikon fermenter, in terrific broth medium (TB) supplemented with carbenicillin 
(0.1% v/v) and glucose (0.1% v/v), under controlled conditions of temperature (37 ºC) and pH (7.00). 
Fermentation was stopped after registering an optical density variation at 600 nm of less than 0.25, in 
a time-frame of 1 hour. The culture was then harvested by centrifugation, resuspended and lysed by 
ultrasonic disruption. Insoluble debris was removed by centrifugation and the cleared lysate was 
subjected to several cycles of cold and warm centrifugations (4 and 40ºC, respectively). All purification 
steps were carried out in sodium chloride solution (0.5 M). The polymer in solution was dialyzed against 
ultrapure water, frozen at -24ºC and freeze-dried. 
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7.2.2 Assessment of the ELR compositions 
The molecular weight and amino acid composition of the samples obtained were determined by matrix-
assisted laser desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF) and amino acid 
content analysis, respectively. These methods, and their results, are described in more detail in the 
Supporting Information. The percentage of residues subject to ionization and the proportion of positive 
and negative charges were also calculated. 
7.2.3 Measurement of the charges 
The ζ-potentials of the polysaccharides and ELRs were determined using a Nano-ZS from Malvern 
(United Kingdom), at 25ºC. Aqueous solutions of each ingredient were used, at 100 μg∙mL-1, 0.15 M 
NaCl and pH values of 4.0 or 5.5. 
7.2.4 Construction of hybrid self-assembled films 
A Q-Sense E4 quartz-crystal microbalance (Q-Sense AB, Sweden) with dissipation monitoring system 
was used to monitor the adsorption of polysaccharides and ELRs onto gold-coated quartz crystals in situ 
(Q-Sense, reference QSX301). The assembled films consisted of a series of polysaccharide/ELR 
combinations at pH values of either 4.0 or 5.5, thus resulting in a total of 36 different conditions. 
Combinations containing chitosan had this polycation as the first layer, whereas those containing 
alginate had this polyanion as the second layer. The quartz-crystal was excited at multiple overtones (1, 
3, 5, 7, 9, 11 and 13, corresponding to 5, 15, 25, 35, 45, 55 and 65 MHz respectively). Adsorption 
took place at 25ºC, using solutions at 100 μg∙mL-1, 0.15 M NaCl and at a constant flow rate of 50 
mL∙min-1, with an adsorption time of 15 minutes and an intermediate rinsing step of 10 minutes. 
7.2.5 Estimation of the film thicknesses 
The Voigt-based viscoelastic model contained in the QTools software from Q-Sense (version 3.0.15.553) 
was used to estimate the thickness of the films from the QCM-D monitoring data. Iterations of the 
model were performed using at least three overtones. The model requires three parameters, namely 
solvent density, solvent viscosity and film density, to be fixed. The solvent viscosity was therefore fixed 
at 0.001 Pa∙s (same as water) and the film density at 1200 kg.m-3 (often assumed to return the lowest 
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calculation error) [29,37,39]. The solvent density was varied by trial and error between 1000 and 1060 
kg∙m-3 until the total error, χ2, was minimized. 
7.3 Results and discussion 
7.3.1 Characterization of the polysaccharides and ELRs 
We selected nine ELRs for this study as the genetically engineered origin of these compounds allows a 
class of materials that can differ in terms of sequence, length and bioactivity without significantly 
altering the original elastin backbone to be studied. The properties of each ELR are summarized in 
Table 7.1 according to their molecular weight, Mn, amino acid sequence and proportions of 
charged/uncharged and positive/negative residues. The acronyms were assigned on the basis of their 
distinct sequence, function and variations on the repeating (VPGVG) sequence. The experimental amino 
acid composition and MALDI-TOF values can be found in Supplemental Information (Supplemental 
Table 7.1, Supplemental Table 7.2, Supplemental Table 7.3, Supplemental Figure 7.1) showing that 
the experimental Mn and number of amino acids agree well with the theoretical values of Table 7.1. 
Arginine (R), histidine (H) and lysine (K) are positively charged when protonated and aspartic acid (D) 
and glutamic acid (E) are negatively charged when deprotonated. The properties of these residues were 
taken into account when calculating the charged and amino acid proportions. A closer look at each ELR 
sequence shows that they are all distinct and that some even exhibit motifs with biological relevance 
that could make them useful for current therapies and applications: 3K-VRGDV and H-RGD6, for 
example, contain the RGD sequence, which promotes cell adhesion. 3K-VRDG(-)V is the negative control 
of the former as it contains the same sequence but with a scrambled, non-functional RDG motif. 
Similarly, HAP3, H3A20 and H3A20H3 exhibit sequences that promote biomineralization, organized as 
single, double and triple blocks, respectively, with the alanine-block (A20 portion) being highly 
hydrophobic. GEG15 and IK24 contain E and K residues, which confer anionic and cationic behavior, 
respectively. Finally, the neutralized V84 lacks ionizable residues and is therefore uncharged. 
Although the original sequence of V84 contains three K-residues, which in theory should confer a 
positive charge on this ELR, it was neutralized in order to use it as a neutral control (see Supplemental 
Information, “neutralization of V84”). This sequence was used to analyze the buildup of a neutral ELR 
hybrid film in comparison with ELRs that are susceptible to ionization. 
 
Chapter 7. Layer-by-layer film-growth using polysaccharides and recombinant polypeptides: a 
combinatorial approach 
 
236 
Table 7.1. List of ELRs used in this work with their corresponding theoretical molecular weight and 
proportions of charged and positive/negative amino acids. *Neutralized lysine residues. 
ELR acronym Sequence 
Mn 
(Da) 
Charged 
proportion 
(%) 
Positive/negative 
amino acid 
proportion (%) 
3K-VRDG(-)V 
MGKKKP-(VPGVG)14[(VPGIG)10AVTGRD 
GSPASS(VPGIG)10]2(VPGVG)14-V 
31371 1.9 71.4/28.6 
3K-VRGDV 
MGKKKP(VPGVG)14[(VPGIG)10AVTGRG
DSPASS(VPGIG)10]2 (VPGVG)14-V 
31371 1.9 71.4/28.6 
HAP3 
MESLLP[[(VPGIG)2(VPGKG)(VPGIG)2]2 
DDDEEKFLRRIGRFG[(VPGIG)2 
(VPGKG)(VPGIG)2]2]3-V 
31877 11.4 60/40 
GEG15 
MD[(VPGVG)2(VPGEG) 
(VPGVG)2]15IGSG 
31948 3.9 4/96 
H3A20 
MESLLP[[(VPGIG)2VPGKG(VPGIG)2]2DD
DEEKFLRRIGRFG[(VPGIG)2VPGKG 
(VPGIG)2]]3-(VPAVG)20-V 
40361 8.8 60/40 
IK24 
MESLLP[(VPGIG)2(VPGKG) 
(VPGIG)2]24-V 
51970 4.0 100/0 
H-RGD6 
MGSSHHHHHHSSGLVPRGSHMESLLP[
[(VPGIG)2(VPGKG)(VPGIG)2]2AVTGRGD
SPASS[(VPGIG)2(VPGKG) (VPGIG)2]2]6-V 
60661 6.4 84.4/15.6 
H3A20H3 
MESLLP[[(VPGIG)2(VPGKG)(VPGIG)2]2 
DDDEEKFLRRIGRFG[(VPGIG)2(VPGKG) 
(VPGIG)2]2]3(VPAVG)20[[(VPGIG)2 
(VPGKG)(VPGIG)2]2DDDEEKFLRRIGRFG
[(VPGIG)2(VPGKG)(VPGIG)2]2]3-V 
71462 9.9 60.8/39.2 
Neutralized 
V84 
MGK*K*K*P-(VPGVG)84-V 35191 0 0/0 
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Like most proteins, the ionizable residues in the backbone of these ELRs represent only a small fraction 
of the whole sequence (maximum of 11.4% in the case of HAP3). Therefore, although ELRs can be 
modified to include specific peptide sequences, they still retain the basic properties of this class of 
polymers. This is a relevant property for the present study, considering that the nonionizable residues 
may interact by hydrophobic interactions. Despite the fact that these interactions are weaker and have a 
shorter range than their electrostatic counterparts, they nevertheless have been shown to play an 
important role in stabilizing the internal structure of multilayers containing uncharged groups, such as 
most proteins, which contain large numbers of hydrophobic groups [40-42]. 
Using a group of ELRs with such distinct properties, we expected to be able to identify the properties 
that are essential for the construction of this kind of hybrid nanostructured film, especially films 
containing complex ELRs with bioactivity and practical relevance. 
7.3.2 Effect of the charged state by means of the ζ-potential 
One of the parameters to be studied was the influence of electrostatic interactions – or lack of them – 
during the growth process. To this end, we measured the charge of each ELR and polysaccharide prior 
to the QCM-D experiments by determining their ζ-potentials at pH 4.0 and 5.5. The results are shown in  
Table 7.2.  
 
Table 7.2. ζ-potentials (mV) for CHI, ALG and the ELRs at pH values of 4.0 and 5.5. 
 
pH 4.0 pH 5.5 
3K-VRDG(-)V -2.7±0.6 -9.3±1.5 
3K-VRGDV -2.1±0.2 -8.4±0.3 
HAP3 -0.4±0.8 -6.8±0.7 
GEG15 -2.9±0.6 -4.4±0.4 
H3A20 -13.3±1.7 -10.7±2.8 
IK24 3.5±0.4 1.6±0.1 
H-RGD6 1.8±0.1 -5.1±1.0 
H3A20H3 -17.7±2.1 -15.0±2.6 
Neutralized V84 1.1±0.8 -1.0±0.1 
CHI 16.8±0.8 13.1±0.3 
ALG -8.3±1.0 -17.5±1.5 
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In the case of the polysaccharides, CHI exhibited a positive and ALG a negative charge as expected and, 
since both contain ionizable groups, their charge varied with the pH, with their potential decreasing at 
the pH value closest to their respective pKa as their charges were progressively neutralized [close to the 
pKa of ALG (≈3.2–4) [43] and CHI (≈6) [25], respectively]. As for the ELRs, it is interesting to note that, 
irrespective of the pH, in general they are all negatively charged despite the fact that all ELRs, except 
GEG15, have a higher proportion of residues that are susceptible of exhibiting a positive charge, with 
the highest being H-RGD6 (84.4%) and IK24 (96%), in comparison to the number of negative ones. 
One would expect that some ELRs should exhibit positive values, especially at pH 4.0, where the 
availability of uncharged protonated –COOH groups would be higher. The complexity of the ELR 
polypeptide family may explain why this did not occur: characteristics such as chain conformation and 
residue exhibition/inhibition may vary among different peptide sequences. Indeed, previous studies 
have shown that the pKa of ionizable side-chains may change significantly, for example with small 
changes in the amino acid sequence [44,45]. However, such a characterization was not in the scope of 
this work since only the effective charge of each polymer in solution was considered when reaching the 
conclusions presented below. The IK24 and H-RGD6 ELRs are indeed positively charged at pH 4.0. In 
the case of the former, although it has an E-residue that can be ionized with a negative charge, the fact 
that the K-residues are in excess does not allow for a charge sign inversion below pH 5.5. A similar 
situation was found for neutralized V84, which contains no ionizable residues, although in this case the 
small charge fluctuation is due to the effect of pH on the N– and C–termini. In contrast, the block-ELRs 
(H3A20 and H3A20H3) are more negative at pH 4.0 than at pH 5.5. Again, it is likely that a different 
conformation arises as a result of organization of the ELR into blocks and their amphiphilic nature. 
Currently, two models are accepted to explain LbL growth driven by electrostatic interactions. One 
states that the LbL ingredients should have a minimum charge density with opposite signs, whereas the 
other states that, rather than having a minimum charge density, it is the charge balance that favors the 
buildup, i.e., that two ingredients are equally and symmetrically charged. Also, the gain of entropy can 
be hypothesized. For instance, it is known that, when using weak polyelectrolytes, polymers with a 
higher number of charged and polar groups tend to be adsorbed as a thin layer with a flat chain 
conformation whereas more neutral ones tend to be adsorbed as a thicker layer and to form loop-type 
structures [46-48]. Since the ELRs used herein are modified versions of the basic repeating block of 
elastin (some with charged amino acids) they would appear to be the ingredient with the most 
hydrophobic backbone rather than the polysaccharides, and thus have a higher contribute to the 
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entropy mechanism due to the formation of loopier and interdigitated layers. Moreover, changing the pH 
of weak polyelectrolytes, namely the polysaccharides used, will also vary their ionizable state, making 
them more charged or less charged. However, unlike the presence or absence of electrostatic charges, 
the real weight of the entropic gain in the LbL mechanism cannot be directly measured, and thus was 
left out of the discussion presented below. In light of the above, we defined 36 test conditions. Each 
condition is a combination of a polysaccharide (CHI or ALG) with one of the nine ELRs. Each one of 
these combinations was then studied at two pH values: 4.0 and 5.5, close to the pKa of ALG and CHI, 
respectively. This allowed combinations containing fully charged/ionized or partially charged (near-pKa 
conditions) forms of polysaccharides with ELRs to be compared. For convenience, each permutation 
combining ELRs and either ALG or CHI at pH 4.0 or 5.5 will henceforth be referred to as ALG40 or 
CHI40 and ALG55 or CHI55, respectively. 
Our first step was to represent graphically the ζ-potentials of the polysaccharides and ELRs at each pH 
in Figure 7.1, in order to estimate the influence of the above-mentioned models. In this graphic, each 
end of the column represents the charge of each ingredient used in each of the 36 combinations. 
Lighter colors are used when the ingredients possess the same charge sign. First, identifying the 
potential combinations meeting the first ESA theory mentioned above is simple, since the only 
requirement is that the ingredients possess charge with opposite sign. Most CHI permutations meet the 
criteria, with only a few ALG ones. Second, we analyzed the charge balance under each condition. For 
CHI combinations, in general the ζ-potential of the highly charged chitosan is not matched by the 
weakly charged ELRs under CHI40 conditions. This situation can be seen graphically by the different 
lengths of the bars on the positive and negative sides, or by bars represented in only one charge side. 
However, at pH 5.5, CHI becomes less charged (+13.1±0.3 mV, in comparison to +16.8±0.8 mV) and 
at the same time the charge of the ELRs shifts to a more negatively charged state (notice that the 
charge of CHI and the block polypeptides H3A20 and H3A20H3 are balanced in either condition), thus 
leading to a more effective net charge balance. A similar trend is observed for ALG combinations. ALG 
at pH 4.0 is partially neutralized and the ζ-potentials of the ELRs shift toward more positive values. This 
way, a more favorable electrostatic situation between ALG and ELRs is achieved but in a different 
manner than when using CHI: whereas with CHI55 balance is achieved by a decrease of its positive 
charge and an increase in the negative charge of the ELRs, with ALG40 a reduction in the electrostatic 
repulsion arising from a lower ionization state of ALG and the ELRs is observed, thereby representing a 
shift toward a situation where uncharged group interaction is maximized. 
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Figure 7.1. Range of ζ-potentials for each polysaccharide/ELR combination. CHI40, CHI55, ALG40 
and ALG55 represent combinations of CHI or ALG at pH 4.0 or pH 5.5. The division serves to indicate 
the charge balance between each polymer in terms of positive (red) and negative (blue) proportion of 
the whole bar length. Bars depicted in light blue and purple represent combinations in which both 
polymers exhibit potential with the same signal. For example, in the first column, where CHI and 3K-
VRDG(-)V were used at pH 4.0, the ζ-potentials were +16.8 mV and -2.7 mV, respectively. In the last 
column, where ALG and V84 were used at pH 5.5, the ζ-potentials were -15.5 mV and -1 mV, 
respectively. 
 
Given the potential mechanisms at work under the different polysaccharide/ELR/pH permutations, we 
have resorted to the QCM-D in order to determine the type of mechanism in which the construction of 
hybrid polysaccharide/ELR films majorly depends. 
7.3.3 QCM-D data acquisition 
Each experiment was conducted using a QCM-D to monitor the sequential adsorption of a single 
polysaccharide and an ELR. In each experiment, the pH of the solutions used (polymeric and rinsing) 
was adjusted to either 4.0 or 5.5. Also, in order to avoid the induction of conformational changes and 
data acquisition noise from the layers that had assembled previously, the pH values of the solutions 
used in each experiment were adjusted to the same value. Typical graphs of frequency (∆F) and 
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dissipation (∆D) variations are depicted for five bilayers of CHI/ELR (Figure 7.2A and Figure 7.2C, 
respectively) and ELR/ALG (Figure 7.2B and Figure 7.2D, respectively) at different pH values. The 
example presented (the combinations using H-RGD6) shows the data obtained for the fifth overtone, 
which corresponds to an excitation frequency of 25 MHz, and is representative of all 36 
polysaccharide/ELR/pH conditions. The graphics obtained for each combination studied can be found 
in Supplemental Figure 7.3. 
 
 
   
Figure 7.2. Representative QCM-D acquisition graphics depicting the 5th overtone variations of 
frequency (A, B) and dissipation (C, D) for hybrid polysaccharide/ELR films at pH 4.0 and 5.5. The case 
of H-RGD6 combinations is depicted. Results for CHI40 (□), CHI55 (■), ALG40 (○) and ALG55 (●) are 
shown. Absolute values of ΔF and ΔD reached values of (A) 24 Hz (□), 200 Hz (■); (B) 223 Hz (○), 81 
Hz (●); (C) 6×10-6 (□), 21×10-6 (■); (D) 32×10-6 (○), 5×10-6 (●). 
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During QCM-D acquisition, a favorable and successful construction is usually identified by a decrease in 
∆F caused by mass adsorption at the surface of the gold-coated quartz sensor. At the same time, 
monitoring of ∆D gives an indirect indication of the film’s viscoelastic properties. For instance, an 
increase in ∆D represents a shift towards a film with a higher viscous component and damping 
properties that becomes “softer”, which is typical of polymeric LbL films. The dissipation values for a 
soft film are higher due to increased energy loss from the crystal, whereas smaller dissipation values 
are obtained for a rigid film. It is this dampening to the crystal’s oscillation that is registered as 
dissipation, ∆D [49,50]. A closer look at Figure 7.2 allows the most favorable conditions for LbL 
construction of these hybrid films to be identified, namely pH values close to the pKa of the 
polysaccharide used, i.e. conditions ALG40 and CHI55, with absolute ∆F5 values of around 225 and 
200 Hz, respectively. Under these conditions, the amplitude of ∆F is greater than for the others. A 
similar trend is observed for ∆D. 
7.3.4 Data modeling and thickness analysis 
The data acquired allowed the thickness of the films obtained under each of the 36 conditions to be 
estimated. When constructing rigid films, the frequency values are related to the adsorbed film mass 
(Δm) and that mass is directly related to ∆F, a relation that is given by the well-known Sauerbrey 
equation (equation 8.1): 
n
FC
m

  (8.1) 
where C is the mass sensitivity constant and n is the overtone number. However, this relation cannot be 
used for soft films that exhibit viscoelastic properties since the water content and swelling behavior are 
also reflected in ∆F and must be taken into account. Therefore, in order to compare every combination 
in this study, the obtained frequency and dissipation values were converted to their estimated thickness 
using the Voigt-based viscoelastic model [51], which is integrated into the QTools software from Q-
Sense, based on equations 8.2 and 8.3: 
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where, considering a total of k thin viscoelastic layers, ρ0 and h0 are the density and thickness of the 
quartz crystal, η3 is the viscosity of the bulk liquid, δ3 is the viscous penetration depth of the shear wave 
in the bulk liquid, ρ3 is the density of liquid, μ is the elastic shear modulus of an overlayer and ω is the 
angular frequency of the oscillation. Together with the integrated Voigt-based viscoelastic model, QCM-D 
constitutes a technique that is both precise and simple to use, allowing one to obtaining a film’s 
properties quickly when comparing to other techniques, such as ellipsometry and surface plasmon 
spectroscopy. The thickness results can be found in Figure 7.3. Also, the numerical thickness and χ2 
values associated with the model fitting can be found in Supplemental Figure 7.3. The results for CHI 
and ALG combinations were subsequently analyzed separately in order to avoid an analysis of 
construction mechanisms that cannot be solely explained by the thickness and potential but are also 
influenced by the specific nature of the polymer itself. 
 
 
Figure 7.3. Thickness values for multilayered films containing five bilayers, as estimated using the 
Voigt-based viscoelastic model, for each polysaccharide/ELR permutation at pH 4.0 and pH 5.5. 
Deviation bars represent two standard deviations. 
 
In LbL growth, different materials tend to adsorb with distinct kinetics and conformations, thus meaning 
that although both CHI and ALG are polysaccharides, they will react differently with ELRs in a multilayer 
hybrid film. The series plotted in Figure 7.3 represent the results obtained when using ALG at pH 4.0 or 
pH 5.5 and CHI at the same pH values. Some combinations were performed in triplicate, leading to an 
estimated maximum standard error of 12% (estimated from HAP3 at ALG40). 
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First it can be seen that the overall thickness values are higher for combinations containing CHI as the 
polysaccharide: the sum of all thickness values for CHI is 566 nm, while that for ALG is 456 nm. If we 
consider solely the role of ESA interactions, the overall construction of the films is more favorable with 
CHI than when using ALG since the former is a polycation and most ELRs are negatively charged. For 
films made of H-RGD6, IK24 and HAP3, ALG40 conditions are actually more favorable than CHI55, but 
this observation can be explained by their exhibited charge, with the first two being positive at pH 4.0 
(1.8 and 3.5 mV, respectively) whereas the third is nearly neutral (-0.4 mV). The overall construction 
phenomenon looks dependent on the charge sign among the ingredients. However, it should be noted 
that the analysis resulting from Figure 7.1 shows that most ALG/pH permutations do not meet the 
criteria to follow a construction based on a minimum charge density, i.e., the ingredients do not 
possess opposite charge sign and the ingredients are all negatively charged. Despite this fact, LbL was 
still possible when using ALG and thus the mechanism of construction must depend on additional 
factors. A more specific look at each polysaccharide combination will allow further data to be obtained 
regarding the growth mechanism at work. 
When analyzing the CHI and ALG combinations separately, another trend was identified. For each 
polysaccharide/ELR condition, the thickness is higher when the polysaccharides were only partially 
charged, i.e., at near-pKa conditions. Following again the example of H-RGD6, for instance, the 
thickness of films at CHI40 and CHI55 conditions were 22 and 51 nm, whereas at ALG40 and ALG 55 
they were 65 and 11 nm, respectively. In the case of CHI/ELR films, the model of charge balance and 
symmetry alone could explain the construction mechanism, but for ALG permutations such model is not 
valid, as denoted above. At pH 4.0, there is less electrostatic repulsion between ALG and ELRs are 
electrostatically more balanced than at pH 5.5. The fact that the majority of permutations involve 
ingredients with the same charge sign means there is no charge symmetry, and thus also conflict with 
the charge balance model. This result suggests that the proposed hybrid multilayer construction 
depends on a lower charge density of the polysaccharides, regardless of charge sign, by increasing the 
availability of neutral binding sites, and therefore materials with a low charge density are a key factor for 
the construction of polysaccharide/ELR films. In this case, we hypothesize that secondary hydrophobic 
interactions are a key force driving LbL growth. The block-ELRs H3A20 and H3A20H3 are a good 
example of this mechanism. As observed in Figure 7.1, these polymers are electrostatically well-
balanced with CHI at both pH values (CHI40/H3A20: +16.8/-13.3 mV; CHI55/H3A20: +13.1/-10.7 
mV; CHI40/H3A20H3: +16.8/-17.7 mV; CHI55/H3A20H3: +13.1/-15.0 mV). Although their ζ-
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potentials would favor ESA balance in both cases, thicknesses are higher at CHI55 than at CHI40, 
where the availability of charged groups is lower in comparison. To further consolidate this observation, 
we have also studied the growth mechanism with the neutralized V84, which has no ionizable groups. It 
is noteworthy that favorable LbL growth under near-pKa conditions is also observed for this ELR. 
Therefore, whereas ESA interactions are present in all other ELRs, the successful construction of 
polysaccharide/(neutralized V84) films relies solely on the density of hydrophobic groups under ALG40 
and CHI55 conditions. 
7.3.5 Effect of molecular weight 
Due to the complexity of the ELR samples tested, several parameters, namely molecular weight, pH, 
zeta-potential, charge density and charge balance between each film component, must be considered to 
determine their contribution to film growth. In this regard, we have tested the obtained data against 
these parameters assuming that hydrophobic forces play an important role in the self-assembly process. 
First of all, we plotted thickness as a function of the ζ-potential and Mn of the ELRs for each set of 
polysaccharide/pH combinations. The variations of thickness with ζ-potential (Supplemental Figure 
7.2A) and Mn (Supplemental Figure 7.2B) are represented, which shows no clear trend in either case. 
At this point, it was assumed that ELRs with a similar Mn exhibit different potentials, and vice-versa. For 
instance, 3K-VRGDV (Mn=31371 Da) has a charge of -8.4±0.3 mV at pH 5.5, whereas another ELR with 
very similar Mn like neutralized V84 (Mn=35191 Da) has a charge of only -1.0±0.1 mV. The ELRs were 
therefore grouped according to their mean charge and their thickness plotted as a function of Mn for 
each defined charge range (see Figure 7.4). 
In general, one would expect that a higher Mn would lead to a thicker film. Thus, whereas a small 
molecule adsorbs in an extended conformation, a lengthier polymer tends to adsorb in a more “loopier” 
manner, thereby providing more anchoring sites for the next layer to adsorb and, potentially, higher 
interpenetration capabilities than smaller ones [52]. For each ζ-potential range selected, the use of fully 
charged polysaccharides (ALG55 and CHI40) leads to a thickness decrease with increasing Mn. Under 
near-pKa conditions of ALG, the overall thickness of the films increases with Mn. 
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Figure 7.4. Variations in film thickness with ELR molecular weight sorted by pH and ζ-potential. 
Results for CHI40 (□), CHI55 (■), ALG40 (○) and ALG55 (●) are shown. The mean thickness of 3K-
VRDG(-)V and 3K-VRGDV films (Mn=31371 Da) is represented. 
 
However, this observation was valid for all ALG40 combinations but not all CHI55 ones, with three of 
the 36 conditions tested being atypical. It can be seen from Figure 7.4D that the thickness under CHI55 
conditions decreases from 49 to 42 nm. The ELR in question is H3A20H3 (Mn=71462 Da), which is 
organized into two charged blocks separated by another non-polar block of alanine residues (A). We 
therefore hypothesize that, during LbL growth, the charged blocks are the first to contact with the 
underlying surface whereas the highly neutral and nonpolar block containing a high number of A-
residues (hydropathy index of 1.8) [53] is much less likely to interact with the hydrated film. Although it 
is true that all ELRs possess hydrophobic residues in their backbone, block-ELRs are spatially organized 
with one block completely charge-free, thus limiting its interaction with aqueous solvents. 
The other two anomalous situations can be seen in Figure 7.4F. The first, at CHI55 for IK24 
(Mn=51970 Da), shows a thickness decrease to 22 nm. IK24 exhibits the highest percentage of 
positively ionizable residues. As such, even when CHI is only partially deprotonated, it is plausible to 
assume that the positive charges of both ingredients (which are stronger and longer in range) repel, 
thereby minimizing the interaction between shorter range hydrophobic groups. The second, at ALG55 
for the same ELR, shows a thickness increase to 27 nm. Under these conditions, the positively charged 
IK24 may interact well with ALG as a result of ESA interactions. Note that these Mn-dependent 
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exceptions do not conflict with the fact that, for each polysaccharide/ELR combination, adsorption is 
more favorable under near-pKa conditions: ALG55 is still a less favorable condition than ALG40, even 
for the polycationic IK24. 
It is unclear why the trend in this behavior does not completely match the molecular weight model for 
LbL assembly and is distinct among many of the studied conditions. Therefore, in light of the uncertain 
influence of Mn on multilayer construction, the fact that it is only favorable in specific cases leads to the 
conclusion that it is not a primary influence on the growth mechanism. 
7.3.6 General model for hybrid multilayer growth 
We have shown that a shift toward near-pKa conditions for both polysaccharides, although of different 
nature, favors the construction of hybrid nanostructured polysaccharide/ELR films. The same 
arguments rule out the theory of minimum charge density, since LbL growth is observed even when 
charges of the same sign are present. Based on this extensive analysis, the LbL growth of hybrid 
polysaccharide and ELR films cannot be explained by ESA interactions alone, thus meaning that 
secondary hydrophobic interactions must be taken into account. The arguments presented herein are 
also valid for the control ELR (neutralized V84). As this ELR exhibits no ionizable groups, the 
construction of films with neutralized V84 was also more favorable under near-pKa conditions, thus 
further clarifying the role of nonelectrostatic forces. A schematic depiction of our findings is provided in 
Figure 7.5. 
 
 
Figure 7.5. Representative scheme of the hypothetical interactions occurring between polysaccharides 
and ELRs. 
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7.4 Conclusions 
The contributions of the molecular weight and electrostatic and hydrophobic interactions to LbL film 
growth have been extensively studied using a QCM-D method. Thus, a comparison of the thickness of 
36 films formed under different conditions (polysaccharide and ELR combinations and the charges of 
each intervening ingredient) has shown that the growth of such hybrid nanostructured films is more 
favorable when the polysaccharide used is partially neutral, i.e., near its pKa. Under these conditions, 
hydrophobic groups prevail over charged ones, thus highlighting the greater importance of short-range 
hydrophobic interactions when compared with ESA interactions. The molecular weight appears to have 
little effect on LbL growth. Future studies that focus on other parameters, such as ionic strength and 
temperature, should be considered in order to determine whether additional factors affect this 
combination model. These conclusions are important in order to correctly predict the most favorable 
parameters for constructing nanostructured films from natural and nature-inspired materials, especially 
since the use of genetically engineered polypeptides could lead to films with tailored properties and 
biologically relevant functions for applications in tissue engineering, drug delivery and biotechnology that 
require precise and improved specificity. 
7.5 Supplemental information 
7.5.1 Neutralization of V84 
The ELR V84 was chemically modified by amidation of the γ-amine group of the biopolymer with 
pentynoic anhydride as acylating agent. The reaction was performed in trifluoroethanol (TFE) with 10 
equivalents of pentynoic anhydride per γ-amine group and 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDAC; 5 equivalents) as catalyst. Pentynoic anhydride was synthesized previously from 
pentynoic acid in a 1:1 (v/v) mixture of dichloromethane and diethyl ether in the presence of 
dicyclohexylcarbodiimide. 
The reaction mixture was stirred for 3 days at room temperature. After this time, the functionalized 
polymer was precipitated into increasing fractions of diethyl ether and dried in a vacuum oven at room 
temperature for 24 h. Once dry, the modified V84 was solubilized in cold water and the crude product 
purified by exhaustive dialysis against water, then frozen and finally freeze-dried. 
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7.5.2 Amino acid composition 
The amino acid composition was determined according to the AccQTag Waters method and the 
derivatized amino acids analyzed by high-performance liquid chromatography (HPLC) using a Waters 
600 gradient system and a Waters 2487 detector (Waters, USA). 
 
Supplemental Table 7.1. Theoretical and experimental amino acid compositions of 3K-VRDG(-)V, 3K-
VRGDV and HAP3. ND = not determined. 
 
3K-VRDG(-)V - 31371 Da 3K-VRGDV - 31371 Da HAP3 - 31889 Da 
 
Theoretical Experimental Theoretical Experimental Theoretical Experimental 
D 2 2.62 2 2.27 9 9.69 
T 2 2.18 2 1.81 0 0 
S 6 5.63 6 4.7 1 0.87 
E 0 0 0 0 7 7 
P 71 74.18 71 70.7 61 59.58 
G 141 139.76 141 141.48 126 132 
A 4 4.8 4 4.31 0 0 
V 99 95.77 99 98.65 61 58.49 
M 1 ND 1 ND 1 0.53 
I 40 41.19 40 39.6 51 47.12 
L 0 0 0 0 5 5.65 
F 0 0 0 0 6 5.94 
H 0 0 0 0 0 0 
K 3 3.29 3 3.13 15 14.76 
R 2 2.41 2 2.18 9 9.5 
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Supplemental Table 7.2. Theoretical and experimental amino acid compositions of GEG15, H3A20 
and IK24. ND = not determined. 
 
GEG15 - 31948 Da H3A20 - 40361 Da IK24 - 51980 Da 
 
Theoretical Experimental Theoretical Experimental Theoretical Experimental 
D 1 1.53 9 8.92 0 0 
T 0 0 0 0.94 0 0 
S 1 0.85 1 0.77 1 1.29 
E 15 15.28 7 6.64 1 0.65 
P 75 76.61 81 82.11 121 118.59 
G 152 152.76 146 144.08 240 255.41 
A 0 0 20 22.09 0 0 
V 135 132.98 101 102.95 121 116.81 
M 1 ND 1 ND 1 0.72 
I 1 0.43 51 48.64 96 87.34 
L 0 0 5 4.44 2 3.51 
F 0 0 6 5.55 0 0 
H 0 0 0 0 0 0 
K 0 0 15 14.7 24 23.23 
R 0 0 9 9.89 0 0 
 
Supplemental Table 7.3. Theoretical and experimental amino acid compositions of H-RGD6, 
H3A20H3 and neutralized V84. ND = not determined. *G+H. 
 
H-RGD6 - 60661 Da H3A20H3 - 71462 Da Neutralized V84 - 35191 Da 
 
Theoretical Experimental Theoretical Experimental Theoretical Experimental 
D 6 6.42 18 18.79 0 0 
T 6 5.51 0 1.1 0 0 
S 24 18.23 1 1.32 0 0 
E 1 1.28 13 13.00 0 0 
P 128 124.95 141 143.68 84 97.84 
G 255 274.43* 272 268.85 169 169.39 
A 12 12.1 20 22.52 0 0 
V 128 122.63 161 165.34 169 154.78 
M 2 ND 1 ND 1 N.D. 
I 96 91.45 102 97.3 0 0 
L 3 3.37 8 7.76 0 0 
F 0 0 12 11.02 0 0 
H 7 * 0 0 0 0 
K 24 22.79 30 29.61 0 0 
R 7 6.9 18 19.64 0 0 
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7.5.3 Molecular weight 
To assess the biopolymer molecular weight, MALDI-TOF mass spectroscopy was performed using a 
Voyager STR instrument from Applied Biosystems (USA), in linear mode, with external calibration using 
bovine serum albumin (BSA). The spectra for each ELR can be found below and are referred as a single 
Figure, namely Supplemental Figure 7.1. 
 
 
 
Peak intensity: 31289 Da 
Mean±SD: 31247±7.6 Da 
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Peak intensity: 31229 Da 
Mean±SD: 31250±8.5 Da 
Peak intensity: 31847 Da 
Mean±SD: 31910±6.1 Da 
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Peak intensity: 40427 Da 
Mean±SD: 40421±12.5 Da 
Peak intensity: 31980 Da 
Mean±SD: 31980±9.4 Da 
Peak intensity: 40427 Da 
Mean±SD: 40421±12.5 Da 
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Peak intensity: 51938 Da 
Mean±SD: 52000±6.34 Da 
Peak intensity: 60548 Da 
Mean±SD: 60542±10.8 Da 
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Supplemental Figure 7.1. MALDI-TOF spectra of the bioproduced ELRs, with major peaks signaled 
and experimental molecular weight distribution. Secondary peaks are assigned to doubly charged 
species. 
Peak intensity: 71440 Da 
Mean±SD: 71431±12.9 Da 
Peak intensity: 35119 Da 
Mean±SD: 35085±13.1 Da 
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7.5.4 ζ-potential and molecular weight effect on thickness: 
 
Supplemental Figure 7.2. Evolution of thickness with (A) ζ-potential and (B) molecular weight for the 
ELRs studied herein. The mean thickness of 3K-VRDG(-)V and 3K-VRGDV (Mn=31371 Da) is represented 
in the latter. 
 
7.5.5 QCM-D acquisition graphics and Voigt-based model fitting result 
Herein are presented the acquisition graphics from the QCM-D experiments for every permutation 
studied. Images are treated as a single figure, namely Supplemental Figure 7.3. 
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3K-VRDG(-)V 
 
 
 
Voigt-based model fitting of the thickness: 
CHI40: 28 nm; χ2 = 300250 
CHI55: 49 nm; χ2 = 30557 
ALG40: 29 nm (mean of three independent experiments: 28±7 nm); χ2 = 72751 
ALG55: 19 nm; χ2 = 161730 
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3K-VRGDV 
 
 
 
Voigt-based model fitting of the thickness: 
CHI40: 23 nm (mean of three independent experiments: 25±3 nm); χ2 = 462440 
CHI55: 41 nm; χ2 = 6017 
ALG40: 24 nm; χ2 = 1784 
ALG55: 18 nm; χ2 = 47101 
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HAP3 
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Voigt-based model fitting of the thickness: 
CHI40: 12 nm; χ2 = 49833 
CHI55: 49 nm (mean of three independent experiments: 42±7 nm); χ2 = 12888 
ALG40: 60 nm (mean of three independent experiments: 54±11 nm); χ2 = 47805 
ALG55: 27 nm; χ2 = 47951 
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GEG15 
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Voigt-based model fitting of the thickness: 
CHI40: 14 nm; χ2 = 50777 
CHI55: 46 nm; χ2 = 128210 
ALG40: 17 nm; χ2 = 95184 
ALG55: 5 nm; χ2 = 185290 
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H3A20 
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Voigt-based model fitting of the thickness: 
CHI40: 18 nm; χ2 = 519260 
CHI55: 49 nm; χ2 = 35556 
ALG40: 27 nm; χ2 = 86154 
ALG55: 11 nm; χ2 = 478450 
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IK24 
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Voigt-based model fitting of the thickness: 
CHI40: 16 nm; χ2 = 138110 
CHI55: 22 nm; χ2 = 142890 
ALG40: 54 nm; χ2 = 46537 
ALG55: 27 nm; χ2 = 82036 
Chapter 7. Layer-by-layer film-growth using polysaccharides and recombinant polypeptides: a 
combinatorial approach 
 
263 
 
H-RGD6 (equivalent to Figure 7.2) 
 
 
   
Voigt-based model fitting of the thickness: 
CHI40: 18 nm (mean of three independent experiments: 22±5 nm); χ2 = 39636 
CHI55: 55 nm (mean of three independent experiments: 51±3 nm); χ2 = 16630 
ALG40: 65 nm; χ2 = 121670 
ALG55: 11 nm; χ2 = 257690 
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H3A20H3 
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Voigt-based model fitting of the thickness: 
CHI40: 17 nm; χ2 = 66528 
CHI55: 42 nm; χ2 = 76254 
ALG40: 36 nm; χ2 = 18522 
ALG55: 4 nm; χ2 = 233630 
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Neutralized V84 
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Voigt-based model fitting of the thickness: 
CHI40: 25 nm; χ2 = 155950 
CHI55: 47 nm; χ2 = 21258 
ALG40: 19 nm; χ2 = 148370 
ALG55: 11 nm; χ2 = 78622 
 
Supplemental Figure 7.3. QCM-D acquisition graphics depicting the 5th overtone variations of 
frequency and dissipation of polysaccharide/ELR hybrid films at pH 4.0 and 5.5. Voigt-based 
viscoelastic model results for thicknesses are shown along the respective χ2. Experiments that were 
performed in triplicate are highlighted in bold. Thickness and χ2 error are shown for the representative 
experiment only. 
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Chapter 7 – Appendix. Nanostructured thin coatings from chitosan 
and an elastin-like recombinamer with acute stimuli-responsive 
behavior7 
Abstract 
In the present work, chitosan (CHI) and elastin-like recombinamers (ELRs) were used to conceive 
nanostructured thin films driven by sequential electrostatic layer-by-layer (LbL), a simple and versatile 
technique that discards the use of harmful reagents. Two similar ELRs were engineered to contain 
negatively charged amino acids and organized and a single monoblock or a triblock. The buildup of the 
films was monitored in real time using a quartz-crystal microbalance with dissipation monitoring (QCM-
D). Wettability transitions were observed from a moderate hydrophobic surface to an extremely wettable 
upon increasing the temperature to 50ºC, accompanied by topography changes at the nanoscale as 
assessed by atomic force microscopy (AFM). Furthermore, the dependence on time for the surface 
molecular rearrangement was studied for the films with each ELR. The potential of this technology may 
stimulate the development of devices and biomaterials for biomedical applications in the near future, 
such as surfaces with tunable and patterned cell adhesion, while the use of ELRs will allow developing 
polypeptides with biological significance. 
                                                 
7
 This appendix is based on the following publication: 
Costa R. R., Ribeiro A. J., Rodríguez-Cabello J. C., and Mano J. F., Nanostructured thin coatings from chitosan and an 
elastin-like recombinamer with acute stimuli-responsive behavior, Materials Science Forum 2013, 730-732: 32-37, 
DOI:10.4028/www.scientific.net/MSF.730-732.32. 
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7A.1 Introduction 
The modification of surfaces has been a key aspect in biology and biotechnology, including cell 
expansion, development of biomaterials and preparation of substrates for regenerative medicine [1-3]. 
The surface is the first contact with the organism and dictates the subsequent biological events, namely 
the cellular events and biointegration. This is an approach with potential impact not only on the 
properties of current healthcare systems but also in more cutting-edge ones in tissue engineering. 
Although several techniques may be used to modify a surface, the last decade has emphasized non-
harmful and versatile techniques to modify polymeric substrates: the sequential adsorption of proteins 
and polysaccharides is one of the most promising today. This approach is known as layer-by-layer and 
is driven by a multitude of intermolecular interactions – such as electrostatic contacts, hydrophobic 
interactions, and hydrogen bonding – that may occur between two distinct materials [4-6]. 
Much work has been done in multilayered systems using poly(styrene sulfonate)/poly(allylamine 
hydrochloride) and CHI/hyaluronan [7]. However, the knowledge obtained from such systems is not 
always easily extrapolated to other materials and that limits the use of potentially more relevant 
combinations for LbL in biomedical applications. In this work, we aimed to apply the concept of LbL to 
CHI used along with ELRs to conceive multilayered substrates driven by electrostatic interactions. While 
chitosan is a well-known biocompatible polycation of natural origin [8,9], ELRs are genetically 
engineered polypeptides mimicking the sequence of natural elastin, showing smart behavior towards 
external stimuli, among them temperature and pH [10]. We hypothesized that different ELRs, although 
similar in nature and sequence, would display distinct adsorption kinetics. Therefore, we biosynthesized 
a negatively charged ELR organized as a single block, and an ELR organized into three blocks – two 
containing the negative residues and one nonpolar – henceforth designated monoblock and triblock, 
respectively. Furthermore, we studied the stimuli-responsive properties of the assembled coatings in 
terms of wettability and topography variations. 
7A.2 Experimental section 
7A.2.1 ELRs expression and purification 
Gene expression of recombinant Escherichia coli strains were induced in a 12 L Applikon fermenter 
under 37ºC and controlled pH (7.00). Subsequent to fermentation, the culture was harvested and lysed 
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by ultrasonic disruption. Insoluble remains were removed by centrifugation and the cleared lysate was 
subjected to purification based on temperature cycles. The polymer in solution was then freeze-dried. 
7A.2.2 Buildup kinetics monitoring 
An E4 QCM-D, from Q-Sense (Sweeden) was used to monitor the adsorption of CHI and the ELRs. 
Aqueous solutions of each polymer were prepared at concentrations of 100 µg.mL-1, pH 4.5 and in 
0.15 M NaCl. The combinations of CHI/monoblock and CHI/triblock and their depositions were studied 
in parallel at the surface of gold-coated sensors, at 25ºC. The adsorption time was 10 minutes. 
7A.2.3 Contact angle measurements 
Contact angles were measured in a DataPhysics OCA15 system using a phosphate-buffered saline 
(PBS) solution for sessile drop experiments. Coatings of CHI/monoblock and CHI/triblock assembled 
onto glass (1 cm2) were tested for their wettability at 4 and 50ºC. The number of layers was defined 
based on the results from the QCM-D. The coatings were immersed in PBS placed under each 
temperature condition. After periods of 10 minutes of immersion in each temperature condition, the 
samples were withdrawn and contact angles were measured. If wettability did not change significantly, 
the samples were placed in immersion for an additional period of 10 minutes at the same temperature. 
7A.2.4 Topography studies 
AFM tests were conducted in a MultiMode STM microscope controlled by a NanoScope III from Digital 
Instruments system, operating in tapping mode at a frequency of 1Hz. A similar protocol to that of 
contact angle measurements was adopted. To assess the influence of pH in the coatings, a similar 
protocol to the contact angle measurements was followed. The samples were immersed in PBS at room 
temperature and 50ºC and then retrieved and introduced in the device. “pH” was also analyzed, for 
values of 7.4 and 12. The analyzed area was 1 μm2. 
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7A.3 Results and discussion 
7A.3.1 ELRs peptide sequence 
Under the scope of electrostatic LbL, we developed two ELRs containing negative amino acids – namely 
aspartic acids (D) and glutamic acids (E) – in order to bond with the protonated amine groups of CHI, 
positively charged under acidic conditions. Other amino acids are present, however, like lysines (K), 
although in lower number. Their final sequence is justified by the fact that these recombinamers include 
motifs with potential for biomineralization, which may prove to be useful for future bone regeneration 
applications. The representative structures of the monoblock and triblock are shown in Appendix Figure 
7.1, along with the corresponding amino acidic sequence. 
 
 
Appendix Figure 7.1. Representative structure of the featured ELRs and corresponding block peptide 
sequence. 
 
The genetic nature of ELRs ultimately allows constructing macromolecules that are more appropriate for 
coatings of medical devices, allowing even to include sequences of biological relevance. However, their 
use for such purpose falls short of expectation and few works exist that use ELRs as ingredients for thin 
films [11-13]. Comparing both recombinamers, the triblock is different from the monoblock as it 
contains a polypeptide based on the pentapeptide VPAVG in the middle of the structure. This variation 
was introduced to evaluate if the buildup kinetics changes from the use of one ELR to another along 
with CHI for LbL, although their peptide sequence is similar, and to predict if other types of 
modifications would have the potential to be more favorable for multilayered buildup. 
7A.3.2 Buildup monitoring of the films 
The ability of CHI and each ELR to adsorb in a sequential fashion was first monitored by QCM-D. This 
technique is able to detect the adsorption of molecules in the order of ng.cm-2 manifested by the 
decrease of the oscillation frequency of the sensor. It can also measure the viscoelastic properties of 
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the resulting surface [14]. Appendix Figure 7.2 shows the frequency and dissipation variations (5th 
overtone, 25 MHz) for CHI/monoblock and CHI/triblock combinations. 
 
 
Appendix Figure 7.2. QCM-D monitoring of the frequency (■) and dissipation (∆) variations for a) 
CHI/monoblock and b) CHI/triblock. The dashed lines mark the end of the adsorption of one bilayer. 
 
The first case, depicted in Appendix Figure 7.2a, shows a progressive decrease of frequency, ΔF, to an 
approximate value of 200 Hz, upon flushing the sensors with the sequence of CHI and the monoblock, 
up to 5 bilayers. Simultaneously, the overall dissipation, ΔD, increases, showing that the film exhibits 
viscoelastic behavior, typical of macromolecular systems [14,15]. It is worth mentioning that the 
dissipation decreases during the adsorption steps of the monoblock, corresponding to an increase of 
rigidity of the film. This characteristic may be usefull for the conception of coatings where a more rigid 
film is advantageous, like for bone regeneration devices. 
Appendix Figure 7.2b, the monitoring of the CHI/triblock buildup is shown. As observed, only 1 bilayer 
of these polyelectrolytes was successfully adsorbed, up to a ΔF of aroud 80 Hz. The ΔF after the 
attempt to deposit a second bilayer displays approximately the same value, therefore the following CHI 
and triblock molecules did not adsorb to the interface. This behavior can be explaned by the 
organization of the ELR: since the negatively charged blocks bond with the polycationic CHI, the 
nonpolar one does not intervene in the electrostatic-driven buildup. Therefore it faces outwards the 
interface of the film, rendering it uncharged, limiting the buildup to a single bilayer. When the 
adsorption of CHI is attempted, it does not adsorb because of the absence of negative aminoacids from 
the ELR. The results from the QCM-D show that, although the selected ELRs are similar in nature and 
peptide sequence, the buildup kinetics along with CHI is different, as previously theorized. 
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7A.3.3 Wettability variations of the films 
ELRs have an intrinsic smart response towards temperature in aqueous solutions. Therefore we 
expected to observe some variation of the wettability of each film with the temperature. The study of the 
buildup kinetics of CHI along with a monoblocked or triblocked ELR was shown in the previous section. 
Based on the QCM-D data, we tested coatings made of 5 bilayers of CHI and the monoblock – 
(CHI/monoblock)5 – and 1 bilayer of CHI and the triblock – (CHI/triblock)1. Contact angle 
measurements are easy and quick to perform and may give useful insight about the molecular 
arrangement of a polymer at a planar surface. It is particularly convenient when the wettability between 
two arrays of conditions is significantly different. Appendix Figure 7.3 shows the contact angle variations 
caused by cyclic changes of the temperature – from 4ºC to 50ºC and vice-versa – and their evolution 
with time. 
 
 
Appendix Figure 7.3. Contact angle variations of (CHI/monoblock)5 (■) and (CHI/triblock)1 (Δ) upon 
temperature changes and evolution with time. 
 
At start, the samples were at equilibrium at 4ºC and displayed a moderately hydrophobic feature, 
around 65º. Upon increasing the temperature to 50ºC, a transition was detected to a completely 
wettable surface in both cases. We have previously demonstrated that this observation is the result of 
the ELR transition at the surface due to the triggering of its self-assemble [12]. As a result of such 
phenomenon, there is a molecular rearrangement that favors the exposure of charged residues to the 
aqueous surroundings, while burying the hydrophobic amino acids underneath. 
The transition time was different for each sample, though. While in the case of (CHI/monoblock)5 the 
superhydrophilic regimen was observed after 60 min, for the (CHI/triblock)1 it took 100 min. This 
longer time can be explained by the exposure of the nonpolar alanines at the interface: the molecular 
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rearrangement is more delayed, since at first the free charged amino acids are present below the 
nonpolar block of the ELR, hindering the rearrangement. The transition is only later fully achieved. This 
does not happen with the monoblock, since its structure does not contain the highly hydrophobic 
portion (see Appendix Figure 7.1). Upon decreasing the temperature to 4ºC, both films recovered the 
moderately hydrophobic feature within 20 min. This result reflects the stimuli-responsive behavior of the 
films due to the properties of ELRs in aqueous solutions. Such behavior is retained and is cyclic when in 
the form of bidimensional substrates. 
7A.3.4 Topography analysis 
We determined that the monoblocked ELR is appropriate for constructing multilayered films. Having in 
mind that we intend to use ELRs using a multilayer approach along with polysaccharides, we studied 
the topography of CHI/monoblock films with different number of layers. The wettability variations found 
in the previous section should be accompanied by topography changes. Appendix Figure 7.4 shows the 
images obtained by AFM for 1, 3 and 5 bilayers. The variations of the topography with temperature 
were also studied, for 25 and for 50ºC. Appendix Table 7.1 shows the root-mean-square roughness 
(RMS) values for each case. As observed, independently of the temperature, the roughness increases 
with increasing number of layers due to the increase of mass at the surface, a typical observation of 
several LbL systems [5]. 
 
 
Appendix Figure 7.4. AFM imaging for (CHI/monoblock)5 films for 1, 3 and 5 bilayers, at 25 and 
50ºC. Similar results were obtained for pH 7.4 and pH 14. Scale bar: 200 nm. 
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Appendix Table 7.1. Root-mean-square roughness for (CHI/monoblock)5 films for 1, 3 and 5 bilayers, 
at 25 and 50ºC, or pH 7.4 and pH 14, respectively. 
 Roughness, RMS (nm) 
Temperature (ºC) or pH 1 bilayer 3 bilayers 5 bilayers 
25 or 7.4 0.874 0.905 1.482 
50 or 14 2.652 2.833 3.679 
 
In Appendix Figure 7.4a to Appendix Figure 7.4c the topographies at room temperature show no 
apparent organization for any of the number of layers. Upon increasing the temperature to 50ºC, the 
formation of nanostructures was detected, caused by the triggering of the ELR self-assembly and 
consequent formation of larger and organized structures. The roughness values also increased in 
accordance. These results relate well with the contact angle measurements: the detected 
nanostructures result from the molecular rearrangement of the ELR, where their cores are mainly 
composed of nonpolar amino acids, while exposing the charged residues to the outer regions. Therefore, 
these are micelle-like structures which organization favors the affinity of the films to water. It is also 
worth mentioning that similar topography and roughness results were obtained for the variation of pH, 
which is also known to trigger the transition of ELRs containing lysines (pka ranging 9.4–10.6 [16]). 
Such organization at the nanoscale may be used in the future development of patterned substrates for 
tunable cell adhesion. 
7A.4 Conclusions 
The presented work shows that polysaccharides and ELRS can be successfully combined following a 
multilayer approach to conceive nanostructured films. Both ELRs are similar in nature and peptide 
sequence; however the buildup kinetics is different, being limited to only 1 bilayer in the case of the 
triblock. Acute wettability variations were observed as a function of temperature for coatings of 
(CHI/monoblock)5 and (CHI/triblock)1, caused by a molecular rearrangement of the ELRs at the surface. 
Topography changes were detected at the nanoscale, where micelle-like structures were formed due to 
the increase of temperature or pH. The properties of the films may be exploited in the future for 
substrates with patterned and tunable cell adhesion. Furthermore, the recombinant nature of such 
elastin-like macromolecules may enable tuning their sequence to favor LbL constructs and even adding 
biological relevant motifs. 
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 Chapter 8. Layer-by-layer assembly of chitosan and recombinant 
biopolymers into biomimetic coatings with multiple stimuli-
responsive properties8 
Abstract 
In this work, biomimetic smart thin coatings using chitosan and a recombinant elastin-like 
recombinamer containing the cell attachment sequence arginine-glycine-aspartic acid (RGD) are 
fabricated through layer-by-layer. The synthetic polymer is characterized for its molecular mass and 
composition using mass spectroscopy and peptide sequencing. The adsorption of each polymeric layer 
is followed in situ at room temperature and pH 5.5 using a quartz-crystal microbalance with dissipation 
monitoring, showing that both polymers can be successfully combined to conceive nanostructured 
multilayered coatings. The smart properties of the coatings are tested for their wettability by contact 
angle (CA) measurements as a function of external stimuli, namely temperature, pH and ionic strength. 
Wettability transitions are observed from a moderate hydrophobic surface (CAs approximately from 62º 
to 71º) to an extremely wettable one (CA considered as 0º) as the temperature, pH and ionic strength 
are raised above 50 ºC, 11, and 1.25 M, respectively. Atomic force microscopy is performed at pH 7.4 
and pH 11 to assess the coating topography. In the latter, the results reveal the formation of large and 
compact structures upon the aggregation of ELRs at the surface, which increase water affinity. Cell 
adhesion tests are conducted using a SaOs-2 cell line. Enhanced cell adhesion is observed in the 
coatings, as compared to a coating with a chitosan-ending film and a scrambled RDG biopolymer. The 
results suggest that such films could be used in the future as smart biomimetic coatings of biomaterials 
for different biomedical applications, including in tissue engineering or in controlled delivery systems. 
                                                 
8
 This chapter is based on the following publication: 
Costa R. R., Custódio C. A., Arias F. J., Rodríguez-Cabello J. C., and Mano J. F., Layer-by-layer assembly of chitosan and 
recombinant biopolymers into biomimetic coatings with multiple stimuli-responsive properties, Small 2011, 7: 2640-2649, 
DOI:10.1002/smll.201100875. 
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8.1 Introduction 
The modification of surfaces has been a key aspect in biology and biotechnology, including cell 
expansion, biomaterials development and preparation of substrates for regenerative medicine) [1-3]. In 
the field of implantable devices, the surface is the first contact with the organism and dictates the 
subsequent biological events, namely the cellular behavior and biointegration. Thus, surface 
engineering is of the utmost significance to lead to the conception of devices with an improved 
biological performance [4-6]. 
Surface modification has been also implemented to produce stimuli-responsive surfaces for a variety of 
applications, including in biomineralization control [7], cell sheet engineering [8,9], surfaces with 
extreme wettabililty transitions [10], and microfluidics [11], mostly based on variations of the hydration 
state of polymeric films deposited at the surfaces. Usually, the modification is performed by grafting 
stimuli-responsive polymers onto a substrate, which are typically synthetic and nonbiodegradable, such 
as poly(N -isopropylacrylamide) (PNIPAAm) [12]. A good example of the latter is the work developed by 
Okano et al. [9] regarding cell-sheet engineering.  
In more recent years, emphasis has been given to non-harmful and versatile techniques to modify 
polymeric substrates: the sequential adsorption of proteins and polysaccharides, known as layer-by-
layer (LbL) adsorption, is one of the most promising today. The principle behind LbL adsorption lies in 
the existence of multiple intermolecular interactions, such as electrostatic contacts, hydrophobic 
interactions, and hydrogen bonding, where the cooperative effects of multipoint attractions play the 
most important role. It is a simple and versatile technique which allows producing robust coatings, even 
in substrates with complex geometries; because it discards the need of organic and harmful solvents, it 
is an attractive technique for tissue engineering applications [13-15]. Multilayer systems have already 
been proposed for different biomedical applications, including for biomimetic composite-like coatings, to 
control the release of drugs, or to manipulate the adhesion, differentiation, proliferation and even 
function of attached cells [16-19]. 
In this work, we plan to conceive coatings using natural and nature-inspired macromolecules in a 
multilayered fashion using the LbL approach at mild processing conditions. Natural materials are 
intricate and multifunctional structures that often inspire scientists to design novel classes of 
materials [20]. It is the case of elastin-like recombinamers (ELRs), also designated as elastin-like 
polymers (ELPs). This family of peptide-based polymers was developed by Urry, relying in genetic 
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engineering techniques, and have their basic structure rooted in elastin, the extracellular elastic protein 
of higher animals [21-23]. In aqueous environment they are known to have self-assembly behavior and 
exhibit a transition temperature (Tt): below Tt, the free polymer chains adopt random coil 
conformations; above it, they fold into an organized structure known as β-spiral. Although ELRs respond 
primarily to temperature, the effects of other stimuli, such as pH, ionic strength and concentration, also 
affect the transition phenomenon [24]. Their recombinant nature is one of their attractive properties 
because it allows tuning their physicochemical properties and introducing sequences to extend their 
functionality, including biologically relevant domains [25,26]. The work of Girotti et al. [27], who were 
able to biosynthesize an extracellular matrix analogue enclosing the cell attachment sequence arginine-
(glutamic acid)-(aspartic acid)-valine (REDV), is an example of such versatility. Thus, ELRs are an 
attractive option over the most commonly used formulations in LbL adsorption. 
Swierczewska et al. [28] have previously reported the use of ELRs for LbL thin films. However, the 
peptides were modified and conjugated with either poly(ethyleneimine) (PEI) or poly(acrylic acid) (PAA) 
to provide positive or negative charge, respectively. Our groups have also shown that ELRs can be 
successfully combined with polysaccharides to conceive coatings and some may even be applied using 
a multilayer approach [29,30]. In order to explore the potential of ELR properties and the advantages of 
LbL, we intend to conceive nanostructured thin coatings made from the sequential adsorption of a 
polysaccharide and an ELR modified with the arginine-glycine-(aspartic acid) (RGD) cell adhesion motif, 
labeled ELR-RGD. RGD is expected to increase the cell adhesion in vitro and prove useful in the design 
of devices with tunable cell attachment or even improved host integration. We selected chitosan (CHI) 
because, besides being a well-known biocompatible material, it is one of the few polysaccharides 
exhibiting positive charge (at acidic conditions), is abundant, and its production is environmentally 
safe [31,32]. 
The proposed system will also allow expanding the concept of multilayered films to a new attractive 
class of peptide-based polymers, making them more robust than simple monolayers, and could bring 
new possibilities in the development of nanostructured coatings of materials in tissue engineering. The 
buildup of the multilayers will be monitored in real time using a quartz-crystal microbalance with 
dissipation monitoring (QCM-D). Distinct techniques, such as contact angle measurements, atomic 
force microscopy (AFM), and cell adhesion tests will be used to characterize it. We hypothesize that 
coatings containing this ELR may exhibit changes both in topography and wettability, depending on 
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several stimuli, namely temperature, pH and ionic strength, and improved biological in vitro 
performance. 
8.2 Experimental section 
8.2.1 ELR-RGD expression and purification 
The featured ELR monomers of RGD were designated as ELR-RGD. Expression conditions and 
purification protocols were adapted from Meyer and Chilkoti [33] and Girotti et al. [34]. Gene expression 
of a recombinant Escherichia coli strain BLR(DE3) containing the expressing gene of ELR-RGD was 
induced in a 12 L Applikon fermenter, in terrific broth medium (TB) with 0.1% of carbenicilin and 0.1% 
of glucose, under controlled conditions of temperature (37ºC) and pH (7.00). The fermentation was 
stopped after registering an optical density variation at 600 nm inferior to 0.25, in a time-frame of 1 h. 
Subsequent to fermentation, the culture was harvested by centrifugation, resuspended and lysed by 
ultrasonic disruption. Insoluble debris was removed by centrifugation and the cleared lysate was 
subjected to several cycles of cold and warm centrifugations, of 4 and 40ºC, respectively. All the 
purification steps were carried out in a sodium chloride (NaCl) solution at 0.5 M. The polymer in 
solution was then frozen at -24ºC and freeze-dried. 
8.2.2 ELR-RGD characterization 
Differential Scanning Calorimetry (DSC) experiments were performed on a Mettler Toledo 822e (United 
States) with a liquid nitrogen cooler accessory. Both temperature and enthalpy were calibrated with an 
indium standard at the same experimental conditions used for the studied materials. Water solutions of 
ELR-RGD at 50 mg∙mL-1 were prepared at pH 7.4. In a typical DSC run, 20 μL of the solution were 
placed inside a standard 40 μL aluminum pan hermetically sealed. The same volume of water was 
placed in the reference pan. All samples were equilibrated for 5 minutes at 5°C inside the sample 
chamber just before the beginning of each experiment. A heating rate of 5ºC∙min-1 was used. To assess 
the biopolymer molecular weight, matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) 
mass spectroscopy was performed in a Voyager STR, from Applied Biosystems, in linear mode and with 
an external calibration using bovine serum albumin (BSA). Amino acid composition determination was 
previously used to assess the composition of ELRs [27]. 
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8.2.3 Buildup and characterization of the self-assembled coatings 
Medium molecular weight grade CHI was purchased from Sigma and purified. Solutions of purified CHI 
and ELR-RGD were prepared at 0.1 mg∙mL-1 in 0.15 M NaCl. The pH of the solutions was adjusted to 
5.5. ζ-potential of each solution was determined using a Nano-ZS from Malvern (United Kingdom), at 
25ºC. A Q-Sense E4 quartz-crystal microbalance (Q-Sense AB, Sweden) with dissipation monitoring 
system was used for monitoring in situ the deposition of CHI/ELR-RGD multilayers at the surface of 
gold-coated crystals. This technique has previously been extensively described [35-37]. Very briefly, an 
AT cut quartz crystal can be excited at its fundamental frequency (5 MHz) and at several overtones: 25, 
35, and 45 MHz (fifth, seventh, and ninth overtones, respectively). When a thin film is deposited onto 
the sensor crystal the frequency decreases. If the film is thin and rigid the decrease in frequency (ΔF) is 
proportional to the mass of the film. However, when using polymers, the adsorbed film is not rigid and 
this relation is not valid: the film begins dissipating energy and exhibiting the typical viscoelastic 
behavior, which is evident by the change in the dissipation (ΔD). The crystals were first cleaned in an 
ultrasound bath at 30ºC, and immersed successively in acetone, ethanol, and isopropanol. Adsorption 
took place at 25ºC and pH 5.5 and at a constant flow rate of 50 mL∙min-1. Starting with the CHI 
solution, each one was pumped into the system for 10 minutes. Each deposition cycle was followed by 
a rinsing step with 0.15 M NaCl, at pH 5.5, for 10 min, and ΔFν and ΔD were monitored in real time. 
The frequency of each overtone was normalized to the fundamental resonant frequency of the quartz 
crystal, by diving it by ν (where ν=5; 7; 9). The thickness of the films was estimated using the Voigt 
model through the Q-Tools software, from Q-Sense [38]. The area density was calculated by multiplying 
the thickness by the layer density (1200 kg.m-3 led to obtaining calculations with the best fitting). 
8.2.4 Contact-angle measurements 
Phosphate-buffered saline (PBS) contact angles were measured in a DataPhysics OCA15 system. The 
coatings were prepared at the surface of regular glass microscopy slides, from Marienfeld (Germany). 
The glass was cleaned using the same protocol to which QCM-D crystals were submitted. Coatings up 
to 10 layers – 5 pairs of CHI and ELR-RGD – were characterized for their wettability for each layer 
assembled, at 37ºC and pH 7.4. An approach described by Park et al. [39] was used to measure 
contact angles dependent on several temperature, pH and ionic strength conditions. The 
measurements were performed for a pH range from 4 to 12, ionic strength from 0 to 1.5 M of NaCl, 
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and three relevant temperatures: 25, 37 and 50ºC. The samples were immersed in a beaker of PBS 
placed under each condition. After 1 hour, the samples were withdrawn and contact angles were 
measured. The time of 1 h was determined to be enough to have a stable surface. Upon determining 
the wettability transition parameters, three cycles were performed by changing the transition values 
above and below each transition value. 
8.2.5 Atomic force microscopy measurements 
AFM measurements were performed in a MultiMode STM microscope controlled by the NanoScope III 
from Digital Instruments system, operating in tapping mode at a frequency of 1 Hz. Glass slides were 
cut into pieces of 1×1 cm2 and used as substrates for multilayer adsorption. Surfaces coated with 5 
pairs of CHI/ELR-RGD were immersed in PBS for 30 min. To assess the influence of pH in the coatings, 
a similar protocol to the contact angle measurements was followed. The samples were immersed in 
PBS at two pH values: 7.4 and 11. To avoid the formation of crystals during the acquisition, the 
samples were immersed shortly in ultrapure water for removing excess of saline solution. The samples 
were then retrieved and introduced in the device. The analyzed area was 1×1 µm2. 
8.2.6 Cell culture studies of SaOs-2 osteoblast-like cells 
Cell studies were performed onto coatings of 5 pairs of layers, ending in ELR-RGD, CHI or ELR-RDG(-) 
(negative control), assembled at the surface of glass coverslips with 1 cm of diameter. Tissue culture 
polystyrene (TCPS) was used as a positive control. Cell adhesion was studied using the SaOs-2 
osteoblast-like osteosarcoma cell line. Cells were seeded on the surfaces (5×104 cell∙mL-1) and 
incubated in serum free Dulbecco’s Modified Eagle’s medium (DMEM), loaded with 1% 
antibiotics/antimicotics at 37ºC, 5% carbon dioxide (CO2). The substrates were analyzed at different 
time points: 4 h, 24 h and 3 days. At each time point, cells on the coated surfaces were washed with 
PBS twice, fixed in formalin (3.7%) and nuclei of the cells stained with 4',6 diamidino-2-phenylindol 
(DAPI), and the actin was stained with phalloidin. 
For alkaline phosphatase (ALP) assays, samples collected on each time point were washed with PBS 
and immersed in 1 mL of ultra-pure water to lyse the cells. To each well of a 96-well plate were added 
20 µL of sample plus 60 µL of substrate solution (0.2% (w/v) p-nytrophenyl (pNP) phosphate/1 M 
diethanolamine hydrochloric acid (HCl), at pH 9.8). The plate was then incubated in the dark for 45 min 
Chapter 8. Layer-by-layer assembly of chitosan and recombinant biopolymers into biomimetic coatings 
with multiple stimuli-responsive properties 
 
290 
at 37ºC. After the incubation period, 80 µl of a stop solution (2 M sodium hydroxide (NaOH)/0.2 mM 
ethylenediaminetetraacetic acid (EDTA)), was added to each well. The absorbance was then measured 
at 405 nm using p-nitrophenol as standard. For each experiment, a standard curve was constructed 
from reference suspensions at known cell concentrations. To access cell viability, (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS) assay was 
performed. MTS is bioreduced by cells. The values for absorbance of this reduced product at 490 nm 
are directly proportional to the number of living cells in the substrates. 
8.3 Results and discussion 
8.3.1 ELR-RGD characterization 
For the past two decades, much work has been done on the widely investigated poly(styrene 
sulfonate)/poly(allylamine hydrochloride) (PSS/PAH) system – considered so far as a model of 
multilayered thin films – and CHI/hyaluronan [16]. However, the buildup mechanism is not always 
straightforward to every material and distinct or several forces may influence the construction [40,41]. 
Furthermore, coatings for tissue engineering applications should ideally contain other materials with 
more relevant features, including biological activity. It is the case of the biopolymer used in this work, 
which contains the RGD cell adhesion motif, depicted in Figure 8.1a. 
The ELR-RGD, with 371 aminoacids and theoretical molecular weight of 31371 Da, contains 2 
monomers of RGD, 2 aspartic acids, and 3 lysines isolated at the amino-terminal and exhibits a Tt of 
around 23ºC in solution at physiological pH (data not shown). In contrast to our previous work [30], this 
ELR-RGD was engineered to facilitate electrostatic interactions during the multilayer buildup. In Figure 
8.1b, MALDI-TOF spectrum shows a high intensity peak at 31229 Da, which is approximate to the 
theoretical value for this biopolymer. 
In order to confirm if the produced ELR matched the theoretical amino acidic composition, peptide 
sequencing tests were performed. In Table 8.1, it can be confirmed that the produced biopolymer 
composition matches well the predicted amino acid composition. These results point to the 
bioproduction of a stock of ELR-RGD retaining the desired amino acid sequence. 
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Figure 8.1. Characterization of the ELR-RGD. a) schematic representation of the featured ELR 
chemical structure; b) MALDI-TOF of the biopolymer, with major peak signaled at 31229 Da. 
 
Table 8.1. Amino acid composition of the bioproduced ELR-RGD. ND = not determined. 
Amino acid Predicted Experimental 
Asp (D) 2 2.27 
Thr (T) 2 1.81 
Ser (S) 6 4.7 
Pro (P) 71 70.7 
Gly (G) 141 141.48 
Ala (A) 4 4.31 
Val (V) 99 98.65 
Ile (I) 40 39.6 
Lys (K) 3 3 
Arg (R) 2 2.18 
Met (M) 1 ND 
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8.3.1 Analysis of CHI/ELR-RGD film buildup 
The ability of CHI and ELR-RGD to adsorb in a sequential fashion was first monitored by QCM-D. This 
technique is able to detect mass changes in the order of ng.cm-2 and measure the viscoelastic 
properties of the resulting surface [35-37]. Due to the recombinant nature of ELRs, it is possible to tune 
their structure to appropriately fit a multilayer approach and design coatings for tissue engineering 
substrates. Figure 8.2a shows the normalized frequency (ΔFν/ν, where ν is the overtone) and 
dissipation (ΔD) variations for the 5th overtone (25 MHz) after the construction of 20 layers onto gold-
coated sensors. The ΔFν/ν decreased with time upon flushing the substrate with the sequence of 
polyelectrolytes, to an approximate value of 40 Hz. On the other hand, the ΔD increased, revealing that 
the film is not rigid and exhibits the typical viscoelastic behavior, a common situation when using 
macromolecular systems [36,42]. 
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Figure 8.2. Buildup assessment of CHI/ELR-RGD films. a) QCM-D monitoring of normalized frequency 
(ΔFν/ν, ■) and dissipation (ΔD, □) obtained at the 5
th overtone. Numbers refer to adsorption of CHI (1), 
adsorption of ELR-RGD (3) and rinsing (2 and 4). b) Cumulative thickness evolution and thickness 
increase for the CHI/ELR-RGD film, for 20 layers, estimated using the Voigt model. Odd numbers 
correspond to films ending in CHI and even numbers to films ending in ELR-RGD. Linear fitting matches 
well the cumulative thickness variation (r2=0.99824). 
 
At the working pH of 5.5, we relied on the protonation state of the ELR-RGD aspartic acids: under such 
conditions, these residues are deprotonated and negatively charged (pKa ranging from 3.0–4.7) [43]. 
This would allow them to interact by electrostatic self-assembly (ESA) with the positively charged amine 
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groups of CHI. Prior to the monitoring, the ζ-potential of CHI and ELR-RGD solutions was measured at 
working conditions (pH=5.5 and ionic strength at 0.15 M), showing a charge of +17.0±0.6 
and -8.4±0.33 mV, respectively. ELRs are essentially hydrophobic by nature but can be modified to 
include specific charged residues. CHI is also insoluble in water and can only be dissolved at acidic 
conditions, below its pKa (approximately 6) [44]. It has been reported that electrostatic deposition 
demands appropriate matching of the charge density of the used polyelectrolyte pair, rather than a 
minimum charge density [13,45], but in this case the ζ-potential showed no charge balance (i.e. equal 
absolute values). Although ESA was a driving force of construction, other forces, like hydrophobic 
interactions, are likely to participate on the assembling phenomenon. In fact, Figure 8.2a shows the 
successful combination of the used pair, at the assembly pH of 5.5, near the pKa of CHI. We can 
assume that a fraction of already deprotonated amine groups interacts with the hydrophobic residues of 
the ELR-RGD structure and allow the construction of the coating. 
The QCM-D data was used to estimate the thickness variations of the film along with the adsorption 
cycles. Figure 8.2b shows the results calculated using the Voigt model implemented in the Q-Tools 
software from Q-Sense [38]. It can be observed that the thickness increased linearly during the buildup, 
in accordance with the evolution of ΔFν and ΔD variations. After the deposition of 20 layers, the film 
had a thickness of 81 nm, corresponding to an approximate total area density of 9.6 µg.cm-2 
(multiplication of thickness by the layer density. 1200 kg.m-3 allowed for the best fitting). Figure 8.2b 
also shows the thickness of each layer (“thickness increase” in the graphic). Overall, the increase of 
thickness is higher for the adsorption steps of ELR-RGD. This is the result of the lower charged exhibited 
by the recombinamer, which requires that more material is needed to overcompensate the charges of 
the underlying CHI ones. The results obtained through QCM-D measurements demonstrate that ELR-
RGD can be used successfully with CHI to conceive a viscoelastic polymeric coating using the LbL 
approach. 
8.3.2 Characterization of the self-assembled coatings 
When a material adheres to a substrate, it is expected that such phenomenon will result in 
physicochemical changes at the surface [46,47]. The measurement of contact angles is an easy 
method that allows a quick assessment of the modification of a surface in terms of wettability, and its 
usefulness is even higher when such wettability is significantly different for each layer. Figure 8.3 shows 
the contact angle variation of the CHI/ELR-RGD film with the buildup, up to 10 layers.  
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Figure 8.3. Evolution of the contact angle of the films obtained with sequential adsorption of CHI and 
ELR-RGD, up to 10 layers Odd numbers correspond to films ending in CHI and even numbers to films 
ending in ELR-RGD. Error bars represent two standard deviations (n=9). 
 
The films were adsorbed onto glass (contact angle of 28.6±2.9º). Each measurement was performed 
after 1 hour of immersion in PBS at 37 ºC. While films ending in ELR-RGD retained their moderate 
hydrophobic behavior (approximately between 62º and 71º), the ones ending in CHI increased gradually, 
from 20.4±4.4º in the first layer to 40.1±3.9º in the fifth (layer 9). The increasing values of contact 
angles obtained for CHI-ending films can be explained by the influence of the underlying adsorbed 
layers on the coating interface. When using weak polyelectrolytes, the most charged polymer tends to 
be adsorbed as a thin layer with flat chain conformations, while the less charged polymer tends to be 
adsorbed as a thicker layer, forming loopier-type structures [48,49]. Since ELR-RGD is a modified 
version of the basic repeating block of elastin with charged amino acids, CHI appears as the most 
charged polymer, as already presented by the ζ-potential measurements. Furthermore, the thickness 
increase of each layer displayed in Figure Figure 8.2b helps to demonstrate that the ELR-RGD layers are 
overall thicker than the ones of CHI. Thus, the surface properties of the CHI layer may reflect the effect 
of the underlying ELR one, even in terms of wettability, while the opposite does not occur. 
The featured films were conceived using a recombinant ELR, a biomaterial exhibiting stimuli-responsive 
properties in solution. It would be interesting to observe how the wettability of the films behaves when 
they are exposed to several stimuli. To achieve this goal, we have measured the contact angles of 5 
pairs of layers ending in ELR-RGD, labeled (CHI/ELR-RGD)5, assembled in glass substrates, at different 
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values of temperature, pH, and ionic strength (using NaCl as the ionic component). After the assembly, 
the coatings were placed at different conditions of each studied stimulus (taking 25 ºC, pH 7.4, and 
ionic strength of 0.15 M as starting values), in order to determine if their variation triggers a transition 
that could be detected by differences in wettability. Figure 8.4 shows the contact angle values 
measured upon cyclic variations of temperature (25ºC to 50ºC), pH (7.4 to 11) and ionic strength 
(0.15 M to 1.25 M). 
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Figure 8.4. Contact angle measurements as a function of temperature (□), pH (○), and ionic strength 
(Δ) in a (CHI/ELR-RGD)5 film. Three cycles are represented. Error bars represent two standard 
deviations (n=9). 
 
Taking the case of the temperature, at 25ºC an initial wettability exhibiting values of 67.1±4.7º was 
measured, corresponding to a moderate hydrophobic surface. However, upon increasing the 
temperature to 50ºC, the contact angle values decreased to those of a superhydrophilic surface, 
corresponding to a totally wettable surface. ELRs show a phase transition in solution above Tt, similar to 
the transition of other temperature-sensitive polymers with lower critical solution temperature (LCST). 
However, the hydrophobicity of such a surface did not increase with the switch to high temperatures. In 
fact, while the hydrophobicity of surfaces modified with LCST polymers increases [9], the behavior of 
ELRs when adsorbed onto a surface is opposite to the expected, more in accordance to the case of 
polymers with an upper critical solution temperature (UCST), which become more hydrophilic [50]. 
Such atypical wettability behavior of ELR-RGD temperature-responsive coatings has been previously 
observed in a thin ELR monolayer adsorbed onto CHI substrates [30]. We have shown that upon the 
transition, the collapsed biopolymer aggregates into micelle-like structures, as suggested by topography 
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measurements. They assume a conformation where the hydrophobic chains are directed to the inside 
and the charged residues to the outside of such organizations. Additionally, while the properties of such 
surfaces change at 50ºC, the polymer in solution shows a transition at 23ºC, where the association is 
much more facilitated than at the surface, to which the polymer is tightly connected. 
Similar results to that of temperature response were obtained for pH and ionic strength, and even 
exhibiting similar contact angle values. In the case of pH, ELR-RGD has lysines in its structure, which 
amine groups are protonated below the pKa values ranging 9.4–10.6 [43]. Above the pKa, the amine 
groups are deprotonated and the hydrophobicity of ELR-RGD increases. It is known that the more 
hydrophobic the ELR the lower the Tt in solution is [34]. Thus, with the increase of pH, the mean 
hydrophobicity of ELR-RGD also increases, up to a pH of 11. At this value, the transition to a 
superhydrophilic regimen was detected, as depicted in Figure 8.4. In the case of ionic strength, 
Reguera et al. [51] suggested that an increase in the salt concentration increases the polarity of the 
solvent. This creates a higher difference in polarity with respect to the hydrophobic moieties of the 
polymer, causing more and more ordered structures surrounding the polymer chains. As observed, a 
transition was detected upon the increase of ionic strength to 1.25 M, which is in accordance to the 
behavior of this family of polymers. These results show that the wettability of (CHI/ELR-RGD)5 films are 
strongly dependent not only on temperature but also on pH and ionic strength, which influence the Tt of 
ELRs in aqueous solutions as well. Furthermore, the films were submitted to three cycles of variations 
and still retained full reversibility and similar contact angle values, showing that the films are robust and 
capable of withstanding sharp changes of the environment, while retaining functionality. 
The results presented so far reflect the nature of the studied ELR, and characterize the conceived film 
as a stimuli-sensitive coating that could prove to be useful in the development of controlled release 
systems and in surfaces capable to control cell behavior. In order to have full understanding of this 
behavior, the wettability was further studied for several arrays of conditions, consisting in the 
combination of pH and ionic strength, at three relevant temperatures: 25ºC (room temperature), 37ºC 
(temperature of the body), and 50ºC (determined to be the temperature of transition of ELR-RGD at the 
surface). The diagram of Figure 8.5 is the graphical representation of the measurements performed in 
(CHI/ELR-RGD)5, in an attempt to characterize the coating wettability. 
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Figure 8.5. Map of the wettability of (CHI/ELR-RGD)5 films as a function of condition arrays of 
temperature, pH, and ionic strength stimuli. Open symbols stand for a moderate hydrophobic surface 
(contact angle of about 67º) and closed ones for a superhydrophilic surface. The blue squares 
represent measurements performed at 25ºC and 37ºC and the red circles measurements at 50ºC. 
 
To our knowledge, this is the first time that ELR-adsorbed surfaces are extensively characterized for 
their responsive character towards external stimuli. There are two areas represented, or phases: (i) one 
represented by open squares and full circles and (ii) the other represented by full squares and full 
circles. Blue squares and red circles stand for 25ºC/37ºC and 50ºC, and open/full symbols stand for a 
moderate hydrophobic (characteristic CA of 66.8±3.5º) or a completely wettable surface, respectively. 
The measurements performed have revealed the conditions of wettability transition for temperature, pH, 
and ionic strength: 50ºC, 11, and 1.25 M, respectively. The transition was also revealed to be rapid and 
independent of the contribution of the other stimuli: an “all-or-nothing” response towards external 
stimuli. In other words, the wettability of these systems shifts from a moderate hydrophobic regimen to 
superhydrophilic only when a stimulus equals or exceeds the above mentioned values, and there is no 
evidence of cross-dependencies between the three variables. Therefore, observing Figure 8.5, one can 
easily identify the parameters of transition at room temperature and 50ºC. In the former, the wettability 
shifts at pH 11 or ionic strength 1.25 M, as previously stated; in the latter, 50ºC is already the 
temperature at which the wettability shifts, therefore any combination of the other two stimuli can be 
disregarded. 
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The measurements performed at 37ºC are of particular interest for biomedical applications, since 
ultimately these coatings are intended to be used in a biological environment. In the graphic, the 
wettability of the surfaces at 37ºC is similar to the case at room temperature, showing transitions 
dependent on pH and ionic strength at 11 and 1.25 M, respectively. However, our measurements 
showed that in the range of pH 10–11 and of ionic strength 1–1.25 M, intermediate values could be 
observed (CAs of 30.5 ±20.6º). Such behavior is an interesting one: upon heating an ELR in solution 
above the Tt, aggregation occurs and the solution becomes cloudy; given a few hours, or further 
increasing the temperature, the aggregates gradually settle and the result is a clean phase separation of 
solvent and polymer [52]. At the studied surfaces, the equivalent to this “cloudy point” could only be 
observed for this small range of values and the wettability shift is only fully achieved – and quickly, not 
gradually as in solution – for pH 11 and ionic strength 1.25 M, as is the case at room temperature. 
Thus, the diagram summarizes the response of the films ending in ELR-RGD as a function of three 
distinct variables, showing an independent and immediate effect of three of the parameters influencing 
the conformation of ELRs. 
The molecular organization of a surface may give valuable information about the physical properties of 
a substrate. Figure 8.6 shows the surface roughness for the 5th pair of layers assembled in glass, 
ending in either CHI (layer 9) or ELR-RGD (layer 10), and AFM images of (CHI/ELR-RGD)5 films at 
physiological and transition pH values. An approach similar to that of contact angle measurement was 
followed: the samples were placed at room temperature in PBS buffered at two distinct pHs – 7.4 and 
11 – and withdrawn for immediate topography image acquisition. We expected that with increasing pH 
the surface roughness would increase as well, due to the triggering mechanism of CHI and ELR-RGD 
transitions above each pKa. The AFM images in Figure 8.6 show the topography changes of (CHI/ELR-
RGD)5 and reveal the formation of large and compact structures upon the aggregation of ELRs at the 
surface – “micelle-like” structures which  increases the water affinity at the interface by the exposure of 
hydrophilic groups. In fact, such organization is predicted even by the earliest theories of the natural 
elastin conformation [53]. 
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Figure 8.6. RMS-roughness of 5 pairs of CHI/ELR-RGD layers, ending in CHI (grey) and ELR-RGD 
(white). Error bars represent two standard deviations (n=3). The insets are AFM images at pH 7.4 and 
11, for the 5th pair of layers, ending in ELR-RGD, in a 1×1 μm2 area. Data are means±standard 
deviation (SD) (n=3; p<0.05, * are samples at the same pH, # are samples at different pH). 
 
The analysis of the roughness showed that it increased with pH, from 3.6±0.3 nm to 4.9±0.3 nm ((root-
mean-square roughness, RMS), showing that the topography of the films responded to pH changes, 
regardless of the last adsorbed layer. As a side note, the corresponding contact angle of the (CHI/ELR-
RGD)4CHI films displayed a value of 64.3±3.6º upon increasing the pH, higher than the value obtained 
for layer 9 due to the deprotonation of CHI. Such result reinforces the fact that the properties of a 
modified surface reflect mainly those of the material present at the interface, as is often expected upon 
after such approach. The effect of pH on roughness was greater when the last layer was composed of 
ELR-RGD, as evidenced by the higher values displayed at each condition. Such structural changes were 
more visible when the ELR-RGD is deposited as the last layer, since the macromolecular segments 
exhibit more degrees of freedom for conformational rearrangements. “pH” and ionic strength may 
influence the electrostatic interactions between each layer but similar results were obtained for 
temperature changes. We suggest that such similar results evidence that the aggregation of the ELR is 
the factor that contributes the most to the increase of roughness. Similar results were also obtained in 
previous studies [30]. 
The rough character of the surface also contributes to the atypical extreme hydrophilic nature of the 
substrate, based on a simple lotus effect. In fact, the Wenzel model predicts that the change from a 
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hydrophobic surface towards a more hydrophilic one is amplified in substrates exhibiting nano/micro 
scale roughness [54]. 
8.3.3 Cell culture studies of SaOS-2 osteoblast-like cells 
Smart surfaces have been used in different fields in situations where it is relevant to control the 
adhesion of cells or microorganisms, protein adsorption or transport properties for the release of 
bioactive agents. In many cases, it is desirable that the substrate interacts favorably with cells. It has 
been reported that the RGD sequence is the minimal sequence required for recognition by cell 
membrane integrins, such as α5β1 and αVβ3 integrins [55-57]. The affinity of cells for materials should 
be improved with the incorporation of a peptide having this sequence. 
So far, we have been able to expand the concept of LbL to a class of materials that is not commonly 
used in literature. We also presented results showing that the films display distinct properties for 
different conditions of temperature, pH and ionic strength. This feature could be exploited to modulate 
protein and cell adhesion by playing with one of the mentioned stimuli. Unfortunately, the presented 
transition values are simply not suitable for most biological applications. We expect to take advantage 
on the recombinant nature of ELRs in the near future to produce films that could be triggered at lower 
values. Nonetheless, the biological performance of the current films was analyzed in order to determine 
if this kind of multilayer film is suitable for future tissue engineering devices with good response from 
cells, without any hazardous reaction. 
In vitro studies were performed using SaOs-2 osteoblast-like cells. Although other possibilities could be 
explored, one of the uses we envisaged for these coatings is in orthopedic applications in order to 
improve host integration. To prove that the superior cell attachment was due to a specific interaction 
with RGD, the cell behavior was compared to surfaces with a negative control of ELR containing a 
scrambled RDG sequence, labeled RDG(-), in the form of 5 bilayers with CHI, (CHI/ELR-RDG(-))5. The 
scrambled RDG sequence has been previously shown to have significantly less cellular adhesion [58] 
and is similar to ELR-RGD in all aspects, except for the position of the G and D aminoacids. 
The SaOs-2 cell viability on ELR-RGD and CHI ending films – (CHI/ELR-RGD)5 and (CHI/ELR-RGD)4/CHI 
respectively – was assessed at different time points. Independently of the wettability changes of the 
coatings, cell culture was performed at 37ºC, at which the surface is moderately hydrophobic (see 
Figure 8.5), under serum-free conditions. Cell viability and activity was assessed through MTS and ALP 
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assays. A qualitative evaluation of the cell number attached to the surfaces was performed using optic 
microscopy and with DAPI and phalloidin staining of cells. 
Figure 8.7a shows the MTS assay in the different surfaces after 4 h, 24 h and 3 days (note: contact 
angles showed that the films still retain their properties during the studied time-frame). 
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Figure 8.7. In vitro tests on films ending in CHI, ELR-RGD and ELR-RDG(-). a) Cell viability of SaOs-2 
cells for 4 h, 24 h and 3 days. Data are means±SD (n=3; *p<0.05). b) ALP assays on the studied films. 
Data are means±SD (n=3; *p<0.05). 
 
The results show that, for every time point, all tested samples are non-cytotoxic towards the SaOs-2 cell 
line, and therefore the materials used to construct the multilayers did not cause toxicity problems 
neither to the attached cells nor to the cells suspended in culture. Among the various biological 
functions of osteoblasts, secretion of ALP is an important indicator determining the activity of the cells. 
The statistical analysis of the data (Figure 8.7b) shows significant differences in SaOs-2 activity adhered 
to (CHI/ELR-RGD)5 in comparison to (CHI/ELR-RGD)4/CHI coatings, at 4 h, and (CHI/ELR-RDG
(-))5 and 
(CHI/ELR-RGD)4/CHI at 24 h. After 3 days the differences in cell activity become more evident in the 
surface with ELR-RGD in comparison to films ending in ELR-RDG(-) or CHI. 
Differences in the number of cells attached to the different surfaces were also observed, as seen in 
Figure 8.8. 
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Figure 8.8. DAPI (blue) and phalloidin (red) staining of the studied cells cultured for distinct times on 
the studied multilayer substrates, ending in CHI, ELR-RGD and ELR-RDG(-). Tests performed at 4 h, 24 
h, and 3 days. Scale bar: 100 µm. 
 
Comparing the microscopy images, after 4 h of incubation, ELR-RGD surfaces show a significant 
attached number of cells, compared with non-modified surfaces or the negative analog RDG. Based on 
the cell densities of the samples at 24 hours and 3 days, it is possible to verify that (CHI/ELR-RGD)5 
coatings demonstrated a very significant cell proliferation in comparison to the coatings ending in CHI 
and in (RDG)(-). Besides the higher number of cells on the surfaces with RGD, cells seeded on those 
substrates spread significantly more than the ones on chitosan or the negative control. Thicker and well 
organized filamentous actin bundles were observed in cells growing on RGD surfaces. From our results, 
adsorption of ELR-RGD has shown to enhance cell adhesion and activity when compared to the CHI-
ending films substrates and the scrambled RDG sequence, showing good in vitro performance of the 
presented films. 
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8.4 Conclusions 
Our results show that ELRs containing biologically relevant peptide sequences can be successfully 
combined with CHI in a sequential multilayer approach based on electrostatic and hydrophobic 
interactions. QCM-D results allowed us to study the construction of the polymeric films and its 
properties, showing the buildup of a film with a linear growth. Although glass was used to assemble 
such coatings, it is expected in the future that such straightforward surface modification technique will 
allow us to coat other substrates with more complex geometries, including scaffolds or particles. The 
stimuli-responsive properties of the films were extensively studied, showing acute and independent 
cyclic response towards temperature, pH and ionic strength; the values of transition for each stimulus 
were identified: 50ºC, 11, and 1.25 M, respectively. Below each critical transition point, the surfaces 
were more hydrophobic. Above those, the surface acquired a very hydrophilic character due to the 
biopolymer chain collapse and subsequent exposure of charged residues to the outer region of the 
coating. The transition was also evident in the changes in the topography of the surfaces as we 
increased the pH of the film above the transition values, increasing their roughness due to the 
aggregation of ELR chains on the top layer. 
SaOs-2 osteoblast-like cells were used to test the biological performance of the multilayered system 
studied in vitro of the films. The cells showed increased adhesion and activity with ELR-RGD ending 
coatings, in comparison to the ones ending with both CHI and the non-bioactive ELR-RDG(-). This work 
demonstrates the potential to use natural and nature-inspired macromolecules to modify surfaces 
taking advantage of a simple layer-by-layer technique, which can be further extrapolated to more 
complex devices. The potential of this technology can further stimulate the development of other similar 
biomedical products in the near future, such as devices entirely processed through layer-by-layer for the 
delivery of pharmaceuticals, cell culture or structures for tissue engineering. 
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 Chapter 9. Nanostructured and thermoresponsive recombinant 
biopolymer-based microcapsules for the delivery of active 
molecules9 
Abstract 
Multilayer capsules conceived at the nano- and micro-scales are receiving increasing interest due to 
their potential role as carriers of biomolecules for drug delivery and tissue engineering. Herein we report 
the construction of microcapsules by the sequential adsorption of chitosan and a biomimetic elastin-like 
recombinamer into nanostructured layers on inorganic microparticle templates. The release profile of 
bovine serum albumin, which was studied at 25 and 37°C, shows higher retention and Fickian diffusion 
at physiological temperature. The self-assembled multilayers act as a barrier and allowed for sustained 
release over 14 days. The capsules studied are non-cytotoxic towards L929 cells, thereby suggesting 
multiple applications in the fields of biotechnology and bioengineering, where high control of the delivery 
of therapeutics and growth/differentiation factors is required. 
                                                 
9
 This chapter is based on the following publication: 
Costa R. R., Custódio C. A., Arias F. J., Rodríguez-Cabello J. C., and Mano J. F., Nanostructured and thermoresponsive 
recombinant biopolymer-based microcapsules for the delivery of active molecules, Nanomedicine: Nanotechnology, Biology 
and Medicine 2013, 9 : 895-902, DOI:10.1016/j.nano.2013.01.013. 
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9.1 Introduction 
Recent advances in biomedicine have been driven by the need to develop systems that can effectively 
encapsulate, protect and deliver an active agent with specific kinetics [1-5]. Such need comes at a time 
when various classes of biomolecules of interest for the treatment of several diseases and the 
development of new biomedical devices are becoming widely available. With this increasing availability, 
the use of smart materials to control the delivery and release of specific agents has followed a similar 
trend. 
Ideally, a biomolecule carrier should act as a compartment in which the permeability of a drug to the 
exterior can be tuned as this would allow the release rate to be controlled when concerning both 
therapeutics in traditional drug-delivery applications as well as tissue engineering agents that influence 
the proliferation and differentiation of cells. The layer-by-layer (LbL) self-assembly of macromolecules – 
a simple, versatile and inexpensive surface-engineering technique that can be used, under mild 
conditions, to encapsulate sensitive active agents and biomaterials by either manipulating the 
architecture of a device or by way of external stimuli – is an approach with the potential to address this 
issue. These “capsules” could then deliver the encapsulated agents to the target cells by making use of 
simple release mechanisms into the biological environment [6-9] or by digestion of the cells 
themselves [10-13]. Although often applied to flat surfaces, LbL can be used to coat surfaces with 
complex geometries and shapes and can be extrapolated to three dimensions [14-19]. Hollow 
multilayer capsules are a good example of 3D structures that can act as drug carriers. Inorganic 
particles are typically used as templates for this purpose as they can be chelated under non-aggressive 
conditions [20-22]. The use of LbL techniques will therefore ultimately allow control of both the release 
profile of a specific agent and the permeability of the system by varying the materials and number of 
layers in the capsule architecture. 
The concept of post-construction permeability is of great interest for drug-delivery and tissue-engineering 
applications as a carrier must be able to retain and preserve the drug but also release it when 
necessary and in a controlled fashion. An ability to switch the permeability of a multilayer capsule 
between an “open” and a “closed” state has been demonstrated previously [23-25], but has yet to be 
fully validated. Temperature, for example, has been suggested to be a possible mechanism for post-
loading therapeutic agents using temperatures as high as 50 to 70°C [26-30]. However, such 
temperatures are not suitable for biological applications. Herein we intend to demonstrate the 
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entrapping properties of self-assembled coatings with varying numbers of nanolayers combined with the 
response of a biocompatible system towards an external temperature-based stimulus. 
In light of the likely benefits of natural and nature-inspired biomaterials combined with stimuli-
responsiveness [31,32], we aimed to construct a new generation of therapeutic containers using a 
multilayer approach. Chitosan (CHI) and a biomimetic elastin-like recombinamer (ELR) – a recombinant 
version of elastin-like polymers (ELPs) – were used as constituents for the microcapsule shell. CHI is a 
well-known natural material with cationic behavior [33]. whereas ELRs are genetically engineered 
polypeptides that mimic natural elastin and exhibit a primary smart response towards temperature. 
These recombinant macromolecules are soluble below a specific critical transition temperature (Tt) in 
an aqueous medium, but undergo a phase separation characterized by the dominant presence of 
hydrogen bonds and hydrophobic interactions above it [34-38]. They also allow fine control over the 
peptide structure, thus making it possible to introduce motifs with biological relevance, such as cell-
adhesion and mineralization promoters, into their primary valine-proline-glycine-valine-glycine (VPGVG) 
sequence [14,39,40]. 
The primary structure of the ELR used herein was designed to present a bioactive behavior by the 
inclusion of L-arginine-glycine-L-aspartic acid (RGD) residues, while exploiting the negative aspartic acid 
moieties to enable subsequent self-assembly with chitosan into nanostructured multilayers (schematic 
structure can be found in Supplemental Figure 9.1). The present work focuses on our ability to 
construct CHI/ELR microcapsules and to use the temperature-responsive nature of ELRs to control the 
permeability of engineered multilayer systems. The resulting microcapsules were characterized for their 
encapsulation efficiency of a model protein, namely bovine serum albumin (BSA). The permeability of 
the BSA-loaded microcapsules with a varying number of layers was studied at 25 and 37°C, and the 
biocompatibility of these structures was evaluated in vitro. 
9.2 Experimental section 
9.2.1 Materials for the microcapsule composition 
Medium molecular weight chitosan was purchased from Sigma (reference 448877) and purified by a 
series of filtration and precipitation in water and ethanol steps, followed by freeze-drying. ELR 
bioproduction was induced using a fermentation process from an Escherichia coli strain BLR(DE3) 
containing the appropriate expression gene. Subsequent to fermentation, the culture was harvested and 
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lysed by ultrasonic disruption. Insoluble debris was removed by centrifugation and the cleared lysate 
was subjected to several cycles of cold and warm centrifugations. The polymer in solution was stored at 
-24°C and then freeze-dried. The detailed methodology has been described previously [35]. 
9.2.2 ELR aggregate-size measurements 
ELR aggregate size was measured using a Nano-ZS from Malvern (United Kingdom) in the temperature 
range 25–37°C after stabilization for 5 minutes. Samples were prepared at 300 µg∙mL-1 in phosphate 
buffer solution (PBS, Sigma reference P4417), pH 7.4. A total of 20 runs were performed for each 
sample to obtain a final average value at constant temperature. 
9.2.3 Entrapment of BSA in calcium carbonate particles 
BSA entrapment was achieved following the method described by She et al. [8]. Thus, to encapsulate 1 
mg of BSA, aqueous solutions of anhydrous sodium carbonate (Na2CO3 granular, ≥99.5%, Sigma 
reference 222321) and calcium chloride (CaCl2 anhydrous powder Reag. Ph Eur, VWR reference 
1.02378.0500) were prepared at 1 M. Co-precipitation of both solutions was performed by adding 100 
µL of Na2CO3 followed by 100 µL of CaCl2 to 200 µL of BSA tagged with fluorescein isothiocyanate 
(FITC) (66 kDa, Sigma reference A9771) at 5 mg∙mL-1 and stirring rapidly for 30 seconds. Stirring was 
then stopped and the suspension of newly synthesized calcium carbonate (CaCO3) microparticles left to 
react and precipitate for 15 min. The supernatant was then removed and the particles washed twice 
with ultrapure water to remove residual salts and non-entrapped protein. Each supernatant was retained 
for fluorescence measurements and determination of entrapment losses. 
9.2.4 Construction of the multilayer shells and microcapsule formation 
The CaCO3 sacrificial templates entrapping FITC-BSA were immersed alternately in chitosan and ELR 
solutions [300 µg∙mL-1, pH 5.5, 0.15 M of sodium chloride (NaCl, Reag. Ph Eur, Panreac reference 
131659] for 10 min each, then washed with 0.15 M NaCl (pH 5.5). Centrifugation was avoided to avoid 
damage and aggregation of the particles each time the samples were to be retrieved from solution; 
simple precipitation of the suspension was used instead (3 to 5 min). This process was repeated to 
increase the number of bilayers until the desired coating had been obtained (1, 3 and 5 bilayers). After 
construction, the CaCO3 core was removed by chelation with ethylenediamine tetraacetic acid (EDTA 
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powder, ACS reagent, 99.4–100.6%, Sigma reference E9884; 0.2 M, pH 5.5). Each supernatant and 
solution was retained for fluorescence measurements and determination of losses during the 
construction and chelation stages. 
9.2.5 Determination of pre-loading encapsulation efficiency 
Fluorescence measurements were performed using a Synergie HT microplate ELISA reader (BioTek, 
USA). Thus, 150 μL of sample was pipetted into a white, opaque 96-well plate in triplicate. Distilled 
water was used as blank. The excitation (λexc) and emission (λem) wavelengths used for the calibration 
curve and FITC-BSA mass calculations were 485 and 528 nm, respectively. All supernatants collected 
during entrapment, construction and chelation were measured and quantified. The percentage of 
fluorescein isothiocyanate (FITC)-BSA mass lost was plotted both for each stage and cumulatively. The 
encapsulation efficiency was calculated by subtracting the cumulative losses of each architecture from 
the initial FITC-BSA mass. 
9.2.6 In vitro biological performance 
A murine fibroblast cell line (L929, European Collection of Cell Cultures) was used for the biological 
assays. Thus, L929 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen 
reference 42400-028) with phenol red supplemented with 10% of fetal bovine serum (FBS, Invitrogen, 
reference 10270-106) and 1% antibiotic/antimicotic (Gibco reference 15240062) in a humidified 
atmosphere with 5% carbon dioxide (CO2) at 37°C. For the cell viability test, 2×10
3 cells were seeded 
on 48-well plates and incubated at 37°C, 5% CO2. After 24 hours, microcapsules were added to the 
culture medium in a ratio of 40 microcapsules per cell. After each culturing period, samples were 
washed twice with phosphate-buffered saline (PBS). A 250 μL aliquot of fetal bovine serum (FBS)-free 
culture medium and 50 μL of (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) (MTS) reagent were added to each well. A cell-free well was used as control. Plates 
were incubated for 3 h at 37ºC, 5% CO2, protected from light. After incubation, 100 μL of this solution 
was transferred to a 96-well plate and the plate read using a Synergie HT microplate ELISA reader 
(BioTek, USA) in 490 nm absorbance mode. 
Visualization of the actin cytoskeleton was performed using (tetramethylrhodamine B isothiocyanate)-
phalloidin (TRITC-phalloidin, Sigma reference P1951). After each culture period, samples were washed 
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twice with PBS and fixed with 4% formalin in PBS for 15 min at room temperature. After fixation, cells 
were incubated with TRITC-phalloidin (10 μg∙mL-1) for 45 min and washed three times with PBS. To 
stain the nucleus, the cells were incubated with 4',6-diamidino-2-phenylindole (DAPI, Sigma reference 
D9564) (1 μg∙mL-1) for 5 min then washed with PBS. Cells were observed under an Axioimager Z1M 
Zeiss fluorescence microscope (Zeiss, Germany). 
9.2.7 Quantification of FITC-BSA release 
The microcapsules were resuspended in PBS at either 25 or 37°C. The upper limit of five bilayers for 
the microcapsule architecture was chosen to study the effect of temperature along with small changes 
in the number of different layers. This study was conducted over 14 days, removing the surrounding 
PBS from each container every 24 h. An additional sample was taken after 12 h from the start of the 
study. PBS was fully refreshed at each time point, and 100% BSA was considered to be the total mass 
remaining in the microcapsules after their construction. The release experiments were performed under 
mild agitation to improve the diffusion of BSA through the incubating medium. All experiments were 
performed in triplicate (n=3), with each sample containing the number of capsules resulting from the 
attempted encapsulation of 1 mg of BSA. To determine the type of release profile for each condition, 
the release kinetics were determined using the Korsmeyer kinetic model (equation 9.1): 
nKt/M
t
M 

 (9.1) 
where Mt /M∞ is the fraction of protein released at time t, K is the rate constant for the Korsmeyer 
model, and n is the exponent that characterizes the release mechanism [41]. The Korsmeyer model is 
used when the release mechanism from a swellable polymeric device is not well-known or when more 
than one type of release phenomenon could be involved. The fitting was performed for all architectures 
and for each temperature. 
9.2.8 Microscopy characterization of the CaCO3 microparticles and multilayered 
microcapsules 
A Leica Cambridge S360 scanning electron microscope (United Kingdom) was used to evaluate the 
morphology of the sacrificial templates. Specimens were pre-coated with a conductive layer of sputtered 
gold and micrographs recorded at 10 kV. An Olympus FV1000 confocal laser scanning microscope 
(CLSM, Germany) was used to evaluate the morphology of (CHI/ELR)5 microcapsules loaded with FITC-
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BSA. A final layer consisting of a cationic dye (rhodamine B, 10-6 M) was further adsorbed. All samples 
were stabilized at either 25 or 37°C and observed under hydrated conditions. 
9.3 Results 
In order to evaluate the thermal response of the featured ELR, the size variations of peptide aggregates 
in aqueous solution were measured as a function of temperature. The results, which are plotted in 
Figure 9.1, show an increase in aggregate size from around 10 to 3000 nm in aqueous PBS solution. 
This variation occurs at a Tt of 29°C and is accompanied by an increase in solution turbidity, thus 
showing that this ELR possesses a Tt in solution above the working room temperature and below the 
physiological one of 37°C. 
 
 
Figure 9.1. Aggregate size profile for a 300 µg∙mL-1 ELR solution in PBS over the temperature range 
25–37°C. Means±standard deviation (SD) are represented. Insets show a transparent solution below 
29°C and increased turbidity above it. 
 
CaCO3 particles were prepared by co-precipitation of Na2CO3 and CaCl2 solutions under vigorous 
stirring in a BSA medium and subsequently tagged with FITC. The resulting inorganic particles, with a 
diameter of around 5-6 µm (Figure 9.2A), were used as BSA-containing sacrificial templates for the 
alternating incubation with aqueous chitosan and ELR solutions. After construction, the core was 
chelated with EDTA to form hollow microcapsules, as confirmed by CLSM Figure 9.2B). 
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Figure 9.2. (A) SEM image of a CaCO3 microparticle containing entrapped BSA. (B) CLSM image of a 
microcapsule containing FITC-BSA after chelation. (C) A graphic showing the stage losses measured 
during construction of the microcapsules. Data represent mean±SD (n=3; *p<0.05). 
 
Structures with one, three and five bilayers, henceforth referred to as (CHI/ELR)1, (CHI/ELR)3 and 
(CHI/ELR)5, were constructed to study the effects of capsule architecture on the subsequent release of 
BSA at 25 and 37°C. In order to determine the total encapsulation efficiency, the fluorescence of each 
supernatant was measured at each stage and the losses calculated with respect to the initial FITC-BSA 
content in the precipitation medium (1 mg). Although a loss of 9% was registered during the entrapment 
stage (Figure 9.2C), losses during the construction stage were higher for capsules with fewer layers. 
The effect of the shell architecture became more evident during the chelation stage, with our 
observations showing a “burst-release” of 13% for (CHI/ELR)1 and 10% for (CHI/ELR)5. 
CLSM images of (Chi/ELR)5 microcapsules at 25 and 37 °C are shown in Figure 3. The capsules are 
significantly smaller at 37 °C (Figure 9.3B, 3.21±0.63 µm) than at 25 °C (Figure 9.3A, 5.51±0.56 
µm), most probably due to a layer rearrangement as a result of the effect of different solvent 
temperatures on the stimuli-responsive ELR molecules. 
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Figure 9.3. Left: CLSM images of pre-loaded (CHI/ELR)5 microcapsules at (A) 25 and (B) 37°C. The 
final layer was tagged with rhodamine B. Right: size distribution and fractional frequency (f ). The 
normal distribution approximation, which fits a 95% confidence interval, is depicted. 
 
The cytotoxicity of these microcapsules was determined to ascertain whether they could be used in 
biological systems. Thus, an in vitro biological evaluation was carried out using the L929 mouse 
fibroblast cell line. The cell viability was assessed by MTS after culture in a microcapsule-containing 
medium (either loaded with BSA or unloaded). The graphic in Figure 9.4A shows a quantitative 
comparison with the lone L929 control and confirms that the cells cultured in the presence of 
(CHI/ELR)5 retained their viability at every time-point (24 h, 3 days and 7 days). Furthermore, 
fluorescence microscopy of cells cultured in the absence (Figure 9.4B) and presence (Figure 9.4C) of 
BSA-loaded (CHI/ELR)5 microcapsules confirmed that the cell morphology remained unchanged when 
in contact with the microcapsules. This was the case for both BSA-loaded and -free microcapsules. 
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Figure 9.4. (A) Viability of L929 cells after 24 h and 3 and 7 days in the presence of empty and BSA-
loaded (CHI/ELR)5 microcapsules. The positive control was L929 cells in the same medium with no 
microcapsule addition. Data represent mean±SD (n=3; *p<0.05). DAPI (blue) and phalloidin (red) 
staining in fluorescence microscopy of L929 cells after contact with (B) microcapsule-free medium and 
(C) BSA-loaded (CHI/ELR)5 microcapsules for 24 hours. Scale bar: 50 µm. 
 
The ability to retain an active agent and protect it until delivery is one of the most important features of 
a drug-delivery system. Our results showed BSA retentions of greater than 70% of the initial 1 mg after 
construction of the microcapsules, with cumulative losses of 28%, 26% and 25% for (Chi/ELR)1, 
(CHI/ELR)3 and (CHI/ELR)5, respectively (see Figure 9.2C for stage losses, and Supplemental Figure 
9.3 and Supplemental Table 9.1 for detailed cumulative calculations). However, an ability to release this 
active agent in a controlled manner after encapsulation is equally important. As such, the influence of 
the total number of layers and temperature on the release profile of BSA from the capsules was 
investigated. BSA release at different temperatures was studied over a period of 14 days, and the 
cumulative release profiles for (CHI/ELR)1, (CHI/ELR)3 and (CHI/ELR)5 capsules loaded with BSA at 
room (25°C) and physiological temperatures (37°C) can be seen in Figure 9.5. 
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Figure 9.5. Cumulative release of BSA from (CHI/ELR)1, (CHI/ELR)3 and (CHI/ELR)5 microcapsules: 
■□, ○●, and ▲Δ, respectively, in PBS (pH 7.4), at (A) 25°C and (B) 37°C. 
 
During this sub-study, 100% of BSA was considered to be the total mass remaining in the 
microcapsules after their construction. The estimated number of microcapsules in each tested sample 
was approximately 8×108, as calculated by dividing the volume occupied by the precipitated 
microcapsules (around 70 μL) and the volume occupied by a single microcapsule (diameter of 
5.51 μm), disregarding the empty spaces between them. PBS was fully refreshed at each time point, in 
order to simulate a biological environment in which the delivered therapeutic agent is taken up by the 
targeted cells. Irrespective of the temperature and number of layers, an initial analysis of the profiles 
shows that BSA release is sustained over the period studied, with a visible absence of significant burst 
release at the initial time-points. The release kinetics were markedly influenced by the temperature (see 
rate constants, K, in Table 9.1), with smaller quantities of released FITC-BSA being detected from 
microcapsules incubated at 37°C. In the case of the more permeable (CHI/ELR)1 capsules, these 
structures showed a cumulative release of 79% at 25°C after 14 days in PBS, while a value of 52% was 
obtained at 37°C. The same trend was observed for (CHI/ELR)3 and (CHI/ELR)5. 
Release was also dependent on the number of layers in the capsule architecture. Thus, irrespective of 
the temperature, more layers resulted in greater BSA retention. This finding confirms the shell’s ability 
to act as a tunable barrier against the diffusion of an encapsulated agent. The Fickian or non-Fickian 
release behavior of BSA was given by the exponent of the Korsmeyer kinetics model, n, shown in Table 
9.1. 
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Table 9.1. Exponents of the Korsmeyer kinetics model (n ), correlation factors (r 2) and rate constant 
(K ) for each architecture studied. 
 25ºC 37ºC 
Number of 
bilayers 
K n r 2 K n r 2 
1 1.41 0.49 0.95 1.30 0.40 0.96 
3 1.39 0.48 0.95 1.22 0.42 0.97 
5 1.32 0.41 0.91 1.14 0.43 0.98 
 
Fitting with other models (zero-order, first-order and Higuchi) can be found in the Supplementary 
Information (Supplemental Figure 9.6 to Supplemental Figure 9.11). The data for capsules incubated at 
25°C fit an anomalous (non-Fickian) mode of diffusion (n > 0.43), thus suggesting a combination of 
pure protein diffusion and shell relaxation/swelling mechanisms under these conditions. The 
(CHI/ELR)5 capsules were an exception to this, with a Fickian mode of diffusion (n < 0.43). The 
capsules also follow a Fickian diffusion model at 37°C. In comparison to the capsules at 25°C, a pure 
diffusion mechanism occurs under physiological conditions. This effect results from the restructuration 
of the film which occurs upon deposition of each additional layer [42]. The result is a more densely 
packed multilayer structure with decreasing polymeric mobility and no anomalous relaxation/swelling 
mechanism, together with a more compact and stable shell. 
9.4 Discussion 
The development of drug-delivery systems that can encapsulate, protect and deliver a therapeutic 
molecule or growth factor in a controlled fashion is of major importance for both current healthcare 
applications and in the fields of tissue engineering and regenerative medicine. Herein we have exploited 
temperature and the smart response of ELRs as an actual drug-release mechanism for a pre-
encapsulated model protein. Furthermore, our aim was to develop a system that is able to respond at a 
temperature which will be useful for future applications in human biological studies. 
We have conceived and developed biocompatible thermoresponsive microcapsules by taking advantage 
of the self-assembly properties of chitosan and an ELR using a multilayer approach. The fact that the 
majority of LbL studies performed to date have involved conventional polyelectrolytes has hindered the 
extrapolation of this technology to systems exhibiting other capabilities and complexities, including those 
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that could respond to external stimuli. We have previously demonstrated that, unlike most conventional 
multilayer combinations, combining these two materials is more favorable when both electrostatic and 
hydrophobic interactions are exploited, thus allowing for the construction of films as thin as 40 nm 
(considering a total of five bilayers) [43]. This is feasible if construction is performed under conditions 
close to the pKa of the polysaccharide, where both protonated and deprotonated groups can be used. 
Our results, especially those observed in CLSM (Figure 9.2B and Figure 9.3), demonstrate that it is 
possible to extrapolate this technology from 2D to 3D and to construct micrometric devices using a non-
conventional combination of polymers. 
In order to determine the pre-encapsulation efficiency (see Figure 9.2C), all three construction stages 
were screened for each architecture [(CHI/ELR)1, (CHI/ELR)3 and (CHI/ELR)5]. There was no 
difference between any of the cases studied during the entrapment stage. Note that at this stage the 
shell has not yet been assembled, thus meaning that the encapsulation efficiency is solely dependent 
on the protein/CaCO3 interaction, which at this point in the process is common for all groups. In the 
following construction stage, and in contrast to our expectations, the losses were higher for thinner 
capsules. As more adsorption steps and manipulation are involved as construction proceeds, we 
expected to find higher protein losses for (CHI/ELR)5 microcapsules since BSA should diffuse 
continuously from the sacrificial core, even if only in insignificant quantities. The explanation for our 
finding may reside in the fact that the protein lost to the polymer incubation solutions may be retaken 
up during the addition of subsequent layers to the shell. Indeed, using CLSM we were able to identify a 
high concentration of FITC-BSA near the capsule shell (see Figure 9.2B). As for the chelation stage, 
although there is a statistically significant difference between (CHI/ELR)1 and (CHI/ELR)3, the 
numerical difference is not meaningful (12.7% vs. 11.3%, respectively). Thicker capsules are also able 
to retain more protein than those with a lower number of bilayers since multilayer shells can act as 
barriers that hinder the diffusion of molecules from the inner cavity to the surrounding medium [8]. 
The microcapsules described herein have been shown to undergo temperature-dependent size 
variations, with two possible shrinkage mechanisms explaining the shrinkage observed upon increasing 
the temperature. Thus, as discussed previously, the ELR collapses to a more ordered, self-assembled 
state upon increasing temperature above Tt [35-37], although it is also likely that shrinkage is further 
amplified by a thermodynamic rearrangement of the layers. Such a rearrangement is driven by the 
tendency of shells with an even number of layers (1:1 ratio of electrostatic forces) to minimize the 
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shell/water interface [30]. This is the same mechanism used for post-loading procedures, which have 
been reported to take place at typical temperatures in the range 50–70°C [27-30]. 
Despite the fact that such structures have been reported to respond to temperature changes, this has 
only been applied as a means to post-encapsulate molecules within pre-formed microcapsules. 
However, other than the exploitation of post-encapsulation procedures, the temperatures required for 
this are not suitable for biological applications. To the best of our knowledge, this is the first time that 
such a significant size reduction has been observed at temperatures as low as 37°C. For example, 
using oppositely charged copolymers of poly(styrene sulfonate) (PSS) and poly(allylamine hydrochloride) 
(PAH) with poly(N -isoproprylacrylamide) (PNIPAAm), Glinel et al. [27] have reported a size reduction of 
only 15% at 60 °C, whereas the present work shows a reduction of 42% at 37°C. Furthermore, these 
microcapsules retain a temperature response over a relevant temperature range and the changes occur 
under physiological conditions, similar to what has been demonstrated for the ELR in solution (Figure 
9.1). These results allow us to anticipate future applications in the field of biomedicine in areas such as 
drug delivery, cell/tissue engineering and regenerative medicine. 
In order to be used in biomedicine, it was important to assess whether the microcapsules and their 
content were harmful to cells. The biological performance in vitro is presented in Figure 9.4. This study 
showed that the viability of L929 cells in contact with the capsules (loaded and unloaded) was 
comparable to those used as positive control. The morphology of lone L929 cells and cells in contact 
with loaded (CHI/ELR)5 microcapsules was also similar. These results show that these structures are 
non-cytotoxic towards L929 cells and can therefore be safely used in biomedical applications. Such 
applications could include the simple release of a biomolecule from a drug release device, with the 
microcapsules being compacted to form a tablet that can be administered orally. Since these 
microcapsules are highly retentive at physiological temperatures, they could release specific active 
agents in quantities within a therapeutic time window. Further possibilities include transcutaneous 
vaccines for the delivery of biomolecules into the skin, and the local application or injection of 
microcapsules loaded with growth factors at a defect site in a tissue or organ to facilitate its 
regeneration. This site could also be a tumor, with low molecular weight anti-cancer drugs being loaded 
into these reservoirs to kill tumor cells [44]. It should be noted that the temperature at tumor sites is 
usually slightly higher than 37°C and hyperthermic treatments are used to further increase the 
temperature locally. For the specific use of these microcapsules in cancer treatments, experiments at 
slightly higher temperatures (e.g., up to 42°C) using low molecular weight molecules (most 
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chemotherapeutic drugs have low molecular weights) should be performed in the future. Growth factors, 
which tend to have a higher molecular weight than chemotherapeutic agents, are also of interest for 
tissue-engineering applications, where they could be used in vitro to control cell metabolism and 
proliferation and to trigger stem cell differentiation. Vascular endothelial growth factor (VEGF, around 40 
kDa), for example, has shown great potential in angiogenesis, one of the most relevant mechanisms in 
tissue-engineering applications. Similarly, human platelet-derived growth factor (PDGF, around 20-30 
kDa) is one of the most active factors in cell migration and differentiation. However, the success of 
these growth factors in therapeutic applications often requires a spatiotemporal controlled-release 
system for delivery [45]. This could be achieved by diffusion of the encapsulated load into the medium 
and by internalization of individual capsules by the cells. The latter case would require the cells 
concerned to be larger than the individual microcapsules. We did not observe the uptake of capsules by 
L929 cells in this study, most probably because the size difference between L929 (around 5 to 10 µm) 
and microcapsules at 37°C (3.21±0.63 µm, Figure 9.3B) is too small for such a phenomenon to occur. 
In contrast, some stem cells, such as adipose stem cells, may reach 50 µm, thus meaning that 
applications which envisage their differentiation may be exploited in the future using this kind of 
micrometric device. 
Figure 9.5 shows the BSA-release properties of microcapsules with different numbers of layers at 
distinct temperatures, together with the Korsmeyer model fitting parameters calculated in Table 9.1. It 
should be noted that these systems were not designed to operate in an “on/off” basis, such as when 
exploiting a temperature-dependent post-loading approach, but rather to achieve distinct release profiles 
that could prove to be useful for the sustained release of molecules in the body or in vitro. 
The permeability of BSA to the exterior was easily tuned by varying the number of layers. Thus, similarly 
to the chelation stage during construction, the multilayer shell was able to act as a more effective 
barrier as the number of layers in it increased, thus allowing for a more sustained release and retentive 
microcapsule. The results obtained at 25 and 37°C were also interesting as the capsules proved to be 
more retentive at the latter. These results relate well with the size variations observed in Figure 9.3: the 
thermoresponsive effect of the CHI/ELR microcapsules results in a reduction in both their size and their 
permeability, thus making them more retentive. It is notable that, regardless of the test conditions, 
100% of the BSA contained in the microcapsules was not released, most likely due to an interaction 
between the protein and the nanostructured shell. It is possible that a combination with enzymatic 
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degradation, a mechanism which has been used previously [6,46,47], could lead to total release of the 
load. However, such a study was outside the scope of this work. 
9.5 Conclusion 
In summary, size and permeability variations have been achieved by exploiting the temperature 
response of the ELR, which is amplified by a thermodynamic rearrangement of the multilayer structure 
at the molecular level. The use of different numbers of layers has allowed the permeability of the shells 
to be tuned, thus resulting in distinct release profiles for each architecture tested. We envisage the 
exploitation of these properties at physiological temperature for applications where a long-term release 
with low initial drug burst is desired. Similarly, the degradation mechanisms of a cellular environment 
can be simulated to release an active agent completely over the appropriate time period. Due to 
micrometric size of these capsules, delivering small quantities of growth factors or differentiation agents 
directly to the cells by digestion is envisaged. The genetically encoded nature of ELRs offers the 
possibility to engineer molecules containing biologically relevant motifs that could be recognized by 
specific cells, such as the present case of RGD inclusion. All these possibilities, together with their non-
cytotoxic character, make these microcapsules a promising alternative for more highly effective drug 
delivery and tissue engineering. 
9.6 Supplemental information 
9.6.1 Schematic structure of the ELR 
 
2
MGKKKP (VPGVG)14 {(VPGIG)10 (AVTGRGDSPASS) (VPGIG)10}2 (VPGVG)14 V  
Supplemental Figure 9.1. Schematic of the ELR used. The bioactive sequence containing the 
negatively charged aspartic acids (RGD) is represented in green. 
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9.6.2 Morphology of the sacrificial CaCO3 templates: 
2 µm 6 µm
A B
 
Supplemental Figure 9.2. Morphology of the sacrificial CaCO3 templates observed by SEM. (A) 
Calcium carbonate microparticles with no entrapped BSA (≈2 μm) can be compared to (B) their 
counterparts containing BSA in their interior (≈5-6 μm). In (B) a rhombohedron can be observed in the 
background. 
9.6.3 Cumulative losses and encapsulation efficiency 
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Supplemental Figure 9.3. Cumulative losses during microcapsule construction (from entrapment to 
chelation). Means±SD are represented. 
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Supplemental Table 9.1. Calculated encapsulation efficiency, Ee, in %. 
 Stage losses   
Number of 
bilayers 
Entrapment, 
Le 
Construction, 
Lb 
Chelation, 
Lc 
Total 
loss 
Encapsulation 
efficiency, Ee 
1 9.07 6.20 12.71 27.98 72.02 
3 9.07 5.26 11.39 25.72 74.28 
5 9.07 5.01 10.75 24.83 75.17 
 
9.6.4 Release kinetics calculation 
9.6.4.1 Korsmeyer kinetics 
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Supplemental Figure 9.4. Release kinetics of the encapsulated BSA at 25ºC. Korsmeyer kinetics 
(log cumulative percent drug released vs. log time), with correlation values (r 2). 
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1 bilayer
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Supplemental Figure 9.5. Release kinetics of the encapsulated BSA at 37 ºC. Korsmeyer kinetics 
(log cumulative percent drug released vs. log time), with correlation values (r 2). 
9.6.4.2 Zero-order release 
The zero-order release kinetics parameters were determined using the model (equation S1): 
tKQQt 00   (S1) 
where Qt is the cumulative amount of protein released at time t, Q0 is the initial amount of protein and 
K0 is the rate constant for the zero-order model. 
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Supplemental Figure 9.6. Release kinetics of the encapsulated BSA at 25ºC. Zero-order kinetics 
(cumulative percent drug released vs. time), with correlation values (r 2). 
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Supplemental Figure 9.7. Release kinetics of the encapsulated BSA at 37ºC. Zero-order kinetics 
(cumulative percent drug released vs. time), with correlation values (r 2). 
 
9.6.4.3 First-order release 
The first-order release kinetics parameters were determined using the model (Equation S2): 
303.2/)()( 0 KtQLogQLog t   (S2) 
where Qt is the cumulative amount of protein released at time t, Q0 is the initial amount of protein and 
K is the rate constant for the first-order model. 
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Supplemental Figure 9.8. Release kinetics of the encapsulated BSA at 25ºC. First-order kinetics (log 
cumulative percent drug remaining vs. time), with correlation values (r 2). 
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1 bilayer
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Supplemental Figure 9.9. Release kinetics of the encapsulated BSA at 37ºC. First-order kinetics (log 
cumulative percent drug remaining vs. time), with correlation values (r 2). 
 
9.6.4.4 Higuchi release model 
The Higuchi release kinetics parameters were determined using the model (Equation S3): 
2/1tKQ H  (S3) 
where Q is the cumulative amount of protein released at time t and KH is the rate constant for the 
Higuchi model. 
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Supplemental Figure 9.10. Release kinetics of the encapsulated BSA at 25ºC. Higuchi kinetics 
(cumulative percent drug released vs. square root of time), with correlation values (r 2). 
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Supplemental Figure 9.11. Release kinetics of the encapsulated BSA at 37ºC. Higuchi kinetics 
(cumulative percent drug released vs. square root of time), with correlation values (r 2). 
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 Chapter 10. Cellular uptake of multilayered capsules produced 
with biomimetic and genetically engineered macromolecules10 
Abstract 
Multilayered microcapsules of chitosan and biomimetic elastin-like recombinamers (ELRs) were 
prepared for intracellular delivery of active agents. Two ELRs containing either the bioactive RGD 
sequence or a scrambled nonfunctional RDG were used to construct two types of functionalized 
polymeric microcapsules, both with spherical shape around 4 μm in diameter. Cell viability studies 
using human mesenchymal stem cells (hMSCs) were performed for microcapsule/cell ratios between 
5:1 and 100:1. After 3 and 72 hours of incubation no cytotoxicity was found. Nonetheless, cells 
incubated with RGD-functionalized microcapsules exhibited higher mean viability values than RDG ones. 
Internalization efficacy and bioavailability of encapsulated proteins was assessed by monitoring 
fluorescence changes of DQ-ovalbumin. The data showed that microcapsules’ surface functionalization 
did not influence significantly the internalization by hMSCs, although DQ-ovalbumin was degraded faster 
from within RGD-functionalized microcapsules. The developed microcapsules let foresee strategies for 
targeting intracellular drug delivery and to increase drug efficacy. 
 
                                                 
10
 This chapter is based on the following publication: 
Costa R. R., Girotti A., Santos M., Arias F. J., Mano J. F., and Rodríguez-Cabello J. C., Cellular uptake of multilayered 
capsules produced with biomimetic and genetically engineered macromolecules, submitted (2013). 
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10.1 Introduction 
In the field of drug delivery, there has been great interest in the development of nano- and micro-
carriers of active agents, such as micelles, liposomes, polymersomes, and polymer capsules [1-3]. 
Such devices may control the release of encapsulated biomolecules and also their efficacy by delivering 
them to the location where they are most needed. In particular, the use of nanostructured nano- and 
micro-capsules made using layer-by-layer (LbL) strategies has been studied as a method to encapsulate 
and deliver drugs in a controlled manner [4-8]. The principle behind LbL adsorption lies in the existence 
of intermolecular interactions attracting distinct polymer chains, such as electrostatic contacts, 
hydrophobic interactions, and hydrogen bonding, which drive the assembly of layers with only a few 
nanometers onto a surface [9-11]. With this simple and versatile technique, robust coatings can be 
assembled into bidimensional templates and even complex three-dimensional substrates. For instance, 
spherical nanostructured microcapsules have been conceived resorting to sacrificial silica (with 500 nm 
to 5 µm, dissolved in hydrogen fluoride) and porous calcium carbonate particles (with 3 to 5 µm, 
dissolved in ethylenediamine tetraacetic acid, EDTA) [12]. These structures have already been found to 
be useful as drug carriers – including of stem cell differentiation promoters – with release kinetics 
dependent on the number of layers or external stimuli, and as biosensors [13-15]. 
Multilayer microcapsules may encapsulate and deliver bioactive agents to cells or tissues following 
conventional release mechanisms to the biological environment [16] or by digestion within the cells 
themselves [17]. The latter possibility is particularly interesting: by delivering an active agent directly to 
the cells, where the whole metabolic machinery is found, high drug concentrations could be made 
available to the targeted tissue using minimal cargo amounts during its encapsulation. Moreover, it 
could also be possible to circumvent undesirable side effects to circumventing tissues or cells due to 
premature drug leakage. 
Carriers such as dendrimers, micelles and biodegradable nanoparticles have been frequently developed 
for the intracellular delivery of bioactive agents [18-21]. As carriers, multilayer-coated capsules present 
several advantages that are not often found together in other conventional fabrication techniques: (i) 
they can be prepared under mild conditions, what makes it possible for large amounts of sensitive or 
easily denatured biological molecules [22] and even cells [23] to be encapsulated, (ii) it is possible to 
encapsulate drugs with low water solubility [5], (iii) they allow controlling better the release kinetics by 
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varying the number of layers and their composition [24], and (iv) the shell can provide a high degree of 
functionality by selecting biofunctional constituents that may participate in biological mechanisms [25]. 
The primary objective of the present work is the design of multilayer microcapsules made of natural and 
nature-inspired macromolecules exhibiting bioactive sequences for intracellular drug delivery. Namely, 
chitosan (CHI) and elastin-like recombinamers (ELRs) were used as constituents of the multilayer shells 
which were assembled onto spherical particles of calcium carbonate. CHI is a well-known polycationic 
polysaccharide of marine origin which shows biocompatibility, adhesiveness and nontoxicity, as well as 
bacteriostatic, fungistatic, anti-microbial and hemostatic activities [26]. ELRs, a recombinant type of 
elastin-like polymers (ELP), are temperature-responsive and biomimetic polypeptides that are soluble in 
aqueous media below a specific critical transition temperature (Tt) but undergo a phase separation 
above it [27]. Their recombinant and modular nature is most likely their most attractive property 
because it allows tuning their physicochemical properties and introducing selected relevant amino acid 
domains to extend their physiological functionality [28,29]. LbL adsorption can be exploited using ELRs 
alongside polysaccharides, such as CHI and alginate, by taking advantage of strong electrostatic 
interactions and the stabilizing effect of weaker hydrophobic interactions [30]. 
Herein, human mesenchymal stem cells (hMSCs) were incubated with ELR-functionalized 
microcapsules with the cell adhesion motif arginine-glycine-aspartic acid (RGD). The inclusion of the 
loop RGD motif of the human structural protein fibronectin in the primary structure of the ELR was 
expected to add bioactive character to the microcapsules, while exploiting the negatively charged 
aspartic acids to enable the electrostatic self-assembly mechanism with CHI to occur. It has been 
reported that the RGD sequence is the minimal sequence required for recognition by the cell adhesion 
receptor integrins [31].  It is also known that nano/micro-particles modified with RGD show enhanced 
internalization [32-34]. However, this comparison is often made with unmodified  controls, that is, do 
not undergo any functionalization. Therefore, in addition to RGD, we also constructed microcapsules 
functionalized with an ELR containing a nonfunctional scrambled RDG sequence. To our knowledge, this 
is the first time that the internalization efficacy of RGD-functionalized LbL microcapsules is compared 
with a microcapsule type that substitutes the bioactive group with a nonfunctional analogue, similar in 
every aspect except for the position of the G and D residues, instead of removing it. 
The resulting microcapsules will be characterized in terms of morphology, and cytotoxicity after 
incubation with hMSCs. The internalization efficacy of the microcapsules will be quantified by flow 
cytometry in order to identify the existence – or absence – of a receptor-mediated uptake and 
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consequent influence in the intracellular processing between each microcapsule type. Furthermore, 
Capsules loaded with DQ-ovalbumin will permit to follow the availability of this protein inside the cells by 
monitoring the fluorescence changes of the capsules. 
10.2 Experimental section 
10.2.1 Materials 
Medium molecular weight chitosan (ref 448877), sodium carbonate anhydrous (Na2CO3, ref 222321) 
and EDTA (ref E9884) were purchased from Sigma-Aldrich. Chitosan was further submitted to a 
purification stage consisting in a series of filtration and precipitation in water and ethanol steps, adapted 
from the method described elsewhere [30], followed by freeze-drying. The final degree of deacetylation 
was determined to be 82% by 1H-NMR. Calcium chloride (CaCl2) was purchased from VWR (ref 
1.02378.0500). Two custom-made ELRs containing either a RGD or RDG sequence – henceforth 
referred to as ELR-RGD and ELR-RDG(-), respectively – were purchased from Technical Protein 
Nanobiotechnology (Spain). The characterization of the molecular weight and amino acid composition of 
the acquired batches were determined by matrix-assisted laser desorption/ionization time-of-flight mass 
spectroscopy (MALDI-TOF) and amino acid content analysis, respectively, and can be found 
elsewhere [25]. DQ-ovalbumin (ref D12053) was obtained from Invitrogen. 
Paraformaldehyde (ref P6148), Triton X-100 (ref T9284) and AccutaseTM (ref A6964) were purchased 
from Sigma-Aldrich. Human mesenchymal stem cells from human adipose tissue, (hMSCs, ref R7788-
115) its basal medium, Dulbecco’s modified Eagle’s medium (DMEM, ref 31966-021), fetal bovine 
serum (FBS, ref 16000-044), penicillin streptomycin solution (ref SV30010), trypsin-ethylenediamine 
tetraacetic acid (EDTA, ref SV30010), Dulbecco's phosphate-buffered saline (DPBS, ref 14190-136), 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, ref 15630049), Trypan Blue stain 0.4% (ref 
15250061), Alexa Fluor 488 phalloidin (ref A12379), LIVE/DEAD® Viability/Cytotoxicity Kit, for 
mammalian cells (ref L3224), Alamar Blue® (ref DAL1025) and DAPI (ref D21490) were supplied by  
Invitrogen . All cell culture plastic-ware and consumables were acquired from NUNC. 
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10.2.2 Measurement of the charges 
The ζ-potentials of the ELRs were determined using a Nano-ZS equipment from Malvern (United 
Kingdom), at 25ºC. Aqueous solutions of each ingredient in phosphate-buffered saline (PBS) (pH = 7.4) 
were used, at a concentration of 300 μg∙mL-1. 
10.2.3 Synthesis of calcium carbonate sacrificial templates 
Aqueous solutions Na2CO3 and CaCl2 were prepared at a concentration of 1 M. Typically, the 
coprecipitation of both solutions was performed by adding 1 mL of Na2CO3 solution followed by 1 mL of 
CaCl2 to 4 mL of ultrapure water (Milli-Q) under heavy stirring for 30 s. The stirring was then stopped 
and the suspension of the newly synthesized calcium carbonate (CaCO3) microparticles was left to 
precipitate and react for 15 min. The supernatant was removed and the particles were washed three 
times with 0.15 M sodium chloride (NaCl) adjusted to pH 5.5. To produce microcapsules preloaded 
with a protein cargo, the medium where the precipitation occurs consisted of an aqueous solution of 
DQ-ovalbumin at a concentration of 160 μg∙mL-1. Unless otherwise stated, all changes of solutions 
during the template synthesis and construction of microcapsules were performed by leaving the particle 
suspension precipitating for 10 min, followed by removal of the supernatant and replacement with the 
next solution – polymeric or for washing. 
10.2.4 Construction of the multilayer shells and microcapsule formation 
The CaCO3 sacrificial templates were immersed alternately in solutions of CHI and one of the ELRs 
(300 µg∙mL-1, pH 5.5, 0.15 M NaCl) for 10 min under mild stirring. Each adsorption step was followed 
by three washing steps with 0.15 M NaCl, pH 5.5: to disaggregate the substrates, the first was 
accompanied by four sequential ultrasound pulses of 3 seconds each, with the following being just 
rinsed. This process was repeated until 2 CHI/ELR bilayers were assembled. After the construction of 
the multilayers, the CaCO3 core was dissolved by EDTA, at 0.2 M, pH 5.5. From this point on, the 
precipitation of the microcapsules was aided by centrifugation steps (1000 rpm, 25 min) and 
ultrasound pulses timed as described above. The newly formed hollow microcapsules then followed a 
washing procedure with EDTA (0.2 M, pH 7.4) and four with ultrapure water. The microcapsules were 
stored at room temperature until use for a maximum of 24 h in a renewed medium of ultrapure water. 
In the case of microcapsules intended for cellular assays – loaded with DQ-ovalbumin – DMEM was 
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used for the washings and storage instead of water. The microcapsule production yield resulting from 
the mixture of 1 mL of Na2CO3 and CaCl2 was estimated to be with a total of 1.1×10
6 microcapsules 
by microscopy observation. 
10.2.5 Characterization of the hybrid microcapsules 
The morphology of the produced microcapsules – designated (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 – 
was determined using an environmental scanning electron microscopy (ESEM) (FEI Quanta 200FEG). A 
number of 2.2×104 microcapsules suspended in 200 μL of H2O was placed on top of a silicon wafer 
(1 cm2) and dried overnight at 37ºC before the analysis. The samples were placed inside the 
equipment in a platform with a 20º tilt. Transmission electron microscopy (TEM) images were obtained 
using a JEOL JEM-1011 HR instrument operating at 80 kV. Prior to the observation, a number of 104 
microcapsules suspended in 60 μL of H2O was pipetted onto a TEM grid and left to dry overnight at 
room temperature. A confocal laser scanning microscope (CLSM, Olympus FV1000, Germany) was 
used to evaluate the morphology of the microcapsules. For this, a final solution of a cationic dye 
(rhodamine B, 10-6 M) was further adsorbed after the normal construction of the microcapsules. All 
samples were stabilized at 37°C and observed under hydrated conditions. The fluorescence intensity 
profiles of 3 distinct microcapsules were plotted using ImageJ software (to assess the formation of 
spherical hollow structures (provided by NIH, version 1.47v). 
10.2.6 Cell culture 
hMSCs were cultured in DMEM supplemented with 10% FBS and 100 U∙mL-1 penicillin, 0.1 mg∙mL-1 
streptomycin replaced every two day and maintained at 37ºC in a 5% carbon dioxide (CO2) humidified 
environmental chamber. Near-confluence cells (passages 2–6) were harvested after enzymatically 
treatment with trypsin/EDTA or AccutaseTM and suspended in culture medium, cell counts were 
evaluated using a standard Trypan Blue exclusion assay and seeded at 3×103 cell∙cm-2 on the diverse 
surfaces utilized and then incubated during 24 hours in standard conditions. Afterwards, the culture 
medium was refreshed by serum-free medium containing a suspension of CHI/ELR microcapsules. 
After 3 h of CHI/ELR microcapsules co-incubation, the cultures were maintained for longer times, by 
supplementing the microcapsule suspension with additional fresh medium to reach the final serum 
concentration of 2% FBS. 
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10.2.7 Cell viability assays 
Metabolic activity was evaluated by Alamar Blue® and cell viability by LIVE/DEAD® assays. The relative 
number of hMSCs metabolically active within each experimental condition was evaluated by the Alamar 
Blue® assay according to the manufacturer guidelines. Briefly, 24 hours after cells seeding, cells culture 
was washed and then (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules in serum-free culture 
medium were added in incremental ratios of 5 to 100 microcapsules per cell. After 3 and 72 h of 
microcapsules co-incubation, the fluorimetric reduction of 10% Alamar Blue® reagent in culture medium 
was measured with a microtiter plate reader (SpectraMax M2e Molecular Devices). Non-treated cells 
were employed as positive control and their fluorescence was considered as the 100% of cells viability. 
The viability of cells co-incubated with CHI/ELR was also examined by a LIVE/DEAD® assays. Ten 
microcapsules per cell of each CHI/ELR microcapsule type were added to the cell culture. The ratio of 
microcapsules per cell was selected after obtaining the results of the cell viability assays. In this assay, 
the co-incubation with calcein AM and ethidium homodimer-1 allows distinguishing the cytoplasm of live 
cells (with esterase cleavage of calcein accompanied by green fluorescence), and dead cells (which 
compromised membranes enable to stain nucleic acids with red fluorescence). LIVE/DEAD® assays was 
carried out at different time points (0, 72 and 240 h) according to the manufacturing specifications. 
10.2.8 Statistical analysis 
Values reported reflect means±standard error (SE) of four samples of four independent cell culture 
viability experiments at 3 or 72 hours of incubation. The influence of microcapsules/cell ratio on cell 
viability was analyzed using one-way analysis of variance (ANOVA) and the post test of Bonferroni. All 
treatment-related effects were considered to be statistically significant at p-value less than 0.05. All data 
was analyzed using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA).  
10.2.9 Internalization and intracellular processing experiments 
hMSCs were seeded on circular cover glasses (diameter: 10 mm; Thermo Scientific CB00100RA1) 
deposited in a 48-well plate and incubated during 24 h in standard conditions. (CHI/ELR-RGD)2 and 
(CHI/ELR-RDG(-))2 microcapsules were added to the culture. After 3 or 72 h of incubation, samples 
were washed with DPBS three times. 
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Samples for microscopy analysis – confocal, phase-contrast, epifluorescence, and differential 
interference contrast (DIC) microscopy (Nomarski) – were fixed in 4% paraformaldehyde for 10 min, 
permeabilized with 0.2% Triton X-100, and stained with DAPI. A confocal microscope (Leica 
Microsystems, Heidelberg GmbH, microscope confocal Leica SP5) was used for analyzing 
microcapsules inside the cells. Z-series were performed with a Z-step of 1 µm. The images of each 
fluorophore and phase contrast were overlaid to obtain a multilayer image using ImageJ software 
(National Institutes of Health). Bright field and fluorescence microscopy were performed in a NIKON 
Eclipse Ti fluorescence microscope, equipped with a digital camera system (Digital sight DS-2MBWc), 
using blue, green and red filters. 
10.2.10 Cell analysis by flow cytometry 
1.5×105 hMSCs were seeded in a 25 cm2 flasks and cultured as described above.  (CHI/ELR-RGD)2 
and (CHI/ELR-RDG(-))2 microcapsules were added at a microcapsule-to-cell ratio of 10:1 and incubated 
during 72 h. The cell cultures dissociated by AccutaseTM treatment – specially developed for gentle and 
effective cell dissociation – were washed, counted, suspended in DPBS, 25 mM HEPES 5% FBS and 
analyzed in a flow cytometer (Beckman Coulter). The assay was repeated three times. All treatment-
related effects were considered to be statistically significant at p-value less than 0.05. All data was 
analyzed using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA).  
10.3 Results and discussion 
First, CaCO3 microparticles were coated with two bilayers of chitosan and the ELRs containing either 
the motif RGD or RDG. Hollow capsules were produced by their subsequent incubation with EDTA and 
chelation of the sacrificial core – henceforth referred to as (CHI/ELR-RGD)2 or (CHI/ELR-RDG
(-))2, 
respectively. The morphology of the microcapsules was evaluated by CLSM and SEM, and the capsules’ 
wall by TEM (Figure 10.1). TEM (Figure 10.1A), which was used solely to observe the wall delimiting the 
interior and exterior of the microcapsules, showed a multilayer shell that could be distinguished at the 
borders of the structure. For the morphological analysis, the samples for microscopy observation were 
prepared at 37ºC. 
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Figure 10.1. (A) Representative TEM image of a microcapsule showing a detail of the multilayer shell 
delimited by the dashed lines. (B) CLSM micrograph of several microcapsules with the wall tagged with 
rhodamine. Micrograph is representative of both (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules. 
(C) Fluorescence intensity plot profile of three individual microcapsules depicted in (B). The peaks 
coincide with the capsules’ walls, while the plateau in between corresponds to the hollow interior. SEM 
images of (D) (CHI/ELR-RGD)2 and (E) (CHI/ELR-RDG
(-))2 microcapsules, with a vertical tilt of 20º. 
 
It is known that this kind of polysaccharide/polypeptide microcapsules experience size variations 
according to the temperature of the incubation medium. Costa et al. [36] demonstrated that this class 
of microcapsules have a diameter of 5.5 μm at room temperature but shrink when incubated at 37ºC, 
to around 3 μm. Therefore, this temperature was chosen to prepare the samples and assess their 
morphology under a temperature similar to that of a biological environment. 
The preparation of individual polymeric capsules while avoiding aggregation is difficult but necessary for 
applications that require cellular uptake and survival. Figure 10.1B shows several CHI/ELR 
microcapsules observed under CLSM. All microcapsules showed diameters of 3–4 μm and had their 
own individual walls (which served as polymeric reservoirs for the rhodamine dye) and hollow interior 
(hence not dyed after the 10 minutes treatment). The graphic in Figure 10.1C, where the fluorescence 
intensity is plotted as a function of the length of the lines drawn, confirms that the interior was empty 
and thus the dissolution of the CaCO3 core was successful. In Figure 10.1D, the morphological analysis 
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of (CHI/ELR-RGD)2 microcapsules shows that the integrity of the wall was maintained through the 
process of its construction to the moment of their use. This observation indicates that the used 
operational conditions permitted to obtain individual spherical microstructures. No signs of aggregation 
were found, what makes the produced microcapsules suitable for the subsequent cellular studies. In 
Figure 10.1E, microcapsules made of CHI and the ELR-RDG(-) can be observed. Unlike RGD, RDG is a 
nonbioactive motif similar to RGD in all aspects, except for the position of the G and D amino acids. As 
such, the scrambled RDG sequence was previously shown to have significantly less cellular adhesion in 
respect to its functional RGD counterpart [37,38]. These microcapsules resembled in morphology and 
size the (CHI/ELR-RGD)2 microcapsules (Figure 10.1D). With such similarity, it was expectable that 
differences in the mechanism and efficacy of internalization of these two microcapsule types – if any – 
would be solely caused by their peptide sequence bioactivity rather than by a morphological 
discrepancy. 
Mesenchymal stem cells (MSCs) are hypoimmunogenic and pluripotent able to differentiate in in vitro, 
ex vivo and in vivo, into multiple cells types such as osteocytes, adipocytes, chondrocytes, neurocytes, 
hepatocytes, myocytes, and hematopoietic-supporting stroma. These characteristics have been 
considered crucial factors when aiming to develop new candidates for clinical use, especially in tissue 
engineering and regenerative medicine applications, such as transplantation, local implantation, gene 
therapy, and drug delivery [39,40]. Cellular therapies in particular can be envisaged in order to 
internalize molecules with the aim to control cellular behavior, such as the induced differentiation of 
MSCs into osteoblasts [41]. Therefore, the option to use hMSCs in a model of internalization of 
CHI/ELR microcapsules could open the direct applicability of the methodology described herein. 
In order to demonstrate if this kind of hybrid nanostructured microcapsules are suitable for biological 
applications, we analyzed the in vitro viability of hMSCs by means of their metabolic activity in the 
presence of (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2. We studied the dose-dependent response effect 
for two experimental times: 3 h and 72 h. hMSCs were co-incubated with increasing microcapsule/cell 
ratios within a range of 5 to 100 units per cell. In Figure 2, the cell viability is represented normalized in 
respect to the positive control, that is, cells cultured without microcapsules. As observed in Figure 
10.2A and Figure 10.2B, after 3 h and 72 h of incubation with (CHI/ELR-RGD)2, the metabolic activity 
did not vary significantly for the studied ratio range in respect to the positive control. 
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Figure 10.2. Metabolic activity of hMSCs incubated with increasing ratios of (A, B) (CHI/ELR-RGD)2 
and (C, D) (CHI/ELR-RDG(-))2 microcapsules for (A, C) 3 h and (B, D) 72 h. Data represent means of 
four experiments, each performed in quadruplicate, normalized in respect to the positive control. Error 
bars represent one standard error (mean+SE). No significant statistical differences were found (p-value 
higher than 0.05). 
 
In light of our results, (CHI/ELR-RGD)2 hybrid microcapsules are not only noncytotoxic for hMSCs but 
can also help maintaining a high cellular metabolic activity over a high ratio of microcapsules in respect 
to the number of cells. A similar trend was observed for ELR-RDG(-)-functionalized microcapsules. For 
both time-points (Figure 10.2C and Figure 10.2D), there were no apparent metabolic activity differences 
in respect to the positive control as a function of microcapsule concentrations. 
Analyzing the graphics for 72 h of incubation (Figure 10.2B and Figure 10.2D), one can observe that 
there is a decrease in the mean metabolic activity of cells incubated with either microcapsule type for 
the highest microcapsule/cell ratios. This decrease can be seen for a ratio higher than 50:1 for 
(CHI/ELR-RGD)2 and 60:1 for (CHI/ELR-RDG
(-))2 microcapsules. When considering cell viability, one 
could expect that a large quantity of microcapsules will reduce nutrient and gas exchanges between the 
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internal cellular compartment and the culture medium, eventually leading to cell death [42]. Although 
the microcapsules presented herein are noncytotoxic towards hMSCs even for the highest studied ratios, 
it is plausible to affirm that a large number of microcapsules will have negative impact in the metabolic 
activity of the cells. 
Despite the high metabolic activity observed in comparison to the positive control, it was also apparent 
that cells incubated with (CHI/ELR-RDG(-))2 microcapsules were less viable than their biofunctional 
analogues. For instance, after incubating 10 microcapsules per cell during 72 h with hMSCs, a viability 
of 139% (ELR-RGD-based elements) was estimated in comparison to 105% (ELR-RDG(-)-based elements), 
accounting for a reduction of 24%. 
In Figure 10.3, the metabolic activity measurements for every microcapsule/cell ratio were coupled 
together and their mean was calculated to estimate the cellular viability for each microcapsule type. 
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Figure 10.3. Estimated metabolic activity of hMSCs incubated with (CHI/ELR-RGD)2 and 
(CHI/ELR-RDG(-))2 microcapsules for 3 and 72 h. Data represent means of the viability results 
performed for microcapsule/cell ratios from 5:1 to 100:1, as compared to the positive control (PC, cells 
cultured without microcapsules). Error bars represent one standard error (mean+SE). No significant 
statistical differences were found (p-value higher than 0.05). 
 
In the case of the longest incubation time (72 h), hMSCs incubated with RGD-functionalized 
microcapsules exhibited a mean metabolic activity of 114%, while RDG(-)-functionalized ones exhibited 
102%. These differences in bioactivity do not account for a significant difference between each 
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microcapsules type, although the mean bioactivity values of (CHI/ELR-RGD)2 are higher for all time-
points. This small disparity could be the result of RGD-induced integrin activation in the dorsal region of 
the cells, a non-selective interaction, which is known to be involved in several metabolic pathways, such 
as those of proliferation and differentiation [43,44]. 
In light of these results, it seems possible to apply rather large amounts of hybrid microcapsules to 
hMSCs without severely affecting their viability, even when using the non-functional RDG analogue. The 
lowest microcapsule/cell ratios also provided the most favorable conditions for hMSCs incubation with 
both types of functionalized microcapsules. Given these results, we selected a concentration of 
10 microcapsules per cell for all subsequent experiments. This way, it would be possible to keep the 
microcapsule/cell ratio to a minimum while avoiding a massive and systematic microcapsule 
administration and ensuring a high cellular metabolic activity in respect to the positive control. 
Cell viability assays by LIVE/DEAD® were carried out to complement the metabolic activity data for a 
time-frame of 10 days and can be observed in Figure 10.4.  
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Figure 10.4. Representative microphotographs of LIVE/DEAD® assay of hMSCs incubated with (A, B 
and C) (CHI/ELR-RGD)2 and (D, E and F) (CHI/ELR-RDG
(-))2 microcapsules at 0 (A, D) and 72 h (B, E)  
and 240 h times points. (C, F). 
 
In respect to the (CHI/ELR-RGD)2 microcapsules effect, after an incubation period of 72 h, the green 
calcein staining confirmed that the cells were alive and well-spread on the surface (Figure 10.4B). The 
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same trend is observed for the (CHI/ELR-RDG(-))2 (Figure 10.4E), with no visible differences between 
each case. In order to assess if the cells could remain alive after being cultured in the presence of 
hybrid microcapsules, complete DMEM was added after 72 h to the co-incubation medium. Then this 
mixture was maintained for another 168 h to a total of 10 days of culture before LIVE/DEAD® assays 
were performed. As observed in Figure 10.4C and Figure 10.4F, no dead cells were encountered, 
clearly indicating that hMSCs viability was not affected by the incubation with the foreign microcapsule 
components – as supported by the metabolic activity assays – even after a longer exposition time. 
In order to determine if this class of hybrid microcapsules could be internalized by cells, hMSCs were 
co-incubated first with (CHI/ELR-RGD)2 for 72 h. To aid in this microscopy visualization, the 
microcapsules were loaded with DQ-ovalbumin. This commercially available product is a conjugate of 
ovalbumin heavily labeled with BODIPY dyes. Due to a characteristic self-quenching mechanism, it 
exhibits a bright red fluorescence characterized by the close proximity of the fluorescent dyes, but it 
shifts to a strong green upon proteolysis. This means that it would be possible to follow the 
internalization of the microcapsules and the intracellular processing of the cargo by fluorescence assays. 
Confocal microscopy (Figure 10.5) confirmed the presence of internalized RGD-functionalized 
microcapsules after 72 h of incubation. A yellow color (resulting from the simultaneous fluorescence 
emission of red and green) could be observed in different planes of the cells, evidencing that the 
microcapsules containing DQ-ovalbumin were processed by the hMSCs. In Figure 10.5A, the arrows 
point to bright green dots, indicating the presence of fully degraded microcapsules. To reflect upon the 
electrostatic interactions between capsules and cellular membrane, the charges of ELR-RGD and 
ELR-RDG(-) in aqueous solution were determined by ζ-potential measurements. They were shown to 
have a charge of -5.7±1.2 mV and -6.3±1.2 mV, respectively, in PBS. One could argue that the negative 
charge of the ELR outer layer could potentially hinder the internalization by conflicting with the 
electrostatic nature of the cellular membrane [45]. However, electrostatic interactions alone were 
previously unable to account for cellular adhesion to surfaces modified with polycations [46] and thus is 
expected to have little influence in comparison to the bioactive properties of the used macromolecules. 
Therefore, these results show that cellular uptake of CHI/ELR microcapsules can be achieved and that 
their intracellular degradation can be followed by the used fluorophore. 
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Figure 10.5. Confocal microscopy of hMSCs containing (CHI/ELR-RGD)2 microcapsules within their 
cytoplasm. The nuclei are stained with DAPI (blue) and the microcapsules loaded with DQ-ovalbumin. 
The schematics represent the relative position of each plane in the cell (A, B and C). The arrows in (A) 
point to bright green dots, representing fully processed DQ-ovalbumin. (D) Bright field image was 
merged with the fluorescence-only image in (C). 
 
After confirming that cellular uptake of this class of microcapsules can be successful, the cells that 
could effectively internalize microcapsules loaded with DQ-ovalbumin were quantified by flow cytometry. 
Figure 10.6 shows the results obtained by flow cytometry and the quantification of the internalization 
efficiency for both microcapsule types. For this analysis, the study of Semmling et al. [47], who 
performed a “flow cytometry”-based assay to analyze the uptake of polyelectrolyte capsules, was taken 
into consideration. In the case of (CHI/ELR-RGD)2 microcapsules, in Figure 10.6A, viable hMSCs after 
72 h of incubation were represented by the area delimited in yellow. Viable cells include cells that were 
either empty (with low side-scattering intensity, Iss) or internalized microcapsules (with high Iss). Outside 
these borders, cellular debris, apoptotic cells and microcapsule debris are usually identified here. 
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Figure 10.6. Flow cytometry 2D density plots of hMSCs after a 72 h incubation with (A, B) 
(CHI/ELR-RGD)2 and (C, D) (CHI/ELR-RDG
(-))2 microcapsules. The density of the events is color-coded 
from blue (low frequency) to red (high frequency).  (A, C) Side-scattering intensity (ISS) is plotted as a 
function of forward-scattering intensity (IFS). The area delimited in yellow corresponds to viable cells 
either empty (low ISS) or with internalized microcapsules (high ISS), and was established based in a 
control of hMSCs cultured in the absence of microcapsules. (B, D) The events corresponding to viable 
cells were sorted according to red (Ired) and green (Igreen) fluorescence intensities and events 
corresponding to empty or cells containing microcapsules were subdivided. (E) Internalization efficiency 
of each type of capsule for three independent experiments. Data represent means of three independent 
experiments. Error bars represent two standard errors (mean±SE). No significant statistical differences 
were found (p-value higher than 0.05). 
 
In Figure 10.6B, the identified viable cells were re-plotted according to their red (Ired) and green (Igreen) 
fluorescence intensities emitted by the DQ-ovalbumin. It should be noted that a cell can bear DQ-
ovalbumin-loaded microcapsules in every of these processing stages, that is, DQ-ovalbumin exhibiting 
red, green, or both. Thus, events with high intensity in either of these spectra corresponded to cells 
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containing DQ-ovalbumin in distinct stages of intracellular processing: intact, degraded, or in process of 
degradation. Within the delimited area in Figure 10.6B are found empty cells, verified from a control of 
cells cultured without microcapsules. The data indicate that 63±17% of the hMSCs have internalized 
(CHI/ELR-RGD)2 microcapsules, as depicted in Figure 10.6E. 
This same analysis was performed for (CHI/ELR-RDG(-))2 (see Figure 10.6C and Figure 10.6D), after 
which an internalization efficiency of 53±10% was determined. No statistical differences were found 
between both cases, indicating that the exhibition of RGD did not influence the incorporation of the 
microcapsules by the hMSCs, in respect to microcapsules exhibiting RDG. Nonetheless, the mean 
internalization efficacy for (CHI/ELR-RGD)2 was higher than its nonbioactive counterpart, which may 
indicate a minor contribution of receptor-mediated interactions in the cellular uptake. 
Our results indicate that the internalization of LbL microcapsules is not affected significantly when 
coupled with biofunctional components, contrary to what was demonstrated by other authors.[48,49] 
For instance, Caruso and coworkers [48] showed that poly(styrene sulfonate)/poly(allylamine 
hydrochloride) (PSS/PAH) capsules (around 500 nm in diameter) functionalized with humanized A33 
monoclonal antibodies could be internalized specifically by LIM1215 colorectal cancer cells. However, 
in another work, De Koker et al. [50] inhibited different endocytic pathways and actin polymerization in 
bone-marrow-derived dendritic cells. Their results demonstrated that microcapsules with around 3 μm 
are internalized via macropinocytosis – a nonspecific endocytosis mechanism for foreign materials 
roughly between 500–2000 nm [51]. Therefore it is likely that macropinocytosis was the major 
endocytosis mechanism involved in the cellular uptake of carrier devices of this class and size (around 
3–4 μm in diameter), to which surface functionalization does not play a determinant role. 
Upon internalization of a drug carrier, it is important to ensure that the agent is not only delivered but 
also available for use by cells. Thanks to the use of DQ-ovalbumin, the consumption of this cargo by 
cells could be conveniently assessed by fluorescence changes. After quantifying the cellular uptake, the 
bioavailability of DQ-ovalbumin was evaluated by co-incubating cultured hMSCs with each kind of 
microcapsules in parallel for 3 and 72 h. In Figure 10.7, representative bright-field and fluorescence 
microscope images can be observed for (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules loaded 
with DQ-ovalbumin. The schematic representation in Figure 10.7A shows the various stages of cellular 
uptake and intracellular processing of encapsulated protein. Until the cargo reaches a fully degraded 
state, the intensity of green fluorescence increases and red decreases: their simultaneous emission 
results in the orange and yellow intermediate colors observable under the fluorescence microscope. 
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After 3 h of incubation and a rinsing step with DPBS, few microcapsules were detected within the cells, 
with these few occurrences being mostly red or bright orange.  
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Figure 10.7. The scheme (A) depicts the various degradation stages that DQ-ovalbumin undergoes. 
Representative microscopy images of (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules loaded 
with DQ-ovalbumin incubated with hMSCs after (B, D) 3 or (C, E) 72 h of incubation and DAPI staining 
(nuclei of the cells stained in blue). A shift from red/orange to green/yellow indicates a transition 
between fully intact to degraded cargo. Images are of fluorescence and differential interference contrast 
(DIC) microscopy at 40× magnification.  
 
This observation was common for both (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 microcapsules (Figure 
10.7B and Figure 10.7D). A closer observation permits to detect some green dots after 3 h of 
incubation, like in the case of (CHI/ELR-RGD)2 microcapsules (Figure 10.7B). Such observation is 
consistent with the work of Rivera-Gil et al. [17], in which the same fluorescent protein was used. In 
their work with nonbiodegradable poly(styrene sulfonate)/poly(allylamine hydrochloride) (PSS/PAH) 
microcapsules, they concluded that a green fluorescence exhibited in capsules that are not expected to 
degrade – hence efficiently protecting their cargo – would still be permeable and prone to this 
fluorescence change. Variables such as the pH and ionic strength influence the permeability of the 
polyelectrolyte capsules, thus DQ-ovalbumin would still be able to diffuse through the multilayer shell 
and exposed to proteases and be degraded. 
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After 72 h of incubation, a higher amount of microcapsules were detected interacting with the cells, in 
comparison to the shorter time-point, with a predominant presence of yellow capsules found in the case 
of hMSCs incubated with RGD-functionalized microcapsules and red capsules in the case of cells 
incubated with the non-functional analogue ones. This observation indicates that, even after 72 h of 
incubation, distinct stages of microcapsule/cell internalization and intracellular processing could be 
found. However, judging by the intense yellow and occasional green dots in Figure 10.7C, the 
bioavailability of DQ-ovalbumin encapsulated within (CHI/ELR-RGD)2 microcapsules seemed higher. 
The microscopy comparison between both types of microcapsules (Figure 10.7) seems to indicate that 
both (CHI/ELR-RGD)2 and (CHI/ELR-RDG
(-))2 situations bear little difference in respect to the number of 
apparent internalized carriers. Nonetheless, a dominant emission fluorescence towards the green 
spectrum – that of cleaved DQ-ovalbumin – was dominant in the former. This result shows that the 
cargo of RGD-functionalized microcapsules was processed faster, evidencing a higher bioavailability of 
DQ-ovalbumin for this carrier type. In this sense, the bioavailability rate of the cargo does not follow the 
results from the cellular uptake quantification shown in Figure 10.6: the internalization efficacy does not 
seem much influenced by the surface functionalization, whereas the intracellular processing of their 
cargo does. The study of the internalization mechanism and intracellular processing has not been much 
researched. It is true that the role of macropinocytosis was previously demonstrated [50] but it is known 
that functionalizing an interface can mediate specific integrin interactions [52]. Given that the surface 
functionalization in this work had little influence in the internalization efficacy, one would expect that the 
degradation of their cargo would be similar after the studied time of exposure. It could be suggested 
that the distinct functionality of the adsorbed recombinamers triggers distinct proteolytic pathways, just 
as RGD may active proliferation- and differentiation-related integrins. However, the study of such 
mechanism was out of the scope of this work. Such mechanism should be studied in the future in order 
to properly determine carrier and cargo fates upon cellular uptake, especially for carriers of the same 
class internalized by similar endocytic mechanisms. With these results, we conclude that CHI/ELR 
microcapsules can be internalized by hMSCs, regardless of their surface functionalization, and may act 
as suitable carriers for the intracellular delivery of active agents. 
10.4 Conclusion 
We presented the fabrication of multilayer microcapsules made of natural and nature-inspired polymers 
for intracellular delivery of active agents. Thanks to the nature of the constituents, the microcapsules 
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were noncytotoxic as their degradation does not result in harmful products for the cells. Cellular uptake 
was demonstrated, showing their potential as carriers for drug delivery directly to the cellular machinery. 
In the future, this way of delivery may help minimizing drug losses and increasing their delivery control 
and efficacy. The internalization efficacy demonstrated for hMSCs lets foresee their use in cell/tissue 
engineering and regenerative medicine where it is important to control the differentiation of stem cells 
into specific phenotypes. This work confirmed that CHI/ELR microcapsules could interact and be 
internalized by cells, but experiments with microcapsules loaded with actual active agents are envisaged, 
such as molecules that trigger the differentiation of cells into specific phenotypes. The mechanism of 
internalization of the microcapsules at this scale did not depend on the surface functionalization. They 
were internalized via macropinocytosis although the ELR functionalization suggested a minor role of 
integrin-mediated mechanisms. In this context, the recombinant nature of ELRs will be of interest to 
further study the microcapsules’ endocytosis mechanism. In particular, it is possible that the production 
of smaller capsules by using nanotemplates may increase the influence of RGD and facilitate 
internalization [53]. The inclusion of bioactive motifs other than this generic motif may constitute a 
strong advantage of using such recombinant technologies, allowing exploring not only specific 
recognition processes but also degradation pathways for targeted delivery and increased drug efficacy. 
Therefore, multilayer microcapsules using biomimetic ingredients for intracellular delivery let foresee 
new strategies to increase the availability of molecules of interest in cells and for targeted biomedical 
applications. 
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 Chapter 11. Multifunctional compartmentalized capsules with a 
hierarchical organization from the nano- to the macro-scales11 
Abstract 
Inspired by the cells’ structure, we present compartmentalized capsules with temperature and 
magnetic-based responsiveness, and hierarchical organization ranging from the nano- to the visible 
scales. Liquefied alginate macroscopic beads coated with a layer-by-layer (LbL) chitosan/alginate shell 
served as containers both for model fluorophores and microcapsules, which in their turn encapsulated 
either another fluorophore or magnetic nanoparticles (MNPs). The microcapsules were coated with a 
temperature responsive chitosan/elastin-like recombinamer (ELR) nanostructured shell. By varying the 
temperature from 25ºC to 37ºC, the two-hour release of rhodamine encapsulated within the 
microcapsules and its diffusion through the external compartment decreased from 84% and 71%. The 
devices could withstand handling and centrifugal stress, with 50% remaining intact at a rotation speed 
of 2000g. MNPs attributed magnetic responsiveness towards external magnetic fields. Such 
customizable system can be envisaged to transport bioactive agents and cells in tissue engineering 
applications. 
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11.1 Introduction 
Considerable research efforts have been focused on miniaturized compartmental engineering systems 
with optimized properties over the past decade due to their wealth of potential applications in fields 
such as catalysis, sensors, drug delivery, disease models, energy storage and microreactors [1-3], 
which often require complex phenomena to occur simultaneously. Such a multifunctional device that is 
capable of addressing several reactions at once would, however, be difficult to develop. Perhaps not 
surprisingly, nature gives us an elegant example of a multifunctional entity in the form of biological cells. 
Due to their unique hierarchical and compartmentalized organization, they allow numerous compounds 
to be transported, proteins to be synthesized and enzymatic reactions to be regulated within their 
cytoplasm. However, building artificial cells is still a technology in its infancy. In an attempt to mimic 
cells, a great deal of research has focused on hierarchical nano- and microcompartments [4-6]. Multi-
shelled organic and inorganic capsules prepared by template-assisted strategies are usually 
accompanied by harsh processing conditions [7-9]. In contrast, compartmentalized assemblies of 
polymeric multilayer nano/microcapsules within larger partitions have been achieved by using non-
aggressive bottom-up strategies [10-14]. In any case, compartmentalization has allowed combining 
properties and confine reactions that could not be achieved otherwise with single-component 
assemblies [4]. 
The most attractive characteristic of compartmentalized devices does not necessarily involve their 
potential ability to mimic intracellular reactions, such as confining drugs and enzymatic reactions into 
partitions [15-17]. Compartmental systems should ideally be customizable by assembling 
subcompartments which exhibit functions that are not coupled naturally. Moreover, following a proper 
selection of the constituents, the range of such functions could be widened by exploiting the properties 
of stimuli-responsive materials [18]. Some examples that would benefit from such approach are the 
release control of several biomolecules delivered simultaneously for enhanced drug delivery [19], the 
immobilization of such a device spatially for targeted therapies [20], and the control over a multitude of 
cellular events that lead to stem cell differentiation [21]. 
In our goal to construct a hierarchical multifunctional device, we aimed to demonstrate that both 
molecular compounds and inorganic iron oxide magnetic nanoparticles can be encapsulated in distinct 
compartments. We report the construction of liquefied microcapsule-containing gel beads manufactured 
using a hybrid “ionic gelation” strategy of alginate assisted by a layer-by-layer (LbL) approach. LbL is a 
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simple and versatile technique which allows producing robust coatings, even in substrates with complex 
geometries. Because it discards the need of organic and harmful solvents, it is an attractive technique 
for tissue engineering applications [22-24]. In three-dimensional structures, namely spherical capsules, 
the semi-permeable nature of multilayer coatings can be used to tune the permeability of molecules of 
interest in or out, or to completely confine them [13,25-27]. Herein, liquefied alginate macrocapsules 
delimited by multilayer shells of chitosan/alginate (CHI/ALG) were intended to containing 
microcapsules made of CHI/”elastin-like recombinamer (ELR)” inside. The latter, on their side, 
contained either magnetic nanoparticles (MNPs) or model molecular compounds, such as the model 
low molecular weight fluorophores fluorescein isothiocyanate and rhodamine. 
CHI and ALG are two well-known polysaccharides of marine origin which show biocompatibility, 
adhesiveness, non-toxicity, as well as bacteriostatic, fungistatic, anti-microbial and hemostatic 
activities [28,29]. ELRs, a recombinant type of elastin-like polymer (ELP), are temperature-responsive 
polypeptides that are soluble in aqueous media below a specific critical transition temperature (Tt) but 
undergo a phase separation above it [30-32]. Lastly, MNPs are structures susceptible to magnetic fields. 
They are often used to enhance medical imaging diagnosis of soft tissues (e.g., magnetic resonance 
imaging, MRI) and temperature-triggered treatments such as hyperthermia and tissue ablation [33-35]. 
In light of the potential applications of compartmentalized structures, we have studied the properties of 
each of the structures that can be found at the nano-, micro- and macro-scales, the permeability of the 
multilayer shells at distinct temperatures (namely the coatings containing the temperature-responsive 
ELR) and the response to external magnetic fields. We hypothesized that such systems could be 
fabricated and customized to display smart tunable permeability and spatial 
mobilization/immobilization. 
11.2 Experimental section 
11.2.1 Materials 
Medium molecular weight chitosan was purchased from Sigma-Aldrich (ref 448877) and purified by a 
series of filtration and precipitation in water and ethanol steps, adapted from the method described by 
Signini and Filho [36], followed by freeze-drying. The degree of deacetylation was determined to be 82% 
(Supplemental Figure 11.1). Alginic acid sodium salt from brown algae was purchased from Sigma-
Aldrich (ref 71238) and used as received. 
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11.2.2 Bioproduction of the elastin-like recombinamers 
An ELR containing a L-arginine-glycine-L-aspartic acid (RGD) motif was bioproduced using a 
fermentation process from an Escherichia coli strain BLR(DE3) containing an appropriate expression 
gene, obtained using an appropriate protocol for gene design [37]. After fermentation, the culture was 
harvested and lysed by ultrasonic disruption. Insoluble debris was removed by centrifugation and the 
cleared lysate was subjected to several cycles of cold (4ºC) and warm (40ºC) centrifugations, at 
10000 rpm for 10 minutes each. Finally, the polymer was dialyzed against ultra-pure Milli-Q water at 
4°C in dialysis membranes with a 12 kDa molecular weight cut-off for a minimum of 6 hours, after 
which the water was changed. After 4 changes of water, the biopolymer was frozen and freeze-dried. 
Characterization of the bioproduct was done previously [22,38]. 
11.2.3 Synthesis of magnetic nanoparticles 
In a typical synthesis to synthesize spherical iron oxide MNPs, 10 mL of a solution containing 1.2 g of 
iron(III) chloride hexahydrate (FeCl3∙6H2O, Sigma-Aldrich ref. 236489) and 0.6 g of iron(II) chloride 
tetrahydrate (FeCl2∙4H2O, Sigma-Aldrich ref 220299) was added drop-wise to 25 mL of ammonium 
hydroxide solution (NH4OH, made of 33% ammonia, NH3, in H2O) over 4 h under an inert nitrogen 
atmosphere. The products of the reaction were collected by magnetic separation and washed three 
times with ethanol and water. The last washing step was made with ethanol, after which the products 
were left to dry at room temperature. 
11.2.4 Characterization of the MNPs 
The shape and morphology of the magnetite nanoparticles were determined using high resolution 
transmission electronic microscope (TEM, JEOL JEM-1011, operating at 200 kV). Samples were 
prepared by dropping a dilute aqueous solution (concentration = 1 mg∙mL-1) of the nanoparticles onto a 
200-mesh copper grid and allowing the solvent to evaporate. The magnetization of the MNPs was 
measured as a function of the applied external magnetic field (maximum value 10 kOe) using a 
vibrating sample magnetometer (PPMS, Quantum Design) at 300 K. 
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11.2.5 Temperature-induced aggregate measurements 
The aggregate sizes of chitosan, alginate and ELR in solution were measured using the dynamic light 
scattering (DLS) from a Nano-ZS from Malvern (United Kingdom) for temperatures 25ºC/37°C after 
stabilization for 5 min. The samples of alginate and ELR were prepared at 300 µg∙mL-1 in 
phosphate-buffered solution (PBS), pH 7.4. In the case of chitosan, the solvent was acetic acid at 
1% (w/v) and sodium chloride (NaCl) concentration of 0.15 M, pH 5.5. Measurements were performed 
first at 25ºC, then 37ºC and finally back at 25ºC. A total of 20 runs were performed for each sample to 
obtain an average value at stabilized temperature. 
11.2.6 Synthesis of the calcium carbonate sacrificial particles, either empty or 
entrapping fluorophores/MNPs 
Aqueous solutions of anhydrous sodium carbonate (Na2CO3, Sigma-Aldrich ref 222321) and calcium 
chloride (CaCl2, VWR ref 1.02378.0500) were prepared at 1 M. In a typical co-precipitation reaction, 
100 μg of a desired material was entrapped in a medium of 200 µL of H2O by adding 100 µL of 
Na2CO3 followed by 100 µL of CaCl2 with rapid stirring for 30 seconds. The H2O precipitation medium 
contained the material to be entrapped at a concentration of 500 μg∙mL-1. Three distinct ingredients 
were added to the H2O precipitation medium: fluorescein-5(6)-isothiocyanate (FITC, 389 Da, Sigma-
Aldrich ref F3651), rhodamine-B isothiocyanate (Rhod, 536 Da, Sigma-Aldrich ref R1755) and MNPs. 
As a control, empty microcapsules were also fabricated by using solely ultrapure H2O. Stirring was 
stopped after 30 s and the suspension of newly synthesized calcium carbonate (CaCO3) microparticles 
left to react and precipitate for 15 min. The supernatant was then removed and the particles washed 
twice with ultrapure water to remove residual salts and non-entrapped materials. Unless stated 
otherwise, all supernatants were retained for fluorescence measurements and quantification of losses 
until the construction of compartmental capsules was completed. 
11.2.7 Construction of the microparticle multilayer coating 
The CaCO3 sacrificial templates (empty or entrapping either a fluorophore or MNP) were immersed 
alternately in CHI and ELR solutions (300 µg∙mL-1, pH 5.5, 0.15 M of NaCl) for 10 min each, then 
washed with 0.15 M NaCl (pH 5.5 at 0.15 M). Centrifugation was avoided to prevent damage and 
aggregation of the particles each time the samples were to be retrieved from solution; simple 
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precipitation of the suspension was used instead (3 to 5 min). This process was repeated until three 
bilayers had been assembled, (CHI/ELR)3. For the sole purpose of confocal microscopy 
characterization described below, the CaCO3 cores were chelated at this point by immersion in 
ethylenediamine tetraacetic acid (EDTA, Sigma-Aldrich ref E9884; 0.2 M, pH 5.5) for 30 min. 
11.2.8 Construction of multilayer coated external subcompartment-containing 
beads 
A 1% (w/v) solution of alginic acid sodium salt was prepared. In a typical experiment, the 
(CHI/ELR)3-coated microparticles were suspended in 1 mL of alginate solution and the resulting 
suspension extruded through a 25G needle, at a rate of 0.33 mL∙min-1, into a 0.75% (w/v) solution of 
CaCl2 under mild stirring. Alginate beads containing coated microparticles were formed by calcium-
mediated ionic gelation. The beads were immersed alternately in CHI and ALG solutions (300 µg∙mL-1, 
pH 5.5, 0.15 M NaCl) for 10 minutes each, then washed with 0.15 M NaCl (pH 5.5 at 0.15 M). This 
process was repeated until three bilayers had been assembled, (CHI/ALG)3. After the coating had been 
assembled, the beads were immersed in EDTA. At this point, the CaCO3 sacrificial templates are 
chelated simultaneously with the liquefied alginate bead. 
Liquefied alginate beads coated with (CHI/ALG)3 multilayers loaded with not only empty microcapsules 
and Rhod in the ALG medium were also constructed. Rhod was suspended alongside the empty 
microcapsules and encapsulated in the ALG bead compartment instead of in the inner microcapsules. 
In a typical experiment, Rhod was suspended in ALG at 15 μg∙mL-1. This value was determined by first 
calculating the construction losses resulting from the Rhod-loaded microcapsules within the external 
alginate macrocapsule in order to minimize concentration-dependent artifacts (see Supplemental Figure 
11.3 for details). 
11.2.9 Characterization of the compartmental units 
The morphology of the FITC-loaded (CHI/ELR)3 microcapsules was determined using an Olympus 
FV1000 confocal microscope (Germany). TEM images of both empty and MNP-loaded microcapsules 
were obtained using a JEOL JEM-1011 HR instrument operating at 80 kV. Prior to the observation, a 
volume of 60 μL of microcapsule suspension was pipetted onto a transmission electron microscopy 
(TEM) grid and left to evaporate overnight. An Axioimager Z1M Zeiss microscope (Germany) was used to 
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observe (CHI/ALG)3-coated liquefied beads using transmitted light and fluorescence microscopy for 
Rhod-loaded external compartments. The latter also containing FITC-loaded microcapsules were 
observed to assess the distribution of the subcompartments within the macrocapsules. 
11.2.10 Mechanical resistance of the external compartments 
A centrifugal rotation test was performed with the samples suspended in PBS to measure the 
mechanical resistance of the (CHI/ALG)3 macrocapsules. 100 samples were placed in centrifuge tubes 
and rotated at a starting centrifugal load of 500g. After 5 min, the number of intact beads was counted. 
Those that remained intact were submitted to incremental centrifugal loads (500g incremental steps) 
up to a maximum of 5000g. This experiment was performed three times.  
11.2.11 Rhodamine release studies 
The compartmentalized systems were suspended in PBS at either 25 or 37ºC. Prior to this study, Rhod 
was encapsulated in one of two hierarchical locations: the internal (CHI/ELR)3 microcapsules (with 
Rhod added during the co-precipitation stage) or the external liquefied alginate (CHI/ALG)3-coated 
macrocapsules (with Rhod added to the initial alginate solution). The study was conducted for 2 h to 
assess the early release profile in 3 mL of PBS, with 600 μL of surrounding PBS being removed every 
10 min and the container being refilled with the same volume of PBS pre-stabilized at the 
corresponding temperature. 100% of Rhod was considered to be the total mass remaining in the 
compartmental systems after taking construction losses into account. The studies were performed three 
times (n=3). 
11.2.12 Magnetic-based responsiveness 
Macrocapsules containing MNP-loaded microcapsules were suspended in a PBS-filled square 
polystyrene Petri dish placed upon a 1×1 cm2 grid. A 1.3 T permanent neodymium (NdFeB) bar 
magnet (diameter: 4 mm; length: 2.5 cm) was used to apply the external magnetic field. Ten samples 
were placed 3 cm away from the magnet, with the latter placed at a height of 1.4 cm from the PBS 
surface. The movement was recorded on video and the mean normalized distance traversed by the 
samples plotted as a function of time. 
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11.3 Results and discussion 
The conception of a multifunctional compartmentalized device may involve using several ingredients 
from distinct classes of materials, depending on the functionalities desired from a system of this kind, 
and require a huge number of fabrication operations. An illustration of the proposed system is 
illustrated in Figure 11.1. 
 
Figure 11.1. Hierarchical organization of the multicompartmental capsules. Liquefied alginate beads, 
delimited by a (CHI/ALG)3 coating, are visible to the naked eye. Multilayer microcapsules of (CHI/ELR)3 
and molecular compounds can be suspended within the aqueous polymer phase. The former can 
further contain other types of molecular compounds and MNPs. 
 
The borders between compartments consist of multilayer shells with three bilayers for the purpose of 
proof of concept. Our proposition comprises the fabrication of alginate beads by calcium-promoted ionic 
gelation separated from the environment by a multilayer coating of three CHI and ALG layers, 
(CHI/ALG)3, with thickness around 40 nm [39]. Prior to ionic gelation, the microscopic 
subcompartments are suspended in an ALG solution to form beads containing small spherical 
structures. These microcapsules are templated in CaCO3 microspheres and delimited by a coating of 
three CHI and ELR layers, (CHI/ELR)3, with thickness around 25 nm [22]. In the subcompartments we 
encapsulated further components of smaller scales – fluorophores and MNPs. Since the synthesis of 
the CaCO3 templates results from the co-precipitation of equimolar solutions of Na2CO3 and CaCl2, 
various substances can be added to the co-precipitation medium and entrapped within it. After the 
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assembly of all compartments, the inorganic template is removed by treatment with EDTA, which also 
liquefies the alginate bead to a highly viscous medium. The final product is an external macrocapsule 
containing internal microcapsules – henceforth referred to as external (EC) and internal compartments 
(IC), respectively – with each partition being delimited by multilayer membranes. 
To ensure that we could assemble structures from different size scales, the hierarchical organization of 
the proposed system was characterized initially. MNPs, ICs and ECs were observed resorting to distinct 
microscopy techniques and are shown in Figure 11.2. Note that for every experiment performed, ECs 
are always loaded with empty ICs, i.e., without any fluorophore encapsulated, unless otherwise 
specified. Using TEM, the MNPs (Figure 11.2a) were found to have a diameter of about 10 nm which, 
along with the model molecular compounds, represents the smallest scale present in this system. FITC 
was encapsulated within (CHI/ELR)3 microcapsules and could be observed by confocal laser scanning 
microscopy (CLSM) upon removal of the CaCO3 template (Figure 11.2b). We have previously 
constructed multilayer films made of chitosan and ELRs. Characterization of this ELR – amino acid 
sequence, matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF), and differential 
scanning calorimetry (DSC) – which contains a RGD motif, can be found elsewhere.[22,38] 
Although used previously to enhance cell adhesion, the primary reason for using this specific ELR 
herein was to enable LbL construction due to the negative charge provided by the aspartic acids (D), 
with a pKa ranging from 3.0–4.7 [40], thus exploiting the biological function of this sequence was not in 
the scope of this work. The average size of the ICs was 3 μm, what places them at a microscale level. 
The external compartments act as containers where both ICs and molecular compounds can be 
entrapped. Encapsulation of the fluorescent molecule Rhod showed that the (CHI/ALG)3 macrocapsules 
have a diameter of 2 mm (Figure 11.2c) and are therefore representative of the visible scale. 
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Figure 11.2. Scales of hierarchical components. (a) TEM image of MNPs; (b) CLSM image of FITC-
containing (CHI/ELR)3 microcapsules; (c) fluorescence microscopy image of the Rhod-containing 
liquefied ALG bead coated with (CHI/ALG)3. 
 
The proposed formulation contains ingredients that respond to external stimuli. Namely, the polymeric 
constituent ELR is known to respond to temperature, while MNPs to magnetic fields. These properties 
were studied and the results are presented in Figure 11.3. The response to temperature of the 
polymers used herein – CHI, ALG and ELR – was assessed by means of aggregate size measurements 
at 25ºC and 37ºC. In Figure 11.3a, it is shown that the size of ELR aggregates at 25ºC is about 
200 nm. In contrast to this situation, at 37ºC aggregates of around 2000 nm were formed due to the 
temperature transition of ELRs above their Tt (in Supplemental Figure 11.2, the Tt was determined to 
be 29ºC).  
Chapter 11. Multifunctional compartmentalized capsules with a hierarchical organization from the nano- 
to the macro-scales 
 
374 
 
Figure 11.3. Stimuli-responsiveness of the multicompartmental device constituents. (a) aggregate size 
measurements by DLS of CHI (pH 5.5), ALG and ELR (pH 7.4) at 300 µg∙mL-1 for a temperature cycle 
of 25–37–25ºC; (b) magnetization assay of MNPs. 
 
Upon decreasing the temperature to 25ºC once again, it was observed that the aggregate size 
decreases to around 300 nm, confirming that the polypeptide used herein exhibits a reversible 
response towards temperature. Thus, the use of ELRs in such multilayer coatings may mean that the 
permeability of the subcompartments can be tuned simply by switching between room and 
physiological temperatures. As expected, CHI and ALG were not significantly influenced, since they are 
not temperature-responsive. For CHI, the working pH was of 5.5, as the pKa of this polysaccharide is 
around 6. Nonetheless, CHI is not a temperature responsive biomaterial, therefore pH is not expected 
to alter its response to this variable. The use of temperature responsive macromolecules could help in 
controlling the permeability of a carrier coating based on temperature variations, when the release of a 
specific molecular compound needs to be more sustained or pronounced. At the same time, the use of 
CHI and ALG allows herein the assembly of a static coating, i.e. that is not stimuli-responsive under the 
temperature-dependent experimental conditions used further on, used solely for the purpose of 
encapsulating the rest of the components in its interior. 
The other constituent of this system are MNPs. Magnetization measurements with the MNPs are shown 
in Figure 11.3b. Magnetic particles can be classified as ferromagnetic and 
paramagnetic/superparamagnetic. Whereas the former exhibit a permanent magnetic dipole moment, 
with a paramagnetic particle a magnetic dipole moment is induced only when an external magnetic field 
is applied [41-44]. The MNPs showed a saturation magnetization of 40 emu∙g-1 and the typical 
sigmoidal curve of superparamagnetic nanoparticles, thereby confirming their response to magnetic 
fields and potential use for spatial mobilization/immobilization of a host device. In particular, it is known 
Chapter 11 – Multifunctional compartmentalized capsules with a hierarchical organization from the 
nano- to the macro-scales 
 
375 
that the success in therapeutic applications of growth factors often requires a release system for 
delivery with spatiotemporal control [45]. Thus the magnetic component may help achieving a better 
efficacy of the encapsulated agent and reduce losses to surrounding fluids. 
Another important characteristic of these systems is their mechanical resistance. The ECs are visible to 
the naked eye and can therefore easily be handled. However, it is important to determine whether the 
external LbL coating can withstand handling whilst retaining the liquefied ALG. The integrity of the 
(CHI/ALG)3 coating was assessed by submitting the macrocapsules to incremental centrifugal stress. 
Figure 11.4 shows that these macrocapsules can withstand centrifugal stress, with 50% of them 
remaining intact at a rotation speed of 2000g. 
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Figure 11.4. Mechanical resistance of (CHI/ALG)3 macrocapsules, ECs, to incremental centrifugal 
stress, with two standard deviations represented. 
 
At a maximum of 5000g, nearly every macrocapsule was disrupted, with only 5±3% of samples 
remaining intact. The resistance to handling was also assessed by manipulating them using a Pasteur 
micropipette. They can be easily and safely manipulated without disrupting the wall integrity, which is 
an important property when considering not only handling but also transportation or transfer between 
distinct containers, and biological implantation. 
Compartmentalized systems may be useful for entrapping a multitude of molecular compounds with 
tunable permeability. Figure 11.5a shows the distribution of FITC-loaded ICs within an EC, with the 
latter encapsulating Rhod.  
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Figure 11.5. Distribution of the (CHI/ELR)3 ICs within (CHI/ALG)3 ECs by fluorescence microscopy. 
(a) This image was obtained by loading the former with FITC and the latter with Rhod. Separate green 
(b) and red (c) filters are shown. 
 
The separate fluorescent channels are shown (Figure 11.5b and Figure 11.5c). It is clear that the ICs 
are homogeneously distributed in the ALG liquefied medium, showing that a compartmentalized 
structure is definitely conceived. 
To further explore the permeability of the compartments, early release studies were performed by 
loading either the ICs or the ECs with Rhod and plotting the cumulative release of this compound from 
the (CHI/ELR)3 and (CHI/ALG)3 compartments at 25ºC (Figure 11.6a) and 37ºC (Figure 11.6b) as a 
function of time. One important finding from this study was that the release of Rhod encapsulated in the 
ICs was more sustained at 37ºC than at 25ºC (84% and 71%, respectively, after 2 h). This phenomenon 
results from the temperature response of the ELR: at the temperature of 37ºC – above Tt – its transition 
to a more ordered state is triggered and is manifested by the decrease in the shell permeability, an 
effect previously demonstrated for CHI- and ELR-based microcapsules entrapping bovine serum 
albumin (BSA) [46]. Such decreased permeability of the microcapsules can therefore be used as a 
mechanism to control the release of molecular compounds. As such, it could be useful in the field of 
sustained drug-delivery devices for targeting a therapeutic window, micro-reactors confining chemical 
reactions, and sensors for the simultaneous detection of macromolecules or gases by diffusion (in or 
out). It should also be noted that the release of Rhod from the ECs did not change significantly since 
CHI and ALG are not temperature responsive (90% at 25ºC and 92% at 37ºC) 
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Figure 11.6. Kinetics of Rhod release when encapsulated in the internal (CHI/ELR)3 microcapsules 
(□ ) and the external (CHI/ALG)3 compartment (○) at (a) 25ºC and (b) 37ºC for a time, t, of 2 h, with 
two standard deviations represented. Some standard deviations are too small to be distinguished from 
the symbol. 
 
Another important finding was that the release of Rhod from the ICs decreased after an initial burst 
detected at the first time-point. Namely, the Rhod release rate decreased between 10-20 minutes 
(25ºC) and 10–30 minutes (37ºC), with this decrease being more pronounced in the latter case. This 
could be due to the fact that molecules encapsulated within the microcompartmental system have to 
diffuse through the IC coating to the alginate medium and then through the external coating to the 
external environment. This would explain the existence of a time-gap that is not present when Rhod is 
encapsulated within the ECs. Figure 11.7 depicts the proposed mechanism for the initial burst release 
detected in the IC case. 
We hypothesize that this phenomenon results from the release of Rhod by diffusion into the alginate 
medium during construction of the ECs containing Rhod-loaded ICs, mainly at the chelation stage. At 
the start of the release studies, this fraction would behave similarly to the EC case at the first time point, 
with an initial burst similar in magnitude to that of the ECs. The remaining Rhod is released from the 
ICs at a slower rate. In this regard, in Figure 11.5 we had separated the fluorescence channels of FITC 
and Rhod. Indeed, immediately after construction of the multicompartmental device, there is a diffusion 
of FITC throughout the alginate medium, as evidenced by diffuse green zones Figure 11.5b. 
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Figure 11.7. Burst mechanism for Rhod loaded within internal microcompartments. (i) At first, Rhod 
is physically entrapped within CaCO3 templates. (ii) After chelation, a fraction of Rhod is lost and 
quantified. The samples are rinsed to remove the lost fraction. However, another fraction remains free 
within the alginate. (iii) At the start of the release studies, the free Rhod diffuses to the exterior and is 
readily detected. ICs keep releasing Rhod to the alginate medium at a slower rate, and this Rhod is 
detected later in the experiment. 
 
The existence of two release rate constants is consistent with the "double barrier" effect recently 
evidenced by Lecommandoux and co-workers for polymersome-in-polymersome systems [47]. In their 
work, doxorubicin was encapsulated in inner or outer compartments. The fabrication method differed 
from our LbL mechanism: they were fabricated by nanoprecipitation and an emulsion/centrifugation 
process, respectively. They observed lower release kinetics when doxorubicin was encapsulated within 
the internal nanovesicles in comparison to the latter case. 
Theoretically, if such initial burst did not occur, a more prolonged time-gap would be visible from the 
beginning before Rhod from the ICs could be detected. This burst-type release is not necessarily a 
drawback as some applications may benefit from it. For instance, a higher fraction of antibiotics/anti-
inflammatories can be released in the first few minutes after administration when they are most needed, 
with the rest of the load being released subsequently within a therapeutic window. The release of more 
than one molecule from a reservoir with independent and tunable rates may be important in drug 
delivery systems, when the delayed delivery of one active substance with respect to another is desired, 
or to circumvent premature drug leakage [48]. Moreover, tuning the release rate of a molecular species 
could be accomplished further by varying the number of layers of the coating: a substance could diffuse 
through the multilayers with higher release kinetics for thicker coatings, in comparison to a thinner 
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coating [27,46]. Although the primary interest in compartmental devices has focused on systems for 
the delivery of therapeutic molecules, other applications have been proposed in fields ranging from 
actuators to biomaterials for tissue engineering and regenerative medicine [18]. 
The encapsulation method for CaCO3 entrapment was also used to incorporate MNPs within the ICs. 
Figure 11.8a shows MNPs observed by TEM homogeneously distributed within these microcapsules. 
 
 
Figure 11.8. Magnetic characteristics of the multicompartmental system. TEM of a (CHI/ELR)3 
microcapsule (a) containing MNPs and (b) empty. Insets scale: 50 nm. (c) Attraction of (CHI/ALG)3 ECs 
containing MNP-loaded (CHI/ELR)3 ICs by a magnet in a PBS medium. The magnet is placed at a 
height of 1.4 cm on top of a polystyrene cover. The red color is characteristic of the MNPs within the 
hierarchical structure. Squares are 1×1 cm2. 
 
Empty microcapsules were used as a control for MNP-loaded ones. In comparison, Figure 11.8b shows 
empty ICs, where no spherical structure could be detected. As they are empty and the electronic 
density is lower than MNP-containing ICs, the multilayer shell can be discerned, with creases and folds 
which are characteristic of collapsed ultrathin walls due to the drying process. 
In light of our initial findings, we conducted an experiment where MNP-containing ICs were loaded into 
ECs and attracted by a magnet placed at a distance of 3 cm (Figure 11.8c). This strategy adds further 
value to the proposed device in terms of biomimetism. Besides its multicompartmental nature inspired 
by natural cells and self-assembly mechanism of constituents in which the LbL strategy is based upon, 
the use of MNPs can be considered to be a biomimetic approach inspired by unique structures with 
magnetic properties, such as magnetotactic bacteria [49-51]. Magnetic alginate beads have been used 
previously for applications such as water pollution remediation [52] and magnetic hyperthermia-
enhanced doxorubicin release [53], although the magnetic character was not exploited primarily for 
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spatial mobilization. It took 42 s for all the beads to travel this distance and be completely immobilized. 
As soon as the magnetic compartmental units were exposed to the external magnetic field, they 
became attracted to the position at which the maximum magnetic field value was available to them at 
the surface of the PBS medium. As they got closer to the magnet they were exposed to a stronger 
magnetic field and the attraction increased. Movement stopped abruptly once they reached the position 
below where the magnet was placed. The normalized mean distance traveled by MNP-loaded ICs within 
ECs is represented in Supplemental Figure 11.4. This observation shows how the internal 
subcompartments can be customized to possess distinct functions, including distinct types of smart 
responsiveness. Specifically, the entrapment of superparamagnetic nanoparticles within microcapsules 
could be envisaged for applications that require immobilization, such as localized therapies, and 
magnetic resonance imaging. The developed devices should also permit the incorporation of living 
microorganisms and cells inside the EC, as its processing is performed in mild conditions [39]. 
11.4 Conclusion 
In conclusion, we presented a multifunctional system characterized by hierarchical organized spherical 
compartments. We showed that compartmentalized structures delimited by multilayer coatings can be 
customized to exhibit properties that are not found coupled in nature. Although the present work was 
limited to the proof of concept, we envisage that it can be improved in the future. Namely, the 
multilayer organization makes it possible to tune the permeability of the coatings just by changing the 
number of layers. Other stimuli could be coupled together: for instance, temperature, pH or light (e.g., 
from the incorporation of azobenzenes or spiropyrans) could be combined for multifunctional 
biosensors confining reactions. The genetic nature of ELRs further allows synthesizing biofunctional 
polypeptides for advanced applications, such as increased cell adhesion or enhanced biomineralization. 
Cells have been previously encapsulated within alginate beads, but we envision that coupling biological 
material with functionality such as controlled release of growth factors and provision of adhesion sites 
may improve cellular sustained survivability over time. Moreover, the addition of magnetic components 
provides such compartmentalized system potential for biotechnological and biomedical applications 
where spatial immobilization, high local availability of an active agent or monitoring by magnetic 
imaging is required. 
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11.5 Supplemental information 
11.5.1 Deacetylation degree of chitosan. 
Hydrogen-1 nuclear magnetic resonance (1H-NMR) spectra were recorded using a Varian MR-400 
spectrometer to determine the degree of deacetylation (DD) of chitosan. Thus, 10 mg of chitosan was 
dissolved in 1 mL of deuterated water (D2O) and 20 µL of deuterated hydrochloric acid (DCl) to form a 
viscous solution. An aliquot of this solution was placed in a 5 mm NMR tube and the spectrum recorded 
at 60°C. 
The calculation of the DD is presented in Supplemental equation 11.1: 
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where Ix is the area of each of the peaks (x) identified in Supplemental Figure 11.1. The DD of the 
purified chitosan used was 81.6%. 
11.5.2 ELR transition temperature 
The aggregate sizes of ELR in solution were measured using a Nano-ZS from Malvern (United Kingdom) 
in the temperature range 25–37°C after stabilization for 5 min. Samples were prepared at 
300 µg∙mL-1 in PBS, pH 7.4. A total of 20 runs were performed for each sample to obtain an average 
value at stabilized temperature. 
In order to evaluate the thermal response of the featured ELR, the size variations of peptide aggregates 
in aqueous solution were measured as a function of temperature in small increments. It can be seen 
from Supplemental Figure 11.2 that the ELR forms aggregates of 4.4±2.8 nm at 25ºC and 
1290±113 nm at 29ºC. This abrupt size variation gives a Tt of 29ºC for the ELR. ELR self-assembly 
progresses further with increasing temperature 
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Ic = 10.00
Ie = 0.92
 
Supplemental Figure 11.1. 1H-NMR spectrum of the purified chitosan sample, with 10.00 
corresponding to Ic peak and 0.92 to Ie peak. 
. 
 
Supplemental Figure 11.2. Aggregate size proﬁle for a 300 µg∙mL-1 ELR solution in PBS over the 
temperature range, T, of 25–37°C, with two standard deviations represented. 
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11.5.3 Rhodamine encapsulation losses 
The encapsulation efficiency of Rhod in either the inner or the external compartments was determined 
by fluorescence measurements of the retrieved supernatants during their construction using a Synergie 
HT microplate ELISA reader (BioTek, USA). Thus, 150 μL of sample was pipetted into white, opaque 
96-well plates in triplicate. Ultrapure water was used as blank. The excitation (λexc) and emission (λem) 
wavelengths used for Rhod mass calculations were 530 and 590 nm, respectively. All supernatants 
collected during entrapment, construction and chelation stages were measured and quantified. The 
percentage Rhod loss was plotted for both each stage and cumulatively. 
All the supernatants collected during the construction of Rhod-loaded compartments (either internal or 
external ones) were used to calculate the losses occurred prior to the commencement of the actual 
release studies. The graphic in Supplemental Figure 11.3 shows the stage and cumulative Rhod losses 
with respect to the initial encapsulated mass. 
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Supplemental Figure 11.3. Rhodamine losses during the construction of Rhod-loaded 
microcapsules (ICs) within macrocapsules (ECs) and empty microcapsules within Rhod-loaded 
macrocapsules, with two standard deviations represented. 
 
When Rhod was loaded within the inner compartments, the construction process consisted of four 
stages: (i) entrapment within the CaCO3 particles (orange in the graphic), (ii) buildup of the (CHI/ELR)3 
multilayer (yellow), (iii) buildup of the external (CHI/ALG)3 multilayer (purple), and (iv) simultaneous 
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CaCO3 chelation and alginate bead liquefaction (grey). When Rhod was loaded within the external 
compartments, losses are only present in stages (iii) and (iv), when Rhod is introduced into the system. 
The sacrificial template was maintained until the end of stage (iii) to prevent early diffusion during the 
construction. Thus, Rhod could be protected and physically retained within the sacrificial template until 
the final stage of chelation. 
As mentioned previously, the quantity of Rhod loaded initially differed depending on whether it was 
encapsulated within the internal or the external compartments. As a result, we first quantified the Rhod 
losses during the construction of ECs containing Rhod-loaded ICs and found that 85% of Rhod had been 
lost at the end of the construction, thus meaning that only 15 μg of the initial 100 μg were effectively 
encapsulated at time-point “0”. In an attempt to encapsulate roughly the same mass of fluorophore in 
the ECs, we loaded them with the equivalent quantity of 15 μg of Rhod during the ionic gelation step of 
1 mL of alginate. Note that this value disregards the subsequent loss of 47% that was further quantified 
following liquefaction of the bead. Furthermore, empty CaCO3-coated particles were loaded at the same 
time to keep the same subcompartmental structure. 
11.5.4 Magnetic responsiveness assay 
Figure 11.8c depicted the magnetic responsiveness of the MNP-loaded ICs within ECs. As expected, a 
group of eight compartmental units were attracted by a magnet placed 3 cm away from their starting 
point. The normalized distance traveled by each capsule is plotted as a function of time in 
Supplemental Figure 11.4. 
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Supplemental Figure 11.4. Normalized mean distance, d  in arbitrary units, traveled by MNP-loaded 
ICs within ECs as a function of time, t, from their starting point to the point of the highest magnetic field 
value available. 
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As soon as the magnetic compartmental units were exposed to the external magnetic field, they 
became attracted to it. Subsequently they were exposed to an increasingly stronger magnetic field value 
and the attraction increased. Movement stopped abruptly once they reached the position at which the 
maximum magnetic field value was available to them. 
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 Chapter 12. Major conclusions and future perspectives 
The surface modification technique known as layer-by-layer (LbL) was employed successfully in 
accordance to the hypothesis of this thesis. Various substrates – both planar and three-dimensional – 
were coated with natural or biomimetic polymeric constituents distinct in functionality but sharing 
natural roots. It was then possible to develop multilayer devices intended for a wide range of biomedical 
applications, namely adhesive films, coatings for biomaterials, drug delivery carriers – for delivery either 
by drug diffusion or by cellular uptake – and microreactors with customizable properties. 
First, it was demonstrated that multilayer films can retain and exhibit the properties of their natural 
constituents. A phosphonate derivative of levan, a fructose polymer obtained from extremophilic 
microorganisms, allowed fabricating multilayer films with chitosan (CHI) that exhibited superior 
adhesive properties in comparison to a multilayer formulation of CHI and alginate (ALG) – two 
polysaccharides of marine origin widely regarded as good adhesive ingredients. The advantage of using 
levan was also evident by the superior cell adhesion to films containing this polymer, in comparison to 
CHI/ALG films. Future developments of levan-functionalized multilayer films may include tests using 
actual animal tissues to further evaluate their potential as wound healing coatings and tissue sealants 
for post-surgical procedures. 
Elastin-like recombinamers (ELRs) were used as a polypeptide constituent of most multilayer 
formulations presented herein. Its genetic origin, rooted in natural elastin, allowed using constituents 
exhibiting a precise amino acid content, sequence, length, and, most importantly, bioactivity. By using 
an ELR containing the bioactive sequence arginine-glycine-aspartic acid (RGD), substrates with 
enhanced cell adhesion were made. Given the multiple stimuli-responsive nature of ELRs, it was 
demonstrated that, like in the case of levan, films containing these polypeptides also retained such 
responsiveness, namely toward temperature, pH and ionic strength. Raising any of these parameters 
above an upper threshold triggered the transition of the ELR adsorbed at the surface, leading it to 
exhibit charged amino acids toward the interface. This phenomenon was translated by an increase of 
hydrophilicity and surface roughness. 
The buildup feasibility of this ELR-RGD with CHI in a multilayer structure was monitored in situ using a 
quartz-crystal microbalance (QCM). Although a construction based on strong electrostatic interactions 
was first anticipated, there was evidence that weaker hydrophobic interactions could play an important 
role in this process between polysaccharides and polypeptide-based polymers. Resorting to the QCM 
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and the mathematical Voigt-based model for viscoelastic films, several distinct ELRs were combined 
with either CHI or ALG for the construction of hybrid films at distinct values of pH. The estimation of 
each of the films’ thicknesses led to the conclusion that not only electrostatic but also hydrophobic 
interactions drive the self-assembly of this type of multilayer films, judging by how thicker films could be 
obtained when using partially neutralized polysaccharides. This result provides a consistent basis to the 
development of future devices based on this class of coatings by ensuring that the best construction 
parameters are used in order to achieve thick films across various scales – nano to micro – and 
stability. 
LbL extrapolation to 3D was successful in the form of spherical microcapsules of CHI and ELR for the 
purpose of drug delivery, envisaging two forms of administration. The first consisted in the 
pre-encapsulation of a high molecular weight protein, bovine serum albumin (BSA), within the 
microcapsules and its release by diffusion under distinct temperatures. It was demonstrated that the 
permeability of the multilayer shell was dependent on the temperature and on the number of layers. 
Thanks to the incorporation of ELRs in the multilayer formulation, its temperature-triggered phase 
transition led the microcapsules to be more retentive at physiological than at room temperature, a 
phenomenon also accompanied by a significant shrinkage of the capsular structures. As expected, a 
higher number of coating layers also provided a more effective barrier to the diffusion of the 
encapsulated agent. The reduced release rate verified at physiological temperature may help in the 
delivery of active agents (e.g., chemotherapeutics) that are necessary locally in small but controlled 
doses, i.e., within a therapeutic window. Varying the number of layers provided an additional means of 
control over the release kinetics, what helps further to achieve an appropriate drug release and 
bioactivity. Future developments may investigate the potential use of these carriers for the delivery of 
active agents instead of model proteins for a wide spectrum of molecular weights. Ideally, these should 
be studied under sink conditions, which ensure that the release medium is not saturated by drug so 
that its release is controlled solely by the delivery system and is not affected by its solubility. 
The second mechanism consisted in the delivery of microcapsules directly to the interior of the cells, 
where the whole cellular machinery is located. Using RGD- and RDG-functionalized microcapsules (with 
the latter being a nonfunctional analogue of the former) it was possible to determine that the 
mechanism of internalization of these capsules by human mesenchymal stem cells (hMSCs) was due 
majorly to a mechanism of macropinocytosis and not due to the surface functionalization. This is an 
important mechanism of drug delivery since the delivery of drug carriers directly to the cells diminishes 
potential active agent losses to the extracellular environment by diffusion. Furthermore, drugs may be 
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delivered to where they are most needed, ensuring a high drug availability and efficacy. However, the 
intracellular degradation – hence potential drug availability – was faster for RGD-functionalized 
microcapsules. Future experiments may focus on determining the mechanism behind the distinct 
intracellular processing rates, which seemed dependent on the surface functionalization of the 
microcapsules. Furthermore, growth factors and other differentiation agents may be encapsulated to 
exploit stem cell differentiation mechanisms dependent on controllable dosages and carrier size. 
Finally, it was shown that LbL allows achieving higher levels of functionalization, difficult to achieve 
using the most conventional surface modification strategies. Macrocapsules observable with a naked 
eye were delimited by CHI/ALG multilayers. This macrodevice exhibited compartmentalization and 
hierarchical organization from the nano- to the macro-scales. ELR-functionalized microcapsules served 
as microcompartments suspended within a confined ALG liquefied environment. The microcapsules 
could be loaded with magnetic nanoparticles, which provided the possibility to guide spatially the whole 
compartmentalized structure by applying an external magnetic field, which could be useful in 
applications that require mobilization to and immobilization at a site (e.g., guided therapies). 
Compartmentalization was exploited to encapsulate rhodamine as a model low molecular weight 
molecule either in the interior of the microcapsules or in the ALG medium. Release studies at distinct 
temperatures showed that rhodamine when encapsulated in the microcapsules was released at a lower 
rate at physiological temperature, thanks to the use of ELRs. When encapsulated in the ALG 
compartment, the release kinetics was not significantly affected. Incorporating distinct functions in a 
same system by carefully selecting its constituents lets foresee the construction of customizable 
microreactors that may exhibit other types of response, for instance, toward temperature, pH or light. 
Such a device could also be used as a platform for the development of microenvironments that 
simulate the formation of microtissues or the treatment of diseases at a laboratorial level. 
The work developed herein shows how LbL-based strategies have surpassed the simple purpose of 
modifying a surface. From the results obtained in each of the chapters of this thesis, it is clear that LbL 
permits to achieve high degrees of functionalization and complexity, both in bioactivity and geometry, 
for various distinct biomedical applications. Despite the potential of LbL, this technology has been 
limited to the fabrication of bidimensional devices – some already in medical use. Thus, it is expected 
that the superior functionalization may result in the development of strategies useful not only for 
conventional medical applications but also more cutting-edge ones in biomedical engineering, such as 
tissue engineering. 
 
